Datasets:

ZixuanKe

/

nickmuchi-trade-the-event

like 0

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CAPE CANAVERAL AIR FORCE STATION,Fla., May 14, 2020 /PRNewswire/ --A United Launch Alliance(ULA) Atlas V 501 rocket is scheduled to launch the USSF-7 mission for the U.S. Space Force from Space Launch Complex-41 on May 16, 8:24 a.m. EDT. This mission is a collaborative salute to honor front-line responders and those affected by COVID-19. This launch will mark the sixth flight of the X-37B Orbital Test Vehicle (OTV-6) and the second mission for the U.S. Space Force. \"Despite unprecedented circumstances, we continue to launch critical missions,\" said Gary Wentz, ULA vice president of Government and Commercial Programs. \"We are honored to partner with the U.S. Space Force and Air Force to recognize healthcare workers, first responders and other essential personnel affected by the COVID-19 pandemic.\" Along with OTV-6, the mission will deploy FalconSat-8, a small satellite developed by the U.S. Air Force Academy and sponsored by the Air Force Research Laboratory (AFRL) to conduct experiments on orbit. The mission also carries two NASA experiments, including a material sample plate to determine the results of radiation and other space effects on various materials. Another NASA experiment will assess space effects on seeds used to grow food. Another experiment sponsored the Naval Research Laboratory will examine the ability to transform solar power into radio frequency microwave energy which could be transmitted to the ground. An Atlas V 501 configuration rocket, which includes a 5-meter-diameter payload fairing, will launch the USSF-7 mission. The Atlas booster for this mission is powered by the RD AMROSS RD-180 engine, and the Centaur upper stage is powered by the Aerojet Rocketdyne RL10C-1 engine. This will be the 84th launch of an Atlas V rocket and the seventh launch of the 501 configuration. The Atlas V 501 has been used exclusively for national security missions. To date ULA has a track record of 100 percent mission success with 138 successful launches. With more than a century of combined heritage, ULA is the worlds most experienced and reliable launch service provider. ULA has successfullylaunched more than 135 missionsto orbit that provide Earth observation capabilities, enable global communications, unlock the mysteries of our solar system, and support life-saving technology. For more information on ULA, visit the ULA website at www.ulalaunch.com, or call the ULA Launch Hotline at 1-877-ULA-4321 (852-4321). Join the conversation at www.facebook.com/ulalaunch, twitter.com/ulalaunchand instagram.com/ulalaunch. SOURCE United Launch Alliance Related Links https://www.ulalaunch.com", "role": "user" }, { "content": "United Launch Alliance Set to Launch the Sixth Orbital Test Vehicle for the U.S. Space Force Mission dedicated to front-line responders and those affected by COVID-19", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: FULLERTON, Calif., Nov. 30, 2020 /PRNewswire/ -- Milton Security, a global leader in Cybersecurity who offers true Extended Detection & Response (XDR) and Managed Detection & Response (MDR) today announced the release of the Milton Argos Platform 2.0 (MAP). MAP uses the best of Artificial Intelligence/Machine Learning and human expertise. \"We have grown to call this 'AI Assisted Threat Hunting',\" said James McMurry, CEO and Founder of Milton Security. \"This truly hybrid approach with Milton's cutting edge AI & ML technology supporting our operations, allows our Threat Hunters to be the best at what they are uniquely qualified for: detect, deter and mitigate threats in real time,\" said McMurry. \"In response to the growing security skills gap and attacker trends, extended detection and response (XDR) tools, machine learning (ML), and automation capability are emerging to improve security operations productivity and detection accuracy.\" Gartner \"As MAP is capable of analyzing millions of events per second, coupled with 'AI Assisted Threat Hunting', we are able to uncover even the most subtle of IoC's, leveraging intelligence from a wide variety of sources,\" said Ethan Coulter, President of Milton Security. \"MAP allows us to serve our customers in any vertical efficiently and effectively.\" \"Ingesting and analyzing over 250 billion events per month, MAP has proven its ability to scale. As an example, in November we were able to stop thousands of attacks, including ransomware attacks against critical infrastructure,\" said McMurry. \"Every day, we hear of large attacks against schools, city governments, and critical infrastructure. These types of ransomware attacks, if not detected and mitigated in the initial phases, can literally wipe out a complete network. Our team using MAP can mitigate, and reduce the Time To Detect.\" The benefits of using the Milton Argos Platform 2.0 include Live Threat Hunting : Unleash the full potential from your existing security telemetrySecurity Monitoring : Boost eyes on glass coverageIncident Response : Decrease time to remediation.Threat Anticipation : Our enriched Intelligence feeds help us anticipate potential threats that are unique to your business 2020 has been a tumultuous year, both economically and from a threat actor activity perspective. Throughout this year, Milton has maintained its track record as a primary partner for high profile organizations and government entities to keep their assets secure. Milton Security was recently awarded a multi-year, multi-million dollar contract to protect a government agency, winning over dozens of other firms. About Milton Security, Inc.: Milton Security operates a 24*7*365 a unique Extended Detection & Response (XDR) and Managed Detection & Response (MDR) service that provides Threat Hunting As A Service using customers' existing security infrastructure. Using a combination of AI, ML, and Human Correlation, Milton Threat Hunters scout for threats and assists with incident response activities in real time 24 hours a day. Eat. Sleep. Cyber. Repeat. Milton Security, Inc., is a Service Disabled Veteran Owned Small Business started in 2007. www.miltonsecurity.com | +1.888.714.9001 | [emailprotected] Media contact:Lydia Coulter[emailprotected]714-515-4011 SOURCE Milton Security, Inc. Related Links http://www.miltonsecurity.com", "role": "user" }, { "content": "Milton Security Releases Map 2.0 to Detect and Mitigate Ransomware Attacks", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BOSTON--(BUSINESS WIRE)--LifeYield LLC today announces several software updates for its enterprise and direct to advisor clients to aid in quantifying and improving investor outcomes for investor household portfolios, and advisor practice management effectiveness and efficiency. LifeYields API library, which serves the largest wealth management platforms in the world, has enhanced its multi-account and product overlay capabilities at client firms to guide action based on a bird's eye view of an investors household portfolio. These enhancements make it easy for LifeYields enterprise partners to coordinate multiple, complex accounts and trading systems to create improved investor outcomes where client financial benefits can be quantified in dollars and cents. For advisor clients, LifeYield has made many upgrades to its LifeYield Advantage Suite to help advisors engage website visitors, win new business and earn greater wallet share by showcasing improved after-tax returns and income. Greater Enterprise Support For Complex Households Comprehensive Household Management, or Householding, is the concept at the core of LifeYields offering where data is aggregated and coordinated across the entire household of client accounts to improve investor and advisor outcomes. Householding enables long-term asset allocation and tax-smart asset location to be optimized, as the portfolio is managed and rebalanced across all accounts over time. The objective is to maximize retirement income during the accumulation, ongoing management and drawdown phases of a clients life. LifeYields updated API catalog of overlay capabilities gives enterprise partners the flexibility to coordinate and optimize the tax efficiency of multiple accounts, no matter how complex. LifeYields partners can easily apply LifeYields householding technology to investor accounts requiring a mixture of order management systems, whether they are managed, models, or traded with discretion. The API updates also make it easier for enterprise partners to further enhance retirement income through tax-smart, multi-account withdrawals from taxable, tax-free and tax-deferred accounts. Our enterprise partners can now offer a household portfolio management ecosystem producing better results for investors and advisors. Our enhanced API capabilities give them greater freedom to use our tax efficiency software in a way that improves the user experience, and in dealing with existing trading technology. Most importantly, the enhancements help quantify the financial benefits while showing the client how to achieve those improvements on a step by step basis. This, in turn, produces better outcomes for the advisor, said Steve Zuschin, executive vice president, Advisor Success. LifeYield Advantage Suite Enhancements For Advisors LifeYields Advantage Suite serves independent advisors and RIAs. New upgrades have transformed LifeYields cloud-based, household management solution by upgrading the analysis and reporting capabilities of its software and by offering tools to grow an advisors book of business. Expanded Annuity Analysis LifeYields updates reveal new opportunities to enhance investors retirement income and start important conversations about financial goals. LifeYield can now measure the dollars-and-cents benefits and tax implications of any annuity vehicle as it is incorporated into a household portfolio, showing how annuities could improve a clients after-tax rate of return and the overall household portfolio tax efficiency. Modern annuities are designed to work best as part of a households portfolio to meet retirement income needs. LifeYields technology paves the way for a simple, transparent dialogue about how to coordinate investment and annuity vehicles to aid clients in reaching their goals. This new feature helps determine how much of the clients assets should be moved into an annuity, and the financial benefits of the decision. Placing the Advisors Value Front and Center Many clients hold assets with different advisors and custodians, such as in 401(k)s, bank accounts, and other external accounts. Upgrades to LifeYields analysis and reporting can help the advisor provide guidance on the investors overall tax efficiency, while enhancing the advisors ability to grow their business. LifeYield now considers held away accounts and shows the client how those assets would benefit from coordinated, household-level tax optimization. When considering an IRA rollover, this creates a direct, potent appeal for investors to consolidate with a LifeYield user, as they can immediately see a projection of the extra potential retirement income they would realize as a result of the consolidation. Additional new outputs include a Proposal report to show prospects the benefits of tax optimization; a direct Client Review report to illustrate an investors asset allocation and progress; and a more intuitive Social Security report, designed to display benefits and drive action. Reporting enhancements coincide with new, website-ready widgets, as digital prospecting efforts become a top priority for growing advisory firms. Advisors can immediately show the bottom-line value they can add to an investors retirement income. These digital marketing tools are now available for LifeYield partners to embed into their websites to convert web traffic. One calculator computes an estimate of extra income that could be earned through optimizing for asset location. Another calculator estimates the added retirement income clients and prospects could receive by working with an advisor using LifeYields Social Security Advantage optimizer. Householding technology has taken on new relevance this year as a way for advisors to maximize the value of the things under their complete control, such as cost, risk, tax efficiency and how to maximize their Social Security benefits, Zuschin said. With these enhancements, advisors can easily show prospects what they can accomplish together and explore a greater range of retirement income solutions and their quantified impact on client portfolios. To learn more about the latest updates to LifeYields technology, click here. About LifeYield LifeYield, the financial services leader in household-level management, helps advisors maximize retirement income for clients. From accumulation through withdrawal, the LifeYield Advantage Suite uses the industry-leading Taxficient Score to illustrate tax efficiency and improve asset location across IRAs, 401(k)s and taxable accounts to boost client returns. Its intuitive Social Security Advantage software helps over 80,000 advisors plan optimal retirement income strategies and filing benefits for clients as they approach retirement. LifeYields software is integrated with the largest wealth management, RIA, insurance, asset management and fintech providers. For more information, please visit www.lifeyield.com and follow the company at @lifeyield.", "role": "user" }, { "content": "LifeYield Upgrades Tools for Advisors and Enterprise Clients to Command Greater Wallet Share and New Business Householding tech leader expands API support for complex accounts alongside improved advisor reporting and annuity analysis", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Elastic (NYSE: ESTC) (Elastic), the company behind Elasticsearch and the Elastic Stack, announced that Janesh Moorjani, Elastic's chief financial officer, will present at the following investor conferences. A live webcast and replay of the event will be available on Elastics Investor Relations page at ir.elastic.co. About Elastic Elastic is a search company built on a free and open heritage. Anyone can use Elastic products and solutions to get started quickly and frictionlessly. Elastic offers three solutions for enterprise search, observability, and security, built on one technology stack that can be deployed anywhere. From finding documents to monitoring infrastructure to hunting for threats, Elastic makes data usable in real time and at scale. Founded in 2012, Elastic is a distributed company with Elasticians around the globe. Learn more at elastic.co. Elastic and associated marks are trademarks or registered trademarks of Elastic N.V. and its subsidiaries. All other company and product names may be trademarks of their respective owners.", "role": "user" }, { "content": "Elastic to Present in Upcoming Investor Conferences", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: JACKSON, Wyo., Jan. 27, 2021 /PRNewswire/ --Prime Movers Lab an investor in breakthrough scientific startups that will revolutionize the world's most important industries and transform billions of lives today announced it has raised $245 million for its second early-stage investment fund. Prime Movers Lab Fund II will invest in early-stage companies reinventing human augmentation, energy, transportation, infrastructure, manufacturing and agriculture. The firm's first fund, Prime Movers Lab Fund I, a $100 million investment fund, is supporting, among other innovations, advancing sustainable food production, ending the global pandemic, providing clean energy and pioneering space infrastructure. Fund I is one of the leading early-stage funds launched in 2018 and includes several innovative companies planning to go public in 2021. \"Given the extraordinary performance of our first fund, we are thrilled to announce our second fund backed by world-class limited partners including Bill Ackman, the Lerner family office, the University of Wyoming, Dmitry Balyasny, Joe Lonsdale, and dozens of other leading institutions, families and entrepreneurs,\" said Prime Movers Lab founder and general partner Dakin Sloss. \"Like we did with our first fund, our second fund will back breakthrough scientific innovations to further build upon important advancements taking place across the 18 areas of scientific-driven commercial disruption where we are focused.\" Prime Movers Lab takes a diversified approach and is focused on areas of rapid innovation that include human longevity, cognition and enhancement; solar, nuclear and energy storage; space, aviation and autonomous transportation; water, building and communication infrastructure; robotics, 3D printing and semiconductors; farming, engineered food and synthetic biology. Prime Movers Lab's diversified approach across multiple verticals and startups allows for both investor success and for revolutionary innovation with mass commercial purpose to reach beyond the lab. For its Fund I, Prime Movers Lab investments include positions in a diverse portfolio of companies such as Momentus (in-space infrastructure), Heliogen (industrial solar heat), Covaxx (coronavirus vaccine), and Upward Farms (aquaponics indoor vertical farming). Momentus has already announced its public exchange listing through a planned SPAC merger, today listed on the NASDAQ exchange under the ticker: SRAC. \"At Prime Movers Lab, we remain fully focused on identifying technologies with unlimited upside and then making sure we bring resources to the table to ensure startup companies can commercialize, grow and succeed as transformative ongoing businesses,\" said Prime Movers Lab General Partner Brandon Simmons. \"There are a lot of people who provide money and not much else. But our team delivers what entrepreneurs truly need to succeed in their missions to transform billions of lives.\" Prime Movers Lab takes pride in its founder-friendly approach, supporting startup entrepreneurs in their journeyswell beyond providing the useful capital needed to grow. Prime Movers Lab is rooted in real partnership and works hand in hand with each entrepreneuras trusted advisors to make hires, close customers, set strategy and build the company. This includes offeringentrepreneurial-minded leaders comprehensive resources and integrated coaching to support the transformation of world-class technical experts into extraordinary executives. The Prime Movers Lab teamhas developed in-depth academic scientific research, commercialized novel scientific intellectual property, scaled significant enterprises, and mentored renowned scientists on their entrepreneurial journeys. As a result, Prime Movers Lab has quickly become the leading choice for startup company founders who are on a mission to do two things: commercialize breakthrough science and serve humanity. Prime Movers Lab partners Sloss, Simmons and Suzanne Fletcher, who previously worked with hundreds of entrepreneurs while managing the Stanford StartX Fund, help shepherd dozens of scientifically and community-minded entrepreneurial founders.Additional partners include the nation's No. 1 business strategist Tony Robbins and former CEO of Asseta Anton Brevde. The team also includes numerous scientists such as Principal Systems Engineer Dan Slomski and Principal Chemical Engineer Carly Anderson, along with a network of world-leading subject-matter experts ready to convey their many decades of accumulated scientific and business knowledge and experience. \"Prime Movers Lab partners are brilliant business strategists and our most valuable thought partners (a function of equal parts intellect and openness),\" said founder and CEO of Upward Farms Jason Green. \"They are the only investors with whom we conduct and benefit from weekly conversations and always act in service to our company. The firm is stacked with talent design, engineering, executive coaching and more. Beyond just being capital partners, Prime Movers Lab truly stands out as a cross-functional agency that is a force multiplier for our own talent.\" Mei Mei Hu, founder and CEO of Covaxx shared similar sentiments.\"The team is a group of superhero troubleshooters and offers untold amounts of strategic insight, support and engagement,\" Hu said. \"We have built numerous companies and have never had such a thoughtful, connected and invested partner. Prime Movers Lab is a truly different type of investor and an invaluable partner.\" About Prime Movers Lab Prime Movers Lab invests in breakthrough scientific startups founded by Prime Movers, the inventors who transform billions of lives. We invest in early-stage companies reinventing human augmentation, energy, transportation, infrastructure, manufacturing, and agriculture. Our team is dedicated to supporting entrepreneurs in their mission to commercialize breakthrough science and serve humanity. For more information, visit: www.primemoverslab.com. Media Contact: Jami Schlicher JConnelly 973-647-0655 [emailprotected] SOURCE Prime Movers Lab Related Links http://www.primemoverslab.com", "role": "user" }, { "content": "Prime Movers Lab Launches Second Scientific Startup Fund Investment Fund Raises $245MM to Support Dozens of Breakthrough Scientific Disruptors Ready to Transform Billions of Lives", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: RICHMOND, Va., April 6, 2021 /PRNewswire/ --Dominion Energy, Inc. (NYSE: D) will host its first-quarter 2021 earnings call at 10 a.m. ET on Tuesday, May 4, 2021. Management will discuss matters of interest to financial and other stakeholders including recent financial results. A live webcast of the conference call, including accompanying slides and other financial information, will be available on the investor information pages at investors.dominionenergy.com. For individuals that prefer to join via telephone, domestic callers should dial 1-800-341-6228 and international callers should dial 1-334-777-6993. The passcode for the telephonic earnings call is 46791738#. Participants should dial in 10 to 15 minutes prior to the scheduled start time. A replay of the webcast will be available on the investor information pages by the end of the day May 4. A telephonic replay of the earnings call will be available beginning at about 1 p.m. ET on May 4. Domestic callers may access the recording by dialing 1-877-919-4059. International callers should dial 1-334-323-0140. The PIN for the replay is 38488843. About Dominion EnergyMore than 7 million customers in 16 statesenergize their homes and businesses with electricity or natural gas from Dominion Energy (NYSE: D), headquartered inRichmond, Va.The company is committed to sustainable, reliable, affordable and safe energyand to achieving net zero carbon dioxide and methane emissions from its power generation and gas infrastructure operations by 2050.Please visit DominionEnergy.comto learn more. SOURCE Dominion Energy Related Links http://www.dominionenergy.com", "role": "user" }, { "content": "Dominion Energy Schedules First-Quarter 2021 Earnings Call", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SANTA ANA, Calif., Dec. 22, 2020 /PRNewswire/ -- Why is the Honest Globe Facility Expanding?Considering the speed of blossoming new partnerships, we are re-establishing our foundation to satisfy expanding demand. The new Honest Globe manufacturing facility has more space and an even better allocation of resources to support these new opportunities. ... allows for scalability, since we are able to fulfill more orders without adding further operational costs. Tweet this What Does This Mean for Honest Globe? This facility expansion is a massive sign of growth and scale for Honest Globe. We have the available resources to reach out and educate more future customers about all-natural and hemp-related products that honor our connection to nature. How Specifically? By creating space for even more automated equipment, we are capable of producing even more premium plant-based products. Because we were able to build out our customized facility, it fits our needs perfectly and more efficiently than ever before. More customers means a greater scope of awareness about our mission and the presumed customer benefits of Honest Globe products.The improved system allows for scalability, since we are able to fulfill more orders without adding further operational costs. What If You Place an Order Now?We are even more prepared to fulfill your increasing orders from our new manufacturing facility! Order Elixicure here or inquire about other Honest Globe brands here. About Honest Globe Inc & Elixicure:Elixicure All Natural Pain Relief is manufactured by Honest Globe Inc., developers of Over-The-Counter (OTC), luxury cosmetic, health and beauty products. The company's products are made with naturally derived ingredients, using certified industry-standard Good Manufacturing Practices (GMPs).Elixicure and Honest Globe comply with the most rigid standards set by the FDA, which established GMPs for the Food, Beverage, Drug, Cosmetic, Medical Device and Supplement industries. GMP Guidelines outline and identify minimum operating and testing requirements and standards that manufacturers must meet to ensure products are consistent in quality from batch to batch and safe for human use or consumption.\"We believe in honoring our connection to nature. Our vision is to improve the quality of peoples' lives by creating high-quality effective plant-based products.\" -Eyal Kotler, CEOFor more information visit https://honestglobe.com/SOURCE Honest Globe Related Links http://honestglobe.com/", "role": "user" }, { "content": "Honest Globe Expanding Facility and Manufacturing Capabilities", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONGVIEW, Texas, Oct. 19, 2020 /PRNewswire/ -- Texas Super Lawyers honors five attorneys from trial firm Ward, Smith & Hill in the 2020 edition of its top Texas attorneys listing. An honoree since 2003, firm founder Johnny Ward has been recognized for his work in intellectual property litigation and included among the Top 100 attorneys in Dallas-Fort Worth. Name partner Wesley Hill, Of Counsel T. John Ward and partner Chad Everingham also earned honors for their representation of clients in intellectual property litigation, with name partner Bruce Smith earning recognition for his expertise working with plaintiffs in personal injury disputes. Thomson Reuters publishes the annual list in the November editions of Texas Monthly and Super Lawyers magazines. Texas Super Lawyers highlights the state's top attorneys after a rigorous selection process based on peer nominations and extensive editorial research is completed. The full list is available at http://www.superlawyers.com. Ward, Smith & Hill has received multiple honors for its intellectual property and patent litigation expertise, including recognition in Texas Rising Stars, The Best Lawyers in America and the prestigious legal guideIAM Patent 1000 The World's Leading Patent Professionals, which features top global patent law firms. Longview, Texas-based Ward, Smith & Hill, PLLC, has tried more than 350 cases to verdict, earning a national reputation in high-stakes claims involving complex commercial litigation, intellectual property law, oil and gas matters, bad faith insurance claims, and serious personal injury claims. The firm frequently assists lawyers nationwide in complex cases before Texas juries. To learn more about the firm, visit http://www.wsfirm.com. Media Contact:Sophia Reza214-559-4630[emailprotected] SOURCE Ward, Smith & Hill, PLLC Related Links https://wsfirm.com", "role": "user" }, { "content": "Five Ward, Smith & Hill Attorneys Honored in 2020 Texas Super Lawyers Listing Founder Johnny Ward named to Top 100 in Dallas-Fort Worth for intellectual property litigation", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--American Express Company (NYSE: AXP) today announced that Lisa W. Wardell, Chairman and Chief Executive Officer of Adtalem Global Education Inc., has been elected to its Board of Directors, effective March 8, 2021. Ms. Wardell will also join the Boards Risk Committee. Lisa has extensive experience leading large-scale business transformations, and successfully executing portfolio repositionings in the financial services sector through strategic partnerships, business development and mergers and acquisitions, said Stephen J. Squeri, Chairman and Chief Executive Officer of American Express. She also brings her strong expertise in implementing and advancing diversity at global companies, along with her prior regulatory and investment experience, all of which will be key assets for our Board. Ms. Wardell has served as President and CEO of Adtalem, a leading provider of workforce solutions and educational services since 2016, and was elected Chairman of the Board in 2019. Ms. Wardell has led the acquisition and integration of companies in Adtalems financial services vertical, including ACAMS, the largest membership organization for Anti-Financial Crime professionals globally, as well as the turnaround and sale of Adtalems non-core assets. She has also focused the company on enhancing the diverse representation of its senior leadership and Board. Prior to Adtalem, Ms. Wardell was Executive Vice President and Chief Operating Officer of The RLJ Companies, a strategic investment firm, where she was responsible for strategic partnerships, mergers and acquisitions, business strategy, operations and finance. She previously served as a principal at private-equity firm Katalyst Venture Partners, which invested in technology start-up companies; was a senior consultant in Accentures communications and technology strategic services practice; and served as an attorney in the commercial wireless division of the Federal Communications Commission. Ms. Wardell currently serves on the boards of Lowes Companies Inc. and THINK450, the innovation and business development arm of the National Basketball Players Association. She is also a member of the Executive Committee of The Business Council, The Executive Leadership Council, and CEO Action for Diversity and Inclusion. She was named by Black Enterprise magazine as one of the 300 Most Powerful Executives in Corporate America in 2017 and has been featured on CNBC as well as in The Wall Street Journal, Washington Post, Business Insider and other publications. Ms. Wardell received a bachelors degree from Vassar College and a law degree from Stanford University. She received an MBA from the University of Pennsylvanias Wharton School of Business. ABOUT AMERICAN EXPRESS American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. Learn more at americanexpress.com and connect with us on facebook.com/americanexpress, instagram.com/americanexpress, linkedin.com/company/american-express, twitter.com/americanexpress, and youtube.com/americanexpress. Key links to products, services and corporate responsibility information: charge and credit cards, business credit cards, travel services, gift cards, prepaid cards, merchant services, Accertify, InAuth, corporate card, business travel, and corporate responsibility. Source: American Express Company Location: Global", "role": "user" }, { "content": "American Express Elects Lisa W. Wardell to Board of Directors", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ATLANTA, April 27, 2021 /PRNewswire/ -- Supersapiens announces a $13.5 million capital raise led by MICA Ventures AG. The new energy management ecosystem, powered by Abbott's Libre Sense Glucose Sport Biosensor, has secured the largest investment in thesports continuous glucose monitoring (CGM) space, garnering investment from preeminent fitness and performance brands including the founder of Zwift and Wahoo. Supersapiens Closes $13.5 Million in Early-Stage Funding Joining lead investor Michael Hartweg, founder of MICA Ventures AG, is Ed Baker, former VP of product and growth at Uber and head of international growth at Facebook, Harvey Schwartz, former co-president and CFO of Goldman Sachs, Rmi Duchemin, co-founder of OC Sport, and Eric Min, founder and CEO of Zwift. Supersapiens also attracted global investment from CM Ventures, Rubix Ventures, Swiss Startup Group, and Wahoo Fitness. \"Sports continuous glucose monitoring (CGM) is an absolute game changer for all athletes. This is the beginning of a massive performance revolution,\" said Hartweg, founder of MICA Ventures AG. The Supersapiens ecosystem, powered by Abbott Libre Sense, empowers athletes to optimize fueling, maximize training time, and can help increase performance gains. Its data interpretation tools represent the future of fueling and sports performance. \"I have been using glucose as a proxy for performance for the past 33 years. As an athlete, I am intimately aware of the impact glucose has on the ability to achieve your goals. It gives me a great sense of pride to now bring this knowledge to the world, as there is no better tool for visualizing your training and recovery than sport CGM. With a global backing from industry moguls and visionaries like Eric Min, we're turning Supersapiens into a key system that no athlete will train without,\" said Phil Southerland, founder and CEO of Supersapiens.Supersapiens' partnership with global healthcare leader, Abbott, makes it the only energy management ecosystem that directly integrates with a Bluetooth-enabled CGM for sports the Abbott Libre Sense Glucose Sport Biosensor. This strategic partnership allows Supersapiens to scale quickly and, more importantly, offers athletes access to truly meaningful glucose data minute-by-minute fuel levels live-streamed directly to their personalized device. In its first 12 weeks on the market, Supersapiens has more than 2,000 paying athletes on their system, positioning them as the global leader in energy management for sports. Since their launch in late 2020, their prominence has increased significantly. Supersapiens is working on their first hardware product, a wrist wearable called the Supersapiens Reader Version Zero, which will allow athletes to see their live-streaming fuel data with a quick glance. The device will allow athletes using it to become the first to build a full training and coaching ecosystem around CGM for sports performance.\"Once athletes have minute-by-minute fuel data right during a workout, they can quickly identify the correlation between their glucose levels and performance translating more fueled training minutes into bigger performance gains,\" said Todd Furneaux, Supersapiens co-founder and president.The Supersapiens ecosystem powered by Abbott's Libre Sense is now available in Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland, and the United Kingdom. For markets where Supersapiens has yet to be released, athletes can secure their spot on the waitlist. Learn more about the full line of Supersapiens products and purchase Abbott's biosensor at www.supersapiens.com.About SupersapiensSupersapiens is a US-based sports technology company focused on energy management systems to empower athletes to effectively manage in-training fueling to sustain high-intensity work, properly manage glucose levels to maximize recovery, and achieve bigger performance gains.The Abbott Libre Sense Glucose Sport Biosensor is intended for athletes to measure glucose. Athletes are defined as individuals who perform exercise with the purpose of improving wellness and performance. When used with a compatible product, the biosensor allows athletes to correlate their glucose levels and their athletic performance. The biosensor is not intended for use in the diagnosis, treatment, or monitoring of a disease.The Supersapiens ecosystem, including the Abbott Libre Sense Glucose Sport Biosensor, is not yet available for sale in the U.S. For a full list of references and FAQs, please visit our Education Hub and Help Center.Contact: Mark Riedy, [emailprotected], 415-302-2923SOURCE Supersapiens Related Links http://www.supersapiens.com", "role": "user" }, { "content": "Supersapiens Closes $13.5 Million in Early-Stage Funding USA - English Espaa - espaol Deutschland - Deutsch France - Franais Funding from MICA Ventures AG, founder of Zwift, and Wahoo will accelerate global market expansion of the next key fitness wearable", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ATLANTA--(BUSINESS WIRE)--NCR Corporation (NYSE: NCR), a global enterprise technology provider for the banking, retail and hospitality industries, today announced that President and Chief Executive Officer Michael D. Hayford will present to investors at the RBC Capital Markets Technology, Internet, Media and Telecommunications Virtual Conference on Nov. 17, 2020 at 1:20 p.m. Eastern Time. Chief Financial Officer Tim Oliver will present to investors at the Bank of America Leveraged Finance Virtual Conference on Nov. 30, 2020, at 8:15 a.m. Eastern Time. Additionally, Tim Oliver will present to investors at the Wells Fargo Securities Virtual TMT Summit on Dec. 1, 2020 at 1:20 p.m. Eastern Time. A live webcast and replay of the sessions will be available in the Investor Relations section of NCR.com (investor.ncr.com) for 90 days following the sessions. About NCR Corporation NCR Corporation (NYSE: NCR) is a leading software- and services-led enterprise provider in the financial, retail and hospitality industries. NCR is headquartered in Atlanta, Ga., with 36,000 employees and does business in 180 countries. NCR is a trademark of NCR Corporation in the United States and other countries. Web site: www.ncr.com Twitter: @NCRCorporation Facebook: www.facebook.com/ncrcorp LinkedIn: www.linkedin.com/company/ncr-corporation YouTube: www.youtube.com/user/ncrcorporation", "role": "user" }, { "content": "NCR to Present at Upcoming Investor Conferences", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BOSTON--(BUSINESS WIRE)--Early Black Friday Cricut Joy deals for 2020 have arrived. Find the best sales on top-selling Cricut machines and bundles, such as the Cricut Joy Starter Bundle and Essential Bundle. Check out the best deals listed below. Best Cricut Joy Deals: Best Cricut Deals: Want some more deals? Click here to browse the entire selection of active deals at Walmarts Black Friday sale and click here to check out Amazons latest Black Friday-worthy deals. Consumer Walk earns commissions from purchases made using the links provided. Cricut helps hobby-crafters and scrapbookers to utilize different materials more easily. Its latest cutting machine to hit the market is the Cricut Joy, a portable, yet a powerful cutting machine that can fit the palm of one's hand. This portable Cricut can also be bundled with the Smart Materials which are designed for cutting materials on the Cricut Joy without using a cutting mat. Opting for the Cricut Joy + Essentials Bundle is always a smart choice, especially when they go on sale. About Consumer Walk: Consumer Walk reports the latest online retail news. As an Amazon Associate and affiliate Consumer Walk earns from qualifying purchases.", "role": "user" }, { "content": "Best Cricut Joy Black Friday Deals (2020): Early Cricut Machine, Bundle & More Savings Shared by Consumer Walk Early Black Friday Cricut Joy cutting machine deals for 2020 are here, explore the best early Black Friday Cricut Joy Smart Materials and Cricut Joy Essential and Starter Bundle sales below", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LEXINGTON, Mass., May 27, 2020 /PRNewswire/ --Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE technology,today announced that, due to public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, the location of the Company's 2020 Annual Meeting of Stockholders (the \"Annual Meeting\") has been changed to a virtual format only. As previously announced, the Annual Meeting will be held at 11:30 a.m. EasternTime on Wednesday, June 17, 2020. Stockholders will not be able to attend the Annual Meeting in person; however, the Annual Meeting will be held virtually instead, and the stockholders of record will be able to listen, vote and ask questions during the meeting through an online platform. As described in the proxy materials for the Annual Meeting that were previously distributed, you are entitled to participate in the Annual Meeting if you were a stockholder of record as of the close of business on April 20, 2020, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. In order to attend the Annual Meeting virtually via the Internet, you must register in advance at www.proxydocs.com/PULMprior to 5:00 p.m. Eastern Time on June 15,2020. You will be required to enter the control number included on the proxy card, voting instruction form or notice previously delivered to you. Upon completing your registration, you will receive further instructions via email, including your unique links that will allow you to access the virtual Annual Meeting and vote online during the meeting. You will be permitted to submit questions at the time of registration. Whether or not stockholders plan to attend the Annual Meeting, the Company urges stockholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials. A notice regarding this change to a virtual meeting format is being filed with the Securities and Exchange Commission together with this press release. About Pulmatrix Pulmatrix is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE technology. The Company's proprietary product pipeline is initially focused on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with allergic bronchopulmonary aspergillosis (\"ABPA\"), and PUR1800, a narrow spectrum kinase inhibitor in lung cancer. Pulmatrix's product candidates are based on iSPERSE, its proprietary engineered dry powder delivery platform, which seekstoenabletherapeutic delivery to thelungs by either optimizing drug lung delivery for systemic treatment or maximizing locallung concentrations and reducing systemic side effects to improve patient outcomes. Investor Contact Timothy McCarthy, CFA 212.915.2564 [emailprotected] SOURCE Pulmatrix, Inc. Related Links http://www.pulmatrix.com", "role": "user" }, { "content": "Pulmatrix to Host 2020 Annual Meeting of Stockholders Virtually", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ARLINGTON, Va., Nov. 19, 2020 /PRNewswire/ --The AES Corporation(NYSE: AES) announced that it has priced $800 million aggregate principal amount of 1.375% senior notes due 2026 (the \"2026 Notes\") and $1 billion aggregate principal amount of 2.450% senior notes due 2031 (the \"2031 Notes\" and together with the 2026 Notes, the \"New Notes\"). AES intends to allocate an amount equal to the net proceeds from this offering to one or more eligible green projects. Pending such allocation, AES intends to use the net proceeds from this offering to fund purchases of any and all of its 5.500% senior notes due 2025 (the \"2025 Notes\"), 6.000% senior notes due 2026 (the \"6.000% 2026 Notes\") and 5.125% senior notes due 2027 (the \"2027 Notes\" and, together with the 2025 Notes and the 6.000% 2026 Notes, the \"Tender Offer Notes\") in tender offers (the \"Tender Offers\"), to fully redeem any of the Tender Offer Notes not tendered in connection with the Tender Offers, to fully redeem the $65.0 million aggregate principal amount outstanding of its 4.500% notes due 2023 (the \"2023 Notes\") and $63.0 million aggregate principal amount of its 5.500% notes due 2024 (the \"2024 Notes\" and together with the Tender Offer Notes and the 2023 Notes, the \"Outstanding Notes\"), to pay certain related fees and expenses and for general corporate purposes. This press release does not constitute an offer to purchase or the solicitation of an offer to sell the Outstanding Notes. In conjunction with the Tender Offers, AES is soliciting consents to the adoption of certain proposed amendments to the indentures governing the Tender Offer Notes to substantially remove all the restrictive covenants and events of default, as well as to alter the notice requirements for optional redemption with respect to each series of Tender Offer Notes. The closing of the offering of the New Notes is expected to occur, subject to certain customary conditions on December 4, 2020 (T + 10). About AES The AES Corporation (NYSE: AES) is a Fortune 500 global energy company accelerating the future of energy. Together with our many stakeholders, we're improving lives by delivering the greener, smarter energy solutions the world needs. Our diverse workforce is committed to continuous innovation and operational excellence, while partnering with our customers on their strategic energy transitions and continuing to meet their energy needs today. For more information, visit www.aes.com. Safe Harbor Disclosure This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and of the Securities Exchange Act of 1934. Forward-looking statements are not intended to be a guarantee of future results, but instead constitute AES' current expectations based on reasonable assumptions. Such forward-looking statements include, but are not limited to,our financing plans, including the offering of the New Notes and the details thereof, the proposed use of proceeds therefrom, the ultimate allocation of amounts relating to the offering of the New Notes to eligible green projects,and other expected effects of the offering of the New Notes,the Tender Offers and Consent Solicitations, the details thereof, other expected effects of the Tender Offers and Consent Solicitations and the proposed concurrent debt financing to satisfy the financing condition and the use of proceeds therefrom. Actual results could differ materially from those projected in AES' forward-looking statements due to risks, uncertainties and other factors. Important factors that could affect actual results are in AES' filings with the Securities and Exchange Commission (the \"SEC\"), including, but not limited to, the risks discussed under Item 1A: \"Risk Factors\" and Item 7: \"Management's Discussion & Analysis\" in AES' 2019 Annual Report on Form 10-K and in subsequent reports filed with the SEC. Readers are encouraged to read AES' filings to learn more about the risk factors associated with AES' business. AES undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Any Stockholder who desires a copy of AES' 2019 Annual Report on Form 10-K filed February 27, 2020 with the SEC may obtain a copy (excluding Exhibits) without charge by addressing a request to the Office of the Corporate Secretary, The AES Corporation, 4300 Wilson Boulevard, Arlington, Virginia 22203. Exhibits also may be requested, but a charge equal to the reproduction cost thereof will be made. A copy of the Form 10-K may be obtained by visiting AES' website atwww.aes.com. SOURCE The AES Corporation Related Links https://www.aes.com", "role": "user" }, { "content": "AES Announces Pricing of $1.8 Billion of Senior Notes in a Private Offering", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LAUSANNE, Switzerland, Nov. 17, 2020 /PRNewswire/ --Tetra Pak today unveils findings from its global research study, in partnership with Ipsos1,showing that food safety is a major issue for society. The same amount of respondents believe that COVID-19 is a \"real threat.\" At the same time, concern for the environment remains strikingly powerful2, pointing towards a dilemma in consumers' minds as they try to balance the critical priorities of human existence through safe food and sustainability of our planet. The Tetra Pak Index, in its 13th edition, uncovers a 10% increase in global concern about food safety and future food supplies, now at 40%, compared to 30% from 2019. In addition, more than 50% of consumers not only believe that improving food safety is the responsibility of manufacturers, they see it as the number one issue that companies need to tackle now and in the future. According to this year's research, health is deeply connected to heightened issues of food safety and hygiene, with two-thirds of consumers saying that being healthy is being safe and 60% of consumers globally saying they worry about the food they buy being hygienic and safe. When asked what is key for them in a package, consumers indicate that ensuring food safety is its main purpose. They also express concerns about environmental innovations in packaging impacting food safety, even though the majority of respondents indicate 'using sustainable packaging' as one of the top issues food and beverage brands need to tackle today and tomorrow. Adolfo Orive, President and CEO, Tetra Pak, comments: \"The COVID-19 pandemic has disrupted the status quo, accelerated trends and created a new landscape of consumer needs and opportunities for companies to build on. In particular, the industry needs to address the growing dilemma around food safety and the environment, stepping up towards the twin goals of meeting the human need for food while protecting our planet's ecosystem. This is where food packaging can play a strong role in bringing about harmony. Working closely with our customers and stakeholders, we are already on a journey to create the ultimate sustainable food package - a carton package that is made solely from responsibly sourced renewable or recycled materials, is fully recyclable and carbon-neutral, allowing ambient distribution and meeting food safety requirements. We see this as a critical step in building a sustainable future for the next generation, especially in the aftermath of COVID-19.\" The Tetra Pak Index 2020 also highlights how food waste is rising up the agenda and is now seen as a concern by more than three-quarters of respondents. The impact of COVID-19 on supply chains has accelerated awareness of food waste as a pressing issue. There is a likelihood that this sentiment will grow going forward, as the world strives to feed its growing population. Consumers cite food waste reduction as both the number one environmental issue they can influence themselves and one of the top three priorities for manufacturers. But confusing labelling is a barrier, offering brands a chance for better communication. Dan Esty, Hillhouse Professor at Yale University, comments:\"This year's Tetra Pak Index highlights emerging consumer and social concerns that we see increasingly mirrored by academic research. With a growing global population set to require up to 70% more food by 2050, at a time when biodiversity, climate change and food security are becoming ever more pressing, there is an urgent need for change. Bold initiatives such as those taken by Tetra Pak to rethink future food packaging are therefore the need of the hour.\"Notes to EditorsView or download the Tetra Pak Index 2020 here. View or download the Tetra Pak Index 2019 here.Dan Esty, Hillhouse Professor at Yale University, is Chair of Tetra Pak's Sustainability Advisory Panel. Convened in September 2020, the independent Panel was formed to advise the company on aspects of its sustainability strategy within the business, broader industry and beyond. Meet our advisors.The findings of the 2020 study, conducted by Ipsos, have been compiled based on data from the following inputs: Global consumer research: A global survey of over 8,500 consumers from Australia, Brazil, China, France, India, Nigeria, Pakistan, Russia and USA (n=8501). Results were collected through June - July 2020 from a minimum of 1000 respondents in each market surveyed. Social intelligence: An online social media study analysing approximately 75,000 online consumer conversations in USA and India over the 24 months leading up to June 2020, including both text and image-based data sources. Desk research: A thorough review of existing data and reports. Supplemental data sources: The data collected for the 2020 Index Report has been supplemented with data from Tetra Pak's latest environmental survey, the Consumer Environmental Trends Report 2020. Conducted in July 2020, the survey is comprised of a total of 4,800 consumer interviews based on an online questionnaire in 16 markets: Brazil, Chile, China, France, Germany, Italy, Japan, Pakistan, Saudi Arabia, South Africa, Sweden, Thailand, Turkey, UAE, UK and USA. ABOUT TETRA PAKTetra Pak isaworld leading food processing and packaging solutions company. Working closely with our customers and suppliers, we provide safe,innovativeand environmentally sound products that each day meet the needs of hundreds of millions of peoplein more than 160 countries. Withmore than25,000 employees around the world, we believe in responsible industry leadership and a sustainable approach to business.Our promise, \"PROTECTS WHAT'S GOOD,\" reflects our vision to commit to making food safe and available, everywhere.More information about Tetra Pak is available atwww.tetrapak.comwhere you can also read about the company's journey to develop the world's most sustainable food package. MEDIA CONTACTSLarine UrbinaTel: 940-231-4268[emailprotected] 1Ipsos is a global leader in market research, delivering reliable information and true understanding of Society, Markets and People. 2The Tetra Pak Index 2020 finds consumer concern for food safety has grown compared to this time last year, with 40% of respondents ranking food safety and future food supplies among their top three most worrying issues, compared to 30% in the Tetra Pak Index 2019. 64% of respondents have identified COVID-19 as the issue causing them the greatest worry, pushing the environment down the list of global concerns: from 63% in 2019 to 49% today whereas worries about economic issues are rising, up from 40% to 47%.SOURCE Tetra Pak Related Links http://www.tetrapakusa.com", "role": "user" }, { "content": "Tetra Pak research study reveals food safety-environment dilemma fostered by COVID-19 pandemic", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PANAMA CITY BEACH, Fla.--(BUSINESS WIRE)--The St. Joe Company (NYSE: JOE) (St. Joe) announces Hotel Indigo, a stylish and vibrant boutique hotel, as the brand for its planned hotel in Panama Citys downtown waterfront district. St. Joe intends to build, own and operate the previously announced hotel on a portion of the Panama City Marina property fronting St. Andrews Bay. The City and St. Joe completed a lease agreement on the property earlier in the year. Hotel Indigo is a part of a family of hotel brands from IHG (InterContinental Hotels Group), one of the worlds leading hotel companies. Hotel Indigo properties are designed to be as individual as their surroundings and reflect the local culture, meaning that no two properties are alike. Each hotel is part of the pulse and the rhythm of a place, drawing on the unique story of its local area to inspire every aspect of the hotel, from intriguing design to distinctive local ingredients on menus. St. Joes plans call for a Hotel Indigo featuring 124 guest rooms providing sweeping views of St. Andrews Bay. Hotel Indigo is a unique and exciting brand that we are very pleased to bring to downtown Panama Citys waterfront district, said Patrick Murphy, St. Joes Senior Vice President of Operations. We believe that Hotel Indigo is an ideal fit for this waterfront location and we see this hotel as a great piece of the ongoing revitalization of downtown Panama City. In addition to the Hotel Indigo, St. Joe intends to construct and operate a stand-alone restaurant on the property as well as an event lawn and a public promenade along the waterfront. It has been very exciting to see new private business investment like this hotel project come to Panama City, said Greg Brudnicki, Mayor of Panama City. We look forward to welcoming Hotel Indigo to our downtown where visitors can take in the beautiful views of the bay and enjoy a vibrant downtown Panama City. The Hotel Indigo brand is well-known and loved by travelers to the Gulf Coast who are seeking an upscale stay and local experience and is a great fit for Panama City and the marina area, said Arik Kono, Vice President of Upscale Development for IHG. We are excited to work with The St. Joe Company to bring this project to life. St. Joe anticipates construction on the restaurant and Hotel Indigo to begin in the second quarter of 2021. Important Notice Regarding Forward-Looking Statements This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, including statements regarding the proposed Hotel Indigo in Panama City, Florida including expected construction timeline, as well as the proposed restaurant in Panama City, Florida. These forward-looking statements are qualified in their entirety by cautionary statements and risk factors set forth in St. Joes filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2019. Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020 and September 30, 2020, and subsequent current report filings, as well as the following: (1) the ability of St. Joe to successfully complete the proposed Hotel Indigo, (2) the ability of St. Joe to successfully complete the proposed restaurant and (3) the future interest of prospective customers of a restaurant and Hotel Indigo in Panama City, Florida. About The St. Joe Company The St. Joe Company, together with its consolidated subsidiaries, is a real estate development, asset management and operation company. The Company owns land concentrated primarily in Northwest Florida and has significant residential and commercial land-use entitlements in hand or in process. More information about the Company can be found on its website at www.joe.com. More information on the Companys current project pipeline can be found at www.joe.com/project-updates. About Hotel Indigo Just as no places are alike, no two Hotel Indigo properties are alike. Each Hotel Indigo draws inspiration from the local neighborhood, culture and popular trends in food, drink and design to create a warm and vibrant atmosphere. Our hotels provide a gateway to discover and explore some of the worlds most inspiring cities and neighborhoods. For more information, visit www.hotelindigo.com or connect with Hotel Indigo on Facebook at www.facebook.com/Hotel.Indigo, Twitter at www.twitter.com/HotelIndigo and Instagram at www.instagram.com/hotelindigo. The St Joe Company 2020. St. Joe, JOE, the Taking Flight Design, St. Joe (and Taking Flight Design) , are registered service marks of The St. Joe Company or its affiliates.", "role": "user" }, { "content": "The St. Joe Company Announces Hotel Indigo as the Brand for Its Planned Hotel in Panama Citys Downtown Waterfront District", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- Issue Gracechurch Card Programme Funding PLC - Series 13 - 3 Class A GBP 1,400,000,000 FRN due Jun 2024 ISIN Number XS0992306141 ISIN Reference 99230614 Issue Nomin GBP 1400000000 Period 12/15/2020 to 1/15/2021 Payment Date 1/15/2021 Number of Days 31 Rate 0.45588 Denomination GBP 100000 1400000000 Amount Payable per Denomination 38.72 542060.05 Bank of New York Rate Fix Desk Telephone 44 1202 689580 Corporate Trust Services Facsimile 44 1202 689601", "role": "user" }, { "content": "FRN Variable Rate Fix", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PORTLAND, Ore., Feb. 2, 2021 /PRNewswire/ -- Allied Market Research published a report, titled,\"Electronic Design Automation Software Marketby Type (Computer-aided Engineering (CAE), IC Physical Design and Verification, Printed Circuit Board and Multi-chip Module (PCB and MCM), Semiconductor Intellectual Property (SIP) and Services), and Application (Communication, Consumer Electronics, Automotive, Industrial, Aerospace & Defense, Medical, and Others): Global Opportunity Analysis and Industry Forecast, 20202027.\" According to the report, the global electronic design automation software industry was estimated at $10.20 billion in 2019, and is anticipated to hit $20.89 billion by 2027, registering a CAGR of 9.6% from 2020 to 2027. Download Sample Report: https://www.alliedmarketresearch.com/request-sample/5805 Drivers, restraints, and opportunities: Rise in adoption of FinFET architecture for designing modern processors, advancement in SoC technology, and increase in penetration of IoT, AI, and VR technology fuel the growth of the global electronic design automation software market. On the other hand, availability of the open-source EDA software impede the growth to some extent. However, surge in demand for compact electronic devices and machine learning in EDA is expected to create lucrative opportunities in the industry. Impact of COVID-19 Pandemic on Electronic Design Automation Software Market: The outbreak of the pandemic led to decline in investments and funding in the electronic design automation industry. In addition, factors such as decrease in semiconductor industry revenues, the slowdown in production, and shortage of raw material supply have further impacted the industry. Nevertheless, the government bodies in all across the world are now implementing unlock procedures to aid the market players in terms of economy. With this drift on board, the industry is anticipated to recover soon. Get detailed COVID-19 impact analysis on the Electronic Design Automation Software Market: https://www.alliedmarketresearch.com/request-for-customization/5805?reqfor=covid The Semiconductor Intellectual Property (SIP) segment to dominate by 2027- Based on type, the Semiconductor Intellectual Property (SIP) segment contributed to nearly one-third of the global electronic design automation software market share in 2019, and is expected to lead the trail by the end of 2027. The need of EDA software to offer pre-verified and customizable IP subsystems, architecture design expertise, hardening, signal/power integrity analysis, and IP prototyping kits drive the growth of the segment. On the other hand, the IC Physical Design and Verification segment would also register the fastest CAGR of 12.7% throughout the forecast period, owing to factors such as need for custom IC layout editing, support for the physical implementation of custom digital, analog and mixed-signal designs for device, cell, block , and full chip levels. The consumer electronics segment to maintain the dominant share- Based on application, the consumer electronics segment accounted for more than one-fifths of the global electronic design automation software market revenue in 2019, and is anticipated to dominate by 2027. EDA tools are increasingly used by consumer electronics manufacturers owing to the compact designs of new electronic items. This factor drives the growth of the market in this segment. On the other hand, the automotive segment would exhibit the fastest CAGR of 11.3% from 2020 to 2027. The fact that automotive field is offering great growth prospects to the Computer Aided Engineering (CAE) and semiconductor IP industries further drives the market growth. For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5805 North America garnered the major share in 2019: Based on geography, the market across North America, garnered the major share in 2019, holding nearly two-fifths of the global electronic design automation software market. North America has the highest rate of adoption of advanced technologies such as AI, cloud, and others. Thus, adoption of machine learning integrated Electronic Design Automation (EDA) Software by the electronics manufacturers is boosting the growth of this market. At the same time, the Asia-Pacific region would also showcase the fastest CAGR of 11.6% during the forecast period. This is due to the ever growing smartphone penetration, increasing popularity of smart wearable devices, growing electronic manufacturing companies in countries such as China, India, and Japan. Official Press Release: https://www.alliedmarketresearch.com/press-release/electronic-design-automation-software-market.html Key players in the industry- Autodesk Cadence Design Systems Inc. Keysight Technologies Mentor, a Siemens Business Silvaco Inc. Synopsys Aldec Inc. Altair Altium LLC ANSYS Inc. Similar Research Reports for Information, Communication and Technology: Veterinary Software Market Expected to Reach $2.01 Billion by 2027 Big Data Analytics in Retail Market Expected to Reach $4.43 Billion by 2027 Team Collaboration Software Market Expected to Reach $26,493 Million by 2027 Workforce Management Market Expected to Reach $9,391 Million by 2027 Online/Virtual Fitness Market Expected to Reach $59.23 Billion by 2027 AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model): AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access About Allied Market Research: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of \"Market Research Reports\" and \"Business Intelligence Solutions.\" AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact: David Correa 5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free: 1-800-792-5285UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1-855-550-5975[emailprotected] Web: https://www.alliedmarketresearch.com Follow Us on: LinkedIn Twitter SOURCE Allied Market Research", "role": "user" }, { "content": "Electronic Design Automation Software Market to Reach $20.89 Billion, Globally, by 2027 at 9.6% CAGR: Allied Market Research - Rise in adoption of FinFET architecture for designing modern processors, advancement in SoC technology, and increase in penetration of IoT, AI, and VR technology fuel the growth of the global electronic design automation software market", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- FORM 8.5 (EPT/NON-RI) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY (RI) STATUS (OR WHERE RI STATUS IS NOT APPLICABLE) Rule 8.5 of the Takeover Code (the Code) 1. KEY INFORMATION 2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) 25p ordinary Interests Short Positions Number (%) Number (%) (1) 26,508,865 1.71% 4,272,146 0.28% (2) 3,203,361 0.21% 25,314,280 1.63% (3) 0 0.00% 0 0.00% 29,712,226 1.91% 29,586,426 1.91% All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant Total number of Highest price per unit Lowest price per unit security securities paid/received paid/received 25p ordinary 306,405 18.0300 DKK 17.64 DKK 25p ordinary 830,485 2.1818 GBP 2.137 GBP 25p ordinary 39,530 17.9018 DKK 17.8005 DKK 25p ordinary 959,476 2.1819 GBP 2.135 GBP (b) Cash-settled derivative transactions Number of Price per reference unit securities 24 2.1710 GBP 106 2.1513 GBP 115 2.1715 GBP 164 2.1583 GBP 440 17.7085 DKK 467 2.1713 GBP 526 2.1593 GBP 700 2.1414 GBP 708 2.1752 GBP 855 2.1787 GBP 1,930 2.1640 GBP 2,181 2.1585 GBP 3,595 2.1512 GBP 3,824 2.1697 GBP 5,302 17.9054 DKK 8,606 2.1783 GBP 10,193 17.7973 DKK 10,472 2.1800 GBP 13,509 2.1613 GBP 14,475 2.1541 GBP 23,567 2.1819 GBP 29,429 2.1686 GBP 45,945 2.1641 GBP 58,748 2.1592 GBP 92,469 2.1676 GBP 94,090 2.1610 GBP 153,430 2.1404 GBP 281,300 2.1625 GBP 285,000 17.7000 DKK 352 2.1618 GBP 433 17.6415 DKK 5,000 2.1702 GBP 5,678 2.1778 GBP 6,636 2.1469 GBP 9,116 2.1473 GBP 15,827 2.1456 GBP 18,947 2.1617 GBP 31,607 2.1619 GBP 45,342 2.1642 GBP 63,863 2.1587 GBP 84,328 2.1821 GBP 173,486 2.1658 GBP 252,062 2.1677 GBP 282,377 17.9440 DKK 285,000 2.1346 GBP (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none None (c) Attachments 17 Nov 2020 Large Holdings Regulatory Operations 020 3134 7213 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.", "role": "user" }, { "content": "Form 8.5 (EPT/NON-RI) - G4S plc", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BEIJING, Feb. 8, 2021 /PRNewswire/ -- Sponsored by China National Publications Import & Export (Group) Co., Ltd. (CNPIEC), the \"China Books Around the World\" book sales event has been launched in the Chinese bookstores of 24 countries and regions, including the United States, Canada, the United Kingdom, France, Singapore, Malaysia, and Japan. Traveling thousands of miles from Beijing, quality and content-rich Chinese publications greet local readers at overseas Chinese bookstores. Designed to connect people from across the world through reading with the help of local Chinese bookstores, this event will reach its peak around Chinese New Year in 2021. To widen the spectrum of content and diversify the variety of publications, a diverse array of books is selected for this event which were published by nearly 30 well-known Chinese publishing houses in the past year, including People's Publishing House, Foreign Languages Press, CITIC Press Group, Social Sciences Academic Press (China), The Commercial Press, and People's Literature Publishing House. This event coincides with the Spring Festival of 2021, a special occasion for family reunion of Chinese people. Due to the pandemic of COVID-19, many overseas Chinese might not have the chance to reunite with their families back in China. On this occasion, CNPIEC has gifted these overseas Chinese bookstores with cultural and creative products of traditional Chinese festivity such as Spring Festival couplets, Chinese character \"Fu\" (signifying blessings), window paper-cuts, as well as epidemic prevention supplies and books. This kind gesture not only delivers the blessings and festivity of the Chinese New Year, but also embodies the care and love of their motherland for overseas Chinese and its deep gratitude for their support since the outbreak of COVID-19 in China. Generous support has been garnered from overseas Chinese bookstores. POPULAR Book Company in Singapore and Malaysia work closely with CNPIEC in co-organizing activities despite the increasingly severe local epidemic of COVID-19, putting up posters at 88 branches in Singapore and Malaysia, and promoting the event on their online sales platforms. Xinhua Bookstore in Canada joins hands with CNPIEC in planning a wide range of online and offline Spring Festival activities, including \"Chinese Community Calligraphy and Painting Competition\", \"Traditional Spring Festival Knowledge Quiz\", \"Little Reciters: Chinese Children Recitation Competition\", to carry on the tradition of celebrating the Chinese New Year and appreciate the care of the motherland during the pandemic. CNPIEC is dedicated to the 11th \"China Books Around the World\" event by drawing on its overseas resources amassed over many years, in a bid to nourish the hearts and souls of overseas Chinese and foreign readers, so that they will have a in-depth and comprehensive understanding of modern China through reading. Chinese bookstores in the US and Canada participating in the event: XINHUA BOOK STORE101-10190 152A Street Surrey, BCV3R 1J SURREYCanada XIN HUA BOOKSTORE INC7373A Convoy CT. San DiegoCA92111 USA NIMING BOOKS INC12417.Elliott Ave, El Monte.Los Angeles, CA91732. U.S.A.Tel: (213)-249-2671 Enlighten Books & Gifts1015 S. Nogales St., Ste # 133Rowland Heights, CA 91748Tel: 626-913-2481 World Journal Bookstore141-07 20th AVE.WHITESTONE, NY 11357U.S.A. For overseas Chinese bookstores that are interested in this event or overseas readers who wish to buy Chinese books, please contact:[emailprotected] SOURCE China National Publications Import & Export (Group) Corporation Related Links www.cnpiec.com.cn", "role": "user" }, { "content": "\"China Books Around the World\" Conduct During the Spring Festival", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TROY, Mich.--(BUSINESS WIRE)--J.D. Power mourns the loss of James David Dave Power III, founder and retired chairman of J.D. Power, who passed away this weekend at the age of 89. The world has lost a true pioneer and we have lost a visionary spirit that has continued to inspire, inform and galvanize our companys growth for over 50 years, said Dave Habiger, president and CEO of J.D. Power. Those who were lucky enough to have worked closely with Dave remember a larger-than-life creative presence who encouraged constant innovation and close collaboration with a relentless focus on the values of independence, integrity and quality. Dubbed Mr. Quality by Motor Trend magazine, Power was widely credited with transforming the auto industry by channeling detailed customer experience data into practical insights and critical intelligence that changed everything from manufacturing to marketing. He founded the company in 1968 with his wife Julie, and together they quickly built J.D. Power into one of the worlds most recognizable brands. With customer feedback often seen as less important by companies who provided products or services, Power was constantly motivated to bring attention to the Voice of the Customer. And he would often express his immense pride in his colleagues, or Associates, making such groundbreaking contributions to the company and the industries it served. Data and analytic insights enabled significant quality improvements across every major automotive manufacturer. Today, J.D. Power is known throughout the world as a global leader in consumer insights, advisory services and data and analytics across every major industry. As J.D. Power studies began to detect nascent industry trends and critical quality flaws, the industry began to embrace the companys data as a critical source of industry intelligence, and a key component to product strategy. That recognition was memorialized in 1992 when Power received the Automotive Hall of Fames Distinguished Service Citation, which is awarded each year to the industrys most accomplished leaders. In the years that followed, Power successfully diversified the business, expanding into the financial services, healthcare, home, insurance, technology, media and telecom, travel and hospitality and utilities industries. Building on Powers foundation of concrete experiential data and analytics, J.D. Power is now a global leader in the use of big data, artificial intelligence (AI) and algorithmic modeling to understand consumer behavior. Power stepped back from day-to-day leadership of the company in 2005 but continued to stay involved in an advisory capacity for many years. Even after his retirement, Daves indomitable presence was felt throughout our business, both through the many lives he touched personally and the strong foundation of uncompromising values of independence and integrity he built for our amazing company, Habiger added. He will be deeply missed by all of us, but his spirit will live on in the work we will carry forward each day. _______________________________ J.D. Power is a global leader in consumer insights, advisory services and data and analytics. A pioneer in the use of big data, artificial intelligence (AI) and algorithmic modeling capabilities to understand consumer behavior, J.D. Power has been delivering incisive industry intelligence on customer interactions with brands and products for more than 50 years. The world's leading businesses across major industries rely on J.D. Power to guide their customer-facing strategies. J.D. Power is headquartered in Troy, Mich., and has offices in North America, Europe and Asia Pacific. To learn more about the companys business offerings, visit JDPower.com/business. The J.D. Power auto shopping tool can be found at JDPower.com.", "role": "user" }, { "content": "J.D. Power Mourns Death of Company Founder James David Power III Pioneer in Customer Experience Data and Analytics Transformed Auto Industry with Quality Benchmarks", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Aug. 24, 2020 /PRNewswire/ -- The \"Geographic Atrophy - Market Insights, Epidemiology and Market Forecast - 2030\" drug pipelines has been added to ResearchAndMarkets.com's offering. The report delivers an in-depth understanding of the GA, historical and forecasted epidemiology as well as the GA market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. The GA market report provides current treatment practices, emerging drugs, GA market share of the individual therapies, current and forecasted GA market size from 2017 to 2030 segmented by seven major markets. The report also covers current GA treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.EpidemiologyThe GA epidemiology division provides the insights about historical and current GA patient pool and forecasted trend for each seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.Key FindingsThe total prevalent cases of GA in the 7MM were found to be 2,726,453 in 2017 which is expected to grow during the study period, i.e., 2017-2030.The disease epidemiology covered in the report provides historical as well as forecasted GA epidemiology [segmented as Total Prevalent Cases of GA, Total Diagnosed Cases of GA, Total Diagnosed cases of GA by Age Distribution, Total Geographic Atrophy Cases by Visual Impairment, and Total Treated Cases of GA] scenario of GA in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2017 to 2030.Drug ChaptersDrug chapter segment of the GA report encloses the detailed analysis of GA marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the GA clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.Emerging DrugsPegcetacoplan (APL-2): Apellis PharmaceuticalsPegcetacoplan (formerly known as APL-2), is under development by Apellis Pharmaceuticals. It is an investigational, targeted C3 inhibitor designed to regulate excessive complement activation, which can lead to the onset and progression of many serious diseases. Pegcetacoplan is a type of synthetic cyclic peptide conjugated to a polyethylene glycol polymer that binds specifically to C3 and C3b.Currently two phase III trial is ongoing for GA secondary to age-related macular degeneration (AMD). The Phase III program in GA consists of two 600-patient prospective, multicenter, randomized, double-masked, sham-injection controlled trials to assess the efficacy and safety of multiple intravitreal injections of pegcetacoplan in patients with GA, with the goal of enrolling a total of 1,200 patients across approximately 200 sites worldwide. Company refers to these trials as the DERBY and OAKS trials. Company dosed the first patient in Phase III trials in September 2018. It is expected that both trials will be fully enrolled by the end of the first half of 2020 and anticipated announcement of data from these trials will be in mid-2021.In July 2018, the US FDA granted fast track designation to Pegcetacoplan for GA.In November 2014, Apellis Pharmaceuticals entered into an agreement to acquire Potentia Pharmaceuticals. As part of the acquisition agreement, Apellis obtained the necessary intellectual property rights to develop its complement inhibitor drug compound (APL-2) in ophthalmology.Zimura (avacincaptad pegol): Iveric Bio (formerly Ophthotech Corporation)Zimura also known as avacincaptad pegol, is under development by Iveric Bio. It is designed to target and inhibit complement factor C5. Complement factor C5 is a central component of the complement cascade and is believed to be involved in the development and progression of dry AMD.The drug is currently in Phase IIb trial for the treatment of patients with GA Secondary to Dry AMD. However, in January 2020, the Company announced the design of second Phase III clinical trial of Zimura in geographic atrophy secondary to AMD, ISEE2008. In March 18, 2020, the Company announced that due to the COVID-19 pandemic, it had decided to delay the initiation of patient enrollment in the ISEE2008 trial, which was otherwise on track to begin in March 2020. The Company continues to monitor the situation closely in the United States and abroad to determine when enrollment should begin.The Company expected topline 18-month data from its first Phase III clinical trial evaluating Zimura for the treatment of GA secondary to AMD, OPH2003, will be available by the end of the second quarter of 2020. The primary purpose of the 18-month time point is to gather additional safety data.In April 2020, the US FDA granted Fast Track designation to Zimura for the treatment of GA secondary to AMD.ALK-001: Alkeus PharmaceuticalsAlkeus' drug candidate, ALK-001, is a once-a-day oral drug candidate currently being tested for the treatment of GA, which offers a chemically modified version of the vitamin that is designed to reduce the formation of those toxic clumps. ALK-001 works by replacing the C20 hydrogen atoms of vitamin A with deuterium atoms which makes cleavage of the carbon-hydrogen bond more difficult, thereby reduces Vitamin A dimerization and lipofuscin.The company has completed a phase I clinical study (NCT02230228) which was conducted to assess the safety and pharmacokinetics of ALK-001 in healthy volunteer. At present, a Phase III (NCT03845582; Recruiting) multicenter, randomized, double-masked, parallel-group, placebo-controlled study is ongoing to investigate the safety, pharmacokinetics, tolerability, and efficacy of ALK-001 in GA Secondary to Age-related Macular Degeneration.In January 2011, Alkeus Pharmaceuticals and Columbia University entered into a license agreement for a set of potential therapies for the treatment of dry age-related macular degeneration (dry-AMD), Stargardt disease, and other degenerative diseases of the eye.HMR59 (AAVCAGsCD59): Hemera BiosciencesHMR59 (HMR-1001; AAVCAGsCD59) is Hemera's one-time gene therapy that works by causing retina cells to continuously produce a soluble protein called CD59 (sCD59) that blocks the final step of the complement cascade. This drug is currently being evaluated in the US FDA approved clinical trials to treat both dry and wet AMD. Macular degeneration is felt to be caused by an over activity of an inflammation cascade called complement.In preclinical testing, AAVCAGsCD59 injected in the vitreous of mice 14 days prior to laser CNV reduced CNV formation by ~60% and MAC formation by ~70%. Hemera Biosciences's expecting to initiate a Phase II (NCT04358471; Not yet recruiting) multi-center trial in June 30, 2020, evaluating intravitreal AAVCAGsCD59 compared to sham injection for the treatment of advanced dry AMD with GA. The one-year key findings of a Phase I dose-escalation trial of HMR59 in dry AMD have shown about a 25% reduction in the growth rate of GA.Market OutlookAt present, the therapeutic landscape of GA is devoid of any approved treatment, and to manage this indication, and there is a substantial unmet need for a therapy to slow its worsening. The pathophysiology of GA is poorly understood. Although correlative evidence for complement, inflammation, and GA pathology has been found in human tissues, a causative role for complement, or for inflammation in general, can be demonstrated only in appropriate preclinical models of GA.The current standard of Care is observation, and besides high doses of antioxidant vitamin, zinc supplements are found to produce a beneficial effect in slowing the progression of d-AMD. In the absence of any treatment and because of a poor correlation between BCVA and GA lesions or progression, a multimodal imaging approach is necessary to better follow up GA patients.Several companies tried to develop a drug for this condition, but failed. One such example is Lampalizumab (Genentech/Roche). This drug blocks a region on factor D that is an important binding site for factor B. As a result, factor B cannot be cleaved therefore inhibits the alternate complement pathway.In September 2017, press releases from Roche and Genentech announced that two phase III clinical trials of lampalizumab (Spectri and Chroma), failed to meet their primary end point of reducing mean change in GA lesion area after 48 weeks when compared with sham treatment.At present several pharmaceutical companies are working for the development of novel approach to treat this condition. Key players like Apellis Pharmaceuticals (Pegcetacoplan; APL-2), Alkeus Pharmaceuticals (ALK-001), Iveric bio (formerly Ophthotech Corporation; Zimura), Genentech (Roche; RO7171009; RG6147), Ionis Pharmaceuticals./ Roche (IONIS-FB-LRx), Hemera Biosciences (HMR59), Allegro Ophthalmics(Risuteganib), Stealth BioTherapeutics (Elamipretide), Janssen Research & Development (Palucorcel; CNTO 2476), Regenerative Patch Technologies (CPCB-RPE1), CellCure Neurosciences (OpRegen), Gyroscope Therapeutics (GT005), and others.Key FindingsThe therapeutic market of GA in the seven major markets was USD 276 million in 2017 which is expected to increase during study period (2017-2030). According to the estimates, the highest market size of GA is found in the United States followed by the UK and France. In case of clinical trials of emerging therapies, no active companies in this space currently focusing on Japan and also no visibility around the launch scenarios in Japan hence emerging therapies launch is not considered in Japan.The United States Market OutlookIn 2017, the total market size of GA therapies was USD 181 million in the United States which is expected to increase in the study period (2017-2030).EU-5 Countries: Market OutlookIn 2017, the total market size of GA therapies was USD 83 million in the EU-5 countries which is expected to increase in the study period (2017-2030).Japan Market OutlookThe total market size of GA therapies in Japan was USD 12 million in 2017.Pipeline Development ActivitiesThe drugs which are in pipeline include:1. Pegcetacoplan (APL-2) (Apellis Pharmaceuticals): Phase III2. ALK-001 (Alkeus Pharmaceuticals): Phase III3. Zimura (avacincaptad pegol) [Iveric bio (formerly Ophthotech Corporation)]: Phase IIb4. RO7171009 (RG6147) [Roche (Genentech)]: Phase II5. IONIS-FB-LRx (Ionis Pharmaceuticals./Roche): Phase II6. AAVCAGsCD59 (HMR59) (Hemera Biosciences): Phase II7. Risuteganib (Allegro Ophthalmics): Phase II8. Elamipretide (Stealth BioTherapeutics): Phase II9. Palucorcel (CNTO 2476) (Janssen Research & Development): Phase IIDrugs UptakeHMR59 (Gene Therapy) expected to generate highest market size owing to one time treatment approach, expected premium pricing and impressive early stage efficacy data.Furthermore, there are no significant differences seen in the available efficacy results of APL-2 and Zimura; but Zimura owing to better safety profile expected to have slight edge over APL-2. So, Zimura is expected to generate second highest revenue in the total GA market.Access and Reimbursement Scenario According to findings from the secondary domain, for access and reimbursement of therapies in GA; the change in the BCVA and GA lesions or progression will consider as the optimal primary efficacy measure in GA. The advanced form of AMD is divided into two forms, one of them is GA and another one is Wet AMD. It is worthy to mention here that the patient pool of wet AMD and GA is in similar lines; so we can predict the similar access and reimbursement scenario for upcoming emerging GA therapies. Talking about the assessment by HTA bodies for wet AMD, therapies like Eylea (Aflibercept) and Lucentis (ranibizumab injection) we have explored and have analyzed the reaction of HTA bodies in case of wet AMD. HTA assessment analysis has also provide some directions around the estimated cost of treatment and how these bodies expected to react around GA therapies due to lack of any precedence of approval or assessment in GA. In the case of Eylea, in July 2013, the National Institute for Health and Care Excellence (NICE) recommended Eylea as an option for treating wet AMD. In March 2013, the German HTA body IQWiG released a statement claiming that, following an assessment of the benefits of Eylea, current data was unable to prove the drug was superior to Novartis' Lucentis (ranibizumab) in the treatment of wet AMD. In May 2012, Lucentis was recommended by NICE as an option for the treatment of wet AMD. KOL ViewsTo keep up with current market trends, we take KOLs and SME's opinion working in GA domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or GA market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.Prof. Medical Director, Department of Ophthalmology, University of Bonn, Germany Views: GA is not under diagnosed, at least not to a large extent At present, one could speculate on the aspect that emerging drug will target a specific target population or there will be any eligibility criteria. I am not aware of any specific criteria for eligibility once an effective Tx may become available Perhaps, complement therapy will only work in subject with genetic risk polymorphism in the complement pathway Competitive Intelligence AnalysisThe publisher performs Competitive and Market Intelligence analysis of the GA Market by using various Competitive Intelligence tools that includes - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.Scope of the Report The report covers the descriptive overview of GA, explaining its causes, signs and symptoms, pathophysiology and currently available therapies. Comprehensive insight has been provided into the GA epidemiology and treatment in the 7MM. Additionally, an all-inclusive account of both the current and emerging therapies for GA is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape. A detailed review of GA market; historical and forecasted is included in the report, covering drug outreach in the 7MM. The report provides an edge while developing business strategies, by understanding trends shaping and driving the global GA market. Report Highlights In the coming years, GA market is set to change due to the rising awareness of the disease and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market. The companies and academics are working to assess challenges and seek opportunities that could influence GA R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition. Major players are involved in developing therapies for GA. Launch of emerging therapies, will significantly impact the GA market. A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for GA. Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities. For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/x0f6e Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Geographic Atrophy Market Outlook 2020-2030: Epidemiology, Pipeline, Drugs & Players", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing Massachusetts Financial Services Company Company dealt in AON PLC Class of relevant security to which the dealings being disclosed relate Class A Ordinary Shares (IE00BLP1HW54) Date of dealing 14 January 2021 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in Long Short Number (%) Number (%) (1) Relevant securities 20,021,349 shares 8.76 % (2) Derivatives (other than options): (3) Options and agreements to purchase/sell: Total 20,021,349 shares 8.76 % (b) Interests and short positions in relevant securities of the company, other than the class dealt in Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options): (3) Options and agreements to purchase/sell: Total 3. DEALINGS (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit In Kind Received 231 shares 206.6200 USD In Kind Received 138 shares 206.9000 USD Purchase 5,307 shares 206.6200 USD Sale 243 shares 206.0863 USD Sale 758 shares 206.6200 USD Sale 1,027 shares 205.3004 USD Sale 2,496 shares 205.8916 USD Sale 3,781 shares 204.1333 USD (b) Derivatives transactions (other than options transactions) Product name e.g. CFD Nature of transaction Number of relevant securities Price per unit (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which the option relates Exercise price Type, e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercising Product name e.g. call option Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Nature of transaction Details Price per unit (if applicable) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None Is a Supplemental Form 8 attached? NO Date of disclosure 15 January 2021 Contact name Robert R. Flaherty Telephone number 617-954-5814 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection", "role": "user" }, { "content": "Form 8.3 - Aon plc", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ST. LOUIS, Aug. 24, 2020 /PRNewswire/ --Mallinckrodt Pharmaceuticals(NYSE: MNK), a global biopharmaceutical company, today announced that its Specialty Generics business has been recognized as a Manufacturing Leadership Award winner for outstanding achievement by the National Association of Manufacturers (NAM). The Specialty Generics business' Hobart, N.Y. manufacturing site received awards for outstanding achievement in two categories Operational Excellence Leadership and Engineering and Production Technology Leadership. Spiro Gavaris, President,Mallinckrodt Specialty Genericssaid, \"We are extremely proud to receive the National Association of Manufacturers' prestigious manufacturing leadership awards for the third consecutive year. This recognition further demonstrates Mallinckrodt's history of innovative manufacturing solutions, our focus on being the US-based supplier of choice for specialty generic drugs and active pharmaceutical ingredients, and our commitment to providing patients access to quality medicines.\" This year, Mallinckrodt's Hobart, N.Y. manufacturing site was recognized in the Operational Excellence Leadership category for its Packaging Changeover Improvement Project that successfully reduced the changeover time of packaging lines by 50% and decreased the variability of time to completion. The Hobart site's Packaging Serialization Project was an award winner in the Engineering & Production Technology Leadership category for its achievement in upgrading the facility's packaging lines, which enabled production of fully serialized pharmaceutical finished product with full pallet aggregation two years ahead of FDA requirements. \"We are very pleased that NAM's Leadership Council has recognized our Hobart site for manufacturing leadership in operational excellence, as well as engineering and production technology,\" said David Hollingshead, Senior Director of Manufacturing. \"Achievingsix awards in the last three years is testimony to our employees' dedication to the strategy development and deployment process in becoming a premier manufacturing site.Continuous improvement is core in the mindsets and behaviors of our most important asset our people.\" Mallinckrodt will be recognized at the 16th Annual Manufacturing Leadership Awards Gala which will be held virtually on October 8, 2020. About Mallinckrodt Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market, and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website. About the Manufacturing Leadership Awards The Manufacturing Leadership Awards honor manufacturing companies and individual manufacturing leaders that are shaping the future of global manufacturing. Winning projects and individual manufacturing leaders have demonstrated achievement in one of a wide range of categories, and are chosen by a panel of expert judgesfor results that have delivered clear and compelling value, return on investment, and other tangible outcomes. For more information on the Manufacturing Leadership Awards Gala or Rethink: The Manufacturing Leadership Council Summit, please go to www.MLCRethink.com. About the National Association of Manufacturers The National Association of Manufacturers (NAM) is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. The NAM's world-class staff of policy experts provide unmatched access and information on the key issues affecting your business and bottom line. It is on the front lines of a wide range of policy battles, from immigration reform and labor relations, to energy and the environment, to trade policy and taxes. www.nam.org CONTACTS For Financial/Dailies Media InquiriesRon Bartlett H+K Strategies Senior Vice President 813-545-2399 [emailprotected] Investor RelationsDaniel J. SpecialeVice President, Finance and IRO314-654-3638[emailprotected] Mallinckrodt, the \"M\" brand mark and theMallinckrodt Pharmaceuticalslogo are trademarks of aMallinckrodtcompany. Other brands are trademarks of aMallinckrodtcompany or their respective owners. 2020Mallinckrodt.US-2000671 08/20 SOURCE Mallinckrodt Pharmaceuticals Related Links http://www.mallinckrodt.com", "role": "user" }, { "content": "Mallinckrodt's Hobart, N.Y. Site Recognized With Two Manufacturing Leadership Awards", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, May 28, 2020 /PRNewswire/ -- The \"Internet Radio - Global Market Trajectory & Analytics\" report has been added to ResearchAndMarkets.com's offering. The global analysis and forecast periods covered are 2020-2027 (current & future analysis) and 2012-2019 (historic review). Research estimates are provided for 2020, while research projections cover the period 2021-2027. Amid the COVID-19 crisis and the looming economic recession, the Internet Radio market worldwide will grow by a projected US $4.3 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 17.7%.Internet Radio, one of the segments analyzed and sized in this study, is forecast to grow at over 17.7% and reach a market size of US $6.3 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Internet Radio market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.As part of the new emerging geographic scenario, the United States is forecast to readjust to a 19.4% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US $153.6 Million to the region's size over the next 7 to 8 years. In addition, over US $195.7 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Internet Radio segment will reach a market size of US $308.2 Million by the close of the analysis period.Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Internet Radio market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 17.8% over the next couple of years and add approximately US $553.4 Million in terms of addressable market opportunity.Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Internet Radio market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.Key Topics Covered I. INTRODUCTION, METHODOLOGY & REPORT SCOPEII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Impact of COVID-19 and a Looming Global Recession A Prelude Recent Market Activity Advertisements or Subscriptions - Where Does Internet Radio Earn From? Current & Future Analysis Internet Radio: Gaining Edge over Terrestrial Radio Broadcasting Smartphones - The Savior of Audio Market Competitive Landscape Global Competitor Market Shares Internet Radio Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 2. FOCUS ON SELECT PLAYERS 8tracks (USA) AccuRadio, LLC (USA) Amazon.com, Inc. (USA) AOL Radio (USA) Apple Inc. (USA) Deezer (France) DI.FM (USA) Google Inc. (USA) iHeartMedia, Inc. (USA) Napster (USA) Pandora Media, Inc. (USA) Slacker, Inc. (USA) SomaFM.com, LLC (USA) Spotify Ltd. (UK) TuneIn (USA) 3. MARKET TRENDS & DRIVERS Expanding Internet User Base: A Key Driving Force Rising Smartphone Usage Fueling Growth of Internet Radio Worldwide Mobile Subscriber Base - Key Statistics Soaring Mobile Broadband Penetration Rates to Power Growth for Internet Radio on Mobile Platforms Increased Strain on 3G Networks Brings 4G Networks into the Spotlight Transition from 3G to 4G and 5G Networks: Revolutionizing the Mobile Communications Landscape Internet Radio Technology to Witness Widespread Deployment in Vehicles In-Vehicle Wi-Fi to Encourage In-Vehicle Internet Radio Adoption Will Analog Radio Shutdown be the Future, Aid Internet Radio? Home Audio Systems Cautiously Embracing Internet Radio Monetization of Internet Radio Services Internet Radio and Local Advertising Catalogs: The Heart of On-Demand Services Multi-Channel Distribution: Key to Long-Term Success Marketers Track Web Browsing Trends to Serve Ads Radio Broadcasters Need to Smarten Up to Increase Revenues through Internet Internet Radio: A Platform for Indie Artists 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSISIV. COMPETITION Total Companies Profiled: 79 For more information about this report visit https://www.researchandmarkets.com/r/344gve Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Internet Radio Market Study, 2012-2019 & 2020-2027", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Aug. 19, 2020 /PRNewswire/ --Read the full report: https://www.reportlinker.com/p05126388/?utm_source=PRN The 3D printing market by revenue is expected to grow at a CAGR of over 18% during the period 20192025. The global 3D printing industry has been on a stable growth path over the last decade. 3D printing has opened a plethora of opportunities for mankind. It is permeating many industries and sectors, thereby creating ways to explore new products. The 3D printing market has been growing tremendously in the last decade, and it is witnessing investments by both public and private enterprises. Several governments across the world are keen to invest in this domain, and they have already started investing in the same. The US, UK, Germany, France, and China are the leading countries with the highest adoption and investment rates. The automotive industry is expected to expand at the fastest pace because of the growing acceptance of the technology in automotive part manufacturing. 3D printing technology is largely adopted in the aerospace and defense sectors. The aircraft industry is among the early adopters of the technology. 3D printing continues its industrialization journey despite the outbreak of the COVID-19 pandemic. It is supporting the battle against the COVID-19 pandemic. As many hospitals struggle to get critical medical supplies, this technology has emerged as a solution that enables a quick response to certain supply chain shortages. The agility offered by 3D printing can be useful not only during this pandemic. 3D printing materials for medical applications must be developed for medical environments, meaning that they must withstand high temperatures and be biocompatible. While such materials do exist on the 3D printing market, their variety is much lower than that of more common thermoplastics. The following factors are likely to contribute to the growth of the 3D printing market during the forecast period: Developing Sustainable Future with 3D Printing Scalability from Rapid Prototyping to Production Accelerated Growth due to 3D Printing Software Evolution Increased Initiatives and Spend by Government Agencies The study considers the present scenario of the 3D Printing market and its market dynamics for the period 2019?2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market. 3D Printing Market Segmentation The global 3D printing market research report includes a detailed segmentation by component, end-user, application, process, and geography. 3D printers have grown exponentially in recent years as they become cheaper, more efficient, and more capable. The demand for faster speed and higher printing reliability has driven manufacturers to shift their focus on metal 3D printing to production applications. The industrial 3D printing market is growing at a significant rate around the globe, particularly in developed economies as large manufacturers are likely to use this technology to reduce production costs. Electrics and electronics, food and beverage, aerospace, automobile, and healthcare are the main end-users of commercial printers. The industrial machinery industry is the largest revenue-generating segment. The demand for 3D printing in this industry is growing as the industry is witnessing a slow shift toward efficient production techniques and optimum resource utilization. The UK and Switzerland are the leading countries in the overall manufacturing climate, followed by the US, Japan, and Canada due to their strategies, cost factors, labor contributions, and infrastructure. The aerospace and defense industry has been an early adopter of this technology and continues as a contributor to market growth. The demand for this technology in the aerospace industry is expected to increase during the forecast period owing to the high standard of parts performance and accuracy. 3D printing can be particularly useful for prototyping of jewelry design, architecture, or electronics in the manufacturing of mechanical components, cases, architectural templates, props, and practical consumer goods. Rapid prototyping is a cost-effective option for almost any 3D concept from small pieces to massive outputs. The increasing application in healthcare, manufacturing, and construction, and consumer goods and electronics is expected to drive the 3D printing market in prototyping. The increase in consumer electronics consumption is expected to increase the demand for the tooling segment. The focus on product customization fuels the requirement for new molds and dyes designed for the manufacturing of products. In addition, the growth of renewable energy systems requires sophisticated and professionally designed dye molds and machine tools to produce parts. Owing to the demand for product customization, the increased use of consumer electronics and electrical appliances, and the growth in renewable energy, the demand for equipment is projected to rise at a remarkable pace during the forecast period. Furthermore, advancements such as penetration of IoT and automation are projected to offer several lucrative opportunities during the forecast period. Segmentation by Component 3D Printers o By Sub-products Personal/Desktop Professional Design Industrial o BY Machine Type Metal Polymer Ceramic and Others o 3D Printing Software o 3D Materials o 3D Printing Services Segmentation by End-user Industrial Machinery Aerospace & Defense Healthcare Automotive Consumer Products Others Segmentation by Application Prototyping Tooling Functional Part Manufacturing Segmentation by Process Extrusion VAT Polymerization Powder Bed Fusion Material Jetting Others INSIGHTS BY GEOGRAPHY The 3D printing services market in North America thrives on the ongoing surge in industrial automation in the region. It is witnessing a healthy growth of industries such as manufacturing, chemicals, and energy. The US is the largest market for industrial 3D printers in the world followed by Japan, Germany, and China. Industries are open toward the adoption of these printers as systems for rapid prototyping. The deployment of such printers could save such costs while demonstrating higher efficiency, greater flexibility, and reduced waste at the same time. Thus, these devices are witnessing demand from the manufacturing industry in the country. The efficient use of materials, along with minimized human errors, product customization, and reduced production time and cost, is the main driving factor in the market. However, the high cost of software and the lack of skilled labor limit the growth of 3D printing market share in North America. Segmentation by Geography North America o US o Canada Europe o UK o Germany o France o Spain o Italy o Sweden APAC o China o Japan o South Korea o Australia o India o Singapore Latin America o Brazil o Mexico Middle East & Africa o Saudi Arabia o UAE o Saudi Arabia INSIGHTS BY VENDORS The 3D printing industry is growing, with new companies and investors investing in the market. The introduction of new 3D hardware printing firms has turned the market more dynamic, thus more profitable than ever. The 3D printing market remains a diverse environment, with technology not generally interconnected around each of the core segments. Therefore, greater connectivity is required, which is an important prerequisite for 3D printing as a digital production technology. Businesses are adopting this technology as part of digital transformation strategies, as the COVID-19 pandemic threatens to impact processes and create supply chain shortages. Digitization provided by this technology will provide companies the efficiency and agility they need to fix supply chain challenges and change consumer demands. Prominent Vendors 3D Systems ARC Group EOS GmbH HP Materialise Proto Labs Stratasys SLM Solutions Group AG EnvisionTEC GE Additive XYZprinting Desktop Metal Other Prominent Vendors 3D Hubs Aleph Objects Carbon Cookson Precious Metals (Cooksongold) ExOne Kraftwurx Autodesk Voxeljet New Kinpo Group Beijing Tiertime Technology Formlabs Groupe Gorg Ultimaker Hgans Koninklijke DSM M3D Makexyz Markforged Mcor Industries Monoprice Optomec Ponoko Renishaw Nano Dimension Organovo Prototype Projects SGD Simplify3D Sculpteo Shapeways Denford Ricoh Company Trinckle BigRep ReaLizer Taulman3D KEY QUESTIONS ANSWERED 1. What is the global 3D printing market size and growth rate during the forecast period? 2. What are the factors impacting the growth of the 3D printing market shares? 3. How is the growth of the industrial machinery segment influencing the growth of the 3D printing market trends? 4. Who are the leading vendors in the 3D printing market, and what is their market share? 5. What is the impact of the COVID-19 pandemic on the 3D printing market?Read the full report: https://www.reportlinker.com/p05126388/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com", "role": "user" }, { "content": "The 3D printing market by revenue is expected to grow at a CAGR of over 18% during the period 2019-2025 In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global 3D Printing Market Report", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, Aug. 21, 2020 /PRNewswire/ --Cuyo Productions' CEO, Shelly Ro, launched the company's music video division as director of Latin pop star, Emiliano's newest music video for his single, \"Todo El Espacio.\" Filmed in San Diego, California, Cuyo Production's multi-cultural production team was 55% lead by women. \"Todo El Espacio\" drops at 12 p.m. on August 21, 2020. https://youtu.be/mYJkDzbLTiY. 21-year old, singer-songwriter and composer, Emiliano, has released seven singles and EP's in his career, and during that time has worked with producers such as Kiko Cibrian, among others. \"There was so much chemistry collaborating with Cuyo Productions' Shelly Ro on 'Todo El Espacio.' This was an incredible experience that resulted in a new relationship with a reliable work partner. Shelly's passion for her work helped in delivering the message of 'Todo El Espacio,' and I am looking forward to working with her in future projects- a perfect fit,\" said Emiliano. \"I have always been intrigued about the intersection between music and film in a music video, and when we were presented with the opportunity to work with Emiliano, I knew it was the beginning of a great new collaboration. He is extremely talented, open, giving, and a true artist- I could not have asked for a better partner in crime for my first time in the Director's chair,\" said Ro. Led by founder and CEO, Shelly Ro, Cuyo Productions is an American media production company based in Los Angeles that provides entertainment content for digital platforms, including productions of short films and feature films. Cuyo Productions is the vision of CEO Shelly Ro's desire to create an inclusive space to empower underrepresented groups to tell their story and share their perspective of the world. Ro is moving towards the ideals of artistic excellence, cultural openness, and social diversity. For Further Contact:Isabella McDonald-Brent[emailprotected](818) 489-2978 SOURCE Cuyo Productions Related Links https://cuyoproductions.com/", "role": "user" }, { "content": "Cuyo Productions Co-Produces \"Todo El Espacio\" Music Video For Leading Latin Pop Artist Emiliano English USA - espaol", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, March 27, 2020 /PRNewswire/ --AIkido Pharma Inc. (Nasdaq: AIKI) (\"AIkido\" or the \"Company\") today announced that the record date and distribution date to our stockholders of shares of Hoth Therapeutics, Inc. (\"Hoth\") will be deferred because of the requirement that the shares be registered prior to distribution. AIkido will provide a record date and distribution date for the distribution of the shares promptly once the registration statement is declared effective and will issue an update to shareholders in two weeks on the status of this matter. About AIkido AIkido was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology Forward-Looking Statements Certain statements in this press release constitute \"forward-looking statements\" within the meaning of the federal securities laws. Words such as \"may,\" \"might,\" \"will,\" \"should,\" \"believe,\" \"expect,\" \"anticipate,\" \"estimate,\" \"continue,\" \"predict,\" \"forecast,\" \"project,\" \"plan,\" \"intend\" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law. Contact: Investor Relations: Hayden IR Brett Maas, Managing Partner Phone: (646) 536-7331 Email: [emailprotected] www.haydenir.com AIkido: Phone: 212-745-1373 Email: [emailprotected] www.AIkido.com SOURCE AIkido Pharma Inc.", "role": "user" }, { "content": "AIkido Pharma Inc. Provides Update on Timing of Record Date and Anticipated Distribution Date for Dividend Distribution", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: EATONTOWN, N.J.--(BUSINESS WIRE)--Investview, Inc. (OTCQB: INVU), a diversified financial technology company, today announced that it achieved record global revenues, net revenue and net income in its preliminary financial results for the fourth quarter and year ended March 31, 2021. The Company also reported a near tripling of fourth quarter fiscal 2021 gross revenue as well as significant year-over-year growth in other key financial performance metrics, including new, all-time-high monthly revenue and operating profit margin in the month of March 2021. \"It was a historic, record-breaking year and quarter for Investview, stated Mario Romano, Investviews Director of Finance. Global gross revenues for the year and the fourth quarter were $40.1 million and $18 million respectively, increases of 53% and 291%, respectively, over the same year ago periods. This was driven by strong business momentum across all business verticals including worldwide subscription growth from iGenius, our financial education direct marketing firm and the establishment and optimization of our Bitcoin mining operations, further enhanced by a new generation of digital assets, NDAU, the worlds first adaptive digital currency.'' \"By nearly every measure 2021 was our best year ever, topped off by a fantastic fourth quarter, the best quarter in our history in terms of revenue and profitability, commented Joe Cammarata, Investview CEO. Our entire team is meeting our global business challenges and executing on our commitment to growth as we strive to deliver continued record results to our shareholders. Financial education, transparency and trust remain a driving force with consumers, explained Cammarata,which is leading to increased demand and rapid growth, especially within Gen X and Y, where we are experiencing steadily improving participation rates. Our expanding line of products including the newly announced NDAU digital currency product packages will continue to define Investview as a leading, forward-thinking Fintech brand with a full offering of cutting-edge products that appeal to an increasingly wider, worldwide audience. Twelve Months Ended March 31, 2021 Financial Highlights Fourth Quarter Fiscal 2021 Financial Highlights Note: The numbers included in this release are initial expected results and are un-audited and may differ from numbers reported in our SEC filings due to compliance with US GAAP, and are subject to final review by the Companys independent auditors. Final audited financial statements will be released in our annual 10-K report. About Investview, Inc. Investview, Inc. is a diversified financial technology and global distributor organization that operates through its subsidiaries to provide financial education tools, content, research, and management of digital asset technology that mines cryptocurrencies, with a focus on Bitcoin mining and the generation of digital assets. For more information on Investview and its family of wholly owned subsidiaries, please visit: www.investview.com. Forward-Looking Statements All statements in this release that are not based on historical fact are \"forward-looking statements\" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies, and expectations, can generally be identified by the use of forward-looking terms such as \"believe,\" \"expect,\" \"may, should,\" \"could,\" \"seek,\" \"intend,\" \"plan,\" \"goal,\" \"estimate,\" \"anticipate\" or other comparable terms. These forward-looking statements are based on Investviews current beliefs and assumptions and information currently available to Investview and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. More information on potential factors that could affect Investviews financial results is included from time to time in Investviews public reports filed with the U.S. Securities and Exchange Commission (the SEC), including the Companys Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. The forward-looking statements made in this release speak only as of the date of this release, and Investview, Inc. (INVU) assumes no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.", "role": "user" }, { "content": "Investview (INVU) Announces Record 2021 Financial Results Record-breaking Fiscal 2021 Gross Revenues up 53% Generates Fiscal 2021 Operating Net Income of $1.6 million, a turnaround from a nearly $23 million fiscal 2020 loss Company Growth Accelerating: Record Breaking Fourth Quarter Revenue Growth of 291% year over year to $18 million and operating net income of $6 million $18 Million 4th Quarter Gross Revenue $16.1 Million 4th Quarter Net Revenue $6 Million 4th Quarter Net Income $8.3 Million 4th Quarter Bitcoin Mining Gross Revenue $40.1 Million Annual Gross Revenue $37.7 Million Annual Net Revenue $1.6 Million Annual Net Income (versus a $21.3 Million loss for last fiscal year)", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WESTMONT, N.J., Jan. 29, 2021 /PRNewswire/ --The Health Transformation Alliance (HTA), a cooperative of leading employers across the nation united in the common cause to improve healthcare quality and affordability for employees and their families, today reported that it reached a major milestone in 2020. In the four years since the HTA was formed, the cooperative has saved its member companies $1 billion in healthcare costs. The HTA launched in 2016 when 20 leading U.S. self-insured employers joined together to use their collective data and buying power to provide higher quality health benefits for their employees and their families at the same or lower cost. Among the first 20 companies that bought into the HTA nonprofit cooperative were Verizon Communications, Inc., Weyerhaeuser, Wayne Farms, and Lincoln Financial Group. Today, the HTA has 58 member-owners. In addition to generating healthcare cost savings, the HTA also achieved other milestones in 2020. In the calendar year, lives covered by the HTA's pharmacy programs increased from 2.1 million to 2.4 million; lives covered in its medical programs increased from 20,000 to 560,000; and the number of individuals whose claims data is now included in its data analytics platform grew from 2.6 million to 2.9 million. \"Growing participation in our programs is important because the HTA uses aggregated data and advanced analytics to deliver insights far beyond what a single company can produce,\" said Rob Andrews, CEO of the HTA. \"In addition, the more lives we cover, the more our buying power with healthcare providers and insurers increases. That means we can negotiate and enforce contracts that meet our member companies' healthcare goals and advance their shared interest: better outcomes for employees and their families at the same or lower cost.\" Said David Malfitano, Chief Human Resource Officer at Wayne Farms, \"As a member company of the HTA, one of its most important contributions is unbiased insights supported by high-quality data about where our employees can find care for the best outcomes at a more affordable cost. HTA allows for a fundamental shift from 'fee for service' healthcare to an investment in the actual improvement in health, plus a tremendous reduction of the cost of prescription drugs. The bottom line is the improvement of the health and well-being of our most important asset, our people.\" \"Member companies of the HTA come together to provide our employees and their families with high-quality healthcare information and solutions that meet their needs despite having to work within a broken healthcare system,\" said George Murphy, Senior Vice President of Total Rewards, HR Technology and Operations at Lincoln Financial Group. \"Armed with independent insights and data, we have the ability to tie our healthcare benefits programs to excellence and value.\" About Health Transformation Alliance The Health Transformation Alliance (HTA) is a cooperative of 58 of America's leading employers that have come together to x our broken healthcare system. With responsibility for more than 4 million lives in the United States and a collective annual health care spend of $27 billion, the member companies of the HTA have combined their resources, knowledge, and experience to transform the way healthcare is delivered. To that end, the HTA has developed value-driven solutions in data and analytics, pharmacy, medical and consumer engagement specically designed to improve patient care and economic value. SOURCE Health Transformation Alliance", "role": "user" }, { "content": "Health Transformation Alliance Saved Member Companies $1 Billion in Healthcare Costs", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, April 9, 2021 /PRNewswire/ -- The \"Global Weigh-In-Motion System Market by Type (In-Road, Bridge Weigh, Onboard), Vehicle Speed (Low, High), Component (Hardware, Software & Services), End-use Industry (Highway Toll, Oil & Refinery, Logistics), Sensors, Function, and Region - Forecast to 2027\" report has been added to ResearchAndMarkets.com's offering. The global weigh-in-motion system market is projected to reach USD 1,730 million by 2027 from USD 858 million in 2020, at a CAGR of 10.5% during the forecast period. To make transportation safe, more efficient, and sustainable, the governments of various countries such as the US, China, Japan, and many European countries have defined a roadmap for intelligent transportation infrastructure. For instance, the ITS Strategic Plan 2015-2019, started by the US Department of Transportation (USDOT), focuses on intelligent vehicles, intelligent infrastructure, and the creation of intelligent transportation systems. In the fiscal year 2020, the US Department of Transportation's Federal Highway Administration (FHWA) awarded Advanced Transportation and Congestion Management Technologies Deployment (ATCMTD) grants worth USD 49.6 million to 10 projects using advanced intelligent transportation systems (ITS) that will improve mobility and safety and support vehicle connectivity. The Virginia Department of Transportation (US) issued an order worth USD 135.9 million to construct a 6.24-mile long bypass for Rout6e 29 in Charlottesville (US) and Albemarle County (US). It planned to install an ITS and traffic control devices on the 6.24-mile long bypass. In FY 2020, the Regional Transportation Commission of Southern Nevada (RTC) issued an order worth USD 6 million for the Integrated Safety Technology Corridor project. In 2015, the Government of the Netherlands announced substantial investments in 12 regions and allocated more than USD 77.7 million for ITS until 2018, which involved the use of innovative technologies for traffic management, leading to better traffic distribution. Further, the Delhi government (India) planned to invest about USD 1 billion in 2019 in intelligent traffic management systems, with an aim to renovate the existing traffic system. ITS applications offer benefits of combining information, data processing, communication, and sensor technology and apply them to vehicles and traffic infrastructure and management software to provide a more efficient transport network. A WIM system enables intelligent use of the available transportation infrastructure and vehicles by allowing real-time information and data flow. The system collects data from sensors located in or above the infrastructure. It helps in smooth traffic flow, increases road safety by identifying overweight vehicles, and reduces road wear over a period. Thus, the growing demand for ITS all over the world is expected to drive the WIM market during the forecast period. Globally, the traffic data collection segment is expected to be the fastest-growing segment during the forecast period The traffic data collection system provides real-time monitoring of specific situations and road areas, such as toll highways, bridges, and underpasses, with the help of dedicated video devices. The system extracts useful information about road mobility and traffic, helps enhance road safety, and gives information to users. Thus, the traffic data collection segment is expected to be the fastest-growing segment during the forecast period. Europe is projected to be the largest regional market In 2020, Europe is estimated to dominate the market for weigh-in-motion systems. The region is expected to be a key revenue pocket for the weigh-in-motion market with growing investments by regional governments for transportation infrastructure development projects in national and international highways. Moreover, Europe is dominated by the high-speed weigh-in-motion system, which costs 50-60% higher than low-speed systems. Furthermore, a major reason for the European dominance of the weigh-in-motion system market is the free trade agreements between the EU countries. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary3.1 Introduction3.1.1 Pre- & Post-COVID-19 Scenario3.1.2 Report Summary 4 Premium Insights4.1 Attractive Opportunities in the Weigh-In-Motion System Market4.2 Weigh-In-Motion System Market Size, by Vehicle Speed4.3 Weigh-In-Motion System Market, by Type4.4 Weigh-In-Motion System Market, by End-use Industry4.5 Weigh-In-Motion System Market, by Component4.6 Weigh-In-Motion System Market, by Function4.7 Weigh-In-Motion System Market, by Region 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Increasing Government Initiatives Toward Intelligent Transportation System & Increasing Public-Private Partnerships (PPPs)5.2.1.1.1 Government Support Toward Intelligent Transportation System5.2.1.1.2 Increasing Public-Private Partnerships (PPPs) Model5.2.1.2 Increasing Traffic Congestion5.2.1.3 Low Cost Compared with Static Weigh Scale5.2.2 Restraints5.2.2.1 Lack of Standardized & Uniform Technologies5.2.3 Opportunities5.2.3.1 Increasing Investment in Smart Cities5.2.3.2 Free Trade Agreements5.2.3.3 Onboard WIM System5.2.4 Challenges5.2.4.1 Data Fusion5.2.4.2 Accuracy of Weigh-In-Motion System 6 Industry Trends in Weigh-In-Motion System Market6.1 Introduction6.2 Supply Chain Analysis6.3 Porter's Five Forces6.4 Potential Use Cases6.4.1 Mining Industry6.4.2 Agriculture6.5 Patent Analysis6.6 Trade Analysis6.7 Weigh-In-Motion System Market Scenario6.7.1 Realistic Scenario6.7.2 Low Impact Scenario6.7.3 High Impact Scenario6.8 Decision Chain Analysis: Weigh-In-Motion System 7 Analyst's Recommendations7.1 Europe is Estimated to Dominate the Market for Weigh-In-Motion System7.2 High-Speed WIM Systems - Key Focus Areas7.3 Conclusion 8 Weigh-In-Motion System Market, by Vehicle Speed8.1 Introduction8.1.1 Research Methodology8.1.2 Assumptions & Definitions8.1.3 Industry Insights8.2 Low-Speed8.2.1 Low-Speed WIM System Has the Largest Market Share in WIM System Market by Vehicle Speed8.3 High-Speed8.3.1 High-Speed WIM is the Fastest Growing Market in WIM System Market by Vehicle Speed 9 Weigh-In-Motion System Market, by Type9.1 Introduction9.1.1 Research Methodology9.1.2 Assumptions & Definitions9.1.3 Industry Insights9.2 In-Road System9.2.1 In-Road WIM System Has the Largest Market Share in WIM System Market by Vehicle Speed9.3 Weigh Bridge System9.3.1 Europe Has the Largest Market Share in Weigh Bridge System9.4 Onboard System9.4.1 Onboard WIM System is the Fastest Growing Market in WIM System Market by Type 10 Weigh-In-Motion System Market, by End-use Industry10.1 Introduction10.1.1 Research Methodology10.1.2 Assumptions & Definitions10.1.3 Industry Insights10.2 Highway Toll10.2.1 Highway Toll Has the Largest Market Share in WIM System Market by End-use Industry10.3 Oil & Refinery10.3.1 Oil & Refinery is the Fastest Growing Market in WIM System Market by End-use Industry10.4 Logistics10.4.1 Europe Has the Largest Market Share in Logistics Segment10.5 Others 11 Weigh-In-Motion System Market, by Component11.1 Introduction11.1.1 Research Methodology11.1.2 Assumptions & Definitions11.1.3 Industry Insights11.2 Hardware11.2.1 Hardware Has the Largest Market Share in WIM System Market by Component11.3 Software & Services11.3.1 Software & Services is the Fastest Growing Market in WIM System Market by Component 12 Weigh-In-Motion System Market, by Sensor Type12.1 Introduction12.1.1 Research Methodology12.1.2 Assumptions & Definitions12.1.3 Industry Insights12.2 Image Sensor12.2.1 Image Sensor Has the Largest Market Share in WIM System Market by Sensor Type12.3 Piezoelectric Sensor12.3.1 Europe Has the Largest Market Share in Piezoelectric Sensor Segment12.4 Bending Plate12.4.1 Asia-Pacific is the Fastest Growing Market in Bending Plate Segment12.5 Inductive Loop12.5.1 Europe Has the Largest Market Share in Inductive Loop Segment12.6 Magnetic Sensor12.6.1 North America Has the Second Largest Market Share in Magnetic Sensor Segment12.7 Acoustic Sensor12.7.1 Asia-Pacific is the Fastest Growing Market in Acoustic Sensor Segment12.8 Infrared Sensor12.8.1 Europe Has the Largest Market Share in Infrared Sensor Segment12.9 Radar Sensor12.9.1 North America Has the Second Largest Market Share in Magnetic Sensor Segment as of 201912.10 LiDAR Sensor12.10.1 Europe Has the Largest Market Share in LiDAR Sensor Segment12.11 Thermal Sensor12.11.1 Asia-Pacific is the Fastest Growing Market in Thermal Sensor Segment 13 Weigh-In-Motion System Market, by Function13.1 Introduction13.1.1 Research Methodology13.1.2 Assumptions & Definitions13.1.3 Industry Insights13.2 Vehicle Profiling13.2.1 Europe Has the Largest Market Share in Vehicle Profiling Segment13.3 Axle Counting13.3.1 Axle Counting Has the Largest Market Share in WIM System Market by Function13.4 Weight Enforcement13.4.1 Weight Enforcement Has the Second Largest Market Share in WIM System Market by Function13.5 Weight-Based Toll Collection13.5.1 Europe Has the Largest Market Share in Weight-Based Toll Collection Segment13.6 Traffic Data Collection13.6.1 Traffic Data Collection is the Fastest Growing Market in WIM System Market by Function 14 Weigh-In-Motion System Market, by Region14.1 Introduction14.2 Asia-Pacific14.3 Europe14.4 North America14.5 Rest of the World (RoW) 15 Competitive Landscape15.1 Market Evolution Framework15.2 Overview15.3 Market Evaluation Framework: Revenue Analysis of Top Listed/Public Players15.4 Weigh-In-Motion System: Market Ranking Analysis15.5 Competitive Scenario15.5.1 Product Launches, 2018-202015.5.2 Deals, 2018-202015.5.3 Other Developments, 2018-202015.6 Competitive Leadership Mapping for Weigh-In-Motion System Market15.6.1 Star15.6.2 Emerging Leaders15.6.3 Pervasive15.6.4 Participants15.7 Winners vs. Tail-Enders15.8 Revenue Impact Analysis 16 Company Profiles16.1 Kapsch Trafficcom16.2 Q-Free ASA16.3 International Road Dynamics (Quarterhill)16.4 Mettler Toledo16.5 Transcore (Roper Technologies)16.6 Avery Weigh-Tronix (Illinois Tool Works)16.7 TE Connectivity16.8 Kistler16.9 General Electrodynamic Corporation16.10 Efkon GmbH16.11 Other Players16.11.1 North America16.11.1.1 Intercomp16.11.1.2 Cardinal Scale Mfg.16.11.1.3 Roadsys16.11.2 Europe16.11.2.1 Cross Zlin16.11.2.2 Kemek16.11.2.3 Traffic Data Systems16.11.2.4 Camea16.11.2.5 Axis Communications16.11.3 Asia-Pacific16.11.3.1 Essae Digitronics16.11.3.2 Ashbee Systems 17 Appendix17.1 Insights of Industry Experts17.2 Discussion Guide17.3 Knowledge Store: The Subscription Portal17.4 Available Customizations17.4.1 Weigh-In-Motion System Market, by Type, by Country17.4.1.1 In-Road System17.4.1.2 Bridge Weigh17.4.1.3 Onboard17.4.2 Weigh-In-Motion System Market, by End-use Industry & Speed, by Region17.4.2.1 Asia-Pacific17.4.2.2 Europe17.4.2.3 North America17.4.2.4 RoW For more information about this report visit https://www.researchandmarkets.com/r/jvrq2w Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "The Worldwide Weigh-In-Motion System Industry is Projected to Reach $1.7 Billion by 2027 at a CAGR of 10.5% from 2020", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, March 26, 2021 /PRNewswire/ -- The \"India Medium Voltage Cable Accessories Market by Product Type, Technology and Industry Vertical, Construction and Infrastructure: Global Opportunity Analysis and Industry Forecast, 2019-2027\" report has been added to ResearchAndMarkets.com's offering. India medium voltage cable accessories market was valued at $746.5 million in 2019, and is projected to reach $1,029.1 million by 2027, registering a CAGR of 5.9% from 2020 to 2027. Medium voltage cable accessories range from 3.3kV to 33kV. These cable accessories are specially designed for stress control mechanism for enhanced product performance and to maintain high network reliability.A considerable investment in the construction sector majorly drives growth of the India medium voltage cable accessories market, as growth of the construction sector directly increases demand for medium voltage cable accessories for new constructions. Moreover, increase in investments on infrastructure development by governments, surge in use of underground cables, industrialization, and increase in focus on sustainable ways of generating electricity are expected to boost the market growth. Furthermore, a rise in government initiatives to make wire and cable industry self-reliant, growth in the adoption of e-mobility and surge in number of data centers are expected to provide lucrative growth opportunities for the market. However, the high rate of failure of heat shrink medium voltage cable accessories are expected to hinder growth of the India medium voltage cable accessories market.The India medium voltage cable accessories market is analyzed by product type, technology, industry vertical, and region. Based on product type, it is fragmented into cable joints, connectors, terminations, splice, and other product types. On the basis of technology, the market is segregated into heat shrink, cold shrink, and pre-molded terminations. By application, the market is divided into railways, construction, private utilities, cement, marine, government utilities, oil & gas, healthcare, fertilizer, steel, and others. The railways segment is further sub-segmented into government, and private. The construction segment is further bifurcated into real estate, and infrastructure. The real estate is furthermore sub-segmented into hospitality, institutional, retail, and other real estates. The infrastructure is furthermore sub-segmented into bridges, and roads. The private utilities is categorized as electricity, telecom, and other private utilities. The government utilities are also categorized as electricity, telecom, and other government utilities.The key players operating in the market include 3M India, BBC Cellpack GmbH, Cabseal (Hari Consolidated Pvt. Ltd.), Compaq International (P) Limited, Galathermo Pvt. Ltd., REPL International (Heat Shrink Technologies), Ikebana Engineering Ltd., Nexans, Pfisterer, Raychem RPG, and Yamuna Power Technologies.Key Topics Covered: Chapter 1: Introduction1.1. Report description1.2. Key benefits for Stakeholders1.3. Key Market Segments1.4. Research methodology1.4.1. Primary research1.4.2. Secondary research1.4.3. Analyst tools and modelsCHAPTER 2: Executive summary2.1. CXO perspectiveCHAPTER 3: MARKET OVERVIEW3.1. Market definition and scope3.2. Key findings3.2.1. Top impacting factors3.2.2. Top investment pockets3.3. Porter's five forces analysis3.4. Market dynamics3.4.1. Drivers3.4.1.1. Increase in investments by governments to improve power grid3.4.1.2. Increase in use of underground cables3.4.1.3. Growth in investments in construction sector3.4.2. Restraint3.4.2.1. High failure rate of medium voltage cable accessories3.4.3. Opportunities3.4.3.1. Rise in use of e-mobility3.4.3.2. Government initiatives to makewire and cable industry self-reliant3.4.3.3. Surge in number of data centers3.5. COVID Impact3.5.1. Impact on market size3.5.2. Impact on product pricing3.5.3. End user trends, preferences, and budget impact3.5.4. Key player strategies3.5.4.1. Limiting cuts to R&D expense3.5.4.2. Focusing on next-generation products3.5.4.3. Shifting toward agile supply chain model3.5.5. Opportunity window3.6. Market Share Analysis, 2019CHAPTER 4: India medium voltage cable accessories Market, By PRODUCT type4.1. Overview4.2. Cable Joints4.2.1. Key market trends, growth factors, and opportunities4.3. Connectors4.3.1. Key market trends, growth factors, and opportunities4.4. Terminations4.4.1. Key market trends, growth factors, and opportunities4.5. Splice4.5.1. Key market trends, growth factors, and opportunities4.6. Other Product Types4.6.1. Key market trends, growth factors, and opportunitiesCHAPTER 5: India medium voltage cable accessories Market, BY Technology5.1. Overview5.2. Heat Shrink5.2.1. Key market trends, growth factors, and opportunities5.3. Cold Shrink5.3.1. Key market trends, growth factors, and opportunities5.4. Pre-molded terminations5.4.1. Key market trends, growth factors, and opportunitiesCHAPTER 6: India medium voltage cable accessories Market, BY Industry Vertical6.1. Overview6.2. Railways6.2.1. Key market trends, growth factors, and opportunities6.2.2. Government6.2.3. Private6.3. Construction6.3.1. Key market trends, growth factors, and opportunities6.3.2. Real Estate6.3.3. Infrastructure6.4. Private Utilities6.4.1. Key market trends, growth factors, and opportunities6.4.2. Electricity6.4.3. Telecom6.4.4. Other Private Utilities6.5. Cement6.5.1. Key market trends, growth factors, and opportunities6.6. Marine6.6.1. Key market trends, growth factors, and opportunities6.7. Government Utilities6.7.1. Key market trends, growth factors, and opportunities6.7.2. Electricity6.7.3. Telecom6.7.4. Other Government Utilities6.8. Oil & Gas6.8.1. Key market trends, growth factors, and opportunities6.9. Healthcare6.9.1. Key market trends, growth factors, and opportunities6.10. Fertilizer6.10.1. Key market trends, growth factors, and opportunities6.11. Steel6.11.1. Key market trends, growth factors, and opportunities6.12. Others6.12.1. Key market trends, growth factors, and opportunitiesCHAPTER 7: COMPANY PROFILES7.1.3M INDIA7.1.1. Company overview7.1.2. Key Executives7.1.3. Company snapshot7.1.4. Operating business segments7.1.5. Product portfolio7.1.6. Business performance7.2. BEHR BIRCHER CELLPACK BBC AG7.2.1. Company overview7.2.2. Key executives7.2.3. Company snapshot7.2.4. Operating business segments7.2.5. Product portfolio7.2.6. Business Performance7.3. HARI CONSOLIDATED PVT. LTD.7.3.1. Company overview7.3.2. Key Executives7.3.3. Company snapshot7.3.4. Operating business segments7.3.5. Product portfolio7.3.6. Business performance7.4. COMPAQ INTERNATIONAL (P) LIMITED7.4.1. Company overview7.4.2. Key Executives7.4.3. Company snapshot7.4.4. Operating business segments7.4.5. Product portfolio7.4.6. Business performance7.5. GALA GROUP7.5.1. Company overview7.5.2. Key Executives7.5.3. Company snapshot7.5.4. Operating business segments7.5.5. Product portfolio7.5.6. Business performance7.6. IKEBANA ENGINEERING LTD.7.6.1. Company overview7.6.2. Key Executives7.6.3. Company snapshot7.6.4. Operating business segments7.6.5. Product portfolio7.7. NEXANS S. A.7.7.1. Company overview7.7.2. Key executives7.7.3. Company snapshot7.7.4. Operating business segments7.7.5. Product portfolio7.7.6. R&D expenditure7.7.7. Business performance7.8. PFISTERER7.8.1. Company overview7.8.2. Key Executives7.8.3. Company snapshot7.8.4. Operating business segments7.8.5. Product portfolio7.8.6. Business performance7.9. RAYCHEM RPG7.9.1. Company overview7.9.2. Key Executives7.9.3. Company snapshot7.9.4. Operating business segments7.9.5. Product portfolio7.9.6. Business performance7.10. REPL INTERNATIONAL7.10.1. Company overview7.10.2. Key Executives7.10.3. Company snapshot7.10.4. Operating business segments7.10.5. Product portfolio7.10.6. Business performance7.11. YAMUNA POWER TECHNOLOGIES7.11.1. Company overview7.11.2. Key Executives7.11.3. Company snapshot7.11.4. Operating business segments7.11.5. Product portfolio7.11.6. Business performanceFor more information about this report visit https://www.researchandmarkets.com/r/jp6qou Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Indian Industry for Medium Voltage Cable Accessories to 2027 - Government Initiatives to Makewire and Cable Industry Self-reliant Presents Opportunities", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ATLANTA, Aug. 3, 2020 /PRNewswire/ --Managing effectively through pandemic-related disruptions impacting the overall economy, CatchMark Timber Trust, Inc. (NYSE: CTT) today reported second quarter 2020 results in line with our expectations, which bolstered meeting its full-year operating plan. The company also declared a cash dividend of $0.135 per share for its common stockholders of record on August 31, 2020, payable on September 15, 2020. Second Quarter and Half Year 2020 Results For the quarter ended June 30, 2020, CatchMark: Generated revenues of $21.8 million compared to $28.7 million in second quarter 2019, a decrease primarily related to reduced timberland sales given constraints in completing transactions due to the COVID-19 pandemic. Decreased net loss on a GAAP basis by $24.4 million to $6.2 million from $30.6 million in second quarter 2019, primarily due to a $26.3 million decrease in losses allocated from the Triple T joint venture. Generated Adjusted EBITDA of $9.4 million compared to $15.1 million in second quarter 2019, a decrease primarily from reduced timberland sales. For the second quarter, year-over-year Harvest EBITDA increased by 1% to $7.4 million, Real Estate EBITDA decreased by 80% to $1.6 million, and Investment Management EBITDA increased by 1% to $2.8 million. Produced timber sales revenue of $16.2 million consistent with the $16.3 million generated in second quarter 2019. Increased total harvest volume by 15% to 567,908 tons from 494,626 tons in second quarter 2019 primarily by capitalizing on increasing mill demand driven by robust sales of home remodeling and improvement products during the pandemic. Sold 1,100 acres for $1.7 million compared to 4,000 acres for $8.2 million in second quarter 2019, a decrease of $6.6 million in timberland sales revenue due to a decrease in transactions as a result of pandemic-related constraints. The lower per-acre sales price $1,564 compared to $2,072 resulted from selling timberlands with a lower percentage of pine plantations as part of strategic culling as well as from CatchMark retaining through timber reservations 25,000 tons of merchantable inventory with a 62% sawtimber mix. Generated $2.9 million in asset management fee revenues from the Triple T and Dawsonville Bluffs joint ventures, consistent with the prior year period. Paid a dividend of $0.135 per share to stockholders of record on June 15, 2020. For the six months ended June 30, 2020, CatchMark: Generated revenues of $48.7 million compared to $51.2 million for the first six months of 2019 as higher timber sales revenue from increased harvest volumes was offset by reduced timberland sales revenue. Incurred a net loss of $10.4 million on a GAAP basis compared to $61.0 million in first half 2019, primarily due to a $53.8 million decrease in losses allocated from the Triple T joint venture. Realized Adjusted EBITDA of $22.3 million compared to $25.2 million for first half 2019. Harvest EBITDA increased by 10% to $16.0 million up from $14.5 million for first half 2019 due to increased timber sales from higher harvest volumes. Real Estate EBITDA declined to $6.1 million from $9.8 million due to reduced timberland sales; and Investment Management EBITDA decreased to $5.7 million from $6.2 million as a result of lower income from the Dawsonville Bluffs joint venture, which effectively roundtripped in the third quarter 2019. Increased timber sales revenue by 5% to $34.3 million up from $32.8 million for the first six months of 2019 as timber sales volume increased by 18% to 1.2 million tons from 1.0 million tons. Sold 4,100 acres of timberlands for $6.5 million compared to 4,900 acres for $10.3 million in first half 2019. The lower year-over-year, per-acre sales price resulted from lower average merchantable inventory stocking levels 20 tons per acre compared to 31 tons per acre for prior year sales as well as from CatchMark retaining through timber reservations 0.1 million tons of merchantable inventory with a 52% sawtimber mix. Generated $5.8 million in asset management fee revenues from the Triple T and Dawsonville Bluffs joint ventures, a 3% increase from the same period prior year due to earning incentive-based promotes for Dawsonville Bluffs for exceeding investment return hurdles. Brian M. Davis, CatchMark's Chief Executive Officer, said: \"We delivered a strong second quarter from our harvest operations, managing effectively through the pandemic, and our outlook remains cautiously optimistic about the remainder of the year for meeting our operating plan, colored by the unpredictable impacts of COVID-19. In particular during the quarter, we stepped up harvests in the U.S. South to capitalize on consistent mill uptime and increasing demand for both pulpwood and sawtimber products after initial pullbacks by customers due to uncertainty related to the pandemic. We also closed nearly $2 million of timberland sales during the quarter, ahead of plan, but below the results of a typical quarter due to the pandemic. Working with an active transaction pipeline, we expect to normalize timberland sales during the second half of the year weighted to the fourth quarter. We also expect to benefit going forward from solid housing demand fundamentals and the recent rebound in homebuying.\" During the second quarter, CatchMark's Triple T joint venture, which invests with institutional partners in 1.1 million acres of Texas timberlands, renegotiated its wood supply agreement with Georgia-Pacific. The renegotiated agreement allows Triple T to achieve market-based pricing on timber sales, increases Triple T's reimbursement for extended haul distances, allows Triple T to sell sawtimber to other third parties, and expands Triple T's ability to sell large timberland parcels to third-party buyers. In connection with amending the Georgia-Pacific wood supply agreement, CatchMark invested an additional $5.0 million in the Triple T joint venture on the same terms and conditions as its existing investment and the asset management agreement between CatchMark and Triple T was amended to increase CatchMark's fees for the next two years. Davis said: \"The Triple T amendment was a big accomplishment during the quarter. Triple T, meanwhile, continues to operate to plan. We also will continue to concentrate on achieving our overriding goals of expanding CatchMark's ownership of prime timberlands in high-demand mill markets and managing our operations to generate predictable and stable cash flow throughout the business cycle, supporting our dividend.\" Operations Strong demand for home remodeling and improvement products by homeowners during the pandemic resulted in consistent mill uptime in CatchMark markets during the second quarter. As a result, CatchMark's harvest volumes increased 14% year-over-year in the U.S. South, driven by a 69% increase in stumpage sales, including to key customers outside of existing supply agreements. CatchMark's second quarter 2020 realized stumpage prices for pulpwood and sawtimber continued to hold a significant premium over South-wide averages as a result of assembling prime timberlands in strong micro markets. Realized stumpage prices for pulpwood and sawtimber were 12% and 8% lower, respectively, compared to second quarter 2019, trending with 12% and 13% decreases in South-wide average prices as tracked by TimberMart-South. Pacific Northwest harvest volumes increased ahead of plan to 21,260 tons from 14,513 tons in the three months ended June 30, 2019. Todd P. Reitz, CatchMark's Chief Resources Officer, said: \"Our delivered wood crews were well positioned to respond to increasing mill needs that lined up nicely with our thinning and harvesting plans and we were able to negotiate more volume for the quarter from our mill customers. Again, our presence in strong mill markets and our emphasis on delivered wood sales gave us an advantage in supplying mills in a very tight inventory environment. In the Pacific Northwest, improving fundamentals created opportunity to sell into demand from key regional players.\" Capital Position and Share Repurchases During the second quarter, CatchMark amended its credit agreement with CoBank: removing a reduction in the LTV ratio covenant which would have been effective at the end of 2021, increasing working capital by removing the minimum liquidity balance covenant, and enabling additional investments in joint ventures. The multi-draw term facility commitment was reduced from $200 million to $150 million which lowered unused commitment fees while still providing ample liquidity for future acquisitions. CatchMark borrowed $5.0 million under the multi-draw term facility during the quarter to fund its additional equity investment in the Triple T joint venture. The asset management agreement amendment with Triple T, increasing CatchMark's fees over the next two years, is CAD accretive for the company. As of June 30, 2020, CatchMark had $150.9 million of borrowing capacity remaining under its credit facilities, consisting of $115.9 million under the multi-draw term facility and $35.0 million under the revolving credit facility. Ursula Godoy-Arbelaez, CatchMark's Chief Financial Officer, said: \"After these amendments and transactions, we continue to have ample liquidity for important growth initiatives and other capital allocation priorities, including direct acquisitions and joint venture investments.\" During the quarter, CatchMark repurchased 8,648 shares under its share repurchase program for $67,108 and has $13.7 million remaining in the program for future repurchases as of June 30, 2020. Results for Three Months Ended June 30, 2020 Revenues for the three months ended June 30, 2020 were $21.8 million, $6.9 million lower than the three months ended June 30, 2019 as a result of a $6.6 million decrease in timberland sales revenue and a $0.3 million decrease in other revenues. Timberland sales revenue decreased due to selling fewer acres in the current quarter with a lower per-acre sales price as a result of retaining 25,000 tons of merchantable inventory through timber reservations and selling timberlands with lower percentage of pine plantation. Other revenues were higher in 2019 due to a $0.3 million gain from an early lease termination. Three Months EndedJune 30, 2019 Changes attributable to: Three Months EndedJune 30, 2020 (in thousands) Price/Mix Volume Timber sales (1) Pulpwood $ 8,239 $ (579) $ 381 $ 8,041 Sawtimber (2) 8,034 (630) 728 8,132 $ 16,273 $ (1,209) $ 1,109 $ 16,173 (1) Timber sales are presented on a gross basis. (2) Includes chip-n-saw and sawtimber. Net loss decreased by $24.4 million to $6.2 million for the three months ended June 30, 2020 from $30.6 million for the three months ended June 30, 2019 primarily due to a $26.3 million decrease in losses allocated from the Triple T joint venture, offset by a $1.1 million decrease in net timberland sales. Results for Six Months Ended June 30, 2020 Revenues for the six months ended June 30, 2020 were $48.7 million, $2.5 million lower than the six months ended June 30, 2019 as a result of a $3.9 million decrease in timberland sales revenue offset by a $1.5 million increase in timber sales revenue. Timberland sales revenue decreased due to selling fewer acres in the first half of 2020, with a lower per-acre sales price as a result of timber reservations and a lower average merchantable inventory stocking level. Gross timber sales revenue increased 5% primarily as a result of a $1.8 million increase in timber sales revenue from the Pacific Northwest driven by volume increases. Six Months EndedJune 30, 2019 Changes attributable to: Six Months EndedJune 30, 2020 (in thousands) Price/Mix Volume Timber sales (1) Pulpwood $ 16,972 $ (1,147) $ 29 $ 15,854 Sawtimber (2) 15,852 (955) 3,588 18,485 $ 32,824 $ (2,102) $ 3,617 $ 34,339 (1) Timber sales are presented on a gross basis. (2) Includes chip-n-saw and sawtimber. Net loss decreased by $50.5 million to $10.4 million for the six months ended June 30, 2020 from $61.0 million for the six months ended June 30, 2019 primarily due to a $53.8 million decrease in losses allocated from the Triple T joint venture, offset by a $3.7 million increase in general and administrative expenses primarily due to non-recurring post-employment benefits related to the retirement of the company's former CEO in January 2020. Adjusted EBITDA The discussion below is intended to enhance the reader's understanding of our operating performance and ability to satisfy lender requirements. EBITDA is a non-GAAP financial measure of operating performance. EBITDA is defined by the SEC as earnings before interest, taxes, depreciation and amortization; however, we have excluded certain other expenses which we believe are not indicative of the ongoing operating results of our timberland portfolio, and we refer to this measure as Adjusted EBITDA (see the reconciliation table below). As such, our Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Due to the significant amount of timber assets subject to depletion, significant income (losses) from unconsolidated joint ventures based on hypothetical liquidation book value, or HLBV, and the significant amount of financing subject to interest and amortization expense, management considers Adjusted EBITDA to be an important measure of our financial performance. By providing this non-GAAP financial measure, together with the reconciliation below, we believe we are enhancing investors' understanding of our business and our ongoing results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA is a supplemental measure of operating performance that does not represent and should not be considered in isolation or as an alternative to, or substitute for net income, cash flow from operations, or other financial statement data presented in accordance with GAAP in our consolidated financial statements as indicators of our operating performance. Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Some of the limitations are: Adjusted EBITDA does not reflect our capital expenditures, or our future requirements for capital expenditures; Adjusted EBITDA does not reflect changes in, or our interest expense or the cash requirements necessary to service interest or principal payments on, our debt; Although depletion is a non-cash charge, we will incur expenses to replace the timber being depleted in the future, and Adjusted EBITDA does not reflect all cash requirements for such expenses; Although HLBV income and losses are primarily hypothetical and non-cash in nature, Adjusted EBITDA does not reflect cash income or losses from unconsolidated joint ventures for which we use the HLBV method of accounting to determine our equity in earnings; and Adjusted EBITDA does not reflect the cash requirements necessary to fund post-employment benefits or transaction costs related to acquisitions, investments, joint ventures or new business initiatives, which may be substantial. Due to these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. Our credit agreement contains a minimum debt service coverage ratio based, in part, on Adjusted EBITDA since this measure is representative of adjusted income available for interest payments. We further believe that our presentation of this non-GAAP financial measurement provides information that is useful to analysts and investors because they are important indicators of the strength of our operations and the performance of our business. For the three months ended June 30, 2020, Adjusted EBITDA was $9.4 million, a $5.7 million decrease from the three months ended June 30, 2019, primarily due to a $6.3 million decrease in net timberland sales, offset by a $0.4 million decrease in general and administrative expense. For the six months ended June 30, 2020, Adjusted EBITDA was $22.3 million, a $2.9 million decrease from the six months ended June 30, 2019, primarily due to a $3.7 million decrease in net timberland sales, a $0.6 million decrease in Adjusted EBITDA generated by the Dawsonville Bluffs joint venture and a $0.3 million decrease in other revenues, offset by a $1.8 million increase in net timber sales. Our reconciliation of net loss to Adjusted EBITDA for the three months and six months ended June 30, 2020 and 2019 follows: Three Months Ended June 30, Six Months Ended June 30, (in thousands) 2020 2019 2020 2019 Net loss $ (6,183) $ (30,565) $ (10,432) $ (60,960) Add: Depletion 6,707 6,030 13,648 11,298 Interest expense (1) 3,006 4,395 6,256 8,767 Amortization (1) 1,116 229 1,874 687 Depletion, amortization, basis of timberland, mitigation credits sold included in loss from unconsolidated joint venture (2) 395 Basis of timberland sold, lease terminations and other (3) 1,721 6,668 4,997 8,475 Stock-based compensation expense 705 490 2,577 1,149 (Gain) loss on large dispositions (4) 5 (764) (1,274) (764) HLBV loss from unconsolidated joint venture (5) 2,311 28,600 2,311 56,088 Post-employment benefits (6) 11 2,297 Other (7) 36 4 70 114 Adjusted EBITDA $ 9,435 $ 15,087 $ 22,324 $ 25,249 (1) For the purpose of the above reconciliation, amortization includes amortization of deferred financing costs, amortization of operating lease assets and liabilities, amortization of intangible lease assets, and amortization of mainline road costs, which are included in either interest expense, land rent expense, or other operating expenses in the accompanying consolidated statements of operations. Includes non-cash basis of timber and timberland assets written-off related to timberland sold, terminations of timberland leases and casualty losses. (2) Reflects our share of depletion, amortization, and basis of timberland and mitigation credits sold of the unconsolidated Dawsonville Bluffs joint venture. (3) Includes non-cash basis of timber and timberland assets written-off related to timberland sold, terminations of timberland leases and casualty losses. (4) Large dispositions are sales of blocks of timberland properties in one or several transactions with the objective to generate proceeds to fund capital allocation priorities. Large dispositions may or may not have a higher or better use than timber production or result in a price premium above the land's timber production value. Such dispositions are infrequent in nature, are not part of core operations, and would cause material variances in comparative results if not reported separately. (5) Reflects HLBV (income) losses from the Triple T joint venture, which is determined based on a hypothetical liquidation of the underlying joint venture at book value as of the reporting date. (6) Reflects one-time, non-recurring post-employment benefits associated with the retirement of our former CEO, including severance pay, payroll taxes, professional fees, and accrued dividend equivalents. (7) Includes certain cash expenses paid, or reimbursement received, that management believes do not directly reflect the core business operations of our timberland portfolio on an on-going basis, including costs required to be expensed by GAAP related to acquisitions, transactions, joint ventures or new business initiatives. Conference Call The company will host a conference call and live webcast at 10 a.m. ET on Tuesday, August 4, 2020 to discuss these results. Investors may listen to the conference call by dialing1-888-347-1165 for U.S/Canada and 1-412-902-4276 for international callers. Participants should ask to be joined into the CatchMark call. Access to the live webcast is available at www.catchmark.comor here. A replay of this webcast will be archived on the company's website shortly after the call. About CatchMark CatchMark (NYSE: CTT) seeks to deliver consistent and growing per share cash flow from disciplined acquisitions and superior management of prime timberlands located in high demand U.S. mill markets.Concentrating on maximizing cash flows throughout business cycles, the company strategically harvests its high-quality timberlands to produce durable revenue growth and takes advantage of proximate mill markets, which provide a reliable outlet for merchantable inventory. Headquartered in Atlantaand focused exclusively on timberland ownership and management, CatchMark began operations in 2007 and owns interests in 1.5 million acres* of timberlands located in Alabama, Florida, Georgia, North Carolina, Oregon, South Carolinaand Texas. For more information, visit www.catchmark.com. * As of June 30, 2020 Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as \"may,\" \"will,\" \"expect,\" \"intend,\" \"anticipate,\" \"estimate,\" \"believe,\" \"continue,\" or other similar words. However, the absence of these or similar words or expressions does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of performance and are based on certain assumptions, discuss future expectations, describe plans and strategies, contain projections of results of operations or of financial condition or state other forward-looking information. Forward-looking statements in this press release include, but are not limited to, statements about meeting our operating plan for the remainder of the year and the impact of COVID-19 on our business, our expectation for a more favorable and efficient environment for completing transactions later this year, our expectations for a solid housing market, the impact of the amended wood supply agreement between Triple T and Georgia-Pacific, and our expectations regarding having greater access to working capital and ample liquidity for future investments as a result of our amendments to our credit agreement. Risks and uncertainties that could cause our actual results to differ from these forward-looking statements include, but are not limited to,that (i) we may not generate the harvest volumes from our timberlands that we currently anticipate; (ii) the demand for our timber may not increase at the rate we currently anticipate or at all due to changes in general economic and business conditions in the geographic regions where our timberlands are located, including as a result of the COVID-19 pandemic and the measures taken as a response thereto; (iii) a downturn in the real estate market, including decreases in demand and valuations, may adversely impact our ability to generate income and cash flow from sales of higher-and-better use properties; (iv) timber prices could decline, which would negatively impact our revenues; (v) the supply of timberlands available for acquisition that meet our investment criteria may be less than we currently anticipate; (vi) we may be unsuccessful in winning bids for timberland that are sold through an auction process; (vii) we may not be able sell large dispositions of timberland in capital recycling transactions at prices that are attractive to us or at all; (viii) we may not be able to access external sources of capital at attractive rates or at all; (ix) potential increases in interest rates could have a negative impact on our business; (x) our share repurchase program may not be successful in improving stockholder value over the long-term; (xi) our joint venture strategy may not enable us to access non-dilutive capital and enhance our ability to make acquisitions; (xii) we may not be successful in effectively managing the Triple T joint venture and the anticipated benefits of the joint venture may not be realized, including that our asset management fee could be deferred or decreased, we may not earn an incentive-based promote and our investment in the joint venture may lose value; and (xiii) the factors described in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, Part II, Item 1A. Risk Factors of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and our other filings with the Securities and Exchange Commission. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to update our forward-looking statements, except as required by law. CATCHMARK TIMBER TRUST, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (in thousands, except for per-share amounts) Three Months Ended June 30, Six Months Ended June 30, 2020 2019 2020 2019 Revenues: Timber sales $ 16,173 $ 16,273 $ 34,339 $ 32,824 Timberland sales 1,673 8,224 6,452 10,314 Asset management fees 2,857 2,841 5,832 5,683 Other revenues 1,054 1,322 2,106 2,412 21,757 28,660 48,729 51,233 Contract logging and hauling costs 6,978 7,153 14,255 14,509 Depletion 6,707 6,030 13,648 11,298 Cost of timberland sales 1,463 6,921 4,885 8,481 Forestry management expenses 1,671 1,592 3,505 3,326 General and administrative expenses 3,024 3,203 10,291 6,566 Land rent expense 96 133 220 275 Other operating expenses 1,585 1,629 3,221 3,273 21,524 26,661 50,025 47,728 Other income (expense): Interest income 4 32 50 62 Interest expense (4,070) (4,709) (8,027) (9,331) Gain (loss) on large dispositions (5) 764 1,274 764 (4,071) (3,913) (6,703) (8,505) Loss before unconsolidated joint ventures (3,838) (1,914) (7,999) (5,000) Income (loss) from unconsolidated joint ventures: Triple T (2,311) (28,600) (2,311) (56,088) Dawsonville Bluffs (34) (51) (122) 128 (2,345) (28,651) (2,433) (55,960) Net loss $ (6,183) $ (30,565) $ (10,432) $ (60,960) Weighted-average shares outstanding - basic and diluted 48,744 49,076 48,866 49,069 Net loss per-share - basic and diluted $ (0.13) $ (0.62) $ (0.21) $ (1.24) CATCHMARK TIMBER TRUST, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (UNAUDITED) (in thousands, except for per-share amounts) June 30, 2020 December 31, 2019 Assets: Cash and cash equivalents $ 9,350 $ 11,487 Accounts receivable 6,525 7,998 Prepaid expenses and other assets 6,024 5,459 Operating lease right-of-use asset 2,976 3,120 Deferred financing costs 210 246 Timber assets: Timber and timberlands, net 599,046 633,581 Intangible lease assets 7 9 Investment in unconsolidated joint ventures 4,132 1,965 Total assets $ 628,270 $ 663,865 Liabilities: Accounts payable and accrued expenses $ 6,715 $ 3,580 Operating lease liability 3,118 3,242 Other liabilities 39,666 10,853 Notes payable and lines of credit, less net deferred financing costs 436,967 452,987 Total liabilities 486,466 470,662 Commitments and Contingencies Stockholders' Equity: Class A common stock, $0.01 par value; 900,000 shares authorized; 48,771 and 49,008 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 488 490 Additional paid-in capital 727,409 729,274 Accumulated deficit and distributions (552,367) (528,847) Accumulated other comprehensive loss (35,003) (8,276) Total stockholders' equity 140,527 192,641 Noncontrolling interests 1,277 562 Total equity 141,804 193,203 Total liabilities and equity $ 628,270 $ 663,865 CATCHMARK TIMBER TRUST, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (in thousands) Three Months Ended June 30, Six Months EndedJune 30, 2020 2019 2020 2019 Cash Flows from Operating Activities: Net loss $ (6,183) $ (30,565) $ (10,432) $ (60,960) Adjustments to reconcile net loss to net cash provided by operatingactivities: Depletion 6,707 6,030 13,648 11,298 Basis of timberland sold, lease terminations and other 1,721 6,668 4,997 8,475 Stock-based compensation expense 705 490 2,577 1,149 Noncash interest expense 1,064 314 1,771 564 Other amortization 52 (85) 103 123 Gain on large dispositions 5 (764) (1,274) (764) Loss from unconsolidated joint ventures 2,345 28,651 2,433 55,960 Operating distributions from unconsolidated joint ventures (51) 128 Interest paid under swaps with other-than-insignificant financing element 1,152 1,492 Changes in assets and liabilities: Accounts receivable (1,146) (1,328) 473 35 Prepaid expenses and other assets 50 128 409 641 Accounts payable and accrued expenses 80 1,200 2,656 91 Other liabilities 2,219 1,270 1,177 465 Net cash provided by operating activities 8,771 11,958 20,030 17,205 Cash Flows from Investing Activities: Capital expenditures (excluding timberland acquisitions) (1,054) (938) (3,766) (2,197) Investment in unconsolidated joint venture (5,000) (5,000) Distributions from unconsolidated joint ventures 51 400 847 Net proceeds from large dispositions 5,311 20,863 5,311 Net cash provided by (used in) investing activities (6,054) 4,424 12,497 3,961 Cash Flows from Financing Activities: Repayments of notes payable (20,850) Proceeds from notes payable 5,000 5,000 Financing costs paid (974) (2) (1,004) (33) Interest paid under swaps with other-than-insignificant financing element (1,152) (1,492) Dividends/distributions paid (6,541) (6,578) (13,189) (13,156) Repurchases of common shares (78) (1,405) (2,130) (2,409) Repurchase of common shares for minimum tax withholding (34) (999) (365) Net cash used in financing activities (3,779) (7,985) (34,664) (15,963) Net change in cash and cash equivalents (1,062) 8,397 (2,137) 5,203 Cash and cash equivalents, beginning of period 10,412 2,420 11,487 5,614 Cash and cash equivalents, end of period $ 9,350 $ 10,817 $ 9,350 $ 10,817 CATCHMARK TIMBER TRUST, INC. AND SUBSIDIARIES SELECTED DATA (UNAUDITED) 2020 2019 (in thousands, except for per-ton, per-acre amounts) Q1 Q2 YTD Q1 Q2 YTD Consolidated Timber Sales Volume (tons) Pulpwood 324 354 679 294 304 599 Sawtimber (1) 271 214 484 193 191 383 Total 595 568 1,163 487 495 982 Harvest Mix Pulpwood 54 % 62 % 58 % 60 % 61 % 61 % Sawtimber (1) 46 % 38 % 42 % 40 % 39 % 39 % Period-end Acres Fee 393 392 392 432 424 424 Lease 22 22 22 27 26 26 Wholly-owned total 415 414 414 459 450 450 Joint venture interest (6) 1,092 1,092 1,092 1,104 1,100 1,100 Total 1,507 1,506 1,506 1,563 1,550 1,550 U.S. South Timber Sales Volume (tons) Pulpwood 320 352 672 294 303 597 Sawtimber (1) 250 195 445 188 177 365 Total 570 547 1,117 482 480 962 Harvest Mix Pulpwood 56 % 64 % 60 % 61 % 63 % 62 % Sawtimber (1) 44 % 36 % 40 % 39 % 37 % 38 % Delivered % as of total volume 63 % 61 % 62 % 79 % 74 % 77 % Stumpage % as of total volume (5) 37 % 39 % 38 % 21 % 26 % 23 % Net Timber Sales Price ($ per ton) (2) Pulpwood $ 13 $ 12 $ 13 $ 15 $ 14 $ 14 Sawtimber (1) $ 23 $ 23 $ 23 $ 24 $ 24 $ 24 Timberland Sales Gross sales $ 4,779 $ 1,673 $ 6,452 $ 2,090 $ 8,224 $ 10,314 Acres sold 3,000 1,100 4,100 900 4,000 4,900 % of fee acres 0.7 % 0.3 % 1.0 % 0.2 % 0.9 % 1.1 % Price per acre (3) $ 1,627 $ 1,564 $ 1,611 $ 2,236 $ 2,072 $ 2,103 Large Dispositions (4) Gross sales $ 21,250 $ $ 21,250 $ $ 5,475 $ 5,475 Acres sold 14,400 14,400 3,600 3,600 Price per acre (3) $ 1,474 $ $ 1,474 $ $ 1,500 $ 1,500 Gain $ 1,279 $ $ 1,279 $ $ 764 $ 764 Pacific Northwest Timber Sales Volume (tons) Pulpwood 4 3 7 1 1 Sawtimber (1) 21 18 39 5 13 18 Total 25 21 46 5 14 19 Harvest Mix Pulpwood 18 % 13 % 15 % % 9 % 8 % Sawtimber 82 % 87 % 85 % 100 % 91 % 92 % Delivered % as of total volume 84 % 100 % 91 % 100 % 87 % 90 % Stumpage % as of total volume 16 % % 9 % % 13 % 10 % Delivered Timber Sales Price ($ per ton) (2) Pulpwood $ 31 $ 29 $ 30 $ 40 $ 37 $ 38 Sawtimber $ 91 $ 84 $ 87 $ 101 $ 94 $ 96 (1) Includes chip-n-saw and sawtimber. (2) Prices per ton are rounded to the nearest dollar. Delivered timber sales price includes contract logging and hauling costs. (3) Excludes value of timber reservations. For the quarters ended June 30, 2020 and 2019, we retained 25,000 tons and 6,000 tons of merchantable inventory with a book basis of $204,000 and $69,000 respectively. (4) Large dispositions are sales of blocks of timberland properties in one or several transactions with the objective to generate proceeds to fund capital allocation priorities. Large dispositions may or may not have a higher or better use than timber production or result in a price premium above the land's timber production value. Such dispositions are infrequent in nature, are not part of core operations, and would cause material variances in comparative results if not reported separately. (5) Includes 1% from lump-sum sales in 2019. (6) Represents properties owned by Triple T joint venture in which CatchMark owns a 22.0% equity interest (based solely on capital contributions); and Dawsonville Bluffs, LLC, a joint venture in which CatchMark owns a 50% membership interest. CatchMark serves as the manager for both of these joint ventures. CATCHMARK TIMBER TRUST, INC. AND SUBSIDIARIES ADJUSTED EBITDA BY SEGMENT (UNAUDITED) (in thousands) Three Months EndedJune 30, Six Months Ended June 30, 2020 2019 2020 2019 Timber sales $ 16,173 $ 16,273 $ 34,339 $ 32,824 Other revenue 1,054 1,322 2,106 2,412 (-) Contract logging and hauling costs (6,978) (7,153) (14,255) (14,509) (-) Forestry management expenses (1,671) (1,592) (3,505) (3,326) (-) Land rent expense (96) (133) (220) (275) (-) Other operating expenses (1,585) (1,629) (3,221) (3,273) (+) Stock-based compensation 82 27 197 115 (+/-) Other 409 170 554 577 Harvest EBITDA 7,388 7,285 15,995 14,545 Timberland sales 1,673 8,224 6,452 10,314 (-) Cost of timberland sales (1,463) (6,921) (4,885) (8,481) (+) Basis of timberland sold 1,342 6,525 4,503 7,952 Real estate EBITDA 1,552 7,828 6,070 9,785 Asset management fees 2,857 2,841 5,832 5,683 Unconsolidated Dawsonville Bluffs joint venture EBITDA (34) (51) (122) 522 Investment management EBITDA 2,823 2,790 5,710 6,205 Total operating EBITDA 11,763 17,903 27,775 30,535 (-) General and administrative expenses (3,024) (3,203) (10,291) (6,566) (+) Stock-based compensation 623 463 2,380 1,034 (+) Interest income 4 32 50 62 (+) Post-employment benefits 11 2,297 (+/-) Other 58 (108) 113 184 Corporate EBITDA (2,328) (2,816) (5,451) (5,286) Adjusted EBITDA $ 9,435 $ 15,087 $ 22,324 $ 25,249 CATCHMARK TIMBER TRUST, INC. AND SUBSIDIARIES CASH AVAILABLE FOR DISTRIBUTION (UNAUDITED) (in thousands, except for per share data) Three Months Ended June 30, Six Months EndedJune, 30 2020 2019 2020 2019 Cash Provided by Operating Activities $ 8,771 $ 11,958 $ 20,030 $ 17,205 Capital expenditures (excluding timberland acquisitions) (1,054) (938) (3,766) (2,197) Working capital change (1,203) (1,270) (4,715) (1,232) Distributions from unconsolidated joint ventures 51 400 847 Post-employment benefits 11 2,297 Interest paid under swaps with other-than-insignificant financing element (1,152) (1,492) Other 36 4 70 114 Cash Available for Distribution (1) $ 5,409 $ 9,805 $ 12,824 $ 14,737 Adjusted EBITDA $ 9,435 $ 15,087 $ 22,324 $ 25,249 Interest paid (3,006) (4,395) (6,256) (8,767) Capital expenditures (excluding timberland acquisitions) (1,054) (938) (3,766) (2,197) Distributions from unconsolidated joint ventures 400 974 Adjusted EBITDA from unconsolidated joint ventures 34 51 122 (522) Cash Available for Distributions (1) $ 5,409 $ 9,805 $ 12,824 $ 14,737 Dividends / distributions paid $ 6,541 $ 6,578 $ 13,189 $ 13,156 Weighted-average shares outstanding, end of period 48,744 49,076 48,866 49,069 Dividends per Share $ 0.135 $ 0.135 $ 0.270 $ 0.270 (1) Cash Available for Distribution (CAD) is a non-GAAP financial measure. It is calculated as cash provided by operating activities, adjusted for capital expenditures (excluding timberland acquisitions), working capital changes, cash distributions from unconsolidated joint ventures and certain cash expenditures that management believes do not directly reflect the core business operations of our timberland portfolio on an on-going basis, including costs required to be expensed by GAAP related to acquisitions, transactions, joint ventures or new business activities. SOURCE CatchMark Timber Trust, Inc.", "role": "user" }, { "content": "CatchMark Reports Second Quarter 2020 Results and Declares Dividend", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WALTHAM, Mass., June 3, 2020 /PRNewswire/ --Salary.com, a leading SaaS provider of cloud-based compensation data, software, and analytics, released today Job Architect, a powerfuljob description management toolto keep job descriptions accurate and up-to-date adding velocity to hiring the right people at the right pay. Job Architect can be used as a stand-alone product or as an integrated part of Salary.com's leading CompAnalyst platform. Job descriptions are often created and stored in silos throughout an organization, creating challenges to hiring velocity and the overall strategy of talent management that often leads to the inaccurate pricing of jobs. Worse yet, over time, poor job descriptions make it difficult to retain valuable talent because compensation structures and skills sets are misaligned with the organization's needs or expectations of employees. \"We're seeing unprecedented upheaval in how companies are defining jobs and managing the work that people do,\" said Kent Plunkett, founder and CEO of Salary.com. \"Job Architect helps companies manage their job content library to get job descriptions right and optimize the performance of their people.\" Salary.com's Job Architect helps HR and compensation professionals standardize a job architecture which is foundational to company performance, transparency, and employee engagement. Job Architect brings the power of a central command center for managingjob descriptions and automating the process of market pricing jobs, This comprehensive solution streamlines workflows allowing for efficient review and approval cycles and enables collaboration among key company stakeholders from management, to hiring managers, talent acquisition and recruiters, all of whom have roles in achieving job architecture accuracy. Because Job Architect is fully integrated with the CompAnalyst platform organizations can make better pay decisions. Getting pay right with accurate job descriptions builds the foundation for career planning, pay transparency, and a high performing organization. Visit the company websiteto learn more about Job Architect and request a free demo. About Salary.com Salary.com is the leading SaaS provider of cloud-based compensation market data, surveys and analytics.Founded in 1999, the company serves over 25,000 survey participant organizations, over 8,000 business-to-business software subscribers, and over 30 million employees globally.Salary.com is committed to helping organizations drive company success by aligning compensation practices with recruiting, performance, and development initiatives through easy-to-access data and meaningful insights. The market leading CompAnalyst SaaS platform accelerates compensation workflows, delivers real time data and powers accurate, equitable and competitive compensation. Through its Salary Wizard and pioneering website, Salary.com delivers continually updated, reliable market pay data and career content to over 30 million visitors each year. For more information, please visit the company website at www.salary.com. SOURCE Salary.com Related Links https://www.salary.com", "role": "user" }, { "content": "Salary.com Releases Job Architect, A Powerful Job Description Management Tool to Align Organizational Needs and Improve Company Performance Job Architect simplifies the creation, sharing, and approval of job descriptions to help ensure the right individuals are in the right roles", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PURCHASE, N.Y.--(BUSINESS WIRE)--Black women are building and growing businesses faster than any other segment and yet receive less than one percent of venture capital funding. In addition, only three percent of the people actually leading investments at VC firms are Black according to the National Venture Capital Association. To help further access to funding for Black women, Mastercard today announced a multi-million dollar investment in Fearless Fund, a venture capital fund built by women of color for women of color. The significant investment gaps in women-founded companies, which is especially acute for Women of Color, holds everyone back, said Michael Froman, president of strategic growth, Mastercard. The need to narrow this gender and racial disparity is critical in driving forward innovation and fueling inclusive, sustained economic recovery across our country. We are investing in Fearless Fund and partnering to bring innovative programs to market to help Black women founders get access to the capital and resources they need to achieve their full potential. The investment will allow Fearless Fund to further expand their portfolio of women of color founded and co-founded companies in the CPG, Food & Beverage, Beauty, Fashion, and Technology sectors. Additionally, the social impact of the investment will have a significant role in job creation and wealth distribution in underserved communities. \"This multi-million dollar investment from Mastercard is further proof of their commitment to providing resources in an effort to better serve the hard-working but severely underfunded Women of Color entrepreneurs who so deserve equal capital distribution. We have been working together with Mastercard for almost 3 years now and look forward to growing this relationship,\" says Arian Simone, Co-Founder & General Partner of Fearless Fund. Mastercard has long been an advocate for the small business community and reinforced its investments to support Black communities with the introduction of its Strivers Initiative earlier this year. This initiative is focused on elevating the visibility of Black female business owners overcoming obstacles to maintain and grow their business, while encouraging consumers and businesses alike to shop, share and support them. In Solidarity Across U.S. Cities Last year, Mastercard announced a half-billion-dollar commitment to support Black communities across the U.S. over the next five years, to help close the racial wealth and opportunity gap starting in seven cities. As part of that effort the company is hosting in a series of local In Solidarity events to address financial barriers and how to advance equitable growth. The tour includes Strivers programming, hosted by Arian Simone, General Partner and Co-Founder of Fearless Fund, and in partnership with Create & Cultivate, to drive awareness on the state of Black women-owned business in select cities across the U.S. local markets. The Strivers events will foster dialogue with local leaders and small businesses around delivering on the needs of local businesses and the actions cities can take to advance an equitable business climate. To further underscore its commitment to this community, Mastercard and Fearless Fund launched the Fearless Strivers Grant Contest* to provide Black female small business owners across the U.S. whove been hit hardest by the pandemic with additional grants and tools to help grow their business. These efforts build on Mastercards sustained commitment to building a more inclusive digital economy including its commitment to bring 50 million small and medium-sized businesses into the digital economy, specifically helping 25 million woman entrepreneurs grow their businesses. For more information on how Mastercard is helping close the racial wealth and opportunity gap for Black communities across America visit here. Fearless Strivers Grant Contest Rules NO PURCHASE NECESSARY. THIS IS A SKILL BASED CONTEST. Void where prohibited. Open to black females who are legal U.S. residents (including DC), 18+ and the principal owner of a U.S.-based small business (as described in the Official Rules). Ends 5/23/21. For Official Rules & complete details, Click here. About Mastercard Mastercard is a global technology company in the payments industry. Our mission is to connect and power an inclusive, digital economy that benefits everyone, everywhere by making transactions safe, simple, smart and accessible. Using secure data and networks, partnerships and passion, our innovations and solutions help individuals, financial institutions, governments and businesses realize their greatest potential. Our decency quotient, or DQ, drives our culture and everything we do inside and outside of our company. With connections across more than 210 countries and territories, we are building a sustainable world that unlocks priceless possibilities for all. www.mastercard.com About Fearless Fund Fearless Fund invests in women of color-led businesses seeking pre-seed, seed level, or series A financing. Its mission is to bridge the gap in venture capital funding for women of color founders building scalable, growth aggressive companies. Fearless Fund is built by women of color for women. For more information on Fearless Fund, please visit www.fearless.fund.", "role": "user" }, { "content": "Mastercard Furthers Support for Black Women Entrepreneurs with Multi-Million Dollar Investment in Fearless Fund, a Venture Capital Firm Built by Women of Color for Women of Color Investment continues companys Strivers Initiative elevating and supporting Black, women entrepreneurs", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Nigeria Oil & Gas Downstream Market - Growth, Trends, and Forecasts (2020 - 2025)\" report has been added to ResearchAndMarkets.com's offering. The Nigerian oil refining capacity has increased by 63% between 2010 and 2018. The Nigerian oil & gas downstream sector is driven by the development of large and modular refineries. However, the market is restrained by poor maintenance and supply disruption resulting in a low utilization rate. The increasing refining capacity is expected to drive the demand in the market during the forecast period. Digitalization and modernization of the refining and petrochemical sector are expected to reduce the refining costs and process losses. This, in turn, is expected to create an opportunity for the market during the forecast period. Improving the existing downstream infrastructure and encouraging private sector investment for the refineries and petrochemical plants in is expected to drive the studied market during the forecast period. Key Market Trends Refinery Segment Dominate the Market Nigeria is the second biggest oil-rich country in Africa, after Libya. The country is estimated to hold 37 billion barrels of proven oil reserves. However, despite its rich resources, at present Nigeria's state-dominated oil industry is declining, afflicted by systemic corruption, starved for international investment, and hit hard by weak oil prices. Despite that malaise, oil remains the country's chief source of income. Improving the Infrastructure and Encouraging Private Sector Investment to Drive the Market Nigeria ranked as the 13th largest crude oil producer in the world with an average daily output of about 2 million barrels per day. Such high production country should have proper downstream infrastructure. Competitive Landscape The market for Nigeria oil & gas downstream remains concentrated. Some of the key players are Nigerian National Petroleum Corporation (NNPC), KBR Inc., NDEP plc, Indorama Group, and Midoil Refining & Petrochemicals Company Limited. Key Topics Covered: 1 INTRODUCTION 2 EXECUTIVE SUMMARY 3 RESEARCH METHODOLOGY 4 MARKET OVERVIEW 4.1 Introduction 4.2 Refining Capacity and Forecast, in million ton, till 2025 4.3 Key Projects Information 4.4 Recent Trends and Developments 4.5 Government Policies and Regulations 4.6 Market Dynamics 4.6.1 Drivers 4.6.2 Restraints 4.7 PESTLE Analysis 5 COMPETITIVE LANDSCAPE 5.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements 5.2 Strategies Adopted by Leading Players 5.3 Company Profiles 5.3.1 Nigeria National Petroleum Corporation 5.3.2 Niger Delta Exploration & Production Plc 5.3.3 KBR Inc. 5.3.4 Indorama Group 5.3.5 Midoil Refining & Petrochemicals Company Limited 6 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/2ttxmk", "role": "user" }, { "content": "Nigeria Oil & Gas Downstream Market Growth, Trends, and Forecasts 2020-2025: Improving the Infrastructure and Encouraging Private Sector Investment to Drive the Market - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that its partner, BeiGene, Ltd., has dosed the first patient in South Korea in a pivotal, single-arm clinical trial of zanidatamab (formerly ZW25) monotherapy in patients with advanced or metastatic HER2-amplified biliary tract cancer (BTC). Zymeworks will receive a US$10 million payment under its collaboration with BeiGene as a result of the achievement of this development milestone. Patients with biliary tract cancer generally have a poor prognosis and few treatment options, said Diana Hausman, M.D., Chief Medical Officer at Zymeworks. While BTC occurs in patients throughout the world, the incidence is particularly high in Asia. Our collaboration with BeiGene expands the potential of zanidatamab to help address this global unmet need. Zymeworks and BeiGene are progressing the opening of multiple clinical trial sites in support of the global registration-enabling Phase 2b clinical trial of zanidatamab in patients with HER2-amplified BTC. In the Asia region, multiple sites are open for enrollment in South Korea, and in China all sites have been selected with enrollment anticipated to begin in the first quarter of 2021. This global zanidatamab study may enable the submission of a Biologics License Application by Zymeworks in the United States as early as 2022. Multiple clinical sites are now open to enrollment in the U.S., Europe, and Asia, with additional sites planned, including in Canada and South America. We are pleased to have been able to initiate this important clinical trial and hope that it may help contribute to improving the lives of patients with advanced or metastatic BTC and HER2 amplification, said Lai Wang, Ph.D., Senior Vice President, Head of Global Research and APAC Clinical Development at BeiGene. As our collaboration with Zymeworks continues, this trial may help lead to expedited global regulatory approvals, including in China and South Korea. This pivotal Phase 2b clinical trial is a global, multicenter, open-label, single-arm study designed to evaluate the antitumor activity of zanidatamab monotherapy in patients with HER2-amplified, inoperable and advanced or metastatic BTC, including gallbladder cancer and cholangiocarcinoma (Phase 2:NCT04466891). Patients must have received at least one prior gemcitabine-containing systemic chemotherapy regimen for advanced disease and have experienced disease progression after (or developed intolerance to) their most recent prior therapy. The primary endpoint of the study is the confirmed objective response rate (ORR) by independent central review per the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1). Ongoing clinical trials are evaluating zanidatamab in first-line HER2-positive gastroesophageal adenocarcinoma (GEA) in combination with standard of care chemotherapy (Phase 2: NCT03929666) as well as in combination with the oral CDK4/6 inhibitor palbociclib (Ibrance, Pfizer) and fulvestrant in advanced HER2-positive, HR-positive breast cancer (Phase 2: NCT04224272). Zymeworks, in collaboration with BeiGene, plans to develop zanidatamab as a potential first-line treatment for patients with HER2-positive GEA. BeiGene is also conducting a two-arm Phase 1b/2 trial evaluating zanidatamab in combination with chemotherapy as a first-line treatment for patients with metastatic HER2-positive breast cancer and in combination with chemotherapy and BeiGenes PD-1-targeted antibody tislelizumab as a first-line treatment for patients with metastatic HER2-positive GEA (NCT04276493). In addition, an ongoing Phase 1 trial is evaluating the safety and antitumor activity of zanidatamab as a single agent and in combination with chemotherapy in HER2-expressing cancers that have progressed after prior standard of care treatments, including HER2-targeted agents (Phase 1: NCT02892123). About Zanidatamab Zanidatamab is a bispecific antibody, based on Zymeworks Azymetric platform, that can simultaneously bind two non-overlapping epitopes of HER2, known as biparatopic binding. This unique design results in multiple mechanisms of action including dual HER2 signal blockade, increased binding, and removal of HER2 protein from the cell surface, and potent effector function leading to encouraging antitumor activity in patients. Zymeworks is developing zanidatamab in multiple Phase 1, Phase 2, and registration-enabling clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The FDA has granted Breakthrough Therapy designation for zanidatamab in patients with previously treated HER2 gene-amplified BTC, and two Fast Track designations to zanidatamab, one as a single agent for refractory BTC and one in combination with standard of care chemotherapy, for first-line gastroesophageal adenocarcinoma (GEA). These designations mean zanidatamab is eligible for Accelerated Approval, Priority Review and Rolling Review, as well as intensive FDA guidance on an efficient drug development program. Zanidatamab has also received Orphan Drug designations for the treatment of biliary tract, gastric and ovarian cancers, as well as Orphan Drug designation for the treatment of gastric cancer from the European Medicines Agency. About Biliary Tract Cancer Biliary tract cancer (BTC), including gallbladder cancer and cholangiocarcinoma (bile duct cancer), accounts for approximately 3% of all adult cancers and is associated with a poor prognosis. Globally, more than 210,000 people are diagnosed with BTC every year. Most patients (> 65%) with BTC are diagnosed with tumors that cannot be removed surgically, and even those patients who undergo potentially curative surgery have a high recurrence rate. Treatment options are limited for patients with advanced BTC who experience disease progression after front-line chemotherapy. The human epidermal growth factor receptor 2 (HER2) is a well-described target for anti-cancer therapy. Tumor cells that produce a higher than normal level of HER2 tend to grow more quickly and spread to other parts of the body. About 5% to 19% of patients with BTC have tumors that express HER2, suggesting that these patients may potentially benefit from HER2-targeted therapy. Currently no HER2-targeted therapy has been approved for the treatment of BTC. About the Zymeworks-BeiGene Collaboration In November 2018, Zymeworks and BeiGene entered into license and collaboration agreements in which BeiGene was granted an exclusive license for the research, development, and commercialization of zanidatamab and ZW49 in Asia (excluding Japan), Australia, and New Zealand. The companies are collaborating on joint global development for selected indications, with the goal of developing zanidatamab and ZW49 worldwide across multiple HER2-expressing cancers and lines of therapy. About Zymeworks Inc. Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks lead clinical candidate, zanidatamab, is a novel Azymetric bispecific antibody currently which has been granted Breakthrough Therapy designation by the FDA and is in a registration-enabling clinical trial for refractory HER2-positive biliary tract cancer as well as several Phase 2 clinical trials for HER2-positive gastroesophageal and breast cancers. Zymeworks second clinical candidate, ZW49, is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks proprietary ZymeLink linker-cytotoxin. Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit www.zymeworks.com. Cautionary Note Regarding Forward-Looking Statements This press release includes forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and forward-looking information within the meaning of Canadian securities laws, or collectively, forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements that relate to Zymeworks clinical and preclinical development of its product candidates, expected payment as a result of BeiGenes achievement of a development milestone, planned opening of clinical trial sites, the potential submission of a Biologics License Application, the potential therapeutic effects of zanidatamab, and other information that is not historical information. When used herein, words such as will, may, plan, anticipated, and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon Zymeworks current expectations and various assumptions. Zymeworks believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various factors, including, without limitation, market conditions and the factors described under Risk Factors in Zymeworks Quarterly Report on Form 10-Q for its quarter ended September 30, 2020 (a copy of which may be obtained at www.sec.gov and www.sedar.com). Consequently, forward-looking statements should be regarded solely as Zymeworks current plans, estimates and beliefs. Investors should not place undue reliance on forward-looking statements. Zymeworks cannot guarantee future results, events, levels of activity, performance, or achievements. Zymeworks does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by law.", "role": "user" }, { "content": "Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene Zymeworks to receive US$10 million milestone payment from BeiGene Multiple sites active and recruiting globally in North America, Europe, and Asia", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: IRVINE, Calif.--(BUSINESS WIRE)--RESPAWN, the mental performance nutrition brand made for gamers, today announces the expansion of its consumable lineup with RESPAWN by 5 created in collaboration with Mars Wrigleys 5 gum. RESPAWN by 5 is a new gum made to satisfy taste and add a new layer of focus to the gaming experience. The sugar-free chewing gum is formulated with B vitamins and nutrients such as green tea extract. RESPAWN by 5 comes in three long-lasting, invigorating flavors Cool Mint, Tropical Punch, and Pomegranate Watermelon. The former is a mainstay gum flavor while the latter is among the most popular flavors of RESPAWNs mental performance drink and should be an easily welcomed addition to any gamers arsenal. Expertise in All the Right Areas RESPAWN by 5 was developed by experts from the global innovation team of Mars Wrigleys 5 gum team and the gaming division of RESPAWNs sister company, Razer. This combination of market leaders in the chewing gum and gaming spaces resulted in a superior gum for gamers to fuel their minds and taste buds. It combines the same great taste and long-lasting flavor known to 5 gum with the special blend of ingredients that has made the RESPAWN drink mix so popular. RESPAWN was created to address the clear market for food and beverage products in gaming that help players maintain focus and mental agility during gameplay, without the intense rush provided by many energy products, stated Sean Driscoll, Senior Product Evangelist for Respawn Ltd. Mars Wrigley brings with them immense experience and market leadership in the gum category and was a perfect partner for our new consumable line. Finding an innovative way to service new and existing customers, and uniquely so within the gaming space, is one way we continue growing our gum business, maintain our leadership and demonstrate expertise, says Flip Block, Global Brand Director at Mars Wrigley. It was an easy decision to align with Razer and RESPAWNs existing drink mix line to develop this product and satisfy a new market with RESPAWN by 5. Tested and Approved by Gamers RESPAWN knows gamers as it was born out of gaming lifestyle leader, Razer. As part of early product development, RESPAWN collected quantitative and qualitative data both internally and through the capable resources at Mars Wrigley. Product validation has remained a core element of RESPAWNs product development to guarantee meeting the unique needs of gamers. RESPAWN and Mars Wrigleys 5 gum team organized focus groups and taste tests studying the habits of gamers and their product consumption while gaming, all to determine the best gum offering in form factor, ingredients, and taste. The findings then helped the team adjust and perfect the final flavors and formula. For launch on September 8, 2020, RESPAWN by 5 gum will be available at a select number of retail outlets. ABOUT RESPAWN RESPAWN is the mental performance nutrition brand dedicated to the gaming lifestyle. It was born in 2019 with the goal of producing the best mental performance drink to support brain function for gamers and esports athletes alike. Since then, RESPAWN has expanded its lineup which now includes chewing gum and drinks. RESPAWN is the new choice for gaming enthusiasts and professional streamers who know and appreciate the need to continuously improve gaming performance. RESPAWN is brought to you by Respawn Pte. Ltd., a standalone entity associated with Razer. Razer and FOR GAMERS. BY GAMERS. are trademarks of Razer and are used by Respawn Pte. Ltd. under license. #RESPAWNandGameOn ABOUT MARS, INCORPORATED Mars is a family-owned business with more than a century of history making diverse products and offering services for people and the pets people love. With more than $35 billion in sales, the company is a global business that produces some of the worlds best-loved brands: M&Ms, SNICKERS, TWIX, MILKY WAY, DOVE, PEDIGREE, ROYAL CANIN, WHISKAS, EXTRA, ORBIT, 5, SKITTLES, UNCLE BENS, and COCOAVIA. Mars also provides veterinary health services that include BANFIELD Pet Hospitals, Blue Pearl, VCA and Pet Partners. Headquartered in McLean, VA, Mars operates in more than 80 countries. The Mars Five Principles Quality, Responsibility, Mutuality, Efficiency and Freedom inspire its more than 100,000 Associates to create value for all its partners and deliver growth they are proud of every day. For more information about Mars, please visit www.mars.com. Join us on Facebook, Twitter, LinkedIn, Instagram and YouTube. PRICE & AVAILABILITY $2.99 USD per 15-stick pack $27.99 USD per 10-pack tray (150 sticks) Available for purchase September 8, 2020 For more information, please visit razer.com/respawn/gum. PRODUCT ASSETS Download product images here", "role": "user" }, { "content": "Level Up Your Mind and Taste Buds: RESPAWN and 5 Gum Bring New Chewing Gum Created for Gamers RESPAWN by 5 is a long-lasting, flavorful chewing gum developed with ingredients to maintain focus and reaction time while gaming", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SEATTLE, Nov. 17, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced further SeptiCyte RAPID data demonstrating performance, reproducibility and identification of fungal infections, in two poster presentations at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo on Nov. 16-20. \"Our SeptiCyte technology leverages host-response gene-expression biomarkers to determine the probability of sepsis,\" said Rolland D. Carlson, Ph.D., Chief Executive Officer of Immunexpress. \"The data presented at AMP 2020 continues to strengthen our clinical validation of SeptiCyte RAPID which is based upon the predicate FDA cleared SeptiCyte LAB product. We also demonstrate that SeptiCyte RAPID can identify fungal infections, reinforcing the test's utility to identify sepsis that includes bacterial, fungal, or viral pathogens.\" The first poster titled, \"Comparison of a cartridge-based host gene expression test to a manual method for use in the diagnosis of sepsis,\" compares SeptiCyte RAPID with our 510(k) FDA cleared SeptiCyte LAB, as well as inter-operator performance of SeptiCyte RAPID cartridges. SeptiCyte RAPID combines SeptiCyte technology with the Biocartis Idylla platform* to differentiate infection positive (sepsis) from infection negative systemic inflammation in patients suspected of sepsis. SeptiCyte RAPID results are reported as a SeptiScore between 0 and 15, with higher scores representing higher probability of sepsis. Testing was conducted at two clinical laboratories, Intermountain Healthcare Central Lab and Providence Oregon Regional Laboratory, and SeptiScore results generated by SeptiCyte RAPID were compared to SeptiCyte LAB scores from the initial clinical trial for FDA clearance. Results demonstrate that SeptiCyte RAPID run on the Biocartis Idylla platform correlate strongly with SeptiCyte LAB and are reproducible for 28 clinical samples (r2=0.97 and r2=0.98). Reproducibility for inter-operator performance of SeptiCyte RAPID cartridges on different Idylla machines located at three different laboratories was 0.994. Studies are ongoing for further validation of the performance of SeptiCyte at multiple locations throughout the U.S. These initial results demonstrate that SeptiCyte RAPID, which has a turn-around time of ~1 hour, is a robust and reproducible sepsis test with potential for near-patient testing. Margret D. Oethinger, M.D., Ph.D., Medical Director at Providence Oregon Regional Laboratory said, \"SeptiCyte RAPID, as a host response test, appears to address some of the current challenges of sepsis diagnosis and our technologists found it very easy to run and interpret the test results.\" A second poster titled, \"In Silico Performance of a Rapid Sepsis Test in Patients with Candidemia,\" highlights SeptiCyte RAPID performance in distinguishing patients with candidemia from clinical controls with the SeptiCyte RAPID signature. Immunexpress has previously demonstrated that SeptiCyte RAPID gene expression biomarkers can differentiate both bacterial and viral sepsis from infection negative systemic inflammation. Here, using in silico data from an Affymetrix U219 microarray, the two fungal biomarkers had Area Under the Curves (AUCs) of 1.00, 0.942 and 0.942 for differentiating candidemia (n=6), from healthy patients (n=42), from patients who were initially suspected of sepsis and treated with antibiotics but subsequently demonstrated not to have an infection (n=26) and from infection negative systemic inflammation patients (n=43). This in silico data demonstrates that SeptiCyte RAPID can distinguish Candidemia and complements prior data demonstrating that SeptiCyte RAPID can also differentiate viral and bacterial sepsis. \"Candida infections present a significant clinical challenge, as such a diagnostic for fungal sepsis when blood cultures are negative would enable early targeted therapy and thereby likely improve patient outcomes, so this initial in silico data is encouraging,\" said Tom van der Poll, M.D., Ph.D., Professor of Medicine and Chair of the Department of Medicine in the Amsterdam UMC, University of Amsterdam, the Netherlands. The e-posters and accompanying presentations can be found on the AMP Meeting website and are also accessible through Events page on the Newsroom section of Immunexpress' website at www.immunexpress.com. AboutImmunexpressImmunexpressis a molecular diagnostic company, based out of Seattle, committed to improving outcomes for patients suspected of sepsis.Immunexpress'SeptiCyte technology can assess a patient's dysregulated immune response by quantifying and analyzing gene expression from whole blood, providing actionable results in about an hour to guide the physician in optimizing patient management decisions.SeptiCyte RAPID is a lab test for sepsis that combinesSeptiCyte technology with theBiocartis'Idylla platform*, empowering clinicians to swiftly differentiate infection positive (sepsis) from infection negative systemic inflammation in patients suspected of sepsis; diagnosing bacterial sepsis, viral sepsis, or fungal infections. This powerful combination of technologies enhances certainty for early sepsis diagnosis, to improve clinical outcomes and lower healthcare costs. InMarch 2020,Immunexpressreceived CE Marking ofSeptiCyte RAPID and announced a long-term commercialization partnership with Biocartis inEurope. For more information,visithttp://www.immunexpress.com/. FollowImmunexpressonTwitterandLinkedIn. *Immunexpressis licensed to use theIdylla trademark from Biocartis NV. Media Contacts:Maggie BellerRusso Partners, LLC (646) 942-5631[emailprotected] SOURCE Immunexpress, Inc.", "role": "user" }, { "content": "Immunexpress to Present SeptiCyte RAPID Data at the Association for Molecular Pathology Annual Meeting", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, July 6, 2020 /PRNewswire/ --Read the full report: https://www.reportlinker.com/p05913641/?utm_source=PRN The Global Blockchain in Energy Market is expected to grow from USD 524.22 Million in 2019 to USD 4,830.84 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 44.79%.Market Segmentation & Coverage:This research report categorizes the Blockchain in Energy to forecast the revenues and analyze the trends in each of the following sub-markets:On the basis of Component, the Blockchain in Energy Market is studied across Platform and Services. On the basis of Type, the Blockchain in Energy Market is studied across Private and Public. On the basis of End-User, the Blockchain in Energy Market is studied across Oil and Gas Sector and Power Sector. On the basis of Application, the Blockchain in Energy Market is studied across Energy Trading, Government Risk and Compliance Management, Grid Management, and Supply Chain Management. On the basis of Geography, the Blockchain in Energy Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Blockchain in Energy Market including Accenture, AWS, BigchainDB GmbH, BTL, Grid+, IBM, Microsoft, Nodalblock, Oracle, and Power Ledger Pty Ltd. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Blockchain in Energy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developmentsThe report answers questions such as:1. What is the market size and forecast of the Global Blockchain in Energy Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Blockchain in Energy Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Blockchain in Energy Market?4. What is the competitive strategic window for opportunities in the Global Blockchain in Energy Market?5. What are the technology trends and regulatory frameworks in the Global Blockchain in Energy Market?6. What are the modes and strategic moves considered suitable for entering the Global Blockchain in Energy Market?Read the full report: https://www.reportlinker.com/p05913641/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com", "role": "user" }, { "content": "The Global Blockchain in Energy Market is expected to grow from USD 524.22 Million in 2019 to USD 4,830.84 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 44.79% Blockchain in Energy Market Research Report by Component (Platform and Services), by Type (Private and Public), by End-User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Aug. 19, 2020 /PRNewswire/ --Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cabot Oil & Gas Corporation(\"Cabot\" or the \"Company\") (NYSE:COG)and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Cabotsecurities betweenOctober 23, 2015, andJune 12, 2020, both dates inclusive (the \"Class Period\"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/cog. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that throughout the Class Period, Defendants made materially false and misleading and/or failed to disclose that: (1)Cabothad inadequate environmental controls and procedures and/or failed to properly mitigate known issues related to those controls and procedures; (2) as a result,Cabot, among other issues, failed to fix faulty gas wells, thereby pollutingPennsylvania'swater supplies through stray gas migration; (3) the foregoing was foreseeably likely to subjectCabotto increased governmental scrutiny and enforcement, as well as increased reputational and financial harm; (4)Cabotcontinually downplayed its potential civil and/or criminal liabilities with respect to such environmental matters; and (5) as a result, the Company's public statements were materially false and misleading at all relevant times. OnJuly 26, 2019, during intraday trading hours,Cabotfiled a quarterly report on Form 10-Q with the Securities and ExchangeCommission, reporting the Company's financial and operating results for the quarter endedJune 30, 2019(the \"2Q19 10-Q\"). The 2Q19 10-Q disclosed that the Company had received two proposed Consent Order and Agreements (\"CO&As\") related to two Notices of Violation (\"NOVs\") it had received from the Pennsylvania Department of Environmental Protection (\"PaDEP\") back in June andNovember 2017, respectively, for failure to prevent the migration of gas into fresh groundwater sources in the area surroundingSusquehanna County, Pennsylvania. Following the release of the 2Q19 10-Q,Cabot'sstock price fell$2.63per share, or 12.07%, to close at$19.16per share onJuly 26, 2019. Then, onJune 15, 2020, during pre-market hours, following a grand jury investigation, thePennsylvaniaattorney general's office chargedCabotwith fifteen criminal counts arising from its failure to fix faulty gas wells, thereby pollutingPennsylvania'swater supplies through stray gas migration. Following this news,Cabot'sstock price fell$0.67per share, or 3.34%, to close at$19.40per share onJune 15, 2020. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/cogor you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Cabotyou have until October 13, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz 212-697-6484 | [emailprotected] SOURCE Bronstein, Gewirtz & Grossman, LLC Related Links http://www.bgandg.com", "role": "user" }, { "content": "COG SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Cabot Oil & Gas Corporation Shareholders of Class Action and Encourages Investors to Contact the Firm", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--fuboTV Inc. (NYSE: FUBO), the leading sports-first live TV streaming platform, has acquired Balto Sports, marking the companys first move into the online sports wagering market. Terms of the deal were not disclosed. Balto Sports is a Y Combinator company that develops tools for users to organize and play fantasy sports games. fuboTV intends to leverage its own proprietary technology along with Baltos contest automation software to launch a free to play gaming offering. In connection with the deal, Baltos team will join fuboTV and will be instrumental in driving the companys expansion into both free to play gaming and online sports wagering. The online sports wagering market is expected to reach $155 billion by 2024 according to Zion Market Research. Additional announcements will be forthcoming. David Gandler, co-founder and CEO, fuboTV, commented, As we said in our third quarter earnings announcement last month, fuboTV sees the online wagering space as complementary to our sports-first live TV streaming platform. We believe there are significant synergies between consumers who enjoy wagering and our subscribers who enjoy streaming live sports, creating a flywheel opportunity. As weve previously expressed, one of our goals with wagering is to expand our total available market (TAM) by developing another important revenue stream for fuboTV, as we are doing with our growing ad sales business. The acquisition of Balto Sports will enable us to build a first class, free to play experience that brings consumers the best games around live sports. From there, we see a natural progression to layer on real money wagering in regulated markets complementing fuboTVs live streaming video for a highly engaging user experience within our platform. We will be strategic in our approach to wagering as we consider and evaluate different opportunities and will adjust our plans accordingly. Were excited to launch sports wagering, integrate it into our core offerings and deliver what we believe will be a truly groundbreaking live TV streaming platform to consumers. About fuboTV fuboTV (NYSE: FUBO) is the leading sports-first live TV streaming platform offering subscribers access to tens of thousands of live sporting events annually as well as leading news and entertainment content. fuboTVs base package, fubo Standard, features a broad mix of 100+ channels, including 43 of the top 50 Nielsen-ranked networks across sports, news and entertainment (Primetime A18-49). Continually innovating to give subscribers a premium viewing experience they cant find with cable TV, fuboTV is regularly first-to-market with new product features and was the first virtual MVPD to stream in 4K. fuboTV merged with FaceBank Group in April 2020 to create a leading digital entertainment company, combining fuboTVs direct-to-consumer live TV streaming platform for cord-cutters with FaceBanks technology-driven IP in sports, movies and live performances. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on the current beliefs, expectations and assumptions of fuboTV and on information currently available to fuboTV. The forward-looking statements in this press release represent fuboTVs views as of the date of this press release. These statements may include, but are not limited to, statements regarding future events or future financial and operating performance and fuboTVs plans for, and the anticipated benefits of, and new strategic partnerships. Although fuboTV believes the expectations reflected in such forward-looking statements are reasonable, fuboTV can give no assurance that such expectations will prove to be correct. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause fuboTVs actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by applicable law, fuboTV does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. Important factors that could cause fuboTVs actual results to differ materially are detailed from time to time in the reports fuboTV files with the Securities and Exchange Commission, copies of which are available on the Securities and Exchange Commissions website at www.sec.gov and are available from fuboTV without charge. However, new risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties.", "role": "user" }, { "content": "fuboTV Acquires Balto Sports as First Step Into Online Sports Wagering Market", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: FOSTER CITY, Calif., Oct. 29, 2020 /PRNewswire/ --Auto insurance rates vary significantly between states for a given driver profile and vehicle model. CarInsurance.comhelps consumers assess the total cost of ownership by providing state-specific average insurance cost information for 2020 model cars. Vehicles making the grade for low cost insurance rates are generally: Affordable Well-designed with abundant safety features Tend to be popular with safety-conscious drivers See the complete study: Cheapest cars to insure for 2020 The report includes a searchable and sortable table showing the make, model and style of the lowest-cost 2020 cars to insure by state, along with the average premium. Highlights of the lowest cost autos to insure across the largest number of states include: 2020 Jeep Wrangler Black and Tan (lowest cost to insure in 20 states) 2020 Chrysler Voyager L (lowest cost to insure in nine states) 2020 Jeep Wrangler Freedom (lowest insurance cost in seven states and the District of Columbia) 2020 Chevrolet Express G2500 and G2500 LS (cheapest to insure in seven states) 2020 Hyundai Kona SEL Plus (least expensive to insure in five states) 2020 Buick Envision Preferred (least expensive to insure in two states) \"In addition to state-level insurance cost information for 2020 cars, we provide data on national insurance prices,\" explains Michelle Megna, editorial director for CarInsurance. \"We also share factors impacting auto insurance quotes and offer advice on what types of vehicles to avoid if a driver wants to minimize insurance payments.\" Megna is available to discuss differences in new model car insurance costs between states, elaborate on auto insurance discountsthat consumers can pursue, and explain how to insure a new car. About CarInsurance CarInsurance is owned and operated by QuinStreet, Inc. (Nasdaq: QNST), a leader in providing performance marketplace technologies and services to the FinTech, financial services and home services industries. QuinStreet is a pioneer in delivering online marketplace solutions to match searchers with brands in digital media. The company is committed to providing consumers with the information and tools they need to research, find and select the products and brands that meet their needs. CarInsurance is a member of the company's expert research and publishing division. CarInsurance is a one-stop online destination for car insurance information, providing unbiased, expert advice on how to shop for insurance plans, what consumers should pay and what coverage they can get from a policy. Since 2003, CarInsurance has been educating consumers through its breadth of expert content, tools, and in-depth studies to help site visitors make informed decisions about their car insurance. Twitter: @carinsuranceFacebook: www.facebook.com/carinsurance/ Media contact Jacqueline Leppla Senior Director of Public Relations QuinStreet, Inc Direct +1 775 321 3608 Email: [emailprotected]LinkedIn SOURCE CarInsurance.com Related Links http://CarInsurance.com", "role": "user" }, { "content": "CarInsurance Finds Cheapest New Cars to Insure by State Six vehicles emerge as consistently lowest cost to insure, down from 15 models in 2019", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ENGLEWOOD CLIFFS, N.J., Nov. 25, 2020 /PRNewswire/ --LG SIGNATURE, the ultra-premium brand from LG Electronics known for world-class design and cutting-edge innovations such as OLED 8K TVs, is extending its partnership with the renowned American Ballet Theatre (ABT) for the 2020 holiday season. As the exclusive ABT Global Electronics Partner, LG SIGNATURE will sponsor the first-ever 8K Ultra HD highlight production of the critically acclaimed performance of The Nutcracker, created by celebrated choreographer and ABT Artist in Residence Alexei Ratmansky. Continue Reading (PRNewsfoto/LG SIGNATURE) (PRNewsfoto/LG SIGNATURE) Celebrating LG SIGNATURE's OLED 8K cinematic innovation, The Nutcracker will feature ABT principal dancers Isabella Boylston and James Whiteside in a magical holiday setting at the High Line Hotel in New York City. The performance will premiere on ABT and LG SIGNATURE YouTube channels on Dec. 4 at 6 p.m.EST, giving audiences worldwide the opportunity to enjoy the timeless masterpiece in the comfort of their own homes. A preview video will be available on the ABT and LG SIGNATURE YouTube channels beginning today. \"In a year filled with many challenges, bringing The Nutcracker to life in stunning 8K resolution feels like a holiday hug we all need right now,\" saidPeggy Ang, marketing vice president at LG ElectronicsUSA. \"LG SIGNATURE shares a commitment to passion, excellence and redefining standards, and especially this year we're delighted to play a role in making the arts more accessible to communities across the country.\" \"LG SIGNATURE continues to be an incredible partner, propelling innovation in the arts during these unprecedented times,\" said Kara Medoff Barnett, executive director at American Ballet Theatre. \"In a year when we are unable to offer performances to live audiences, the opportunity to share scenes from Ratmansky's beloved Nutcracker online is both a wonderful holiday gift to our fans and a key milestone in our 80 year-history.\"The award-winning LG SIGNATURE OLED 8K TVs redefine the premium viewing experience thanks to more than 33 million self-lit pixels, 1 billion colors, perfect blacks and limitless contrast. With a picture that's four times sharper than 4K UHD and with 16 times the detail of HDTV, the 88- and 77-inch class LG SIGNATURE OLED 8K TVs exceedthe industry's official 8K Ultra HD definition set by the Consumer Technology Association. For more information about American Ballet Theatre, please visit www.abt.org. To learn more about LG SIGNATURE and its diverse growing lineup of appliances and electronics like the OLED 8K TV, please visit www.LGSIGNATURE.com. About LG SIGNATURELG SIGNATURE is the first ultra-premium brand across multiple product categories from global innovator LG Electronics. Catering to the most discerning consumers, LG SIGNATURE is designed to provide a state-of-the-art living experience that feels pure, sophisticated and luxurious. Combining the very best of everything LG has to offer, the distinctive LG SIGNATURE products were designed with their true essence in mind streamlined to focus on each product's essential function while maintaining LG SIGNATURE's modern, signature design. For more information, visit www.LGSIGNATURE.com.About LG Electronics USALG ElectronicsUSA, Inc., based inEnglewood Cliffs, N.J., is the North American subsidiary of LG Electronics, Inc., a$53 billionglobal innovator in technology and manufacturing. Inthe United States, LG sells a wide range of innovative home appliances, home entertainment products, mobile phones, commercial displays, air conditioning systems, solar energy solutions and vehicle components. The \"Life's Good\" marketing theme encompasses how LG isdedicated to people's happiness by exceeding expectations today and tomorrow. LG is a 2020 ENERGY STARPartner of the Year.www.LG.com. About American Ballet TheatreAmerican Ballet Theatre is one of the greatest dance companies in the world. Few ballet companies equal ABT for its combination of size, scope and outreach. Recognized as a living national treasure since its founding in 1940, ABT annually tours the United States and is the only major cultural institution to do so. For 80 years, the Company, which is headquartered in New York City, has appeared in a total of 132 cities in 45 countries and has performed in all 50 states of the United States. In 2006, by an act of Congress, American Ballet Theatre became America's National Ballet CompanySOURCE LG SIGNATURE", "role": "user" }, { "content": "LG SIGNATURE to Sponsor First 8K Production of Highlights from American Ballet Theatre's 'The Nutcracker' Collaboration of Two Celebrated Brands Brings Beloved Classic to the Masses", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN MATEO, Calif.--(BUSINESS WIRE)--Guidewire Software, Inc. (NYSE: GWRE), the platform P&C insurers trust to engage, innovate, and grow efficiently, today announced that Cognizant, a Guidewire PartnerConnect Consulting Global Premier partner, has achieved the Guidewire Cloud specialization. Cognizant, one of the worlds leading professional services companies, has been awarded this specialization by demonstrating exemplary skills, knowledge, and competency for its delivery of Guidewire Cloud deployments. The achievement of specializations enables insurers to have more clarity and insight into which partners have proven capabilities and expertise globally or regionally. In addition, partners with specializations can better promote their capabilities across Guidewire products and solutions. Achieving this specialization is part of Cognizants commitment to helping clients reach their modernization goals. We are excited to recognize Cognizant for achieving the Guidewire Cloud specialization, earned through their proven cloud solutions expertise to empower our mutual insurance customers on their cloud journeys, said Christina Colby, chief customer officer, Guidewire Software. Our scalable cloud service, Guidewire Cloud, is the optimal way for insurers to experience the full power of Guidewire InsuranceSuite and InsuranceNow and to navigate whats next in times of change. Insurance carriers are looking to transform their core platform, evaluate options for cloud migration and enable digital engagement. They need the right tools to adapt and succeed in a period of rapid industry change, delivered through a process that is both efficient and cost effective, said Meera Krishnamurthy, Global Market Head for Insurance Business Unit, Cognizant. Our partnership with Guidewire and achieving the Guidewire Cloud specialization validates our position of expertise, allowing us to confidently and successfully lead a clients cloud enabled transformative journey on the Guidewire Cloud platform. Please find more information about specializations on the Guidewire website here. About Guidewire PartnerConnect Guidewire PartnerConnect Consulting partners provide consulting services such as business transformation and strategy, implementation and related solution and delivery services. To date, Guidewire Consulting practices worldwide include over 10,000 consultants who have been trained or are experienced in Guidewire products. Guidewire PartnerConnect is an invitation-only program. For more information about Guidewire PartnerConnect please visit https://www.guidewire.com/partnerconnect. About Guidewire Software Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. We combine digital, core, analytics, and AI to deliver our platform as a cloud service. More than 400 insurers, from new ventures to the largest and most complex in the world, run on Guidewire. As a partner to our customers, we continually evolve to enable their success. We are proud of our unparalleled implementation track record, with 1,000+ successful projects, supported by the largest R&D team and partner ecosystem in the industry. Our marketplace provides hundreds of applications that accelerate integration, localization, and innovation. For more information, please visit www.guidewire.com and follow us on Twitter: @Guidewire_PandC. NOTE: For information about Guidewires trademarks, visit https://www.guidewire.com/legal-notices.", "role": "user" }, { "content": "Cognizant Achieves Guidewire PartnerConnect Cloud Specialization", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON & GALWAY, Ireland & SAN DIEGO--(BUSINESS WIRE)--Cell therapy company ONK Therapeutics and blood cancer charity Anthony Nolan have entered into a collaboration to facilitate the development of the next-generation natural killer (NK) cell therapies to improve the lives of patients with hematological malignancies and solid tumors. Anthony Nolan Cell & Gene Therapy Services will provide a consistent supply of umbilical cord blood and cord-derived NK cells as a choice of starting material for both ONK Therapeutics research activities and continued process development work. This source material is scalable and ethically-sourced from consenting donors. The parties bring together their extensive experience in cell sourcing, cell processing, translational research, understanding of the tumor microenvironment, and exploration of NK cells as a foundation for cellular immunotherapy. In doing so they aim to expedite the development of much-needed new lifesaving cell therapies for patients with a broad range of cancers. Diana Hernandez, Head of Immunotherapy at the Anthony Nolan Research Institute says: Our innovative partnership with ONK Therapeutics will serve to accelerate vital research and development into hematological and solid cancer treatments. We see this as an exciting opportunity which will ultimately lead to better treatments, improving the lives of many more cancer patients. Chris Nowers, CEO of ONK Therapeutics says: Anthony Nolan has a rich heritage in stem cell therapy research, including an enviable understanding of the biology of NK Cells and their processing. We look forward to continuing to partner with their team and to benefiting from their extensive know-how as we drive our programs towards clinical trials and beyond. -Ends- Anthony Nolan Cell and Gene Therapy Services www.anthonynolan.org/clinicians-and-researchers/cell-and-gene-therapy-services Anthony Nolan is the pioneering charity that saves the lives of people with blood cancer and blood disorders who need a stem cell transplant. Anthony Nolans Cell and Gene Therapy Services aim to facilitate ethical research and development through the sourcing and supply of donor starting materials to researchers and developers. With a register of over 850,000 donors, a cord blood bank, and four decades of experience providing stem cells, Anthony Nolan has the infrastructure, the expertise, and the skills to support the needs of the cell and gene therapy industry. LinkedIn: www.linkedin.com/showcase/anthony-nolan-cell-&-gene-therapy-services/ Contact: [email protected] ONK Therapeutics www.onktherapeutics.com ONK Therapeutics Ltd is an innovative cell therapy company dedicated to developing the next generation of off-the-shelf, dual-targeted NK cell therapies targeting hematological malignancies and solid tumors. The company was founded in 2015, by Prof. ODwyer MD, of NUI Galway, an expert in translational multiple myeloma research, the tumor microenvironment, and exploitation of NK cells as cellular immunotherapy. Its core proprietary off-the-shelf platform is based on a dual-targeted NK cell expressing both a chimeric antigen receptor (CAR) targeting a known tumor antigen and a TNF-related apoptosis-inducing ligand variant (TRAILv) targeting the death receptor pathway (i.e. DR4 or DR5). This unique approach has the potential to enhance efficacy by addressing both intrinsic (e.g. CAR engagement of a tumor-specific antigen) and extrinsic (e.g. signaling through the death receptor pathway) apoptotic pathways and to reduce the susceptibility to possible target antigen escape through the engagement of tumor antigen-independent TRAILv. Its pre-clinical pipeline comprises four programs: In addition to the unique off-the-shelf, dual-targeted NK cell therapy platform, the company has a strong research focus on strategies to enhance homing and persistence, and overcome exhaustion, including the exploration of proprietary gene edits, such as the deletion of checkpoint inhibitory receptors in NK cells. ONK Therapeutics is headquartered in the med-tech hub of Galway, Ireland, with a wholly-owned US subsidiary, ONK Therapeutics, Inc. based at JLabs @ San Diego. Shareholders include Acorn Bioventures, ALSHC (principally Seamus Mulligan), and Enterprise Ireland. Follow us on Twitter and LinkedIn. LinkedIn: www.linkedin.com/company/onk-therapeutics Twitter: ONK Therapeutics (@OnkTherapeutics) / Twitter NOTES TO EDITORS About Anthony Nolan Anthony Nolan saves the lives of people with blood cancer. The charity uses its register to match potential stem cell donors to blood cancer and blood disorder patients in need of stem cell transplants. It also carries out pioneering research to increase stem cell transplant success and supports patients through their transplant journeys. Every day Anthony Nolan gives three people a second chance at life. Find out more at www.anthonynolan.org Note to sub-editors Please note that Anthony Nolan changed its name in 2001 and is no longer known as Anthony Nolan Trust. What is a stem cell transplant? If a patient has a condition that affects their bone marrow or blood, then a stem cell transplant may be their best chance of survival. Doctors will give new, healthy stem cells to the patient via their bloodstream, where they begin to grow and create healthy red blood cells, white blood cells, and platelets. Key statistics", "role": "user" }, { "content": "Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics Announce Collaboration Anthony Nolan Cell & Gene Therapy Services will provide umbilical cord blood and cord-derived NK cells to facilitate the development of ONK Therapeutics next-generation dual-targeted NK cell therapies Collaboration supports a common mission to improve the lives of patients with hematological malignancies and solid tumors", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TAOS SKI VALLEY, N.M., Oct. 9, 2020 /PRNewswire/ --Taos Ski Valley leaders are thrilled to announce a plan for a return to skiing and riding this winter, offering visitors a welcome respite in the mountains while maintaining aggressive COVID Safe Practices. Taos Ski Valley will operate at 50% of peak capacity for the 2020-2021 winter season, meaning guests will have a once-in-a-lifetime Taos experience in an uncrowded, intimate alpine sanctuary. \"This winter, visitors will find fewer skiers, but all the heart at Taos Ski Valley. We are eager to welcome guests back to the mountain, and transform them with our pristine alpine environment,\" said David Norden, CEO of Taos Ski Valley. \"Of course, an unprecendented year means unprecedented skiing operations. We took our time with the details to make sure our winter planswould help create a sustained, viable ski environment for the entire season. We carefully developed a thoughtful, socially responsible approach with our ski industry peers and the state's tourism and health regulators that offers visitors an incredible experience with crowd-free access to our legendary ski terrain, while still making our staff, community, and guests' health and well-being our top priority.\" Taos Ski Valley's B Corporation ethos has been a beacon as the resort navigated through the pandemic response. Taos has elected to operate at a 50% capacity this winter out of an abundance of caution and care for the greater good, and to create an environment that promotes health and physical distancing. Staff, visitor, and employee well-being has been at the forefront of all decision-making and operations planning for this winter season. Additionally, Taos is committed to supporting the Northern New Mexico community through this crisis and helping to safely rebuild the local economy. Although capacity will be limited, Taos Ski Valley plans to operate dining, lodging, rentals, and retail. 2020-2021 Taos Ski Valley winter season plans include: Lift tickets must be purchased online, in advance of any visit, in order to manage the 50% capacity goal. Tickets will not be offered for sale at the ticket window. Ticket sales will continue until all are sold out. The number of day tickets available will dynamically change based on visitor patterns and season pass usage, so visitors are encouraged to plan ahead. Ticket sales will begin October 15 for the four weeks of early season, and on October 22 for the prime season. A whole new set of season pass optionswill be offered. These complement visitors' unusual work and schooling schedules this year, and support the goal of physical distancing and capacity limitations, while also offering extensive ski days on the mountain. Additionally, Taos is giving back to the community with a contribution to the Taos Community Foundation for every pass sold.Passes go on sale today, and only a limited number of passes are available at these prices during the Early Fall Pass Sale, which runs through October 25. If demand is high, pass sales may close prior to October 25. Midweek$450Skiing or riding MondayThursday with holiday blackouts. Returning passholders from last season receive $50 off. $5.00 contribution to the FundforTaos. Weekday Plus$695Skiing or riding Monday-Friday, with holiday blackouts. Early and late season skiing or riding any day of the week. Option to purchase tickets on any holiday or weekendfor a discounted rate of $85. Two comp tickets per passholder for any holiday weekend days. Returning passholders from last season receive $50 off. $10 contribution to the Fund forTaos. Unlimited$1,600Unlimited skiing or riding, any day of the week, no restrictions, (reservations may be required for opening Thanksgiving holiday weekend skiing.) Returning passholders from last season receive $50 off. Purchase during the Early Fall Sale and receive a complimentary Ikon Base Pass. $25 contribution to the Fund for Taos. Taos Ski Valley's new set of season passes are on sale now andcan be purchased here. Ikon Pass holders will need to make a reservation to ski or ride at Taos Ski Valley through the Ikon Passsystem. Private ski and ride lessons will be offered at the world-renowned Ernie Blake Snowsports School. Private lessons can include up to five guests visiting together. To book a lesson call 888.262.8398. Group lessons and childcare will not be offered this season. The Blake at Taos Ski Valley is planning to operate at 65% capacity, offering guests an elevated ski-in/ski-out experience with added amenities for guests including a spa and on-site or in-room dining. For added peace of mind, cleaning, disinfecting, and HVAC protocols have been significantly heightened, and all guests will be required to go through COVID screening upon arrival. Some guest services, including the ski valet and parking valet, will be eliminated this season. On-mountain restaurants are planning to open (including 192 at The Blake, the Bavarian, Phoenix Grill, Rhoda's Restaurant, Tenderfoot Katie's, and Whistlestop Caf) and will operate with COVID safety protocols including physically distanced seating that maximizes open-air dining whenever possible, new ordering procedures including contactless payment processing, and more. The resort will be cashless,meaning payment for all dining, rentals, ticketing, and retail will be via credit, debit, or prepaid card only. A cashless approach will reduce contact during the payment process. Guests should be prepared to pay with their smartphones or with credit, debit, or prepaid cards. A new skier drop-off areareplaces the parking lot shuttle, which will not operate this season. The new drop-off provides convenient access to the base area. Indoor spaces throughout the resort will be significantly limited this year, so skiers will need to put on boots and gear in designated outdoor areas, in their cars, or in their lodging. Although there will be no locker room access, a no-touch basket check will be available to guests for a fee. No large public gatherings will be allowed, including weddings, conferences, events, and competitions. Taos Ski Valley will look a bit different this winter due to COVID Safe Practices:guests must wear a face covering in all public places, are asked to follow appropriate physical distancing practices, and gatherings of more than 10 people are not allowed. Public, indoor gathering places throughout the resort will be significantly limited this year, so guests who are visiting Taos Ski Valley but don't intend to ski are encouraged to reserve a room with The Blake or one of the other base-area lodgers, or stay home. Taos Ski Valley staff are passing a daily temperature and symptom assessment and will also be wearing face coverings. Seasonal staff will be required to present a negative COVID test prior to commencing work. Buildings and facilities have new operations protocols in place, designed to maintain the highest levels of sanitation. Taos Ski Valley will continue to comply with all federal, state, and local guidelines. Taos Ski Valley leadership hopes that the added precautions will allow for an on-time season opening and the ability to remain open throughout the winter. Taos will continuously monitor all guidelines and the pandemic's affect on the community, and may adjust its business operations at any time in response. \"The snowmaking system is prepped and the lifts will be spinning soon; something we've been envisioning for the last six months,\" continued Norden. \"Our experience over the summer shows us that our guests are as eager as we are to get outside, and we've been gratified by their embrace of our COVID Safe Practices. This season's visitors will find a warm, welcoming resort community, thrilling and invigorating mountain activities, and an even more intimate experience than they have known and loved in Taos in the past.\" The 2020-2021 season is expected to open on November 26, 2020. About Taos Ski ValleyNestled among the pristine peaks of northernNew Mexico,Taos Ski Valleyis undergoing a$300 millionrenaissance, making it one ofNorth America'spremier vacation and adventure destinations. With more than 300 inches of average annual snowfall, 300 days of sunshine and more than 1,200 skiable acres,Taos Ski Valley is the world's only B Corp Certified ski resort, which means it operates with the highest standards of environmental sustainability, and social and economic justice. An independently owned and operated resort, Taos maintains an authentic charm while delivering a world-class experience both on-mountain and off for skiers and riders of all abilities.Taos Ski Valleyis proud to participate in theMountain Collective and Ikon Pass. To learn more aboutTaos Ski Valley and its B Corp commitment, please visitwww.skitaos.com. SOURCE Taos Ski Valley Related Links https://www.skitaos.com/", "role": "user" }, { "content": "Taos Ski Valley unveils 2020-21 winter season plans: big alpine skiing and an intimate experience Taos plans to limit capacity to half the skiers to eliminate crowding, require advance ticket purchase, adhere to strict COVID-Safe Practices", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX) (MedX or the Company), a global leader in teledermatology, will present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22nd at 12:00 PM EDT. Mike Druhan, President of Dermatology Services, will present at the event, outlining MedXs vision for scaling access to its unique dermatological image capture technology and its fully integrated telemedicine platform, DermSecure. Unlike other teledermatology screening tools available, MedXs DermSecure Screening Platform features high-resolution image capture technology for moles, lesions and other skin conditions, providing a complete, virtual dermatological assessment by a certified dermatologist within just 72 hours. To access the live presentation, please use the following details: Planet MicroCap Showcase: VIRTUAL 2021 Date: Thursday, April 22, 2021 Time: 12:00 PM Eastern Time Webcast: https://www.webcaster4.com/Webcast/Page/2059/40755 To book a one-on-one investor meeting with MedX or to watch the Companys presentation, please register for the virtual event here: https://planetmicrocapshowcase.com/signup One-on-one meetings will be scheduled and conducted via private, secure video conference through the conference event platform. The Planet MicroCap Showcase: VIRTUAL website is available here: https://planetmicrocapshowcase.com/ For those unable to attend the live presentation, all company presentation webcasts will be available directly on the conference event platform on this link under the tab Agenda: https://planetmicrocapshowcase.com/agenda About MedX MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also embedded in its products SIAMETRICS, SIMSYS, and MoleMate, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain-free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medx.com About SNN.Network SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies you want to know more about; read and watch content from your favorite finance and investing influencers; create your own watchlist and screen for ideas youre interested in; find out about investor conferences you want to attend - all here on SNN.Network.", "role": "user" }, { "content": "MedX Health to Present at the Planet MicroCap Virtual Event on April 22, 2021", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today reports results for the first quarter of 2021, which reflect continued sales growth and advancement of the companys product pipeline across our four core therapeutic areas. We continue to deliver solid growth, execute against our strategic priorities and make meaningful progress across our pipeline, said Giovanni Caforio, M.D., board chair and chief executive officer, Bristol Myers Squibb. I am proud of our teams hard work and dedication, which led to important milestones with significant potential to benefit patients across multiple disease states. These accomplishments, combined with our financial strength and flexibility, further advance our opportunity to renew our portfolio and drive long-term sustainable growth. First Quarter $ amounts in millions, except per share amounts 2021 2020 Change Total Revenues $ 11,073 $ 10,781 3% Earnings (Loss) Per Share - GAAP 0.89 (0.34 ) N/A Earnings Per Share - Non-GAAP 1.74 1.72 1% FIRST QUARTER FINANCIAL RESULTS All comparisons are made versus the same period in 2020 unless otherwise stated. A discussion of the non-GAAP financial measures is included under the Use of Non-GAAP Financial Information section. FIRST QUARTER PRODUCT REVENUE HIGHLIGHTS $ amounts in millions Product Quarter Ended March 31, 2021 Quarter Ended March 31, 2020 % Change from Quarter Ended March 31, 2020 Revlimid $2,944 $2,915 1% Eliquis $2,886 $2,641 9% Opdivo $1,720 $1,766 (3)% Orencia $758 $714 6% Pomalyst/Imnovid $773 $713 8% Sprycel $470 $521 (10)% Yervoy $456 $396 15% Abraxane $314 $300 5% Empliciti $85 $97 (12)% Reblozyl $112 $8 * Inrebic $16 $12 33% Onureg $15 N/A N/A Zeposia $18 N/A N/A *In excess of +100%. FIRST QUARTER PRODUCT AND PIPELINE UPDATE Cardiovascular mavacamten Regulatory Oncology Opdivo Regulatory Clinical relatlimab Clinical Medical Conferences Hematology Onureg Regulatory Abecma Regulatory Breyanzi Regulatory Inrebic Regulatory Immunology deucravacitinib Medical Conferences Capital Allocation The company continues to maintain a consistent, balanced approach to capital allocation, focused on prioritizing investment for growth through business development along with reducing debt, commitment to dividend and share repurchases. Commitment to Environmental Sustainability, Diversity and Inclusion, Health Equity COVID-19 Pandemic Response During the current world health crisis, the company continues to take all necessary actions to promote public health by carrying out its mission of providing life-saving medicines to the patients who depend on the company, conducting research and supporting relief efforts across the globe. (link) Financial Guidance Bristol Myers Squibb is updating its 2021 GAAP EPS guidance range of $3.12-$3.32 to $3.18-$3.38 and affirming its non-GAAP EPS guidance range of $7.35 - $7.55. Both GAAP and non-GAAP guidance assume current exchange rates. Key 2021 GAAP and non-GAAP line item guidance assumptions are: The 2021 financial guidance excludes the impact of any potential future strategic acquisitions and divestitures, and any specified items that have not yet been identified and quantified. The 2021 non-GAAP EPS guidance is explained and further excludes other specified items as discussed under Use of Non-GAAP Financial Information. The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this press release. Company and Conference Call Information Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram. There will be a conference call on April 29, 2021 at 9 a.m. ET during which company executives will review financial information and address inquiries from investors and analysts. Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 800-458-4121 or international +1 313-209-6672, confirmation code: 3705525, or using this link which becomes active 15 minutes prior to the scheduled start time and entering your information to be connected. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 12:30 p.m. ET on April 29 through 12:30 p.m. ET on May 13, 2021. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 3705525. Use of Non-GAAP Financial Information In discussing financial results and guidance, the company refers to the financial measures that are not in accordance with U.S. Generally Accepted Accounting Principles (GAAP). The non-GAAP financial measures are provided as supplemental information to the financial measures presented in this press release that are calculated and presented in accordance with GAAP and are presented because management has evaluated the companys financial results both including and excluding the adjusted items or the effects of foreign currency translation, as applicable, and believes that the non-GAAP financial measures presented portray the results of the companys baseline performance, supplement or enhance management, analysts and investors overall understanding of the companys underlying financial performance and trends and facilitate comparisons among current, past and future periods. For example, non-GAAP earnings and EPS information are indications of the companys baseline performance before items that are considered by us to not be reflective of the companys ongoing results. This information is among the primary indicators that we use as a basis for evaluating performance, allocating resources, setting incentive compensation targets and planning and forecasting for future periods. In addition, revenue excluding COVID-19 related buying patterns from the first quarter of 2020, non-GAAP gross margin, which is gross profit excluding certain specified items as a percentage of revenues, non-GAAP marketing, selling and administrative expenses, which is marketing, selling and administrative expense excluding certain specified items, and non-GAAP research and development expenses, which is research and development expenses excluding certain specified items, are relevant and useful for investors because they allow investors to view performance in a manner similar to the method used by our management and make it easier for investors, analysts and peers to compare our operating performance to other companies in our industry and to compare our year-over-year results. This earnings release also provides international revenues excluding the impact of foreign exchange. Foreign exchange impacts were derived by applying the prior period average currency rates to the current period revenues and expenses. Non-GAAP financial measures such as non-GAAP earnings and related EPS information are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results. These items are excluded from non-GAAP earnings and related EPS information because the company believes they neither relate to the ordinary course of the companys business nor reflect the companys underlying business performance. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods, including amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, unwind of inventory fair value adjustments, acquisition and integration expenses, restructuring costs, accelerated depreciation and impairment of property, plant and equipment and intangible assets, R&D charges or other income resulting from upfront or contingent milestone payments in connection with the acquisition or licensing of third-party intellectual property rights, divestiture gains or losses, stock compensation resulting from accelerated vesting of Celgene awards, certain retention-related employee compensation charges related to the Celgene transaction, pension, legal and other contractual settlement charges, equity investment and contingent value rights fair value adjustments (including fair value adjustments attributed to limited partnership equity method investments beginning in 2021) and amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. Because the non-GAAP financial measures are not calculated in accordance with GAAP, they should not be considered superior to and are not intended to be considered in isolation or as a substitute for the related financial measures presented in the press release that are prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Reconciliations of the non-GAAP financial measures to the most comparable GAAP measures are provided in the accompanying financial tables and also available on the companys website at www.bms.com. Website Information We routinely post important information for investors on our website, BMS.com, in the Investors section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. We may also use social media channels to communicate with our investors and the public about our company, our products and other matters, and those communications could be deemed to be material information. The information contained on, or that may be accessed through, our website or social media channels are not incorporated by reference into, and are not a part of, this document. Cautionary Statement Regarding Forward-Looking Statements This earnings release and the related attachments (as well as the oral statements made with respect to information contained in this release and the attachments) contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, statements relating to goals, plans and projections regarding the companys financial position, results of operations, market position, product development and business strategy. These statements may be identified by the fact they use words such as should, could, expect, anticipate, estimate, target, may, project, guidance, intend, plan, believe, will and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance, although not all forward-looking statements contain such terms. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements are likely to relate to, among other things, the companys ability to execute successfully its strategic plans, including its business development strategy generally and in relation to its ability to realize the projected benefits of the Celgene Acquisition and the MyoKardia Acquisition, the full extent of the impact of the COVID-19 pandemic on the companys operations and the development and commercialization of its products, potential laws and regulations to lower drug costs, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about the companys ability to retain patent exclusivity of certain products and the impact and the result of governmental investigations. No forward-looking statement can be guaranteed, including that the companys future clinical studies will support the data described in this release, product candidates will receive necessary clinical and manufacturing regulatory approvals, pipeline products will prove to be commercially successful, clinical and manufacturing regulatory approvals will be sought or obtained within currently expected timeframes or contractual milestones will be achieved. Such forward-looking statements are based on historical performance and current expectations and projections about the companys future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond the companys control and could cause the companys future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. Such risks, uncertainties and other matters include, but are not limited to, risks relating to various risks related to public health outbreaks, epidemics and pandemics, including the impact of the COVID-19 pandemic on the companys operations and that the company cannot reasonably assess or predict at this time the full extent of the adverse effect that the COVID-19 pandemic will have on its business, financial condition, results of operations and cash flows; increasing pricing pressures from market access, pharmaceutical pricing controls and discounting, changes to tax and importation laws and other restrictions in the United States, the European Union and other regions around the world that result in lower prices, lower reimbursement rates and smaller populations for whom payers will reimburse; challenges inherent in new product development, including obtaining and maintaining regulatory approval; the companys ability to obtain and protect market exclusivity rights and enforce patents and other intellectual property rights; the possibility of difficulties and delays in product introduction and commercialization; the risk of certain novel approaches to disease treatment (such as CAR T therapy); industry competition from other manufacturers; potential difficulties, delays and disruptions in manufacturing, distribution or sale of products, including without limitation, interruptions caused by damage to the companys and the companys suppliers manufacturing sites; the impact of integrating the companys and Celgenes business and operations, including with respect to human capital management, portfolio rationalization, finance and accounting systems, sales operations and product distribution, pricing systems and methodologies, data security systems, compliance programs and internal controls processes, on the companys ability to realize the anticipated benefits from the Celgene Acquisition; the risk of an adverse patent litigation decision or settlement and exposure to other litigation and/or regulatory actions; the impact of any healthcare reform and legislation or regulatory action in the United States and international markets; changes in tax law and regulations; the failure of the companys suppliers, vendors, outsourcing partners, alliance partners and other third parties to meet their contractual, regulatory and other obligations; regulatory decisions impacting labeling, manufacturing processes and/or other matters; the impact on the companys competitive position from counterfeit or unregistered versions of its products or stolen products; the adverse impact of cyber-attacks on the companys information systems or products, including unauthorized disclosure of trade secrets or other confidential data stored in the companys information systems and networks; the companys ability to execute its financial, strategic and operational plans; the companys ability to identify potential strategic acquisitions, licensing opportunities or other beneficial transactions; the companys dependency on several key products; any decline in the companys future royalty streams; the companys ability to effectively manage acquisitions, divestitures, alliances and other portfolio actions and to successfully realize the expected benefits of such actions; the companys ability to attract and retain key personnel; the impact of the companys significant additional indebtedness that it incurred in connection with the Celgene Acquisition and the MyoKardia Acquisition and its issuance of additional shares in connection with the Celgene Acquisition on its ability to operate the combined company; political and financial instability of international economies and sovereign risk; interest rate and currency exchange rate fluctuations, credit and foreign exchange risk management; the impact of our exclusive forum provision in our by-laws for certain lawsuits on our stockholders ability to obtain a judicial forum that it finds favorable for such lawsuits; and issuance of new or revised accounting standards. In addition, the financial guidance provided in this release relies on assumptions about the duration and severity of the COVID-19 pandemic, timing of the return to a more stable business environment, patient and physician behaviors, buying patterns and clinical trial activities (together, the Recovery Process), among other things. If the actual Recovery Process differs materially from our assumptions, the impact of COVID-19 on our business could be worse than expected and our results may be negatively impacted. Forward-looking statements in this earnings release should be evaluated together with the many risks and uncertainties that affect the companys business and market, particularly those identified in the cautionary statement and risk factors discussion in the companys Annual Report on Form 10-K for the year ended December 31, 2020, as updated by the companys subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the Securities and Exchange Commission. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise. BRISTOL-MYERS SQUIBB COMPANY PRODUCT REVENUES FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020 (Unaudited, dollars in millions) Worldwide Revenues U.S. Revenues(b) 2021 2020 % Change 2021 2020 % Change Prioritized Brands Revlimid $ 2,944 $ 2,915 1% $ 1,958 $ 1,966 Eliquis 2,886 2,641 9% 1,923 1,777 8% Opdivo 1,720 1,766 (3)% 944 1,008 (6)% Orencia 758 714 6% 536 500 7% Pomalyst/Imnovid 773 713 8% 512 489 5% Sprycel 470 521 (10)% 275 300 (8)% Yervoy 456 396 15% 294 257 14% Abraxane 314 300 5% 225 205 10% Empliciti 85 97 (12)% 51 59 (14)% Reblozyl 112 8 ** 98 8 ** Inrebic 16 12 33% 15 12 25% Onureg 15 N/A 14 N/A Zeposia 18 N/A 13 N/A Established Brands Vidaza 54 158 (66)% 5 2 ** Baraclude 113 122 (7)% 4 3 33% Other Brands(a) 339 418 (19)% 143 180 (21)% Total $ 11,073 $ 10,781 3% $ 7,010 $ 6,766 4% ** In excess of +/- 100% (a) Includes products that have lost exclusivity in major markets, over-the-counter (OTC) brands and royalty revenue. (b) Includes Puerto Rico. BRISTOL-MYERS SQUIBB COMPANY CONSOLIDATED STATEMENTS OF EARNINGS FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020 (Unaudited, dollars and shares in millions except per share data) Three Months Ended March 31, 2021 2020 Net product sales $ 10,798 $ 10,541 Alliance and other revenues 275 240 Total Revenues 11,073 10,781 Cost of products sold(a) 2,841 3,662 Marketing, selling and administrative 1,666 1,606 Research and development 2,225 2,372 Amortization of acquired intangible assets 2,513 2,282 Other (income)/expense, net (702 ) 1,163 Total Expenses 8,543 11,085 Earnings/(Loss) Before Income Taxes 2,530 (304 ) Provision for Income Taxes 501 462 Net Earnings/(Loss) 2,029 (766 ) Noncontrolling Interest 8 9 Net Earnings/(Loss) Attributable to BMS $ 2,021 $ (775 ) Weighted-Average Common Shares Outstanding: Basic 2,236 2,258 Diluted 2,265 2,258 Earnings/(Loss) per Common Share: Basic $ 0.90 $ (0.34 ) Diluted 0.89 (0.34 ) Other (income)/expense, net Interest expense(b) $ 353 $ 362 Contingent consideration (510 ) 556 Royalties and licensing income (367 ) (410 ) Equity investment (gains)/losses (601 ) 338 Integration expenses 141 174 Provision for restructuring 45 160 Litigation and other settlements (8 ) 32 Transition and other service fees (15 ) (61 ) Investment income (9 ) (61 ) Reversion excise tax 76 Divestiture gains (16 ) Loss on debt redemption 281 Other (12 ) 13 Other (income)/expense, net $ (702 ) $ 1,163 (a) Excludes amortization of acquired intangible assets. (b) Includes amortization of purchase price adjustments to Celgene debt. BRISTOL-MYERS SQUIBB COMPANY SPECIFIED ITEMS FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020 (Unaudited, dollars in millions) Three Months Ended March 31, 2021 2020 Inventory purchase price accounting adjustments $ 79 $ 1,420 Intangible asset impairment 315 Employee compensation charges 2 Site exit and other costs 23 16 Cost of products sold 417 1,438 Employee compensation charges 15 Site exit and other costs (1 ) 6 Marketing, selling and administrative (1 ) 21 License and asset acquisition charges 25 Inventory purchase price accounting adjustments 17 Employee compensation charges 1 18 Site exit and other costs 56 Research and development 1 116 Amortization of acquired intangible assets 2,513 2,282 Interest expense(a) (34 ) (41 ) Contingent consideration (510 ) 556 Royalties and licensing income (14 ) (83 ) Equity investment (gains)/losses (608 ) 339 Integration expenses 141 174 Provision for restructuring 45 160 Reversion excise tax 76 Divestiture gains (16 ) Loss on debt redemption 281 Other (income)/expense, net (699 ) 1,165 Increase to pretax income 2,231 5,022 Income taxes on items above (300 ) (291 ) Increase to net earnings $ 1,931 $ 4,731 (a) Includes amortization of purchase price adjustments to Celgene debt. BRISTOL-MYERS SQUIBB COMPANY RECONCILIATION OF CERTAIN GAAP LINE ITEMS TO CERTAIN NON-GAAP LINE ITEMS FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020 (Unaudited, dollars and shares in millions except per share data) Three Months Ended March 31, 2021 GAAP Specified Items(a) Non-GAAP Gross Profit $ 8,232 $ 417 $ 8,649 Marketing, selling and administrative 1,666 1 1,667 Research and development 2,225 (1 ) 2,224 Amortization of acquired intangible assets 2,513 (2,513 ) Other (income)/expense, net (702 ) 699 (3 ) Earnings Before Income Taxes 2,530 2,231 4,761 Provision for Income Taxes 501 300 801 Noncontrolling interest 8 8 Net Earnings Attributable to BMS used for Diluted EPS Calculation $ 2,021 $ 1,931 $ 3,952 Weighted-Average Common Shares Outstanding - Diluted 2,265 2,265 2,265 Diluted Earnings Per Share $ 0.89 $ 0.85 $ 1.74 Effective Tax Rate 19.8 % (3.0 )% 16.8 % Three Months Ended March 31, 2020 GAAP Specified Items(a) Non-GAAP Gross Profit $ 7,119 $ 1,438 $ 8,557 Marketing, selling and administrative 1,606 (21 ) 1,585 Research and development 2,372 (116 ) 2,256 Amortization of acquired intangible assets 2,282 (2,282 ) Other (income)/expense, net 1,163 (1,165 ) (2 ) (Loss)/Earnings Before Income Taxes (304 ) 5,022 4,718 Provision for Income Taxes 462 291 753 Noncontrolling interest 9 9 Net (Loss)/Earnings Attributable to BMS used for Diluted EPS Calculation $ (775 ) $ 4,731 $ 3,956 Weighted-Average Common Shares Outstanding - Diluted 2,258 2,298 2,298 Diluted (Loss)/Earnings Per Share $ (0.34 ) $ 2.06 $ 1.72 Effective Tax Rate (152.0 )% 168.0 % 16.0 % (a) Refer to the Specified Items schedule for further details. Effective tax rate on the Specified Items represents the difference between the GAAP and Non-GAAP effective tax rate. BRISTOL-MYERS SQUIBB COMPANY NET DEBT CALCULATION AS OF MARCH 31, 2021 AND DECEMBER 31, 2020 (Unaudited, dollars in millions) March 31, 2021 December 31, 2020 Cash and cash equivalents $ 10,982 $ 14,546 Marketable debt securities - current 1,948 1,285 Marketable debt securities - non-current 288 433 Cash, cash equivalents and marketable debt securities 13,218 16,264 Short-term debt obligations (1,777 ) (2,340 ) Long-term debt (44,505 ) (48,336 ) Net debt position $ (33,064 ) $ (34,412 ) Corporatefinancial-news", "role": "user" }, { "content": "Bristol Myers Squibb Reports First Quarter Financial Results for 2021 Reports First Quarter Revenues of $11.1 Billion, an Increase of 3% YoY; Revenue Increase of 8% Excluding COVID-19 Related Buying Patterns from Prior Year Period Posts First Quarter Earnings Per Share of $0.89 and Non-GAAP EPS of $1.74 Strengthens Leadership in Immuno-Oncology with Multiple Regulatory and Data Milestones for Opdivo and Yervoy Delivers Positive Results from Phase 2/3 RELATIVITY-047 Trial Evaluating Relatlimab and Opdivo for Previously Untreated Metastatic or Unresectable Melanoma Advances Cell Therapy Franchise with FDA Approvals for Abecma and Breyanzi Presents Positive Results from POETYK-1 and POETYK-PSO-2 Phase 3 Trial Evaluating Deucravacitinib (TYK2 inhibitor) for Treatment of Moderate to Severe Plaque Psoriasis Announces FDA Acceptance of New Drug Application for Mavacamten Raises GAAP and Affirms Non-GAAP EPS Guidance for 2021", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SARASOTA, Fla., July 8, 2020 /PRNewswire/ -- The Certified Collectibles Group (CCG) is hiring world-class sports card experts to lead a new service dedicated to expert and impartial certification of sports cards and memorabilia. CCG is a large, global company with over 350 employees worldwide. It is headquartered in Sarasota, Florida, and has offices in the United Kingdom, Germany and China, along with a global network of Official Submission Centers and Authorized Dealers. Are you knowledgeable and passionate about sports cards? The Certified Collectibles Group is hiring the top sports card experts to lead a new service dedicated to expert and impartial certification of sports cards and memorabilia. The CCG companies include the world's largest grading services for coins (Numismatic Guaranty Corporation), paper money (Paper Money Guaranty) and comic books, magazines and concert posters (Certified Guaranty Company). Together, they have certified nearly 60 million collectibles since 1987. Certified Sports Guaranty (CSG) will be the new CCG affiliate dedicated to third-party authentication and grading services for sports cards and memorabilia. CSG will use world-class expertise, cutting-edge technology and operational excellence to join the other CCG companies in quickly becoming the leader in its category. The establishment of CSG presents an incredible opportunity for the world's top sports card experts to build a new grading service backed by a company and ownership team that have a proven track record of success in the collectibles industry. The ideal candidates will be well-known and highly respected throughout the hobby. They must have: Comprehensive knowledge of both vintage and modern sports cards across all major US sports Expansive expertise as it relates to card printing, including printing processes, variants and errors Outstanding abilities to detect counterfeit and altered cards as well as accurately and consistently grade cards The highest level of integrity A strong desire to grow as well as train and lead other team members A willingness to travel domestically and internationally as needed CSG will offer the most competitive salaries in the industry. The company will be based in sunny Sarasota, Florida, which has no local or state income tax. Additional benefits include career advancement opportunities; health, dental and vision insurance; a 401(k) with company match; paid vacation and more. \"I am ready to make very compelling offers to the world's top sports card experts,\" said Steven R. Eichenbaum, CEO of CCG. \"With their expertise and our company's backing, I am confident that we will quickly become the leader in third-party grading services for sports cards, just as we became the leader in third-party grading services for coins, paper money, comic books, magazines and concert posters.\"To learn more about this job opportunity and others at CCG, visit CollectiblesGroup.com/Careers.CCG is a Florida Drug-Free Workplace with a drug-free program which complies with Section 440.102 Florida Statutes.About Certified Collectibles Group (CCG)CCG comprises seven of the world's leading collectibles services companies: Numismatic Guaranty Corporation (NGC), Numismatic Conservation Services (NCS), Paper Money Guaranty (PMG), Certified Guaranty Company (CGC), Classic Collectible Services (CCS), Authenticated Stamp Guaranty (ASG) and Collectibles Authentication Guaranty (CAG). The CCG companies provide expert and impartial services that add value and liquidity to a wide variety of collectibles, including coins, banknotes, comic books, magazines, concert posters, stamps and estate items. Today, the CCG companies have certified nearly 60 million collectibles. 2020 Certified Collectibles Group. All rights reserved. NGC, NCS, PMG, CGC, CCS, ASG, CAG, CSG and CCG are the registered trademarks or unregistered trademarks of Numismatic Guaranty Corporation of America, and/or its related companies in the United States and/or other countries. All other names and marks referenced in this release are the trade names, trademarks, or service marks of their respective owners. SOURCE The Certified Collectibles Group", "role": "user" }, { "content": "CCG Hiring World-Class Sports Card Experts If you are knowledgeable and passionate about sports cards, now is your opportunity to build the new leader in third-party grading", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Granite Point Mortgage Trust Inc. (NYSE: GPMT) (GPMT, Granite Point or the Company) today provided an update on the previously announced internalization of the Companys management function from its external manager, Pine River Capital Management L.P. (Pine River or the Manager). As previously disclosed, the Company and the Manager entered into a confidential arbitration process to determine any amounts payable by the Company to the Manager in consideration of the Managers agreement to terminate Granite Points management agreement and the Managers undertaking of other obligations in connection with the internalization. Today, the arbitral panel issued the award setting the amount payable by the Company to the Manager at $44.5 million. The Company anticipates that it will promptly enter into a definitive agreement with the Manager in respect of the internalization, the form of which was previously negotiated with the Manager in connection with the arbitration process. The Company expects to complete the internalization during the fourth quarter of 2020, with the Company making the one-time cash payment of $44.5 million from funds on hand on the effective date of the internalization. An independent committee of Granite Points Board of Directors negotiated the internalization on behalf of the Company. Following the completion of the internalization, Granite Point will be well-positioned for continued growth and success as an internally-managed commercial real estate finance company. Upon the completion of the internalization, the Company will continue to be managed by its strong senior management team, benefiting from their extensive industry expertise and relationships. The Company has entered into employment agreements with its President and Chief Executive Officer, Jack Taylor; Chief Investment Officer and Co-Head of Originations, Stephen Alpart; General Counsel, Michael Karber; Chief Development Officer and Co-Head of Originations, Peter Morral; Chief Operating Officer, Steven Plust and Chief Financial Officer, Marcin Urbaszek, which will become effective upon the completion of the internalization. In addition to the management team, Granite Point intends to retain personnel across a variety of functions supporting the Company's business, such as originations, underwriting and oversight of investments, legal, financial reporting, tax and treasury, who are currently employees of Pine River and to whom the Company intends to extend offers of employment. About Granite Point Mortgage Trust Inc. Granite Point Mortgage Trust Inc. is a Maryland corporation focused on directly originating, investing in and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. Granite Point is headquartered in New York, NY, and is externally managed by Pine River Capital Management L.P. Additional information is available at www.gpmtreit.com. Forward-Looking Statements This release contains, or incorporates by reference, not only historical information, but also forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. GPMTs actual results may differ from its beliefs, expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as anticipate, estimate, will, should, expect, target, believe, intend, seek, plan, goals, future, likely, may and similar expressions or their negative forms, or by references to strategy, plans or intentions. By their nature, forward-looking statements speak only as of the date they are made, are not statements of historical fact or guarantees of future performance and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify, in particular due to the uncertainties created by the COVID-19 pandemic, including its impact of COVID-19 on the Companys business, financial performance and operating results. The Companys expectations, beliefs and estimates are expressed in good faith and it believes there is a reasonable basis for them. These forward-looking statements are subject to risks and uncertainties, including, among other things, those described in the Companys Annual Report on Form 10-K for the year ended December 31, 2019 and any subsequent Form 10-Q and Form 8-K filings made with the SEC, under the caption Risk Factors. These risks may also be further heightened by the continued impact of the COVID-19 pandemic. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. This release is for informational purposes only and shall not constitute, or form a part of, an offer to sell or buy or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. Additional Information Stockholders of Granite Point and other interested persons may find additional information regarding the company at the SECs website at www.sec.gov or by directing requests to: Granite Point Mortgage Trust Inc., 3 Bryant Park, 24th floor, New York, NY 10036, telephone (212) 364-5500.", "role": "user" }, { "content": "Granite Point Mortgage Trust Inc. Announces Update on Process to Internalize Management Function", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, March 29, 2021 /PRNewswire/ -- The \"Global Commercial Aerospace MRO (Maintenance, Repair & Overhaul) Market: Size, Trends, Forecasts (2021-2025 Edition)\" report has been added to ResearchAndMarkets.com's offering. \"Global Commercial Aerospace MRO (Maintenance, Repair & Overhaul) Market: Size, Trends, Forecasts (2021-2025 Edition)\", provides an in-depth analysis of the commercial aerospace MRO market including detailed description of market sizing and growth. The report provides analysis of the commercial aerospace MRO market by value, by segments and by region. The report further provides detailed segment analysis and regional analysis of the global commercial aerospace MRO market by value, by segment and segment by value. Maintenance, repair and overhaul (MRO) of an aircraft is a process involving repairing, welding, plating or testing services carried by a group of technical, administrative, managerial and supervision actions. The MRO service providers are categorized as in-house airline MRO, third party airline MRO, OEM-affiliated MRO etc. MRO services are common for aerospace maintenance, as aerospace industry conducts consistent research on designing, maintenance and manufacturing of aircrafts, as the scope of the aerospace industry is very wide with a variety of commercial, military & industrial aircrafts that are operating in the earth's atmosphere as well as in space.The global commercial aerospace MRO market has observed constant growth in the past few years and projections are made that in the forecasted period (2021-2025) the market would propel with a steady growth rate. The global commercial aerospace MRO market would be supported by the growth drivers such as increasing number of fleets, growth in urban population, budding developing countries economy, growing tourism, increasing low cost carrier (LCC) penetration and mandatory maintenance programme for ageing aircrafts. However, growth of global commercial aerospace MRO market is being hindered by various challenges. Some of the eminent challenges faced by the market are fluctuating fuel cost, CO2 emission from aviation etc.Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall commercial aerospace MRO market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.The major players dominating the commercial aerospace MRO market are AAR Corp., ST Engineering (ST Aerospace), Deutsche Lufthansa AG (Lufthansa Technik AG) and Airbus SE (Airbus SAS). The four companies have been profiled in the report providing detailed analysis of their financial information and business strategies.Key Topics Covered: 1. Executive Summary2. Introduction2.1 Aerospace: An overview 2.2 Maintenance, Repair and Overhaul (MRO): An Overview 2.3 Segmentation of Aerospace MRO 2.4 Advantages and Disadvantages of Aerospace MRO: An Overview3. Global Market Analysis 3.1 Global Commercial Aerospace MRO Market: An Analysis3.1.1 Global Commercial Aerospace MRO Market by Value 3.1.2 Global Commercial Aerospace MRO Market by Segment (Engine, Airframe, Component & Line)3.1.3 Global Commercial Aerospace MRO Market by Region (North America, Western Europe, Asia Pacific, Middle East, China, Latin America, Eastern Europe, Africa & India)3.2 Global Commercial Aerospace MRO Market: Segment Analysis3.2.1 Global Airframe MRO Market by Value3.2.2 Global Engine MRO Market by Value3.2.3 Global Component MRO Market by Value 3.2.4 Global Line MRO Market by Value4. Regional Market Analysis4.1 Africa Commercial Aerospace MRO Market: An Analysis4.1.1 Africa Commercial Aerospace MRO Market by Value4.1.2 Africa Commercial Aerospace MRO Market by Segment (Engine, Airframe, Component & Line)4.1.3 Africa Commercial Aerospace MRO Market Segments by Value 4.2 Middle East Commercial Aerospace MRO Market: An Analysis4.3 Asia Pacific Commercial Aerospace MRO Market: An Analysis 4.4 China Commercial Aerospace MRO Market: An Analysis 4.5 India Commercial Aerospace MRO Market: An Analysis 4.6 Latin America Commercial Aerospace MRO Market: An Analysis 4.7 North America Commercial Aerospace MRO Market: An Analysis 4.8 Eastern Europe Commercial Aerospace MRO Market: An Analysis 4.9 Western Europe Commercial Aerospace MRO Market: An Analysis 5. Market Dynamics5.1 Growth Drivers5.1.1 Increasing Number of Fleets 5.1.2 Growth in Urban Population 5.1.3 Budding Developing Countries Economy 5.1.4 Growing Tourism 5.1.5 Increasing Low Cost Carrier Penetration 5.1.6 Mandatory Maintenance Programme for Aging Aircraft5.2 Challenges5.2.1 Fluctuating Fuel Cost5.2.2 CO2 Emission from Aviation5.3 Market Trends5.3.1 Implementation of More-Electric Aircraft 5.3.2 Modernisation of SWaP-C Concept6. Competitive Landscape6.1 Global Commercial Aerospace MRO Market Players: A Financial Comparison6.2 Global Engine MRO Market Players by Share7. Company Profiles 7.1 AAR Corp.7.1.1 Business Overview 7.1.2 Financial Overview 7.1.3 Business Strategy7.2 ST Engineering (ST Aerospace)7.3 Deutsche Lufthansa AG (Lufthansa Technik AG)7.4 Airbus SE (Airbus SAS)For more information about this report visit https://www.researchandmarkets.com/r/79gmh Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Commercial Aerospace MRO (Maintenance, Repair & Overhaul) Market to 2025: Implementation of More-Electric Aircraft & Modernisation of SWaP-C Concept", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Brookdale Senior Living, Inc. (\"Brookdale\" or the \"Company\") (NYSE: BKD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Brookdale securities between August 10, 2016, and April 29, 2020, both dates inclusive (the Class Period). Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/bkd. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Brookdale's financial performance was sustained by, among other things, the Company's purposeful understaffing of its senior living communities; (2) the foregoing conduct subjected Brookdale to an increased risk of litigation and, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results and reputation; (3) as a result, the Company's financial results were unsustainable; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firms site: www.bgandg.com/bkd or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Brookdale you have until August 24, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firms expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.", "role": "user" }, { "content": "BKD DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Brookdale Senior Living, Inc. Investors of Class Action and Lead Plaintiff Deadline: August 24, 2020", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SALT LAKE CITY, June 4, 2020 /PRNewswire/ --Ivanti Supply Chain announced that it has added new Enterprise Mobility Management (EMM) capabilities to the Ivanti Avalanche Enterprise Enabler, powered by Ivanti Wavelink. The newly updated solution enables supply chain organizations to quickly provision hundreds of fully managed Android devices leveraging a Near-Field Communications (NFC) bump or QR code deployment. \"Securing and managing Android OS-powered mobile devices can be challenging for supply chain organizations,\" Brandon Black, vice president and general manager, Ivanti Supply Chain Business Unit. \"This is especially true when there is a mix of BYOD and corporate-owned devices being used by warehousing and logistics workers.\" The updated Ivanti Avalanche Enterprise Enabler delivers the following customer benefits: Deploy Faster. Administrators can onboard and update hundreds of mobile devices through a simple NFC bump or QR codes. Application access and control.Organizations can set application parameters based on location. Administrations can also configure what rights the applications have at the time of installation. Multiplatform support.Ivanti Avalanche offers support for both Windows Mobile and Android OS. \"The new granular settings available through the Ivanti Avalanche Enterprise Enabler allow organizations to strike the right balance between corporate security policies and productivity,\" added Black. \"Administrators can now quickly and easily push new application and security settings through NFC bump or QR codes, minimizing worker downtime and reducing strain on IT resources.\" Ivanti Avalanche Enterprise Enabler is currently available as a free add-on to Ivanti Avalanche. For more information, visit www.ivanti.com/wavelink. About Ivanti Supply Chain Ivanti Supply Chain helps organizations leverage modern technology in the warehouse and across the supply chain to improve delivery without modifying backend systems. The company also unifies IT and Security Operations to better manage and secure the digital workplace. From PCs to mobile devices, VDI and the data center, Ivantidiscovers IT assets on-premises and in the cloud, improves IT service delivery, and reduces risk with insights and automation. Ivanti is headquartered in Salt Lake City, Utah and has offices all over the world. For more information, visitwww.ivanti.com/wavelink and follow @GoIvanti. Copyright 2020, Ivanti. All rights reserved. SOURCE Ivanti Related Links https://www.ivanti.com", "role": "user" }, { "content": "Ivanti Supply Chain Adds New Enterprise Mobility Management Capabilities to Ivanti Avalanche With Ivanti Avalanche Enterprise Enabler, supply chain organizations can now more quickly provision hundreds of fully managed Android devices leveraging Near-Field Communications and QR codes", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW PROVIDENCE,N.J.and GRAND RAPIDS, Mich., April 23, 2020 /PRNewswire/ -- Officials from the Transplant Life Foundation announced that the postponed 2020 Donate Life Transplant Games have been rescheduled for July 16-21, 2021.The Games are a multi-sport festival for individuals who have undergone a life-saving transplant surgery. Over the course of six days, attendees will participate in a full schedule of special events that recognize the success of donation and transplantation while honoring the life-saving generosity of donors and their families. \"The decision to postpone the Games was heartbreaking, and completely focused on the health and well-being of our community. It was absolutely the right decision,\" said Bill Ryan, President and CEO of the Transplant Life Foundation.\"We are excited to announce that the 2020 Transplant Games will be held on July 16-21, 2021.\" \"Through the incredible effort of our local partners, NJ Sharing Network, Hackensack Meridian Health, RWJ Barnabas, Novartis Pharmaceuticals, American Dream, Meadowlands Live! Convention and Visitors Bureau, nearly all of the original programming will remain intact on the new dates,\" continued Ryan. At the 2016 bid announcement, Joe Roth, President and CEO of NJ Sharing Network said, \"The Transplant Games are the ultimate representation of what we stand for: courage, achievement, and triumph over adversity.\" Now more than ever those words ring true. The Games will kick-off on Friday, July 16 with a world record attempt, gathering the largest number of Living Donors in one location, prior to the Opening Ceremony at the Prudential Center in Newark. According to lung transplant recipient E. Denise Peoples, \"The competitors marching in team by team is an emotional and joyous launch to the almost week-long event.It truly gives depth and meaning to our theme, 'Honor the Journey'.\" Today, there are 115,000 individuals in the United States waiting for a life-saving transplant, and nearly 4,000 are waiting in New Jersey. Nationwide, 20 people die each day waiting for a transplant. About The Transplant Life FoundationThe Transplant Life Foundation is a 501(c)(3) non-profit whose mission is to promote organ, eye, and tissue donation, as well as to bring awareness to the tremendous advances in the field of transplantation and in the development of immuno-suppressant drugs in the pharmaceutical industry. About NJ Sharing Network NJ Sharing Network saves lives through organ and tissue donation. Located in New Providence, NJ, the organization recovers organs and tissue and belongs to a national network that helps the 115,000 people waiting for a transplant. There are nearly 4,000 New Jersey residents awaiting a life-saving transplant. One organ donor can save eight lives and one tissue donor can restore health to over 75 people. In 2019, 1,400 generous donors gave the gift of life and the number of organ donors surpassed 200 for the first time in New Jersey 206 generous individuals saved lives through donation, resulting in 601 organs transplanted. New Jersey residents can help save lives by registering as organ and tissue donors, having a conversation with family and friends and getting involved at NJSharingNetwork.org. About the Meadowlands Regional Chamber and the MLCVBThe Meadowlands Regional Chamber (MRC) has a membership of more than 1,100 businesses and advocates for both economic and destination development. The Meadowlands Live! Liberty Convention and Visitors Bureau (MLCVB), a division of the Meadowlands Regional Chamber, is the comprehensive destination-marketing channel for travel to the metropolitan New Jersey region. The MLCVB presents its unique sports, entertainment, ecological, cultural and transportation assets as an emerging primary destination as well as an alternative to New York City to attract new and extended visits.The MRC and the MLCVB played crucial roles in bringing the 2014 Super Bowl to the region, and it continues to lead the public debatesurrounding issues that will affect the growth of the region. SOURCE Transplant Life Foundation", "role": "user" }, { "content": "2020 Donate Life Transplant Games Rescheduled To July 2021 At New Jersey Meadowlands The Transplant Life Foundation and NJ Sharing Network will lead 12,000 Transplant Recipients, Living Donors, Donor Families and Supporters in Celebrating the Gift of Life July 16-21, 2021", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LINKPING, Sweden, Nov. 9, 2020 /PRNewswire/--International medical imaging IT and cybersecurity company Sectra[STO: SECT B] has deployed its software for medical imaging at Leeds Teaching Hospitals. It is the first of an initial six trusts in the Northern Pathology Imaging Co-operative (NPIC) to go live, paving the way for one of the most sophisticated interconnected pathology initiatives in the world. The technology from Sectra will underpin the regional program that is digitizing, connecting and applying artificial intelligence to pathology services in the North of England. Leeds Teaching Hospitals went live with Sectra's solution for digital pathology and Vendor Neutral Archive (VNA) in October. Thiswill allow pathology images to be interrogated by professionals electronically from a range of devices-anywhere and at any time. With many pathology departments across the country still reliant on microscopes and glass slides, the new system is allowing pathologists to work more quickly, gain easier access to opinions from colleagues and manage rising demand. Furthermore, the joint VNA will allow the trust to pool imaging and build a platform for artificial intelligence that is crucial to improving diagnoses for cancer and other illnesses. \"Leeds is the first of our six sites to go fully digital. Collectively, we are modernizing our pathology services to become among the most advanced and interconnected anywhere in the world, and we hope to share our experience to help others across the NHS and beyond,\" says Dr. Darren Treanor, NPIC's director, and a practicing pathologist at Leeds Teaching Hospitals NHS Trust. He continues: \"The days of using glass slides and paper notes to determine and communicate a patient's diagnosis are numbered. As we move to digital ways of working, we can improve quality and create a more structured digital workflow.\" Greater benefits are expected as more hospitals in the NPIC go live with the system later in the year. As announced in 2018, the program is part of a partnership between industry, the NHS and academia, funded by UK Research and Innovation and industry partners to connect pathology services across the region using technology. This will lead to the full digitization of NHS laboratories covering a population of three million people, allowing hospitals to pool resources, balance workload, and enable easier access to specialists across the region whose expertise may be quickly needed to make a clinical diagnosis. \"Digital pathology is about far more than replacing microscopes with computers. It's about fundamentally changing how pathology services can be configured across regions and across the country, so that patients can receive faster diagnoses, services can become more intelligent, and the NHS can make best use of its valuable pathologists. NPIC is at the forefront of this transformation,\" says Jane Rendall, UK Managing Director for Sectra. About NPIC Northern Pathology Imaging Co-operative, NPIC (Project no. 104687) is one of five centers supported by a 50m investment from the Data to Early Diagnosis and Precision Medicine strand of the government's Industrial Strategy Challenge Fund, managed and delivered by UK Research and Innovation (UKRI), announced in 2018. NPIC is a unique collaboration between NHS, academic and industry partners. NPIC is deploying digital pathology across hospitals in the North of England and will develop artificial intelligence tools to help diagnose cancer and other diseases. More information can be found athttps://npic.ac.uk/. About Sectra Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linkping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020fiscal year totaled SEK 1,661million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/. CONTACT: For further information, please contact: Dr. Torbjrn Kronander, CEO and President Sectra AB, 46 (0) 705 23 52 27 Marie Ekstrm Trgrdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10 This information was brought to you by Cision http://news.cision.com https://news.cision.com/sectra/r/first-hospital-in-unique-digital-pathology-network-in-uk-now-live-with-sectra-s-solution,c3233076 The following files are available for download: https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c2847625 Sectra's digital pathology solution SOURCE Sectra", "role": "user" }, { "content": "First hospital in unique digital pathology network in UK now live with Sectra's solution", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: FRAMINGHAM, Mass.--(BUSINESS WIRE)--The TJX Companies, Inc. (NYSE: TJX), the leading off-price apparel and home fashions retailer in the U.S. and worldwide, today announced sales and operating results for the fourth quarter ended January 30, 2021. Net sales for the fourth quarter of Fiscal 2021 were $10.9 billion. Overall open-only comp store sales (defined below) were down 3% versus last year. Net income for the fourth quarter was $326 million. Diluted earnings per share were $.27, which includes a debt extinguishment charge (described below) of $.18 per share. The Companys higher tax rate in the fourth quarter of Fiscal 2021 resulted in a decrease in earnings per share of $.05 compared to the prior year. The higher tax rate was primarily due to the Company shifting to a year-to-date net income position in the fourth quarter and the related impact of the jurisdictional mix of profits and losses. The Companys results for the fourth quarter of Fiscal 2021 were negatively impacted by the temporary closure of some of its stores due to the COVID-19 global pandemic. Although the Companys stores in the U.S. were generally open the entire fourth quarter, stores in Europe were closed for approximately 63% of the fourth quarter and stores in Canada were closed for about 32% of the quarter. In total, the Company had stores closed for approximately 13% of the fourth quarter due to the COVID-19 global pandemic (see table below). The Company estimates that these European and Canadian closures may have resulted in approximately $950 million to $1.05 billion in lost sales during the fourth quarter of Fiscal 2021. This range of estimated lost sales assumes all European and Canadian stores operated at similar open-only comp store sales trends as the third and fourth quarters of Fiscal 2021, respectively. Based on managements estimate of profit dollars on this range of lost sales, the Company estimates that fourth quarter Fiscal 2021 earnings per share were negatively impacted by approximately $.18 to $.21. For the full year Fiscal 2021, net sales were $32.1 billion. Fiscal 2021 overall open-only comp store sales were down 4% versus last year. Net income was $90 million. Diluted earnings per share were $.07, which includes a debt extinguishment charge (described below) of $.19 per share. The Companys results for Fiscal 2021 were negatively impacted by the temporary closure of its stores for approximately 24% of the year due to the COVID-19 global pandemic (see table below). Q4 FY21 and Full Year Fiscal 2021 Store Closures by Region (in percent of store days closed) Region Q4 FY21 Fiscal 2021 U.S. 0% 20% Canada 32% 29% Europe 63% 38% Australia 1% 23% Total TJX 13% 24% CEO and President Comments Ernie Herrman, Chief Executive Officer and President of The TJX Companies, Inc., stated, As we report our 2020 results, I want to thank our global Associates for their extraordinary efforts during an unprecedented year. They pulled together and worked as One TJX, and I am especially proud of their commitment to the health and safety protocols for our Associates and customers. I want to give special recognition to our store, distribution, and fulfillment center Associates who have been physically coming in to work to keep our business open. I could not be prouder of our teams around the world who achieved monumental tasks in the face of a global pandemic in 2020. Herrman continued, In terms of the business results, I am very pleased that our fourth quarter open-only comp store sales were down only 3%, exceeding our plans. Our brands, values, and exciting gift assortments resonated with customers, and we achieved these results despite numerous COVID-related headwinds. Overall open-only comp store sales improved each month of the quarter and were positive in January. Further, open-only comp store sales exceeded our plans across each of our divisions, including at HomeGoods which once again delivered a double-digit increase. We also saw continued strength in our home and beauty departments. As we start the new fiscal year, while uncertainty around COVID-19 remains, we feel very good about the strength of the business and our market share opportunities beyond the health crisis. We are convinced that our entertaining, treasure hunt shopping experience, our differentiated, branded merchandise selections, and value proposition will continue to resonate with consumers. We see many opportunities to leverage our flexible business model, gain more customers, and continue driving the successful growth of TJX for many years ahead. Margins For the fourth quarter of Fiscal 2021, the Companys consolidated pretax profit margin was 4.6%, which includes a 2.9 percentage point negative impact due to a debt extinguishment charge (described below) of $312 million. The Companys merchandise margin was up versus the prior year. For the full year Fiscal 2021, the Companys consolidated pretax profit margin was 0.3%, which includes a 1.0 percentage point negative impact due to a debt extinguishment charge (described below) of $312 million in the fourth quarter. Debt Extinguishment Charge On November 30, 2020, the Company completed the issuance and sale of $500 million aggregate principal amount of 1.15%, 7.5-year notes and $500 million aggregate principal amount of 1.60%, 10.5-year notes. The Company used the proceeds to fund its cash tender for $364.50 million of its 4.50% notes and $754.15 million of its 3.875% notes on December 4, 2020, prior to their scheduled maturities of April 15, 2050 and April 15, 2030 respectively. The total charge for the early extinguishment of this debt reduced fourth quarter and full year Fiscal 2021 pretax income by $312 million. Cash and Dividend Update The Company generated $4.6 billion of operating cash flow for the full year Fiscal 2021 and ended the year with $10.5 billion of cash. The Company declared a quarterly dividend in the fourth quarter of Fiscal 2021 at an increased rate of $.26 per share. This represented a 13% increase in the per share dividend compared to the Companys previous dividend paid in March 2020. The Company expects to declare a dividend of $.26 per share in the first quarter quarter of Fiscal 2022, subject to Board approval. Temporary Store Closings The Company currently has approximately 690 stores that are temporarily closed due to government mandates in response to the COVID-19 global pandemic. The vast majority of these stores are located in Europe, where the Company expects stores will be temporarily closed for an estimated 67% of the first quarter of Fiscal 2022. In total, based on restrictions currently in place, the Company expects its stores to be closed for approximately 11% of the first quarter of Fiscal 2022. All of the Companys e-commerce businesses remain open, including tkmaxx.com in the U.K. Open-Only Comp Store Sales Due to the temporary closing of stores as a result of the COVID-19 global pandemic, the Companys historical definition of comp store sales is not applicable this quarter and for Fiscal 2021. In order to provide a performance indicator for its stores as they reopen, the Company has been temporarily reporting a new sales measure: open-only comp store sales. Open-only comp store sales includes stores initially classified as comp stores at the beginning of Fiscal 2021 that have had to temporarily close due to the COVID-19 pandemic. This measure reports the sales increase or decrease of these stores for the days the stores were open in the current period against sales for the same days in the prior year. Sales by Business Segment The Companys open-only comp store sales and net sales by division, in the fourth quarter and full year, were as follows: Fourth Quarter Open-Only Comp Store Sales1,2 Fourth Quarter Net Sales ($ in millions)3,4 FY2021 FY2020 Marmaxx (U.S.)5,6 -7% $6,921 $7,402 HomeGoods (U.S.)7 +12% $2,225 $1,952 TJX Canada -4% $837 $1,135 TJX International (Europe & Australia) +2% $961 $1,718 TJX -3% $10,943 $12,206 Full Year Open-Only Comp Store Sales1,2 Full Year Net Sales ($ in millions)3,4 FY2021 FY2020 Marmaxx (U.S.)5,6 -7% $19,363 $25,665 HomeGoods (U.S.)7 +13% $6,096 $6,356 TJX Canada -8% $2,836 $4,031 TJX International (Europe & Australia) -2% $3,842 $5,665 TJX -4% $32,137 $41,717 1Open-only comparable store sales outside the U.S. calculated on a constant currency basis, which removes the effect of changes in currency exchange rates. 2Open-only comparable store sales exclude e-commerce sites (tjmaxx.com, marshalls.com, sierra.com, and tkmaxx.com) and include Sierra stores. 3Net sales in TJX Canada and TJX International include the impact of foreign currency exchange rates. 4Figures may not foot due to rounding. 5Combination of T.J. Maxx and Marshalls. 6Net sales include Sierras e-commerce and store sales. 7Includes Homesense stores in the U.S. Inventory Total inventories as of January 30, 2021, were $4.3 billion, compared with $4.9 billion at the end of the prior fiscal year. Overall product availability in the marketplace remains excellent and the Company continues to focus its buying towards the categories that have had the strongest demand. The Company is well positioned to deliver a fresh assortment of merchandise to its stores and e-commerce sites throughout the spring season. Outlook For the first three weeks of the first quarter of Fiscal 2022, overall open-only comp store sales trends were better than the fourth quarter of Fiscal 2021, despite unfavorable weather in the U.S. In the periods before and after the unfavorable weather, overall open-only comp store sales were positive. In the first quarter of Fiscal 2022, the Company expects total sales, pretax margin, and earnings per share to be negatively impacted from the temporary store closings described above. Due to the continued uncertainty of the current environment and the difficulty in forecasting the impact of the global pandemic on temporary store closures and consumer behavior, demand, and traffic, the Company is not providing financial guidance at this time. Stores by Concept During the fiscal year ended January 30, 2021, the Company increased its store count by 43 stores to a total of 4,572 stores and increased square footage by 1% over the same period last year. The Companys slower pace of store growth in Fiscal 2021 was due to a reduction of capital spending in response to the global pandemic. The majority of new store openings planned for Fiscal 2021 were delayed until Fiscal 2022. Store Locations1 Gross Square Feet2 FY21 FY21 (in millions) Beginning End Beginning End In the U.S.: T.J. Maxx 1,273 1,271 34.9 34.8 Marshalls 1,130 1,131 32.4 32.4 HomeGoods 809 821 18.8 19.1 Sierra 46 48 1.0 1.0 Homesense 32 34 0.9 0.9 In Canada: Winners 279 280 7.6 7.7 HomeSense 137 143 3.1 3.3 Marshalls 97 102 2.6 2.7 In Europe: T.K. Maxx 594 602 16.7 16.9 Homesense 78 78 1.5 1.5 In Australia: T.K. Maxx 54 62 1.2 1.3 TJX 4,529 4,572 120.7 121.6 1Store counts above include both banners within a combo or a superstore. Includes stores that were or are temporarily closed due to COVID-19. 2Square feet figures may not foot due to rounding. About The TJX Companies, Inc. The TJX Companies, Inc. is the leading off-price retailer of apparel and home fashions in the U.S. and worldwide. As of January 30, 2021, the end of the Companys fiscal year, the Company operated a total of 4,572 stores in nine countries, the United States, Canada, the United Kingdom, Ireland, Germany, Poland, Austria, the Netherlands, and Australia, and four e-commerce sites. These include 1,271 T.J. Maxx, 1,131 Marshalls, 821 HomeGoods, 48 Sierra, and 34 Homesense stores, as well as tjmaxx.com, marshalls.com, and sierra.com in the United States; 280 Winners, 143 HomeSense, and 102 Marshalls stores in Canada; 602 T.K. Maxx and 78 Homesense stores, as well as tkmaxx.com, in Europe; and 62 T.K. Maxx stores in Australia. TJXs press releases and financial information are available at TJX.com. Fourth Quarter and Full Year Fiscal 2021 Earnings Conference Call At 11:00 a.m. ET today, Ernie Herrman, Chief Executive Officer and President of TJX, will hold a conference call to discuss the Companys fourth quarter and full year Fiscal 2021 results, operations, and business trends. A real-time webcast of the call will be available to the public at TJX.com. A replay of the call will also be available by dialing (866) 367-5577 (U.S. only) or (203) 369-0233 through Wednesday, March 3, 2021, or at TJX.com. Important Information at Website Archived versions of the Companys conference calls are available in the Investors section of TJX.com after they are no longer available by telephone, as are reconciliations of non-GAAP financial measures to GAAP financial measures and other financial information. The Company routinely posts information that may be important to investors in the Investors section at TJX.com. The Company encourages investors to consult that section of its website regularly. Forward-looking Statement SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Various statements made in this release are forward-looking and involve a number of risks and uncertainties. All statements that address activities, events or developments that we intend, expect or believe may occur in the future are forward-looking statements. The following are some of the factors that could cause actual results to differ materially from the forward-looking statements: execution of buying strategy and inventory management; operational and business expansion and management of large size and scale; customer trends and preferences; various marketing efforts; competition; economic conditions and consumer spending; the ongoing COVID-19 global pandemic and associated containment and remediation efforts; labor costs and workforce challenges; personnel recruitment, training and retention; data security and maintenance and development of information technology systems; corporate and retail banner reputation; quality, safety and other issues with our merchandise; compliance with laws, regulations and orders and changes in laws, regulations and applicable accounting standards; serious disruptions or catastrophic events and adverse or unseasonable weather; expanding international operations; merchandise sourcing and transport; commodity availability and pricing; fluctuations in currency exchange rates; fluctuations in quarterly operating results and market expectations; mergers, acquisitions, or business investments and divestitures, closings or business consolidations; outcomes of litigation, legal proceedings and other legal or regulatory matters; disproportionate impact of disruptions in the second half of the fiscal year; cash flow; inventory or asset loss; tax matters; real estate activities; and other factors that may be described in our filings with the Securities and Exchange Commission. We do not undertake to publicly update or revise our forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied in such statements will not be realized. The TJX Companies, Inc. and Consolidated Subsidiaries Financial Summary (Unaudited) (In Thousands Except Per Share Amounts) Thirteen Weeks Ended Fifty-Two Weeks Ended January 30, 2021 February 1, 2020 January 30, 2021 February 1, 2020 Net sales $ 10,943,210 $ 12,206,462 $ 32,136,962 $ 41,716,977 Cost of sales, including buying and occupancy costs 7,882,575 8,741,805 24,533,815 29,845,780 Selling, general and administrative expenses 2,193,101 2,135,329 7,020,917 7,454,988 Loss on early extinguishment of debt 312,233 312,233 Interest expense, net 47,163 3,053 180,734 10,026 Income before income taxes 508,138 1,326,275 89,263 4,406,183 (Provision) benefit for income taxes (182,615) (341,485) 1,207 (1,133,990) Net income $ 325,523 $ 984,790 $ 90,470 $ 3,272,193 Diluted earnings per share $ 0.27 $ 0.81 $ 0.07 $ 2.67 Cash dividends declared per share $ 0.26 $ 0.23 $ 0.26 $ 0.92 Weighted average common shares diluted 1,219,479 1,219,365 1,214,703 1,226,519 The TJX Companies, Inc. and Consolidated Subsidiaries Condensed Balance Sheets (Unaudited) (In Millions) January 30, 2021 February 1, 2020 ASSETS Current assets: Cash and cash equivalents $ 10,469.6 $ 3,216.8 Accounts receivable and other current assets 896.1 754.3 Merchandise inventories 4,337.4 4,872.6 Federal, state and foreign income taxes recoverable 36.2 47.0 Total current assets 15,739.3 8,890.7 Net property at cost 5,036.1 5,325.0 Operating lease right of use assets 8,990.0 9,060.3 Goodwill 99.0 95.5 Other assets 949.2 773.5 TOTAL ASSETS $ 30,813.6 $ 24,145.0 LIABILITIES AND SHAREHOLDERS EQUITY Current liabilities: Accounts payable $ 4,823.4 $ 2,672.6 Accrued expenses and other current liabilities 3,553.0 3,066.5 Current portion of operating lease liabilities 1,677.6 1,411.2 Current portion of long-term debt 749.7 Total current liabilities 10,803.7 7,150.3 Other long-term liabilities 1,063.9 851.1 Non-current deferred income taxes, net 37.2 142.2 Long-term operating lease liabilities 7,743.2 7,816.6 Long-term debt 5,332.9 2,236.6 Shareholders equity 5,832.7 5,948.2 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY $ 30,813.6 $ 24,145.0 The TJX Companies, Inc. and Consolidated Subsidiaries Condensed Statements of Cash Flows (Unaudited) (In Millions) Fifty-Two Weeks Ended January 30, 2021 February 1, 2020 CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 90.5 $ 3,272.2 Depreciation and amortization 870.8 867.3 Loss on early extinguishment of debt 312.2 Loss on property disposals and impairment charges 83.8 16.1 Deferred income tax (benefit) (230.7) (6.2) Share-based compensation 58.5 125.0 (Increase) in accounts receivable and other assets (128.5) (60.1) Decrease (increase) in merchandise inventories 588.8 (296.5) Decrease (increase) in income taxes recoverable 10.7 (34.2) Increase in accounts payable 2,111.2 29.3 Increase in accrued expenses and other liabilities 637.3 217.4 Increase in net operating lease liabilities 200.2 29.6 Other (42.9) (93.2) Net cash provided by operating activities 4,561.9 4,066.7 CASH FLOWS FROM INVESTING ACTIVITIES: Property additions (568.0) (1,223.1) Investment in Familia (230.2) Purchase of investments (29.1) (28.8) Sales and maturities of investments 18.5 12.7 Other 7.4 Net cash (used in) investing activities (578.6) (1,462.0) CASH FLOWS FROM FINANCING ACTIVITIES: Payments on revolving credit facilities (1,000.0) Proceeds from long-term debt including revolving credit facilities 5,986.9 Payments of long-term debt and extinguishment expenses (1,418.3) Payments for debt issuance expenses (42.4) Payments for repurchase of common stock (201.5) (1,552.0) Proceeds from issuance of common stock 211.2 232.1 Cash dividends paid (278.3) (1,071.6) Other (29.3) (23.4) Net cash provided by (used in) financing activities 3,228.3 (2,414.9) Effect of exchange rate changes on cash 41.2 (3.2) Net increase in cash and cash equivalents 7,252.8 186.6 Cash and cash equivalents at beginning of year 3,216.8 3,030.2 Cash and cash equivalents at end of year $ 10,469.6 $ 3,216.8 The TJX Companies, Inc. and Consolidated Subsidiaries Selected Information by Major Business Segment (Unaudited) (In Thousands) Thirteen Weeks Ended Fifty-Two Weeks Ended January 30, 2021 February 1, 2020 January 30, 2021 February 1, 2020 Net sales: In the United States: Marmaxx $ 6,920,701 $ 7,402,361 $ 19,362,573 $ 25,664,805 HomeGoods 2,224,758 1,951,658 6,096,237 6,355,770 TJX Canada 836,706 1,134,689 2,836,088 4,031,406 TJX International 961,045 1,717,754 3,842,064 5,664,996 Total net sales $ 10,943,210 $ 12,206,462 $ 32,136,962 $ 41,716,977 Segment profit (loss): In the United States: Marmaxx $ 835,308 $ 998,172 $ 891,180 $ 3,469,794 HomeGoods 274,480 241,581 509,562 680,520 TJX Canada 22,839 130,046 124,143 515,559 TJX International (200,315) 128,738 (503,618) 307,081 Total segment profit 932,312 1,498,537 1,021,267 4,972,954 General corporate expense 64,778 169,209 439,037 556,745 Loss on early extinguishment of debt 312,233 312,233 Interest expense, net 47,163 3,053 180,734 10,026 Income before income taxes $ 508,138 $ 1,326,275 $ 89,263 $ 4,406,183 The TJX Companies, Inc. and Consolidated Subsidiaries Notes to Consolidated Condensed Statements", "role": "user" }, { "content": "The TJX Companies, Inc. Reports Q4 and Full Year FY21 Results; Reports Above-Plan Q4 Overall Open-Only Comp Store Sales of Down 3%; Plans to Declare Quarterly Dividend at Current Rate in the First Quarter of Fiscal 2022 Reported Q4 FY21 net sales of $10.9 billion, which reflects the negative impact of temporary store closures for approximately 13% of the quarter Q4 FY21 overall open-only comp store sales decreased 3%, which was well above the Companys plans Q4 FY21 diluted earnings per share were $.27, which includes a debt extinguishment charge of $.18 per share and a higher tax rate in the fourth quarter that negatively impacted EPS by an additional $.05 The Company estimates that its temporary store closures in Europe and Canada negatively impacted fourth quarter sales by approximately $950 million to $1.05 billion and EPS by approximately $.18 to $.21 (see below) Reported FY21 net sales of $32.1 billion, which reflects the negative impact of temporary store closures for approximately 24% of the year FY21 overall open-only comp store sales decreased 4%, which was above the Companys plans FY21 diluted earnings per share were $.07, which includes a debt extinguishment charge of $.19 per share Generated FY21 operating cash flow of $4.6 billion Declared the previously announced Q4 FY21 dividend at an increased rate of $.26 per share; Announces plans to declare a quarterly dividend at the current rate in the first quarter of Fiscal 2022, subject to Board approval", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO--(BUSINESS WIRE)--Foresight Acquisition Corp. (the Company), a blank check company targeting a technology-enabled consumer or consumer healthcare business, announced today the closing of its initial public offering of 31,625,000 units, which included the full exercise of the underwriters over-allotment option. The offering was priced at $10.00 per unit, generating total gross proceeds of $316,250,000. Each unit consists of one share of Class A common stock and one-third of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Companys units are listed on the Nasdaq Capital Market and trade under the symbol FOREU. Once the securities comprising the units begin separate trading, the Company expects that its Class A common stock and warrants will be listed on the Nasdaq Capital Market under the symbols FORE and FOREWS, respectively. Cowen served as the sole book-running manager for the offering. The offering was made only by means of a prospectus. Copies of the prospectus may be obtained from Cowen, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, email [email protected], telephone: 833-297-2926. A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the SEC) and became effective on February 9, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Forward-Looking Statements This press release contains statements that constitute forward-looking statements, including with respect to the anticipated use of the net proceeds of the public offering discussed above. No assurance can be given that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Companys registration statement and preliminary prospectus for the Companys offering filed with the SEC. Copies of these documents are available on the SECs website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.", "role": "user" }, { "content": "Foresight Acquisition Corp. Announces Closing of $316,250,000 Initial Public Offering", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: --(BUSINESS WIRE)--(AM)(AMGTA)(State of Knowledge on the Environmental Impacts of Metal Additive Manufacturing)(Delft University of Technology)Jeremy Faludi(Dartmouth College)Corrie Van Sice AMGTAAMGTAhttps://www.amgta.org/resources/ CM [](LCA)LCAAMCMAMDEDLCA AMGTASherry HandelFaludiVan SiceAMAMHandelAMGTAAMGTA Jeremy FaludiAMGTAFaludi3D(Thayer School of Engineering)Faludi(University of California Berkeley)(Stanford University)(Reed College) Corrie Van SiceFaludiVan Sice3DAMFaludiMakerBot IndustriesVan Sice2011(New York University)(Interactive Telecommunications Program) AMGTA AMGTA201911(AM)AMGTA AMGTASintavia, LLC(Taiyo Nippon Sanso Corporation)(Nippon Sanso Holdings Corporation)AMQC Laboratories, Inc. AMGTAAMEXCI ABDanish AM HubEOSGE AdditiveMaterialiseNational Manufacturing Institute ScotlandSiemens Digital Industries SoftwareSLM Solutions Inc.Stryker", "role": "user" }, { "content": "AMGTA ", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: , Four Seasons New York, , United Way Worldwide . - (OAK BROOK), , 22 2020 . /PRNewswire/ -- (Ty Warner), - , Hope. , , , United Way COVID-19. - 100% . Ty_Inc_COVID_19 \" , , - . - United Way Worldwide, 135 \". , COVID-19, Four Seasons New York. , - , Hope , - United Way Worlwide . Hope . Ty.com.\" United Ways COVID-19, - (Suzanne McCormick). - Hope \". , COVID-19 - , Four Seasons New York.\" , -, , 18- . . , - - . - , , Four Seasons\". Hope -: https://shop.ty.com/ - \"\". , Ty Inc. - . , - 300 . , Children's Hunger Fund, World Vision, Toy Bank, International Toy Bank, Today Show, Children's Miracle Network, Operation Iraqi Freedom, Toys for Tots, , , \" \", , -, Ronald McDonald House, USO, Mayo Clinic . United Way United Way , . 2,9 9,8 , United Way , 4,7 . . 1 800 40 , . United Way , , , , , , , .. United Way - UnitedWay.org. Twitter: @UnitedWay #LiveUnited. - https://mma.prnewswire.com/media/1158293/Ty_Inc_COVID_19.jpg - https://mma.prnewswire.com/media/1076096/Ty_Logo.jpg Related Links Ty.com SOURCE Ty Inc.", "role": "user" }, { "content": "Beanie Babies , United Way Worldwide COVID-19 P P English English English", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHARLESTOWN, Mass., & HONG KONG--(BUSINESS WIRE)--Vicarious Surgical Inc. (Vicarious or Vicarious Surgical or the Company), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. (D8) (NYSE: DEH), a special purpose acquisition company, today announced that they have entered into a definitive business combination agreement. Upon the closing of this transaction, the combined company will operate as Vicarious Surgical Inc. and will be listed on the New York Stock Exchange (NYSE) under the new ticker symbol \"RBOT. Management Commentary Seven years ago, we started this company in order to solve the long-standing and persistent issues presented by open surgery, standard minimally invasive surgery and legacy robotic surgery, said Adam Sachs, Co-Founder & Chief Executive Officer of Vicarious Surgical. Legacy robotic platforms were introduced with a promise of solving the challenges of open surgery; unfortunately, these legacy robotic platforms have significant limitations including prohibitive cost of adoption, limited mobility and capabilities in the body and required space, set up time and lengthy training. After more than two decades on the market, it is no surprise that legacy robotic penetration is just 3%1. Our robotic solution has arms that replicate human motion, offering remarkable mobility with 9 degrees of freedom per arm with 360-degree visualization, all through a 1.5 cm incision. Our robot can see, reach, and work anywhere inside the abdomen, which effectively shrinks the surgeon and puts her/him inside the human body. Our system fits through a standard door making it portable from operating room to operating room, and does not require a large footprint or facility construction build-out. With cost of goods that are significantly lower than competing products, we believe our robotic solution will offer a cost-effective path to improving patient outcomes and increasing the efficiency of surgical procedures for hospitals and ambulatory surgical centers. We are incredibly proud of the development work we have accomplished to date, which led to our product becoming the first, and only, surgical robot to receive breakthrough designation from the FDA2. Mr. Sachs continued: We are extremely excited to announce our partnership with Donald Tang, David Chu and the rest of the D8 team, which we believe will assist in catalyzing the development of our flagship robot and in establishing a foundation of long-term growth for our Company. Mr. Tang and the D8 team appreciate the potential impact our technology can have on making procedures safer and more available to patients, while simultaneously saving hospitals money and time. We look forward to entering the public markets with the team from D8 at our side. D8 reviewed numerous investment opportunities in search of an exciting growth company to merge with and Vicarious Surgical impressed us with their visionary team and market disrupting products, said Donald Tang, Co-founder and President of D8 Holdings Corp. Beyond the technology and the capabilities of Vicarious Surgicals robot, we were also excited about the positive feedback from surgeons and hospitals. We consider Vicarious Surgical to be a thought leader in the surgical space and we believe the market is ready for surgical robots that drive efficiency and improved quality of patient care. We are excited to work with the Vicarious Surgical team on the next phase of commercialization for their products, bringing what we believe is much needed innovation and choice to patients and practitioners, both in the U.S. and abroad. Company Overview Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company was founded in 2014 by experienced roboticists Adam Sachs, Co-Founder & Chief Executive Officer, Sam Khalifa, Co-Founder & Chief Technology Officer, and Co-Founder & Chief Medical Officer, Dr. Barry Greene, who is a board certified Bariatric and General Surgeon with over 25 years of experience performing advanced laparoscopic surgical procedures. Vicarious Surgicals novel approach to surgery uses a combination of proprietary, human-like surgical robots and virtual reality to transport surgeons inside the patient when performing minimally invasive surgery. The Companys technology was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), making it the first, and only, surgical robot to receive this designation from the FDA2. The Company is backed by technology luminaries including Bill Gates, Vinod Khoslas Khosla Ventures, Eric Schmidt's Innovation Endeavors, Jerry Yang's AME Cloud Ventures and Philip Liangs E15 VC. Vicarious Surgicals management team is led by Co-Founder & Chief Executive Officer, Adam Sachs, Co-Founder & Chief Technology Officer, Sammy Khalifa, Co-Founder & Chief Medical Officer, Dr. Barry Greene, Chief Financial Officer, Bill Kelly, and General Counsel & Chief Legal Officer, June Morris. Vicarious Surgicals management team will continue to lead the combined company following the transaction. Vicarious Surgicals Executive Chairman, David Styka, will serve as Chairman of the combined companys Board of Directors. Co-Founder and President of D8 Holdings Corp., Donald Tang and D8 Holdings Corp director, David Da-I Ho, MD will become members of the combined companys Board of Directors. Key Transaction Terms The transaction is expected to deliver up to $460 million of gross proceeds, including up to $345 million of cash held in D8s trust account (assuming no redemptions are effected). The transaction is further supported by a $115 million private placement of common stock (PIPE), priced at $10.00 per share, including investment by BD - one of the largest global medical technology companies in the world - new institutional investors and existing investors including Bill Gates, Vinod Khoslas Khosla Ventures, Eric Schmidt's Innovation Endeavors, and Philip Liangs E15 VC. Assuming no redemptions, the company is projected to have more than $425 million in cash on the balance sheet after closing. The transaction values the combined company at an enterprise value of approximately $1.1 billion and implies approximately 3.1x 2025 estimated revenue of $355 million. Assuming no public shareholders of D8 Holdings Corp. exercise their redemption rights and based on current assumptions regarding the financial condition of Vicarious Surgical as of the closing of the transaction, current Vicarious Surgical Inc. equity holders will own approximately 64.7%, D8 Holdings Corp. equity holders will own approximately 22.3%, D8s sponsor will own approximately 5.6% and PIPE investors will own approximately 7.4% of the issued and outstanding shares of common stock, options and warrants to purchase shares of common stock, respectively, of the combined company at closing. The transaction, which was unanimously approved by the boards of directors of both Vicarious Surgical and D8, is subject to approval by D8s shareholders and other customary closing conditions. The transaction is expected to close in the third quarter of 2021. A more detailed description of the transaction terms and a copy of the Agreement and Plan of Merger will be included in a current report on Form 8-K to be filed by D8 Holdings Corp. with the United States Securities and Exchange Commission (SEC). D8 will file a registration statement on Form S-4 (which will contain a proxy statement/prospectus) with the SEC in connection with the transaction. Advisors Credit Suisse is serving as financial advisor and capital markets advisor to Vicarious Surgical. Credit Suisse is also serving as exclusive placement agent on the private offering. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. are serving as legal counsel to Vicarious Surgical. UBS Investment Bank is serving as capital markets advisor to D8 and acted as the sole book-running manager for the D8s IPO in July 2020. White & Case LLP is serving as legal counsel to D8. Investor Conference Call Vicarious Surgical and D8 will host an investor conference call to discuss the proposed transaction at 8:00 AM EDT on April 15, 2021. Those who would like to participate may dial 877-465-1289 (201-689-8762 for international callers). A live webcast of the call and any accompanying materials will also be available at https://www.vicarioussurgical.com/ and D8 at https://d8holdingscorp.com/investor-info. D8 will also file the presentation with the SEC in a Current Report on Form 8-K, which will be accessible at www.sec.gov. About Vicarious Surgical Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Companys novel surgical approach uses a combination of proprietary human-like surgical robots and virtual reality to transport surgeons inside the patient to perform minimally invasive surgery. The Companys technology was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), making it the first, and only, surgical robot to receive this designation from the FDA2. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khoslas Khosla Ventures, Eric Schmidt's Innovation Endeavors, Jerry Yang's AME Cloud Ventures, and Philip Liangs E15 VC. The Company is headquartered in Charlestown, MA. About D8 Holdings Corp. D8 Holdings Corp. a special purpose acquisition company seeking a business combination with a company that applies technology and innovation to disrupt large addressable markets. D8s objective is to identify a target business that is under-valued relative to its potential and ready for transformative improvement. D8 plans to leverage our founders unique operational expertise to create a new growth trajectory for a target company and deliver shareholder value. Forward-Looking Statements The information in this press release includes forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as estimate, plan, project, forecast, intend, will, expect, anticipate, believe, seek, target or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and expectations and timing related to potential benefits, terms and timing of the transaction. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Vicarious Surgicals and D8s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Vicarious Surgical and D8. These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political, and legal conditions; the inability of the parties to successfully or timely consummate the proposed business combination, including the risk that any required approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed business combination or that the approval of the shareholders of D8 or Vicarious Surgical is not obtained; failure to realize the anticipated benefits of the proposed business combination; risks relating to the uncertainty of the projected financial information with respect to Vicarious Surgical; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; Vicarious Surgicals ability to manage future growth; Vicarious Surgicals ability to develop new products and solutions, bring them to market in a timely manner, and make enhancements to its products; the effects of competition on Vicarious Surgicals future business; the amount of redemption requests made by D8s public shareholders; the ability of D8 or the combined company to issue equity or equity-linked securities in connection with the proposed business combination or in the future; the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; and those factors discussed in D8s Annual Report on Form 10-K for the year ended December 31, 2020 (the Annual Report) under the heading Risk Factors, and other documents of D8 filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither Vicarious Surgical nor D8 presently know or that Vicarious Surgical and D8 currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Vicarious Surgicals and D8s expectations, plans or forecasts of future events and views as of the date of this press release. Vicarious Surgical and D8 anticipate that subsequent events and developments will cause Vicarious Surgicals and D8s assessments to change. However, while Vicarious Surgical and D8 may elect to update these forward-looking statements at some point in the future, Vicarious Surgical and D8 specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Vicarious Surgicals and D8s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. Additional Information About the Proposed Business Combination and Where to Find It The proposed business combination will be submitted to shareholders of D8 for their consideration. D8 intends to file a registration statement on Form S-4 (the Registration Statement) with the SEC which will include preliminary and definitive proxy statements to be distributed to D8s shareholders in connection with D8s solicitation for proxies for the vote by D8s shareholders in connection with the proposed business combination and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued in connection with the completion of the proposed business combination. After the Registration Statement has been filed and declared effective, D8 will mail a definitive proxy statement and other relevant documents to its shareholders as of the record date established for voting on the proposed business combination. D8s shareholders and other interested persons are advised to read, once available, the preliminary proxy statement / prospectus and any amendments thereto and, once available, the definitive proxy statement / prospectus, in connection with D8s solicitation of proxies for its special meeting of shareholders to be held to approve, among other things, the proposed business combination, because these documents will contain important information about D8, Vicarious Surgical and the proposed business combination. Shareholders may also obtain a copy of the preliminary or definitive proxy statement, once available, as well as other documents filed with the SEC regarding the proposed business combination and other documents filed with the SEC by D8, without charge, at the SEC's website located at www.sec.gov or by directing a request to D8, at Unit 1008, 10/F, Champion Tower, 3 Garden Road, Central, Hong Kong. Participants in the Solicitation D8, Vicarious Surgical and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitations of proxies from D8s shareholders in connection with the proposed business combination. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of D8s shareholders in connection with the proposed business combination will be set forth in D8s proxy statement / prospectus when it is filed with the SEC. You can find more information about D8s directors and executive officers in D8s Annual Report. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests will be included in the proxy statement / prospectus when it becomes available. Shareholders, potential investors and other interested persons should read the proxy statement / prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources indicated above. 1 Vicarious Surgical estimates from data sourced from LSI Market Size Analysis and public filings 2 As of the date of this press release, Vicarious Surgical is not aware of any surgical robotics company that has announced receiving Breakthrough Designation for a full robotics system.", "role": "user" }, { "content": "Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs The transaction values the combined company at an enterprise value of approximately $1.1 billion and is expected to provide more than $425 million in cash on the balance sheet after closing including a fully committed $115 million PIPE, priced at $10.00 per share PIPE participants include strategic investor, BD (Becton, Dickinson and Company) (NYSE: BDX) - one of the largest global medical technology companies in the world - new institutional investors and existing investors including Bill Gates, Vinod Khoslas Khosla Ventures, Eric Schmidt's Innovation Endeavors, and Philip Liangs E15 VC. An investor conference call to discuss the proposed transaction will be conducted today, April 15, 2021, at 8:00 AM ET", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: AMSTERDAM--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of a of the European Mutual Association for Nuclear Insurance (Emani) (Belgium). The outlook of these Credit Ratings (ratings) remains stable. The ratings reflect Emanis balance sheet strength, which AM Best categorises as very strong, as well as its strong operating performance, neutral business profile and appropriate enterprise risk management. Emanis balance sheet strength is underpinned by risk-adjusted capitalisation at the strongest level, as measured by Bests Capital Adequacy Ratio (BCAR), taking into account the mutuals ability to make supplementary capital calls to its members and its financial flexibility. In the unlikely event of a full limit loss, there would be a material depletion of capital due to the large net line size offered by Emani to its members relative to its capital base. However, AM Best believes that the mutuals contractual right to call retrospective premium for six times each members annualised premium contribution would enable the mutual to rebuild its capital base quickly. Emani has good financial flexibility, underpinned by its articles of association, which allows the mutual to write down its liabilities in the event that claims exceed its capital base. The mutuals dependence on reinsurance to offer a large gross line size is considered an offsetting factor in the assessment. Emani has a track record of strong technical performance, demonstrated by a loss ratio averaging 30% during the five-year period ending in 2019. The mutual reported a net combined ratio of 137% in 2019, driven by two mid-size losses. Prospective performance is expected to revert to historic norms, albeit subject to volatility, consistent with a claims profile that is dominated by an infrequent number of low to mid-size losses. Emani has an established position in the nuclear energy sector, writing property and terror cover for nuclear facilities. The mutual provides capacity to over a third of nuclear operators globally, giving the mutual a leading role in its market. Emani also benefits from favourable market conditions, with demand for nuclear coverage expected to remain strong through the medium term. The mutuals narrow focus and the high risk nature of the business written are considered offsetting factors in the assessment. This press release relates to Credit Ratings that have been published on AM Bests website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Bests Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Bests Credit Ratings. For information on the proper media use of Bests Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Bests Credit Ratings and AM Best Rating Action Press Releases. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in New York, London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com. Copyright 2020 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.", "role": "user" }, { "content": "AM Best Affirms Credit Ratings of European Mutual Association for Nuclear Insurance", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TORONTO--(BUSINESS WIRE)--January 14, 2021- New Gold Inc. (New Gold or the Company) (TSX and NYSE American: NGD) reports fourth quarter and annual operational results for the Company as of December 31, 2020, achieving the mid-range of the revised annual production guidance (refer to the Company's July 30, 2020 news release for further information). An earnings conference call and webcast will be held on February 19, 2021 beginning at 8:30 am Eastern Time to discuss the fourth quarter financial results (details provided at the end of this news release). All amounts are in U.S. dollars unless otherwise indicated. The Rainy River Mine achieved the higher end of the revised annual gold equivalent production1 guidance and continued to meet, or exceed, all key operational and cost targets. All deferred construction capital has been completed and the Rainy River Mine is now positioned for strong production growth at lower costs and higher margins that will drive strong free cash flow generation over the life of the mine. The New Afton Mine achieved the mid-range of the revised annual gold equivalent production guidance (copper production achieved the mid-range and gold production achieved the lower end). Operational performance continued to improve over the prior quarter and benefited from the stronger copper prices realized during the quarter. A strategic drilling program was launched in October to unlock the epithermal and porphyry potential of the Cherry Creek trend as well as other near mine targets. Sustainability and ESG New Gold has four key areas of focus: Water, Climate, Indigenous Peoples and Tailings Management. In 2020, New Gold refocused its sustainability efforts to align with the most pressing ESG reporting issues facing the industry. We have adopted an embedded, systems-based approach to execute on our sustainability strategy that aligns with ESG global standards beginning in 2021. Consolidated Fourth Quarter Highlights 1. Refer to the Non-GAAP Financial Performance Measures\" section of this press release. \"During the year, we repositioned the Company for long-term success as we transition to free cash flow generation in 2021. We improved our operational and cost performance, executed on our strategic capital plans, restructured our balance sheet and improved our liquidity position and we have shifted our focus to driving further operational and cost optimizations at both our assets. We begin the new year as a much stronger company with a growing, higher-margin production profile, and following the expiration of our gold hedges at the end of 2020, we are now fully exposed to the higher gold price as well as the stronger copper price. stated Renaud Adams, CEO. The Rainy River Mine is now entering a phase of strong production growth and free cash flow generation and has the potential to extend the life of the underground mine. At the New Afton Mine, we continue to advance all key B3/C-Zone projects on a self-funded basis that will position this asset for a robust free cash flow stream as the C-Zone begins production in the latter part of 2023. We have launched exploration drilling programs at both assets that could increase our resource inventory and potentially extend mine life. Consolidated Fourth Quarter Operational Results Q4 2020 FY 2020 2020 Revised Consolidated Guidance Gold eq. production (ounces)1 120,567 437,617 415,000 455,000 Gold production (ounces) 83,096 293,139 284,000 304,000 Copper production (Mlbs) 18.5 72.1 65 - 75 Average realized gold price, per ounce2 1,623 1,559 - Average realized copper price, per pound2 3.34 2.86 - Rainy River Mine Highlights Rainy River Mine Q4 2020 FY 2020 2020 Revised Guidance Gold eq. production (ounces)1 68,241 233,201 225,000 235,000 Gold eq. sold (ounces) 72,279 235,416 - Gold production (ounces) 66,734 228,919 222,000 232,000 Gold sold (ounces) 70,675 231,112 - Average realized gold price, per ounce2 1,624 1,561 - Rainy River Operating KPIs Rainy River Mine FY 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020 FY 2020 Tonnes mined per day (ore and waste) 118,404 127,684 126,512 145,701 158,638 139,702 Ore tonnes mined per day 18,712 26,012 23,101 36,515 42,918 32,178 Operating waste tonnes per day 73,702 75,596 72,575 62,818 73,921 71,212 Capitalized waste tonnes per day 25,990 26,077 30,836 46,368 41,799 36,313 Total waste tonnes per day 99,692 101,673 103,411 109,186 115,720 107,525 Strip ratio (waste: ore) 5.33 3.91 4.48 2.99 2.70 3.34 Tonnes milled per calendar day 21,980 18,441 23,880 26,998 26,999 24,096 Gold grade milled (g/t) 1.08 1.03 0.78 0.88 0.93 0.90 Gold recovery (%) 91 90 89 89 90 90 Mill availability (%) 88 91 90 90 94 91 Gold production (oz) 253,772 50,381 48,800 63,004 66,734 228,919 Gold eq. production1 (oz) 257,051 51,106 49,633 64,221 68,241 233,201 The Rainy River Mine has achieved the higher end of the revised annual gold eq. production guidance. Operating expenses and cash costs are expected to be below revised annual guidance, primarily due to lower mining costs during the year as well as higher production and sales. All-in sustaining costs (AISC) are expected to be below the revised annual guidance due to lower operating expenses and sustaining capital spend. Sustaining capital is tracking to achieve the lower end of the revised annual guidance estimates, primarily due to realized savings related to Tailings Management Area (TMA) construction. New Afton Mine Operational Highlights New Afton Mine Q4 2020 FY 2020 2020 Revised Guidance Gold eq. production (ounces) 1 52,326 204,416 190,000 220, 000 Gold eq. sold (ounces) 49,860 192,953 - Gold production (ounces) 16,362 64,220 62,000 72,000 Gold sold (ounces) 15,817 60,765 - Copper production (Mlbs) 18.5 72.1 65 75 Copper sold (Mlbs) 17.5 68.0 - Average realized gold price, per ounce2 1,621 1,553 - Average realized copper price, per pound2 3.34 2.86 - New Afton Operating KPIs New Afton Mine FY 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020 FY 2020 Tonnes mined per day (ore and waste) 15,620 16,727 15,358 17,249 17,259 16,652 Tonnes milled per calendar day 15,300 15,377 14,240 15,483 15,358 15,116 Gold grade milled (g/t) 0.47 0.45 0.46 0.44 0.46 0.45 Gold recovery (%) 82 81 81 80 79 80 Gold production (oz) 68,785 16,409 15,494 15,955 16,362 64,220 Copper grade milled (%) 0.78 0.73 0.72 0.71 0.73 0.72 Copper recovery (%) 83 82 83 82 81 82 Copper production (Mlbs) 79.4 18.5 16.9 18.2 18.5 72.1 Mill availability (%) 97 98 92 98 99 97 Gold eq. production1 (oz) 229,091 52,329 48,446 51,315 52,326 204,416 The New Afton Mine achieved the mid-range of the revised annual gold eq. production guidance. Operating expense and cash costs are expected to achieve the lower end of the revised guidance and AISC are expected to be at, or slightly below, the low end of the revised annual guidance, primarily due to lower sustaining capital spend. Sustaining capital is expected to be at, or slightly below, the low end of the revised annual guidance and growth capital is expected to be at the mid-range of revised annual guidance. Fourth Quarter Conference Call and Webcast The Company will host an earnings call and webcast on Thursday, February 19, 2021 at 08:30 AM Eastern Time to discuss the financial results. Details are provided below: About New Gold Inc. New Gold is a Canadian-focused intermediate gold mining company with a portfolio of two core producing assets in Canada, the Rainy River and New Afton Mines. The Company also holds an 8% gold stream on the Artemis Gold Blackwater project located in British Columbia and a 6% equity stake in Artemis. The Company also operates the Cerro San Pedro Mine in Mexico (in reclamation). New Gold's vision is to build a leading diversified intermediate gold company based in Canada that is committed to environment and social responsibility. For further information on the Company, visit www.newgold.com. Cautionary Note Regarding Forward-Looking Statements Certain information contained in this news release, including any information relating to New Golds future financial or operating performance are forward looking. All statements in this news release, other than statements of historical fact, which address events, results, outcomes or developments that New Gold expects to occur are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the use of forward-looking terminology such as plans, expects, is expected, budget, scheduled, targeted, estimates, forecasts, intends, anticipates, projects, potential, believes or variations of such words and phrases or statements that certain actions, events or results may, could, would, should, might or will be taken, occur or be achieved or the negative connotation of such terms. Forward-looking statements in this news release include, among others, statements with respect to: the Companys plans to grow production and generate free cash flow; the Companys production and sales; the Companys cash costs, all-in-sustaining costs and operational expenses; the Companys plans to optimize operations and costs at its assets and plans to extend the life of mine of the Rainy River Mine and the New Afton Mine; the timing of completion for capital projects at Rainy River Mine and the New Afton Mine; the timing and scope of exploration drilling programs at the Rainy River Mine, the New Afton Mine and Cherry Creek; and the timing of receipt of permits at the New Afton Mine. All forward-looking statements in this news release are based on the opinions and estimates of management as of the date such statements are made and are subject to important risk factors and uncertainties, many of which are beyond New Golds ability to control or predict. Certain material assumptions regarding such forward-looking statements are discussed in this news release, New Golds latest annual managements discussion and analysis (MD&A), its most recent annual information form and technical reports on the Rainy River Mine and New Afton Mine filed at www.sedar.com and on EDGAR at www.sec.gov. In addition to, and subject to, such assumptions discussed in more detail elsewhere, the forward-looking statements in this news release are also subject to the following assumptions: (1) there being no significant disruptions affecting New Golds operations other than as set out herein; (2) political and legal developments in jurisdictions where New Gold operates, or may in the future operate, being consistent with New Golds current expectations; (3) the accuracy of New Golds current mineral reserve and mineral resource estimates; (4) the exchange rate between the Canadian dollar and U.S. dollar, and to a lesser extent, the Mexican Peso, being approximately consistent with current levels; (5) prices for diesel, natural gas, fuel oil, electricity and other key supplies being approximately consistent with current levels; (6) equipment, labour and materials costs increasing on a basis consistent with New Golds current expectations; (7) arrangements with First Nations and other Aboriginal groups in respect of the New Afton Mine and Rainy River Mine being consistent with New Golds current expectations, particularly in the context of the outbreak of COVID-19; (8) all required permits, licenses and authorizations being obtained from the relevant governments and other relevant stakeholders within the expected timelines and the absence of material negative comments during the applicable regulatory processes; (9) there being no new cases of COVID-19 in the Companys workforce at either the Rainy River or New Afton Mine and the assumption that no additional members of the workforce are expected to be required to self-isolate due to cross-border travel to the United States or any other country; (10) the responses of the relevant governments to the COVID-19 outbreak being sufficient to contain the impact of the COVID-19 outbreak; (11) there being no material disruption to the Companys supply chains and workforce that would interfere with the Companys anticipated course of action at the Rainy River Mine and the systematic ramp-up of operations; (12) the long-term economic effects of the COVID-19 outbreak not having a material adverse impact on the Companys operations or liquidity position; and (13) Artemis Gold Inc. being able to complete the remaining C$50 million cash payment due on August 24, 2021 for the acquisition of the Blackwater project. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Such factors include, without limitation: significant capital requirements and the availability and management of capital resources; additional funding requirements; price volatility in the spot and forward markets for metals and other commodities; fluctuations in the international currency markets and in the rates of exchange of the currencies of Canada, the United States and, to a lesser extent, Mexico; discrepancies between actual and estimated production, between actual and estimated mineral reserves and mineral resources and between actual and estimated metallurgical recoveries; risks related to early production at the Rainy River Mine, including failure of equipment, machinery, the process circuit or other processes to perform as designed or intended; fluctuation in treatment and refining charges; changes in national and local government legislation in Canada, the United States and, to a lesser extent, Mexico or any other country in which New Gold currently or may in the future carry on business; taxation; controls, regulations and political or economic developments in the countries in which New Gold does or may carry on business; the speculative nature of mineral exploration and development, including the risks of obtaining and maintaining the validity and enforceability of the necessary licenses and permits and complying with the permitting requirements of each jurisdiction in which New Gold operates, the lack of certainty with respect to foreign legal systems, which may not be immune from the influence of political pressure, corruption or other factors that are inconsistent with the rule of law; the uncertainties inherent to current and future legal challenges New Gold is or may become a party to; diminishing quantities or grades of mineral reserves and mineral resources; competition; loss of key employees; rising costs of labour, supplies, fuel and equipment; actual results of current exploration or reclamation activities; uncertainties inherent to mining economic studies; changes in project parameters as plans continue to be refined; accidents; labour disputes; defective title to mineral claims or property or contests over claims to mineral properties; unexpected delays and costs inherent to consulting and accommodating rights of Indigenous groups; risks, uncertainties and unanticipated delays associated with obtaining and maintaining necessary licenses, permits and authorizations and complying with permitting requirements; there being cases of COVID-19 in the Companys workforce at either the Rainy River or New Afton Mine, or both; the Companys workforce at either the Rainy River Mine or the New Afton Mine, or both, being required to self-isolate due to cross-border travel to the United States or any other country; the responses of the relevant governments to the COVID-19 outbreak not being sufficient to contain the impact of the COVID-19 outbreak; disruptions to the Companys supply chain and workforce due to the COVID-19 outbreak; an economic recession or downturn as a result of the COVID-19 outbreak that materially adversely affects the Companys operations or liquidity position; there being further shutdowns at the Rainy River or New Afton Mines; the Company not being able to complete its construction projects at the Rainy River Mine or the New Afton Mines on the timing described herein or at all; the Company not being able to complete the exploration drilling program to be launched at the Rainy River Mine and Cherry Creek on the timing described herein or at all; Artemis Gold Inc. not being able to make the remaining C$50 million cash payment due on August 24, 2021. In addition, there are risks and hazards associated with the business of mineral exploration, development and mining, including environmental events and hazards, industrial accidents, unusual or unexpected formations, pressures, cave-ins, flooding and gold bullion losses (and the risk of inadequate insurance or inability to obtain insurance to cover these risks) as well as Risk Factors included in New Golds Annual Information Form, MD&A and other disclosure documents filed on and available at www.sedar.com and on EDGAR at www.sec.gov. Forward looking statements are not guarantees of future performance, and actual results and future events could materially differ from those anticipated in such statements. All forward-looking statements contained in this news release are qualified by these cautionary statements. New Gold expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, events or otherwise, except in accordance with applicable securities laws. Non-GAAP Financial Performance Measures Average Realized Price \"Average realized price per ounce or pound sold\" is a non-GAAP financial measure with no standard meaning under IFRS. Management uses this measure to better understand the price realized in each reporting period for gold, silver, and copper sales. Average realized price is intended to provide additional information only and does not have any standardized definition under IFRS; it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Other companies may calculate this measure differently and this measure is unlikely to be comparable to similar measures presented by other companies. Technical Information The scientific and technical information contained herein has been reviewed and approved by Eric Vinet, Senior Vice President, Operations of New Gold. Mr. Vinet is a Professional Engineer and member of the Ordre des ingnieurs du Qubec. He is a \"Qualified Person\" for the purposes of National Instrument 43-101 Standards of Disclosure for Mineral Projects.", "role": "user" }, { "content": "New Gold Reports Fourth Quarter and Annual Operational Results; Achieves Annual Production Guidance Provides Notice of Release of Fourth Quarter Financial Results", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HOUSTON, Nov. 4, 2020 /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) (\"Main Street\") is pleased to announce that its Board of Directors declared regular monthly cash dividends of $0.205 per share for each of January, February and March 2021. These monthly dividends, which will be payable pursuant to the table below, total $0.615 per share for the first quarter of 2021, which are consistent with the regular monthly dividends declared for the first quarter of 2020 and fourth quarter of 2020. Since its October 2007 initial public offering, Main Street has periodically increased the amount of its regular monthly dividends paid per share and has never reduced its regular monthly dividend amount per share. Including all dividends declared to date, Main Street will have paid $30.22 per share in cumulative cash dividends since its October 2007 initial public offering at $15.00 per share. Summary of First Quarter 2021 Regular Monthly Dividends Declared Ex-Dividend Date Record Date Payment Date Amount Per Share 11/3/2020 11/3/2020 11/3/2020 1/4/2021 1/28/2021 2/25/2021 1/5/2021 1/29/2021 2/26/2021 1/15/2021 2/12/2021 3/15/2021 $0.205 $0.205 $0.205 Total for First Quarter 2021: $0.615 The final determination of the tax attributes for dividends each yearis made after the close of the tax year. The final tax attributes for 2021 dividends are currently expected to include a combination of ordinary taxable income and qualified dividends and may include capital gains and return of capital. Main Street maintains a dividend reinvestment and direct stock purchase plan (the \"Plan\"). The dividend reinvestment feature of the Plan (the \"DRIP\") provides for the reinvestment of dividends on behalf of Main Street's registered stockholders who hold their shares with Main Street's transfer agent and registrar, American Stock Transfer and Trust Company, or certain brokerage firms that have elected to participate in the DRIP. Under the DRIP, if Main Street declares a dividend, registered stockholders who have not \"opted out\" of the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of Main Street common stock. The direct stock purchase feature of the Plan (the \"DSPP\") provides investors with a convenient and economical method to purchase shares of Main Street common stock. More information about the Plan (including the DSPP prospectus) can be found on the Main Street website (https://ir.mainstcapital.com/dividend-reinvestment-and-direct-stock-purchase-plan). ABOUT MAIN STREET CAPITAL CORPORATIONMain Street (www.mainstcapital.com) is a principal investment firm that primarily provides long-term debt and equity capital to lower middle market companies and debt capital to middle market companies. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides \"one stop\" financing alternatives within its lower middle market portfolio. Main Street's lower middle market companies generally have annual revenues between $10 million and $150 million. Main Street's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. Main Street, through its wholly owned portfolio company MSC Adviser I, LLC (\"MSC Adviser\"), also maintains an asset management business through which it manages approximately $950 million of investments for third parties. MSC Adviser is registered as an investment adviser under the Investment Advisers Act of 1940. FORWARD-LOOKING STATEMENTSThis press release may contain certain forward-looking statements, including but not limited to the continued payment and growth of future dividends and the potential tax attributes for 2021 dividends. Any such statements other than statements of historical fact are likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under Main Street's control, and that Main Street may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual performance and results could vary materially from these estimates and projections of the future as a result of a number of factors, including those described from time to time in Main Street's filings with the Securities and Exchange Commission. Such statements speak only as of the time when made and are based on information available to Main Street as of the date hereof and are qualified in their entirety by this cautionary statement. Main Street assumes no obligation to revise or update any such statement now or in the future. Contacts: Main Street Capital CorporationDwayne L. Hyzak, CEO, [emailprotected]Brent D. Smith, CFO, [emailprotected]713-350-6000 Dennard Lascar Investor RelationsKen Dennard | [emailprotected] Zach Vaughan | [emailprotected]713-529-6600 SOURCE Main Street Capital Corporation Related Links http://www.mainstcapital.com", "role": "user" }, { "content": "Main Street Announces First Quarter 2021 Regular Monthly Dividends Regular Monthly Dividends of $0.205 per Share for each of January, February and March 2021", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Hemp Seeds Market Global Forecast By Product, Application, Regions, Company Analysis\" report has been added to ResearchAndMarkets.com's offering. Worldwide Hemp Seed Market was valued at US$ 388.46 Million in the year 2020 and is expected to be US$ 544.93 Million by 2027 The industry is expected to grow with a CAGR of 4.95% from 2020 to 2027. Hemp seeds or hemp hearts are seed produced by cannabis Sativa or hemp plants. Hemp is often confused with marijuana as they belong to the same family. Hemp seeds contain 1% of THC, the active ingredient in marijuana. Hemp seed has nutritional benefits; they have the most balanced amino acids, essential fats, vitamins, iron and antioxidants. Its protein offers optimal health and well-being of life. Fresh hemp helps in weight loss, sustain energy, recovery from injury, lower cholesterol and blood pressure, improved circulation, immune system, reduced inflammation, and control sugar level in the body. Hemp seed used for both pharmaceuticals and industrial purpose and is driving the hemp market globally. Based on by Product The publisher has segmented Global Hemp Seeds Market into Whole Hemp Seed, Hulled Hemp Seed, Hemp Seed Oil and Hemp Protein Powder. Owing to the surge in research and studies has risen awareness about hemp protein among consumers. Hemp protein powder has the highest market it is consumed in smoothies and shakes, giving consumers an earthy taste. On the other hand, hempseed oil is getting popular because it helps balance oily skin, calm inflammation, and reduces irritation on the skin. The government regulates the hemp seed market across the world. There are various strict policy and licenses from different country that control hemp protein products. State authorities are required to grow and distribute these products. These regulations are one of the most significant challenges faced by the global hemp seed market. Moreover, 2018 farm bill enforcement of rules has removed the requirement to register for Drug Enforcement Administration (DEA) for growing certain kind of cannabis. The United States Department of Agriculture (USDA) recent approval positively impacts the hemp seed products market. Among countries, the United States is investing in manufacturing various industrial hemp types, and China is the highest exporter of raw and processed hemp to the United States, followed by Romania and Hungry. This small scale hemp industry and consumer are likely to propel the U.S hemp seed market in the forecast period. People worldwide are not much come across the benefits of hemp seed so its market will grow steadily, but its health benefits and nutritional benefits will propel the global hemp seed market. The various key players have adopted acquisition and blooming strategy to hike profitability and strengthen their foothold in the hemp seed market globally. Besides, players have relied on product launch to improve their product portfolio and stay competitive. The critical players depicted in the report include Naturally Splendid Enterprises Ltd., Darling ingredients Inc, Agropur, Aurora cannabis. These players concentrate on the development of products which have beneficial uses. Key Topics Covered: 1. Introduction 2. Research & Methodology 3. Executive Summary 4. Market Dynamics 4.1 Growth Drivers 4.2 Challenges 5. Global Hemp Seeds Market 6. Market Share Analysis 6.1 By Product 6.2 By Application 6.3 By Regions 7. Product - Global Hemp Seeds Market 7.1 Whole Hemp Seed 7.2 Hulled Hemp Seed 7.3 Hemp Seed Oil 7.4 Hemp Protein Powder 7.5 Others 8. Application - Global Hemp Seeds Market 8.1 Food & Beverages 8.2 Personal Care Products 8.3 Industrial Products 8.4 Others 9. Regions - Global Hemp Seeds Market 9.1 North America 9.2 Europe 9.3 Asia Pacific 9.4 Latin America 9.5 Middle East & Africa 10. Merger & Acquisitions 11. Company Analysis 11.1 Naturally Splendid Enterprises Ltd 11.1.1 Overviews 11.1.2 Recent Developments 11.1.3 Revenues 11.2 Darling Ingredients Inc 11.3 Agropur 11.4 Aurora cannabis For more information about this report visit https://www.researchandmarkets.com/r/sauib7", "role": "user" }, { "content": "Global Hemp Seeds Markets, 2021-2027 - Whole Hemp Seed, Hulled Hemp Seed, Hemp Seed Oil, & Hemp Protein Powder - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Hess Corporation (NYSE: HES) today announced a 2021 Exploration & Production capital and exploratory budget of $1.9 billion, of which more than 80% will be allocated to Guyana and the Bakken. Net production is forecast to average approximately 310,000 barrels of oil equivalent per day in 2021, excluding Libya. Bakken net production is forecast to average approximately 170,000 barrels of oil equivalent per day in 2021. This forecast includes the impact of operating a two rig program beginning in the first quarter and a planned 45-day turnaround and expansion tie-in at the Tioga Gas Plant in the third quarter, which is expected to reduce full year 2021 Bakken net production by approximately 7,500 barrels of oil equivalent per day. Our capital program reflects our disciplined approach in the current oil price environment to preserve cash, core capabilities and the long term value of our assets, CEO John Hess said. The majority of our 2021 budget is allocated to Guyana, where our three sanctioned oil developments have a Brent breakeven oil price of between $25 and $35 per barrel, and to the Bakken, where we have a large inventory of future drilling locations that generate attractive financial returns at current prices. By investing only in high return, low cost opportunities, we have built a differentiated portfolio of assets that we believe will provide industry leading cash flow growth over the course of the decade. Chief Operating Officer Greg Hill said: In the Bakken, we plan to add a second rig during the first quarter, which will allow us to sustain production and cash flow generation from this important asset. Offshore Guyana, our focus in 2021 will be on advancing our next two sanctioned developments to first oil Liza Phase 2 in early 2022 and Payara in 2024 and on front end engineering and design work for future development phases on the Stabroek Block. We also will continue to invest in an active exploration and appraisal program, with 12-15 wells planned on the Stabroek Block. The $1.9 billion budget is allocated as follows: $670 million (35%) for production, $780 million (41%) for offshore Guyana developments and $450 million (24%) for exploration and appraisal activities. Production Developments Exploration and Appraisal 2021 Estimated Capital and Exploratory Expenditures ($ Millions) By Segment: By Region: Exploration and Production Exploration and Production Production $670 United States $590 Developments 780 South America 1,125 Exploration and Appraisal 450 Asia and Other 185 Total $1,900 $1,900 Note: This budget excludes expenditures associated with the Midstream segment. Hess Corporation is a leading global independent energy company engaged in the exploration and production of crude oil and natural gas. More information on Hess Corporation is available at http://www.hess.com. Cautionary Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as anticipate, estimate, expect, forecast, guidance, could, may, should, would, believe, intend, project, plan, predict, will, target and similar expressions identify forward-looking statements, which are not historical in nature. Our forward-looking statements may include, without limitation: our future financial and operational results; our business strategy; estimates of our crude oil and natural gas reserves and levels of production; benchmark prices of crude oil, natural gas liquids and natural gas and our associated realized price differentials; our projected budget and capital and exploratory expenditures; expected timing and completion of our development projects; and future economic and market conditions in the oil and gas industry. Forward-looking statements are based on our current understanding, assessments, estimates and projections of relevant factors and reasonable assumptions about the future. Forward-looking statements are subject to certain known and unknown risks and uncertainties that could cause actual results to differ materially from our historical experience and our current projections or expectations of future results expressed or implied by these forward-looking statements. The following important factors could cause actual results to differ materially from those in our forward-looking statements: fluctuations in market prices of crude oil, natural gas liquids and natural gas and competition in the oil and gas exploration and production industry, including as a result of the global COVID-19 pandemic; reduced demand for our products, including due to the global COVID-19 pandemic or the outbreak of any other public health threat, or due to the impact of competing or alternative energy products and political conditions and events; potential failures or delays in increasing oil and gas reserves, including as a result of unsuccessful exploration activity, drilling risks and unforeseen reservoir conditions, and in achieving expected production levels; changes in tax, property, contract and other laws, regulations and governmental actions applicable to our business, including legislative and regulatory initiatives regarding environmental concerns, such as measures to limit greenhouse gas emissions and flaring as well as fracking bans; disruption or interruption of our operations due to catastrophic events, such as accidents, severe weather, geological events, shortages of skilled labor, cyber-attacks or health measures related to COVID-19; the ability of our contractual counterparties to satisfy their obligations to us, including the operation of joint ventures under which we may not control; unexpected changes in technical requirements for constructing, modifying or operating exploration and production facilities and/or the inability to timely obtain or maintain necessary permits; availability and costs of employees and other personnel, drilling rigs, equipment, supplies and other required services; any limitations on our access to capital or increase in our cost of capital, including as a result of weakness in the oil and gas industry or negative outcomes within commodity and financial markets; liability resulting from litigation, including heightened risks associated with being a general partner of Hess Midstream LP; and other factors described in Item 1ARisk Factors in our Annual Report on Form 10-K and any additional risks described in our other filings with the Securities and Exchange Commission. As and when made, we believe that our forward-looking statements are reasonable. However, given these risks and uncertainties, caution should be taken not to place undue reliance on any such forward-looking statements since such statements speak only as of the date when made and there can be no assurance that such forward-looking statements will occur and actual results may differ materially from those contained in any forward-looking statement we make. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise.", "role": "user" }, { "content": "Hess Announces 2021 E&P Capital and Exploratory Budget Majority Allocated to World Class Guyana Developments and Bakken Two Rig Program", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, July 14, 2020 /PRNewswire/ --Just in time for beach season,Dating.com,part of the Dating Group and the company behind numerous online dating sites, has polled its users to determine whether or not displaying shirtless pictures on dating profiles has an impact on their chances of finding a match. Results reveal a major disconnect between a majority of men, who believe shirtless pictures helps their chances of finding love, and women, who believe this imagery portrays immaturity. Before posting this summer's oceanfront shirtless snapshot, consider the following standout findings from Dating.com's latest survey: On average, Men with shirtless pictures displayed on their profile have 25% fewer matches. Yet, nearly 90% of men believe that shirtless pictures help their chances of landing a match. More than half of all women surveyed (66%) indicate that shirtless pictures implies a lack of maturity and self-awareness. 76% of women said they'd be unlikely to consider dating a man with shirtless images displayed in their profile for a committed relationship. 15% would be open to a hookup and 9% would consider a friendship. Three out of every five male dating profiles contains at least one shirtless picture. One out of every five female dating profiles contains at least one bikini/bathing suit picture. This same group of women had a more than 40% increase in overall match rates, compared to their covered up counterparts. Members of the LGBTQ+ community are four times more likely to include a shirtless picture in their dating profile. And if modesty isn't typically your strong suit, our experts suggest working towards the following: Analyze the current status of your online dating profile. Replace any shirtless pictures with those that still represent you and your personality, but in a less proactive manner. Family, pet and travel photos are always super lovable and attractive! Wait until you get to know more about your online match before starting to show some skin. Love isn't about looks, and leading with shirtless pictures sends the message that appearance is what you value most. If you'd like to show off your body, plan a beach date together with your new match - socially distanced, of course! This creates a more natural opportunity for you and your match to see a bit more of each other. \"We're here to make online dating more effective for all involved by sharing what we know about dating preferences,\" says Maria Sullivan, dating expert and Vice President of Dating.com. \"As masses of new users enter the online dating scene, given the current lack of in-person relationship-building opportunities amid the pandemic, we want to inform the public of common profile pitfalls before they miss out on a match.\" There is someone special waiting for everyone on Dating.com's extensive, international network of singles. To register, please visitwww.dating.com. About Dating Group: Dating Group is a global social discovery platform, enabling people from around the globe to connect through the power of shared interests and mutual benefits. Dating Group has offices in seven countries and a team of more than 500 professionals with more than 73 million registered users across the entire portfolio. Our brands include Dating.com, DateMyAge, LovingA, Tubit, AnastasiaDate, ChinaLove, and many more, each with a unique platform tailored to different communities defined by interest, geography and demographics. SOURCE Dating.com Related Links http://Dating.com", "role": "user" }, { "content": "Dating.com Finds That Shirtless Dating Profile Pictures Hurt Men's Chances of Finding Love Online Online Dating Giant Reveals Divide Between Men and Women When It Comes to Showing Skin on Profiles", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: REDWOOD SHORES, Calif., Oct. 28, 2020 /PRNewswire/ --Today, Oracle announced that The Pennsylvania State University (Penn State) will now offer Oracle Academy computing education curriculum and resources across 22 campuses, which serve nearly 100,000 students. Through the collaboration, students receive hands-on technology experience and develop skills to become career-ready in the era of cloud computing, artificial intelligence, data science, and beyond. (PRNewsfoto/Oracle) \"In today's economy, technology is essential to every industry,\" said Donald J.WelchPh.D., Penn State's vice president for Information Technology and chief information officer. \"Oracle Academy's wide range of resources including creative and engaging curriculum designed for diverse groups, personalized faculty trainings, and access to Oracle Cloud Free Tier provide Penn State students with unique opportunities to understand and experience the technologies changing the world.\" \"We are thrilled that Penn State has joined Oracle Academy in a shared mission to advance computing education,\" said Denise Hobbs, North America Regional Director, Oracle Academy. \"Deploying Oracle Academy resources at one of the world's leading higher education and research institutions highlights the value of our program and helps bring essential computing knowledge and skills to more American university students.\" Oracle's leadership in cloud and emerging technologies propels Oracle Academy's innovation-focused curriculum, resources, and workshops. As an Oracle Academy Institutional Member, Penn State will gain free access to a wide range of computing tools and training, including: Oracle Academy Cloud Program: Access to Oracle Autonomous Database and Compute Virtual Machines (VM) through Oracle Cloud Free Tier, as well as 3,500 hours of free cloud credits annually for emerging technologies, infrastructure, database, application development, and more. Oracle Application Express (APEX): Access to Oracle Application Express (APEX) for hands-on practice in the cloud. APEX is a cloud-based, low-code development platform that enables users to build scalable, secure enterprise apps, with world-class features, that can be deployed anywhere. NetSuite: Access to NetSuite and NetSuite OneWorld software as a service (SaaS) solutions to provide students with practical, hands-on business computing experience in enterprise resource planning (ERP), sales and marketing, ecommerce, supply chain, and more. Curriculum and Learning Resources: College-ready and career-focused curriculum and learning modules in Java, database, and project management. A sampling of courses include: Artificial Intelligence with Machine Learning in Java, Oracle Application Express (APEX) Development Foundations, and Oracle Primavera P6 Professional Project Management Fundamentals. The Penn State faculty are fully supported by Oracle Academy to help students learn, build, explore, and become innovators and leaders in and outside of the classroom. Supporting Resources Join Oracle Academy Learn about Oracle Cloud Follow Oracle Academy on Twitter, Instagram, Facebook About Oracle AcademyAs Oracle's global, philanthropic educational program, Oracle Academy advances computing education around the world to increase knowledge, innovation, skills development, and diversity in technology fields. The program engages with thousands of educational institutions and educators in more than 120 countries, helping millions of students become college and career ready.About OracleThe Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.TrademarksOracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners. SOURCE Oracle Related Links www.oracle.com", "role": "user" }, { "content": "Pennsylvania State University Joins Oracle Academy to Help Students Become Cloud Developers and Technology Leaders Penn State's 22 Campuses Gain Free Cloud Resources, Curriculum, Faculty Training, and Technology", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Feb. 24, 2021 /PRNewswire/ -- America's favorite flash-frozen beaded ice cream treat Dippin' Dots will now be available on the streets of New York through a new co-branded Dippin' Dots/Doc Popcorn flagship store opening early April by local 25-year old entrepreneur Neil Hershman. The store is currently under construction in the Flatiron District at 1 Madison Avenue (aka 24 East 23rd Street), off Madison Square Park. Hershman has opened and acquired five 16 Handles frozen yogurt franchises throughout New York City, including a Times Square flagship, and says that bringing Dippin' Dots to a central downtown Manhattan location presents a unique opportunity to grow his dessert empire. \"I focus on brands that offer great products, but more importantly great experiences, and I believe that the new Dippin' Dots and Doc Popcorn flagship on Madison Square Park will be an outstanding addition to my portfolio,\" said Hershman. \"I grew up like many others eating Dippin' Dots exclusively at an amusement park or sports game. I wanted to bring that same experience to the millions of young adults and families traveling through Manhattan daily, knowing full well the multi-generational brand recognition that Dippin' Dots has earned by making such a delicious and unique treat for 30+ years,\" said Hershman. \"Adding the complementary Doc Popcorn co-brand was also a no-brainer for me because I love the boutique-style, high quality popcorn and believe the new brand has big potential in New York if it can attract the loyal daytime customer looking for a healthy snack alternative. I'm likewise optimistic on the eventual return of normalcy to New York City within the next 24 months and look forward to building out a strong catering and delivery business for both brands.\" By combining two leading snack and treat brands in one space, the new dual-concept store will give New Yorkers the opportunity to satisfy sweet and savory snack cravings with the offerings of Doc Popcorn's fresh-popped, kettle-cooked popcorn and Dippin' Dots' ice cream. When opened, the store will include favorite ice cream flavors like Rainbow Ice, Cookies and Cream and BananaSplit, in addition to several popcorn flavors, including Better Butter and Caramel Bliss. \"We are excited to partner with Neil as an experienced franchisee to bring our brands to New York City in such a marquee location,\" said Steve Rothenstein, Senior Director of Franchising for Dippin' Dots and Doc Popcorn. \"The new store represents a true partnership between our corporate team and a franchisee for this flagship location.\" Construction updates and future details for the store's official opening can be found by following @DippinDotsNYC on Instagram. Dippin' Dots beaded ice cream was created in 1988 using cryogenic technology to invent an unconventional ice cream that's remarkably fresh and flavorful. For the past 30 years, millions of people have fallen in love with the iconic treat, which is available in thousands of franchise locations, theme parks, stadiums, arenas, zoos, movie theaters, fairs and festivals, as well as shipped right to customers' homes. Doc Popcorn handcrafts a wide variety of fresh-popped specialty flavors of popcorn free of trans fat, MSG, artificial colors and preservatives. About Dippin' Dots, L.L.C. Dippin' Dots has produced and distributed its flash frozen tiny beads of ice cream, yogurt, sherbet and flavored ice products since 1988. Made at the company's production facility in Paducah, Kentucky, Dippin' Dots distributes its unique frozen products in all 50 states and 7 countries through its franchised and direct distribution network. For more information, including franchise opportunities, visit www.dippindots.com. Follow Dippin' Dots on Facebook, Instagram and Twitter. About Doc Popcorn Using whole grain kernels, proprietary flavor blends and other high-quality ingredients, Doc Popcorn handcrafts a wide variety of fresh-popped specialty flavors of popcorn free of trans fat, MSG, artificial colors and preservatives. Born in Boulder, Colo., Doc Popcorn started franchising in 2009 and has been consistently recognized as one of the top food franchises in the country by Entrepreneur's Franchise 500. For more information and to inquire about franchise opportunities, please visit www.docpopcorn.com. SOURCE Dippin' Dots Related Links www.dippindots.com", "role": "user" }, { "content": "Dippin' Dots and Doc Popcorn to Debut Flagship Franchised Store in New York City Local Businessman Neil Hershman to Open Co-Branded Store by April, Adding to Portfolio of Dessert Brands in NYC", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHESAPEAKE, Va., Dec. 7, 2020 /PRNewswire/ --MozaicID Mobile Credential Reader sales continue as ports work to meet compliance with the U.S. Coast Guard Reader Rule by December 31, 2020. All ports that fail to meet full compliance with the TWIC Reader Rule may be liable to the United States for civil penalty. Continue Reading MozaicID The MozaicID MCR is the preferred Mobile TWIC Reader that is in full compliance with the U.S Coast Guard TWIC Reader Rule. MozaicID provides U.S. TWIC Reader Rule compliance solutions via the MozaicID MCR product for ports from coast to coast, including Port of Galveston, Canaveral Port Authority, Georgia Port Authority and many more. See the MozaicID MCR in action here: https://vimeo.com/483576921 The Reader Rule applies to facilities and vessels certified to carry over 1,000 passengers and requires owners and operators to\"conduct electronic inspections of Transportation Worker Identification Credentials (TWICs) as an access control measure.\" Learn more about the requirements for the TWIC Reader Rule here: https://www.dco.uscg.mil/Portals/9/NMC/pdfs/announcements/2020/MSIB-13-20-change-1.pdf About MozaicIDMozaicID has developed groundbreaking, integrated security solutions, providing identity verifications for the U.S. Department of Homeland Security, U.S. Coast Guard and other agencies. The premier product, the MozaicID MCR is the leading solution on the market providing assured smartcard authentication and identity verification. Operating as a stand-alone product that requires zero connectivity during normal credential reading operations. MozaicID is an industry innovator within the security ecosphere with access to the most up-to-date resources and technologies. For more information, visit www.MozaicID.com Contact:Stephen Winn(757) 767-7744[emailprotected]www.MozaicID.comSOURCE MozaicID", "role": "user" }, { "content": "MozaicID MCR Sales Continue as the U.S. Coast Guard TWIC Reader Rule Enforcement Date Approaches MozaicID MCR (Mobile Credential Reader)", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: (), 26 2021 . /PRNewswire/ -- GCL System Integration Technology Co., Ltd. (GCLSI ) (Shenzhen:002506), , G-Home Enpal, . GCLSI . . G-Home GCL (BOS). , . 2020 GCLSI Enpal 5000 G-Home. . GCLSI . , , (Thomas Zhang). Enpal , . G-Home . G-Home GCLSI . , , . G-Home (HEMS), , . GCLSI , . . GCLSI , . GCLSI GCL System Integration Technology Co. Ltd (002506.SZ) (GCLSI) GCL Group, , , , . GCL System Integration . 8 , 4,3 , . : https://www.gclsi.com/. Related Links https://www.gclsi.com/ SOURCE GCLSI", "role": "user" }, { "content": "GCLSI G-Home Enpal - P USA - English USA - English Latin America - espaol esko - etina USA - English Polska - Polski", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Middle East Herbal Shampoo Market Growth, Trends and Forecasts (2020 - 2025)\" report has been added to ResearchAndMarkets.com's offering. The Middle East herbal shampoo market is projected to witness a CAGR of 4.57% during the forecast period (2020 - 2025). The demand for herbal shampoo in the region is majorly boosted by increased consumer demand for sustainable, chemical-free, and eco-friendly products, along with a surge in product developments cued from contemporary market potentials. This drives manufacturers to the emerging category of Ayurveda and botanical extracts, gaining traction for its functional and earthy subtlety among consumers. Companies are even bringing premiumization in the herbal shampoo category to appeal to consumers by personalizing it to meet their needs and emphasizing its superior quality or exclusivity. Additionally, consumer demand for zero-waste products is growing with the increased awareness regarding climate change and the contribution of meager waste management to this devastation. Key Market Trends Increased Preference For Herbal Products Owing to Functional Benefits The growing preference for chemical-free products and the rising popularity of environmentally-sustainable products drive the demand for herbal shampoo in the region. The natural ingredients used in hair segments are amla, bhringaraj, reetha, hibiscus, neem, tulsi, shikakai, etc. When used as herbs, these ingredients give essential nutrition required by the hair for their healthier and stronger growth. Furthermore, modern shampoos use silicone to compensate silky rich feel of the hair, but these are reported as hazardous to the environment, as they are not easily decomposed. However, the same silky texture is given by certain herbs, like hibiscus, that is nature friendly. Premium Shampoos Emerging as New Splurge Worthy Segment Backed by splendid economic state and high purchasing power of Middle Eastern consumers, the premiumization bandwagon has become more like a market driver than a trend in the region. The fad, which was initially pervasive in fashion products, has taken over the personal care industry, making herbal and botanical-based products its primary carrier. Manufacturers are using this as a strategy to make their brand more appealing to consumers by personalizing it to meet their needs and emphasizing its superior quality or exclusivity. Moreover, it is distinctly feasible for manufacturers to turn an Ayurvedic- or herbs-derived shampoo into a highly luxurious and better product, making consumers believe that it can enhance their hair health. Competitive Landscape The market studied is consolidated, with major market share held by the leading players, including Dabur India Ltd, Procter & Gamble, the Himalaya Drug Company, and Unilever PLC. Key Topics Covered: 1 INTRODUCTION 1.1 Study Assumptions and Market Definition 1.2 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET DYNAMICS 4.1 Market Drivers 4.2 Market Restraints 4.3 Porter's Five Forces Analysis 5 MARKET SEGMENTATION 5.1 By Distribution Channel 5.1.1 Supermarkets/Hypermarkets 5.1.2 Convenience Stores 5.1.3 Specialist Retailers 5.1.4 Online Retailers 5.1.5 Other Distribution Channels 5.2 By Country 5.2.1 Saudi Arabia 5.2.2 United Arab Emirates 5.2.3 Egypt 5.2.4 Rest of Middle East 6 COMPETITIVE LANDSCAPE 6.1 Most Adopted Strategies 6.2 Market Share Analysis 6.3 Company Profiles 6.3.1 Dabur India Ltd 6.3.2 Procter & Gamble 6.3.3 The Himalaya Drug Company 6.3.4 Unilever 6.3.5 Khadi Global 6.3.6 Bioveda Action Research Company 6.3.7 Just Herbs 7 MARKET OPPORTUNITIES AND FUTURE TRENDS Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/sweyoe About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.", "role": "user" }, { "content": "Middle East Herbal Shampoo Market Growth, Trends and Forecasts Report 2020-2025: Focus on Saudi Arabia, United Arab Emirates & Egypt - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HUNT VALLEY, Md., April 22, 2021 /PRNewswire/ --The McCormick Flavor Forecast has been uncovering the trends that transform the way we cook, flavor, and eat for over two decades. The Flavor Forecast 21st Edition continues to connect consumers and food professionals with the latest global flavors and ingredients to delight the senses and bring eating experiences to the next level. McCormick Flavor Forecast 21st Edition Reveals Global Trends Driving the Tastes of Tomorrow McCormick team members across five global regions connected with notable culinary experts to uncover the latest innovations in flavor. The research over the past year included a series of virtual, interactive at-home culinary experiences led by chefs exploring a range of flavors from nutritious to indulgent that offer unique tastes, colors, and textures for both food and drinks. \"The pandemic sizably shifted the way we have lived our lives over the past year, yet food continues to be a way to bring people together, even virtually. Despite global travel restrictions, lockdowns, and logging in from vastly different time zones, it was moving to see everyone committed to our mission to study emerging trends and identify the flavors that will undoubtedly spark inspiration for both the home cook and professional chef for years to come,\" said Kevan Vetter, Executive Chef and Director of Culinary Development for McCormick. This year's four flavor trends move plants further into the spotlight; invite comforting global flavors to the table in approachable ways; dive deep into the fresh, undiscovered ingredients and textures of the coast; and reignite our health and wellness focus through the reemergence of mindful eating and intentional ingredients based on ancient philosophy.Plants Pushing Boundaries represents how the plant-based world is now mainstream and has developed into a culinary trend that uniquely honors vegetables, fruits, and botanicals that deliver indulgence, brilliant color, hearty texture, and delightful sensation through flora-focused eating. Key flavors ube (purple yam), Szechuan buttons (edible flower buds), and trumpet mushrooms Humble Noshis inspired by the Yiddish word \"nashn\" meaning to nibble on and combines rising global flavors with the means to 'travel locally' via our plates. It connects us with food and drinks that people have found comfort and nourishment in while satisfying cravings from around the world. Key flavors - chaat masala (Indian spice blend), pandan kaya (Malaysian jam), and crisped chilies Underwater, Under Discoveredtakes flavors from the coasts to kitchens, delving into less explored ingredients and textures from fresh and salt water like seaweeds and algae for culinary innovation. This trend uproots underwater botanicals that infuse snacks, meals, and beverages with an earthy flavor for a new take on fresh. Key flavors dulse (red sea lettuce flakes), spirulina (blue-green algae), and sea grapes (soft, green algae) Physiological Eatingrepresents the re-emergence of mindfulness and intention, inspired by ancient practices and beliefs for mind-body balance, a sense of harmony, growth, and self-love. It also focuses on the Ayurvedic practice, which uses six tastes (sweet, sour, salty, bitter, astringent, and pungent) to achieve balance, and warming and cooling techniques to provide comfort to the body. Key flavors coriander, lemon, sea salt, cumin, turmeric, and ginger To add an extra dash of fun, McCormick has partnered with Sanctuary, the popular astrology and mystical services app, to guide consumers to their flavor destiny. Inspired by the McCormick Flavor Forecast 21st Edition's trends, Sanctuary has leveraged its astrological know-how to curate 2021 \"Flavor Horoscopes\" and other engaging content, including hand-picked recipes for every sign.In addition, McCormick is partnering with HelloFresh to offer a special meal kit to experience the Plants Pushing Boundaries trend. The kit featuresa recipe for Mozzarella & Mushroom Hoagiesthat transforms the classic overstuffed Philly sandwich favorite into an indulgent plant-based alternative. The sandwiches are available to order from HelloFresh on the May 15-21 menu (use promo code: HFPARTNER12).Consumers, foodservice professionals, and product developers alike can draw inspiration from the McCormick Flavor Forecast 21st Edition. To learn more, including more details about each trend, the limited-edition Hello Fresh meal kit and curated \"Flavor Horoscope\" content by Sanctuary, visit: www.flavorforecast.com.Media:To download high-resolution images and full recipes, please click here.About the Flavor Forecast Since 2000, the McCormick Flavor Forecast has identified top trends and ingredients to discover the tastes of tomorrow. For over 130 years, McCormick & Company has been guided by a passion for flavor. This passion drives our constant pursuit of what's next in flavor. Created by a global team of McCormick experts including chefs, culinary professionals, trend trackers and food technologists the Flavor Forecast inspires culinary exploration and innovation around the world. Visit www.flavorforecast.com to learn more.About McCormick McCormick & Company, Incorporated is a global leader in flavor. With over $5 billion in annual sales across 160 countries and territories, we manufacture, market, and distribute spices, seasoning mixes, condiments and other flavorful products to the entire food industry including e-commerce channels, grocery, food manufacturers and foodservice businesses. Our most popular brands include McCormick, French's, Frank's RedHot, Stubb's, OLD BAY, Lawry's, Zatarain's, Ducros, Vahin, Cholula, Schwartz, Kamis, DaQiao, Club House, Aeroplane and Gourmet Garden. Every day, no matter where or what you eat or drink, you can enjoy food flavored by McCormick.Founded in 1889 and headquartered in Hunt Valley, Maryland USA, McCormick is guided by our principles and committed to our Purpose To Stand Together for the Future of Flavor. McCormick envisions A World United by Flavor where healthy, sustainable, and delicious go hand in hand. To learn more, visit www.mccormickcorporation.com or follow McCormick & Company on Twitter, Instagram and LinkedIn.Contacts: Kendra Ferguson McCormick & Company Mobile# 410-456-4379 [emailprotected]Sunshine Sachs [emailprotected]SOURCE McCormick & Company Related Links https://www.mccormickcorporation.com", "role": "user" }, { "content": "McCormick Flavor Forecast 21st Edition Reveals Global Trends Driving the Tastes of Tomorrow Influential tastemakers identify four new flavor themes: Plants Pushing Boundaries, Humble Nosh, Underwater Under Discovered, and Physiological Eating", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN MATEO, Calif.--(BUSINESS WIRE)--Incorta, the Direct Data Platform, today announced that it has been recognized as an Overall Leader in Analytical Data Infrastructure by Dresner Advisory Services 2020 Industry Excellence Awards, having ranked in the top percentile in the Customer Experience and Vendor Credibility models. This award showcases vendors within the Dresner Advisory Services 2020 Wisdom of Crowds Report that demonstrate excellence across product, technology, sales, service, value, and confidence. The report collects data from end users and provides a broad market assessment including current usage, key drivers, technology priorities, and future intentions, as well as performance ratings of relevant vendors. Receiving this honor from Dresner Advisory Services is a reaffirmation of our commitment to helping customers and end-users leverage data to drive impactful business decisions, said Osama Elkady, CEO and co-founder, Incorta. Our mission has, and always will be, to build products that expand our customers data capabilities and to cut project time and cost by more than 80 percent with speed, simplicity, and accuracy. Were proud to be recognized as a leader in achieving this goal. Incorta enables data-driven enterprises to be more agile and competitive by resolving their most complex data analytics challenges. Incortas Direct Data Platform gives enterprises, including Broadcom, Duluth Trading, Stanford University, NOW Foods and 10 of the Fortune 25 companies, the means to acquire, enrich, analyze, and act on their business data with unmatched speed, simplicity, and insight. Vendor ratings in our annual research on which the Industry Excellence Awards are based are derived completely from the first-hand input of the end-user community, said Howard Dresner, founder and chief research officer at Dresner Advisory Services. Winning vendors are those that deliver high levels of value and confidence to their customers. We congratulate Incorta on their recognition as an Overall Leader in 2020. As recognized in this award, Incorta has an impact on the real-world experience of Fortune 1000 companies as they work with the Direct Data Platform to optimize business solutions. For more information about how Incorta is revolutionizing business intelligence and data management for the worlds leading enterprises, visit www.incorta.com. About Incorta Incorta is the data analytics company on a mission to help data-driven enterprises be more agile and competitive by resolving their most complex data analytics challenges. Incortas Direct Data Platform gives enterprises the means to acquire, enrich, analyze and act on their business data with unmatched speed, simplicity and insight. Backed by GV (formerly Google Ventures), Kleiner Perkins, M12 (formerly Microsoft Ventures), Telstra Ventures, and Sorenson Capital, Incorta powers analytics for some of the most valuable brands and organizations in the world. For todays most complex data and analytics challengings, Incorta partners with Fortune 5 to Global 2000 customers such as Broadcom, Vitamix, Equinix, and Credit Suisse. For more information, visit https://www.incorta.com. About Dresner Advisory Services Dresner Advisory Services was formed by Howard Dresner, an independent analyst, author, lecturer and business adviser. Dresner Advisory Services, LLC focuses on creating and sharing thought leadership for Business Intelligence (BI) and related areas.", "role": "user" }, { "content": "Incorta Named an Overall Leader in Dresner Advisory Services' Industry Excellence Awards The annual award recognizes Incorta for Customer Experience and Vendor Credibility in Analytical Data Infrastructure", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HAMILTON, ON, March 10, 2021 /PRNewswire/ -The Centre for Probe Development and Commercialization (CPDC) announced that its Board of Directors has appointed Bruno Paquin as Chief Executive Officer (CEO). The CEO appointment has taken effect on March 4, 2021. Dr. John Thornback, Chair of the Board of Directors said, \"We are pleased to announce that Bruno Paquin has been appointed CEO of CPDC with immediate effect. The Board feels that Bruno has done an excellent job as interim CEO over the past few months and we are looking forward to working with Bruno, and everyone in the CPDC family, our clients and employees, as he leads us through the next phases of development to a successful future. Dr. Paquin joined CPDC in 2018, where he supported the Centre as Senior Director of Business Development. Prior to joining CPDC, Bruno was VP Business Development at Immuni T from 2011 to 2018, where his role was central to the growth of the company and to building a pipeline of sponsored research programs. Prior to Immuni T, Bruno started as the Head of the Technology Development Unit at Genizon Biosciences to become the Executive Director, Head of Business Development, from 2000 to 2011. Bruno received his PhD in Biochemistry from Universit de Montral. Bruno Paquin said, \"I am honoured to be named CPDC's CEO and thankful to the Chair and all the members of the Board of Directors for their confidence. The CPDC is an exceptional organization transforming patients' life by fostering the development of revolutionizing drugs. With the support of the leadership team and that of all the employees, I look forward to leading CPDC to its continuing success and shaping its bright future.\" About CPDC The Centre for Probe Development and Commercialization (CPDC) is a private, not-for-profit company dedicated to improving patient's lives by advancing drugs for the diagnosis and treatment of diseases. Created in 2008, with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University and the Ontario Institute for Cancer Research (OICR), CPDC has become a global leader in the discovery, development and commercialization of next-generation radiopharmaceuticals. With an established pipeline of products and a robust and reliable manufacturing unit, CPDC supplies innovative diagnostic and therapeutic radiopharmaceuticals that are used daily in Canada and around the world. CPDC currently employs over 110 staff in Hamilton and Toronto. For more information about CPDC, please visit: www.imagingprobes.caor contact [emailprotected]. SOURCE Centre for Probe Development and Commercialization Related Links imagingprobes.ca", "role": "user" }, { "content": "CPDC Announces Appointment of Bruno Paquin as Permanent CEO", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, March 16, 2021 /PRNewswire/ -- The \"Overview of Stellantis' (FCA-PSA) Light Commercial Vehicle (LCV) Strategies, 2021\" report has been added to ResearchAndMarkets.com's offering. This study assesses Stellantis' LCV strategies and takes a close look at the implications of the consolidation on the European LCV market. The research service offers a point of view of the expected changes that the newly merged company will implement to maintain its leading position in the region; emerging growth opportunities in the European LCV market are also examined. The proposed merger between Fiat Chrysler Automobiles (FCA) and the PSA Group will be one of the most significant mergers among automotive original equipment manufacturers (OEMs). The joint entity will be called Stellantis, and it will become the fourth-largest automotive OEM in terms of sales volumes. The new group will have a combined revenue of more than $180 billion and an operating profit margin of 6.8%. The expected synergy is approximately $4 billion. The combined annual R&D potential is more than $6.5 billion per year, which is a fair amount to invest in electrification and other technologies. One of the most important outcomes of this merger is that Stellantis will become the largest van maker not just in Europe but across the world as well. In 2019, FCA and PSA (together) sold 1.12 million LCVs and vans, accounting for 13% of the global market share. The impact of this consolidation will be especially evident in Europe's most profitable vehicle segment, that is, light commercial vehicles (LCVs) and vans. LCV demand has been increasing steadily over the past 5 years in Europe due to the high penetration of eCommerce. After integrating Opel-Vauxhall into its portfolio in 2017, PSA attained a leading position in the European LCV space. After this merger, FCA and PSA (together) will control more than 34% of the LCV market share in Europe. The future outlook is positive due to increasing orders from delivery service providers, which will further drive LCV demand in Europe in the near future. More than sales volumes, the importance of LCVs for Stellantis lies in their profitability. LCVs offer lower production and development costs than passenger vehicles (PVs), resulting in higher profit margins in the range of 8-11% for OEMs. In addition, customers do not expect advanced technology features in vans, which further reduces production costs. Profitability also comes from shared platforms among OEMs, which allows for common parts and component sharing. This reduces the cost per vehicle for OEMs and raises profit margins. FCA and PSA have a 30-year joint development relationship in the LCV space; therefore, the synergies associated with shared van development already exist for Stellantis. PSA also produces LCVs for Toyota, and Stellantis will increase production capacity for Toyota to win merger approval from the EU. This can increase Stellantis' market share up to 36%. LCV electrification is another important objective that both PSA and FCA are trying to accomplish. In Europe, electric LCVs (eLCVs) are expected to account for 15% of the total LCV share by 2025 and nearly 35% by 2030. With a big push from European pollution reduction regulations, OEMs are looking at the electrification of their LCV fleets as a viable option and are expanding their electric LCV lineups. PSA has begun electrifying its small vans. The Group expects 100% electrification of its LCV lineup by 2021. PSA's LCV electrification strategy will lay the foundation for Stellantis to maintain and strengthen the Group's leading position in the European LCV market. Key Topics Covered: 1. Strategic Imperatives Why Is It Increasingly Difficult to Grow? The Strategic Imperative The Impact of the Top Three Strategic Imperatives on the FCA-PSA Merger in the European LCV Industry Growth Opportunities Fuel the Growth Pipeline Engine Growth Drivers and Restraints 2. FCA-PSA Merger - An Overview Merger Implications - Stellantis' Business Strength Merger Implications - Stellantis' Investment Spending Capability Merger Implications - Cost Synergies 3. Merger Impact on the European LCV Industry LCVs - More Profitable than Passenger Cars for Stellantis Stellantis' Performance in the European LCV Market Stellantis' LCV Manufacturing Footprint in Europe 4. LCV Electrification Focus LCV Electrification will be Key to Stellantis' Success in Europe eLCV Strategy - Multi-Energy Platforms eLCV Strategy - Shift from Multi-Energy to 100% Electrified Modular Platforms Stellantis' eLCV Strategy - Vertical Integration of the EV Value Chain 5. Retail and Aftermarket, Autonomous Development and Regional Expansion Retail and Aftermarket Network Optimization through Multi-Brand, Multi-Channel, and Multi-Service and Digitalized Offerings Autonomous Strategy for Commercial Vehicles - Focus on Robo Taxis Expansion into New Geographies 6. Growth Opportunity Universe Growth Opportunity - Increasing Profit Margins through Platform Consolidation and Plant Capacity Utilization 7. List of Exhibits Companies Mentioned Fiat Chrysler Automobiles (FCA) Opel PSA Group Stellantis Toyota Vauxhall For more information about this report visit https://www.researchandmarkets.com/r/a1qbwu Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "2021 Overview of Stellantis' (FCA-PSA) Light Commercial Vehicle (LCV) Strategies: The Plan to Embrace Electrification, and Partnerships with Technology Companies to Develop Autonomous Robo Taxis", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: --Endo to acquire BioSpecifics in an accretive all-cash transaction -- DUBLIN, Oct. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced it has agreed to acquire all of the outstanding shares of BioSpecifics Technologies Corp. (NASDAQ: BSTC), a commercial-stage biopharmaceutical company, for $88.50 in cash per share, or an estimated enterprise value of approximately $540 million (net of approximately $120 million in cash acquired) at the anticipated time of deal closure. Endo has had a strategic relationship with BioSpecifics since 2004. Under the terms of the relationship, BioSpecifics receives a royalty stream from Endo related to Endo's collagenase-based therapies, which currently include XIAFLEX, marketed by Endo Pharmaceuticals, for the treatment of Dupuytren's contracture and Peyronie's disease, and Qwo, the first FDA-approved injectable treatment for cellulite, which is expected to be launched by Endo Aesthetics in Spring 2021. \"Acquiring BioSpecifics is consistent with our strategic priority to expand and enhance our portfolio through additional investment in the significant long-term growth potential of both XIAFLEX and QWO - two of our most durable and differentiated products,\" said Blaise Coleman, President and Chief Executive Officer of Endo. \"This transaction will also immediately enhance Endo's adjusted EBITDA and create significant value for shareholders of both organizations.\" Under the terms of the merger agreement, Endo, through a wholly owned subsidiary, will commence an all-cash tender offer to acquire 100 percent of the outstanding common stock of BioSpecifics for $88.50 per share. The Edwin H. Wegman Marital Trust has entered into a Support Agreement committing it to tender its shares into the tender offer.The closing of the tender offer will be subject to certain conditions, including that not less than a majority of shares of BioSpecifics common stock are tendered, the expiration of the waiting period under antitrust laws and other customary conditions. Upon the successful completion of the tender offer, Endo's acquisition subsidiary will be merged into BioSpecifics, and any remaining shares of BioSpecifics will be canceled and converted into the right to receive the same consideration payable pursuant to the tender offer. The transaction is expected to close in late 2020 and Endo expects to fund the transaction with cash on hand. The transaction has been unanimously approved by the boards of directors of both companies. Endo's financial advisor is PJT Partners LP and legal counsel is Skadden, Arps, Slate, Meagher & Flom LLP. AboutEndoInternationalplc Endo International plc (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, Pennsylvania. Learn more at www.endo.com or connect with us on LinkedIn. About BioSpecifics Technologies Corp.BioSpecifics Technologies Corp. is a commercial-stage biopharmaceutical company. BioSpecifics discovered and developed a proprietary form of injectable collagenase (CCH), which is currently marketed by Endo, as XIAFLEXin North America for the treatment of Dupuytren's contracture and Peyronie's disease. Endo announced that it received FDA approval of CCH for the treatment of moderate to severe cellulite in the buttocks of adult women; Qwo is expected to be available commercially in the U.S. starting in the first half of 2021. The CCH research and development pipeline includes several additional potential indications including adhesive capsulitis and plantar fibromatosis. For more information, please visitwww.biospecifics.com. ForwardLookingStatement This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Canadian securities legislation. Statements including words such as \"believes,\" \"expects,\" \"anticipates,\" \"intends,\" \"estimates,\" \"plan,\" \"will,\" \"may,\" \"look forward,\" \"intend,\" \"guidance,\" \"future\" or similar expressions are forward-looking statements. These forward-looking statements include, among others, statements relating to Endo's or BioSpecifics Technologies Corp.'s future financial performance, business prospects and strategy, including the tender offer, the merger, the ability to successfully complete such transactions and other similar matters. Actual results could differ materially from those contained in these forward-looking statements for a variety of reasons, including, among others, the risks and uncertainties inherent in the tender offer and the merger, including, among other things, regarding how many of BioSpecifics Technologies Corp.'s stockholders will tender their shares in the tender offer, the possibility that competing offers will be made, the ability to obtain requisite regulatory approvals relating to the acquisition, the ability to satisfy the conditions to the closing of the tender offer and the merger, the expected timing of the tender offer and the merger, the risk of stockholder litigation relating to the transaction, including resulting expense or delay, difficulties or unanticipated expenses in connection with integrating BioSpecifics Technologies Corp.'s operations into Endo's and the possibility that anticipated synergies and other benefits of the transaction will not be realized in the amounts anticipated, within the expected timeframe or at all, the effect of the announcement of the tender offer and the merger on Endo's and BioSpecifics Technologies Corp.'s business relationships, competition, including technological advances, new products and patents attained by competitors, challenges to patents, the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement, the expected tax treatment of the transaction, challenges inherent in product research and development, clinical trial outcomes and quality, availability and affordability of products, and other circumstances beyond Endo's and BioSpecifics Technologies Corp.'s control. You should not place undue reliance on these forward looking statements. Certain of these and other risks and uncertainties are discussed in Endo's and BioSpecifics Technologies Corp.'s filings with the Securities and Exchange Commission (\"SEC\") and, in Endo's case, with securities regulators in Canada on the System for Electronic Document Analysis and Retrieval, including the Schedule TO (including the offer to purchase, letter of transmittal and related documents) Endo will file with the SEC, the Solicitation/Recommendation Statement on Schedule 14D-9 BioSpecifics Technologies Corp. will file with the SEC and their respective Form 10-K's and 10-Q's under the caption \"Risk Factors\" and as otherwise enumerated therein. Endo assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws. Additional Information and Where to Find It The tender offer has not yet commenced. This press release is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any shares of common stock of BioSpecifics Technologies Corp. or any other securities, nor is it a substitute for the tender offer materials that Endo and Beta Acquisition Corp. (\"Merger Sub\") will file with the SEC upon commencement of the tender offer. At the time the tender offer is commenced, Endo and Merger Sub will file tender offer materials on Schedule TO, including an offer to purchase, a letter of transmittal and related documents with the SEC, and BioSpecifics Technologies Corp. will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the offer. The offer to purchase all of the issued and outstanding shares of BioSpecifics Technologies Corp. common stock will only be made pursuant to the offer to purchase, the letter of transmittal, and related documents filed as a part of the Schedule TO. THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS OF BIOSPECIFICS TECHNOLOGIES CORP. ARE URGED TO READ CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION SUCH HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES. The tender offer materials and the Solicitation/Recommendation Statement will be made available for free at the SEC's website at www.sec.gov. Copies of the documents filed with the SEC by Endo will be available free of charge on Endo's website. In addition, security holders of BioSpecifics Technologies Corp. may obtain free copies of the tender offer materials by contacting the information agent for the tender offer that will be named in the Tender Offer Statement on Schedule TO. Copies of the documents filed with the SEC by BioSpecifics Technologies Corp. will be available free of charge on BioSpecifics Technologies Corp.'s website. SOURCE Endo International plc Related Links http://www.endo.com", "role": "user" }, { "content": "Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX and Qwo", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: GREENEVILLE, Tenn.--(BUSINESS WIRE)--Forward Air Corporation (NASDAQ: FWRD) (the Company or Forward) is executing a growth strategy that involves organic infrastructure investments, such as its ongoing LTL network expansion, as well as inorganic investments, including acquisitions of complementary businesses. Today, Forward announced that 11 new Final Mile terminal locations were added in the first quarter of 2021, with 8 of the new locations leveraging existing LTL terminal infrastructure. The cohabitation of Final Mile and LTL operations positions Forward for organic growth on a national scale while greatly reducing the level of investment required for traditional Final Mile expansion into new markets. This allows Forward to provide faster end-to-end service, moving freight from manufacturers or retailers directly to their customers doors. The Companys organic growth strategy has also led to the expansion of its LTL network footprint by leveraging existing Final Mile facilities. Tom Schmitt, Chairman, President and Chief Executive Officer said, This is an exciting time at Forward as our growth trajectory continues across each of our businesses. Our Final Mile service offering has been a key area of focus over the past two years as we have expanded across the country. When we leverage existing facilities within our network, we improve our speed-to-market with lower initial investment. We are also realizing operational efficiencies by integrating Final Mile customers within our traditional LTL terminals. In the first quarter of 2021, Forward Final Mile added operations in Denver, CO, Jacksonville, FL, Miami, FL, Orlando, FL, Tampa, FL, Hiawatha, IA, Frederick, MD, Bozeman, MT, Charlotte, NC, Memphis, TN and Nashville, TN. About Forward Air Corporation Forward Air Corporation (NASDAQ: FWRD) is a leading asset-light freight and logistics company. We provide LTL, final mile, truckload and intermodal drayage services across the United States and in Canada. Headquartered in Greeneville, Tennessee, Forward operates approximately 200 facilities across the country and employs more than 5,200 people nationwide. We are more than a transportation company. As a single resource for your shipping needs, Forward is your supply chain partner. For more information, visit our website at www.forwardaircorp.com. This press release may contain statements that might be considered as forward-looking statements or predictions of future operations including with respect to the expected growth and future expansion of the Companys network and footprint and the expected efficiencies and improvements in service resulting from cross-utilizing Final Mile and LTL terminals. Such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are based on managements belief or interpretation of information currently available. These statements and assumptions involve certain risks and uncertainties including that the Company is not able to utilize existing facilities to achieve planned synergies and expansion within the Final Mile space. Actual events may also differ from these expectations as a result of the risks identified from time to time in our filings with the Securities and Exchange Commission. You should consider the forward-looking statement contained herein in light of such risks. We assume no duty to update these statements as of any future date.", "role": "user" }, { "content": "Forward Air Corporation Expands Final Mile Footprint in First Quarter", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SANTA MONICA, Calif.--(BUSINESS WIRE)--Ring, whose mission is to make neighborhoods safer, today announced Ring Floodlight Cam Wired Pro, its most advanced outdoor security camera equipped with 3D Motion Detection with radar and Birds Eye View. The all-new Ring Floodlight Cam Wired Pro is a re-imagined floodlight that builds upon the features of the popular Ring Floodlight Cam to monitor outdoor spaces with motion-activated LED lights and HD video, providing homeowners more insight into whats happening around their property. Four years ago, we reinvented the ordinary floodlight with our original Ring Floodlight Cam, and now were bringing more cutting-edge features to this device with Ring Floodlight Cam Wired Pro, said Jamie Siminoff, Rings Founder and Chief Inventor. By expanding our 3D Motion Detection technology and Birds Eye View to Ring Floodlight Cam Wired Pro, were giving customers greater insight about whats taking place on their property for additional peace of mind. Ring Floodlight Cam Wired Pro Now the most advanced outdoor camera in Rings lineup, the newly re-designed Ring Floodlight Cam Wired Pro is equipped with Rings new innovative features, 3D Motion Detection and Birds Eye View, a 110db siren and color night vision. Additionally, new Audio+ helps users hear whats happening more distinctly, with crisp, clear sound thanks to an array microphone for enhanced audio and echo cancellation. Users can easily hardwire Ring Floodlight Cam Wired Pro to the outside of their home and connect to wifi for around-the-clock power. Ring Floodlight Cam Wired Pro enables customers to check in on their property anytime from anywhere from their mobile or Alexa-enabled device, and see and speak with visitors in real-time. Designed with privacy and security in mind, Ring Floodlight Cam Wired Pro includes advanced features such as Customizable Motion Zones that trigger recordings, and Privacy Zones that exclude areas in the camera field of view from video recording. For an advanced security option, Ring Floodlight Cam Wired Pro also supports Rings video End-to-End Encryption, currently in technical preview. Expanding 3D Motion Detection Around the Home Committed to providing customers with new features that make their cameras work better for them, Ring is expanding its 3D Motion Detection technology to Ring Floodlight Cam Wired Pro to give customers more control of the motion alerts they receive. With 3D Motion Detection technology, Ring Floodlight Cam Wired Pro allows homeowners to customize which areas of their property to monitor by selecting distance thresholds. The radar sensor determines when an object crosses the distance threshold by measuring its specific distance from the camera, and the camera then only activates once that threshold is crossed, sending homeowners a motion alert. Powered by 3D Motion Detection, Birds Eye View provides an aerial map view of the motion events in front of the floodlight camera and clearly shows the path visitors take when visiting the property. Also available on the Ring Video Doorbell Pro 2, this new feature creates a visual representation of the path traveled once a visitor crosses the selected threshold but before a motion alert is sent, so the homeowner has greater understanding of whats happening when viewing individual videos from each device in the Ring app. Pricing and Availability Ring Floodlight Cam Wired Pro is $249.99 and is available for pre-order at Ring.com and Amazon.com. Ring Floodlight Cam Wired Pro will begin shipping to customers on May 6, 2021. Additionally, the original Ring Floodlight Cam is now available for an all-new low price of $199.99 on Ring.com and Amazon.com. Media Assets Click here for images and other media assets. About Ring Since its founding in 2013, Ring has been on a mission to make neighborhoods safer. From the video doorbell, to Ring Alarm, which was named #1 in Customer Satisfaction for DIY Home Security Systems by J.D. Power in 2020, Rings smart home security product line, as well as the Neighbors app, offer users affordable whole-home and neighborhood security. At Ring, we are committed to making home and neighborhood security accessible and effective for everyone -- while working hard to bring communities together. Ring is an Amazon company. For more information, visit www.ring.com. With Ring, youre always home.", "role": "user" }, { "content": "Ring Introduces Ring Floodlight Cam Wired Pro, Its Most Advanced Floodlight Camera Yet Equipped with 3D Motion Detection and Birds Eye View, Ring Floodlight Cam Wired Pro delivers more insight into motion events around customers property.", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO, April 22, 2020 /PRNewswire/ -- According to Arizton's recent research report, Garden Equipment Battery Market - Global Outlook and Forecast 2020-2025is expected to grow at a CAGR of over 8% during the period 20192025. Key Highlights Offered in the Report: The global garden equipment battery market would realize an absolute growth of approximately 60% - a leap of over $3,300 million revenue between 2019 and 2025. The garden equipment battery market is experiencing high demand in residential applications as battery-powered and electric-powered equipment are increasingly being preferred among the consumers. Contributing over $1.9 million incremental revenue during 2019-2025, lawn mowers offers a profitable revenue potential opportunity for market vendors. Registering a high growth CAGR of around 8%, the Li-ion battery segment will contribute over $2,100 million incremental revenue during 2019-2025. With nearly 90% of the market revenue coming from North America and Europe, vendors are emphasizing on the innovative strategies and promotional measures to bolster the overall garden equipment battery market growth. Vendors such as Husqvarna Group, Exide Technologies, and Trojan Battery among others, emphasize on offering products which caters to diversified vertical markets. Key Offerings: Market Size & Forecast by Revenue | 20192025 Market Dynamics Leading trends, growth drivers, restraints, and investment opportunities Market Segmentation A detailed analysis by products, power sources, battery, end-users, and geography Competitive Landscape Profile of 3 key vendors and 20 other vendors Get your sample today! https://www.arizton.com/market-reports/garden-equipment-battery-market Garden Equipment Battery Market Segmentation The usage of turf care equipment has become crucial to achieving well-manicured areas with watering and proper fertilization processes. Consumers are focusing on landscaping services, along with other recreational activities. This can be attributed to high disposable incomes in different regions, coupled with the presence of a large number of athletic fields and golf courses. Cordless machines have gained significant traction among users as they help to reduce the hassle related to gas-powered lawnmower models, thereby avoiding limitations and inconvenience related to corded models. Cordless devices are gaining popularity in the market as they are lightweight, thereby enabling users to work for a long duration. Lithium-ion (Li-Ion) batteries have significantly become leading battery technology in garden equipment, outperforming other battery types such as lead-acid and nickel-cadmium. Li-Ion batteries are poised to become the first choice for cordless tools, including lawnmowers, leaf blowers, chainsaws, snowblowers, turf equipment, or pole saws. Market Segmentation by Products Lawn Mowers Turf Equipment Pole Saws Chainsaws Leaf Blowers Garden Tillers Snow tillers Trimmers and Edgers Brushcutters Market Segmentation by Power Sources Corded Cordless Market Segmentation by Battery Type Lithium-ion Lead Acid Others Market Segmentation by End-users Residential Users Professional Landscaping Services Golf Courses Government & Others Garden Equipment Battery Market Dynamics Gardening and landscaping services involve art and technology of the landscape and construction management, the aesthetic appeal of the garden areas, sustainability, and garden and landscape project planning. The landscaping industry has reached maturity in developed countries. To cater to its growth, the key vendors are focusing on becoming full-service landscaping providers and offering programs that are formulated to meet changing customer demands. These landscaping companies offer varied range of services such as edging, laying sod, cutting, and mowing the yard and ground areas. In addition to this, several maintenance services such as fertilization, weeding, and pruning are also of key importance among the landscapers and professional workers. Key Drivers and Trends fueling Market Growth: Development of Sustainable Cities Consumer Preference for Eco-Friendly Products Increasing Adoption of Green Spaces Increasing Number of Golf Courses Garden Equipment Battery Market Geography The demand for landscaping services in the US is largely bolstered by increasing discretionary spending. The region is considered as one of the largest markets for garden equipment owing to its fast-expanding landscaping industry, coupled with the growing demand for backyard beautification among households. The rise in multifunctional landscaping design and the increasing trend among homeowners to maintain and beautify outdoor spaces with minimal hassles are propelling the demand for electric and battery-operated devices. Leading vendors in North America are leveraging advanced technologies for the introduction of new variants of gardening tools in the market. At present, several players are focusing on the introduction of eco-friendly alternatives, which emit less harmful emissions and are superior and better in performance. Get your sample today! https://www.arizton.com/market-reports/garden-equipment-battery-market Market Segmentation by Geography Europe Germany Italy UK France Spain Sweden Netherlands Belgium North America US Canada APAC China Japan South Korea Australia Others MEA South Africa UAE Saudi Arabia Others Latin America Brazil Mexico Argentina Major Vendors Exide Technologies Husqvarna Group Trojan Battery Other vendors include - AL-KO Kober Group, Chervon, East Penn Manufacturing, Einhell, Harris Battery, Inventus Power, Makita Corporation, Marshall Batteries, Mean Green Products, MTD Products, Positec Tool Corporation, Richpower Industries, Snow Joe, Stanley Black & Decker, Stihl, Techtronic Industries (TTI), The Toro Company, Wen Products, Yamabiko Corporation, and Yucell Industry. Explore our garden tools profile to know more about the industry. Read some of the top-selling reports: Cordless Power Tools Market - Global Outlook and Forecast 2020-2025 Pressure Washer Market - Global Outlook and Forecast 2020-2025 Stationary Lithium-ion Battery Market - Global Outlook and Forecast 2020-2025 Zero-turn Lawn Mower Market - Global Outlook and Forecast 2020-2025 About Arizton: Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services. We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. Mail: [emailprotected]Call: +1-312-235-2040 +1-302-469-0707 SOURCE Arizton Advisory & Intelligence", "role": "user" }, { "content": "The Global Garden Equipment Battery Market to Generate Revenues of Around $9 Billion During the Period 2020 2025 - Market Research by Arizton", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PLANTATION, Fla., Aug. 17, 2020 /PRNewswire/ --Nowwith over 50 restaurants across the state of Florida, La Granjais satisfying the appetite of many who want a homemade food served fast.Patrons crave food with a Latinflavor.It all started with the owner's father having abig dream of bringing Peruvian flavors to America.Now La Granjarestaurants are located in several counties, from Miami Dade to Browardto Palm Beachto Orange County.And it's not \"fast food\", since it's homemade food served fast.However, anyone can eat in and out of the restaurant in just5-10 minutes. Continue Reading To find the nearest La Granja Restaurant, go to https://www.lagranjarestaurants.com/en/locations/ The grilled Chicken Sandwiches come with boneless, skinless chicken breast servedin a bun with fries on the side. Drinks to choose from are Passion Fruit or all major soft drinks. Others might prefer the mouthwateringCrispy Chicken Sandwich. LaGranjaopened its first South Florida location inMargatein 1993.Serving Peruvian cuisine praised by locals, LaGranjahas become a favorite place for many to grab a quick lunch or a family dinner.Regular customers note their love affair with the 1/4 chicken meal as a reason for their constant return. Dine at LaGranjaand have a choice of chicken, steak, seafood or pork with two sides of your preference. There are over 50 restaurants in Floridaone can choose to dine in, and people can find the nearest locationathttps://www.lagranjarestaurants.com/en/locations/. LaGranjaRestaurants servedelicious dishes with big portions and authentic flavors.Checkout La Granja'smenu.https://www.lagranjarestaurants.com/en/menuWhen ordering, customers can choose from a wide variety of platters and side options.Each platter comes with a sizable portion of meat and twoor more sides. Dishes are seasoned to perfection and paired with perfect additions, of whicharroz,frijoles, and fried plantains are most popular.LaGranjaalso provides delicious beef platters.LomaSaltadois one of the most important dishes, which issauteedbeef with onions and tomatoes seasoned with special seasoning, creamy garlic, and yellow hot pepper which adds muchflavor and aroma. Vinegar and soy sauce are addedto make it a scrumptious meal for beef lovers.At LaGranja, delectable platters are served with sides that are a step above the rest.Family platters are available to make dinner quick and hearty.Visit LaGranja.Choosedine-in, curbside, or delivery with DoorDashor Grubhub.For information about LaGranjaRestaurants, go towww.lagranjarestaurants.com.Related Imagesenjoy-a-grilled-or-crispy.png Enjoy a grilled or crispy delicious chicken sandwich at a La Granja restaurant. To find the nearest La Granja Restaurant, go to https://www.lagranjarestaurants.com/en/locations/ SOURCE La Granja Restaurants", "role": "user" }, { "content": "La Granja Features Grilled Boneless Chicken Breast Sandwich With French Fries for Lunches and Dinners La Granjas in Broward County are seeing a surge of interest in boneless chicken breast with rice, beans, bananas and a soda for lunch and dinners. The surge in sales is on Sundays, especially as other chicken restaurants are not open then. People can choose yellow rice or white rice with a grilled or chicken sandwich. Besides their popular 1/4 chicken with rice and bean meals, many people prefer chicken sandwich lunches and dinners on the go.", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: FRIEDRICHSDORF, Germany--(BUSINESS WIRE)--Today, Maxon announced the immediate availability of Redshift for macOS including support for M1-powered Macs as well as Apples Metal Graphics API. Redshift, the award-winning, production-ready renderer, offers a rich feature set including ray switches, flexible shading networks, motion blur, AOVs, deep output, layered EXR and much more. Unlike other GPU renderers, Redshift is a biased renderer that enables artists to adjust the quality of individual techniques in order to get the best performance/quality balance for production. As a Universal solution, Redshift is optimized for high-end performance across both M1- and Intel-powered Macs. Redshift for macOS signifies a milestone, bringing cutting-edge cinematic rendering to Mac artists. And native support for M1-powered Macs means substantial efficiency improvements to workflows, since the integrated graphics in M1 provide a huge increase in graphics performance combined with low power consumption. When Redshift joined the Maxon family in 2019, extending support to our user community on the Mac platform was a top priority, says Maxon CEO, David McGavran. So were thrilled that creatives working in macOS environments can now take advantage of this powerful and flexible GPU-accelerated renderer built to meet the specific demands of contemporary high-end production. Early testers of Redshift on macOS have reported some significant performance results. James Rodgers, Director at UK-based Lunar Animation reported, Were seeing some crazy results when rendering with Redshift on Mac Pro. A typical frame from the very effects heavy game cinematic we created for Mythic Legends, an action-packed strategy mobile game by Outfit7, previously took 26 minutes to render per frame. Now its rendering in only 58 seconds! Redshift for Intel-based Macs will be available this week. Support for M1-based Macs will be made available with the release of macOS Big Sur (11.3). As is typical with Redshift, updates to enhance stability and optimization will be regular and ongoing. Supported Host Apps and System Requirements About Maxon Maxon makes powerful, yet approachable software solutions for content creators working in 2D and 3D design, motion graphics, visual effects and visualization. Maxons innovative product portfolio helps artists supercharge their creative workflows. Its product lines include the award-winning Cinema 4D suite of 3D modeling, simulation and animation technology, the diverse Red Giant lineup of revolutionary editing, motion design and filmmaking tools, and the high-end production, blazingly fast Redshift rendering solutions. Maxons team is comprised of fun, passionate people who believe in building and empowering a successful artistic community. From its popular, inclusive events to its free Cineversity educational resources, Maxon recognizes that developing strong connections with creatives and fostering their professional growth is integral to Maxons ability to stay on top of industry trends and better serve customers. Maxon is part of the Nemetschek Group.", "role": "user" }, { "content": "Maxon Announces Redshift for macOS Including Native Support for M1-Powered Macs Extended Compatibility Provides Powerful Options for 3D Content Creators", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BOSTON--(BUSINESS WIRE)--Brightcove Inc. (NASDAQ: BCOV), the global leader in video for business, today announced that it will host a virtual Analyst Day on Tuesday, March 9, 2021. Jeff Ray, CEO and the Executive Team members will discuss the companys strategy and vision, growth drivers, business and financial outlook, and how Brightcove will create value for its customers and shareholders. The Brightcove Executive Team will provide presentations beginning at 10:00 a.m. Eastern Time with the event expected to conclude at approximately 2:00 p.m. Eastern Time. A registration link is available on our website at http://investor.brightcove.com/index.php/events-presentations. Also, a live webcast of the presentation will be available on the Events page of the Brightcove investor relations website at http://investor.brightcove.com/index.php/events-presentations. A replay of the webcast will also be available for a limited time. About Brightcove When video is done right, it can have a powerful and lasting effect. Hearts open. Minds change. Creativity thrives. Since 2004, Brightcove has been helping customers discover and experience the incredible power of video through its award-winning technology, empowering organizations in more than 70 countries across the globe to touch audiences in bold and innovative ways. Brightcove achieves this by developing technologies once thought impossible, providing customer support without parallel or excuses, and leveraging the expertise and resources of a global infrastructure. Video is the worlds most compelling, exciting medium. Visit www.brightcove.com for more information. Video That Means Business.", "role": "user" }, { "content": "Brightcove to Host Virtual Analyst Day", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MINNEAPOLIS, Feb. 17, 2021 /PRNewswire/ --Metavention, Inc. announces the initiation of an FDA-approved clinical investigation, DeLIVER (NCT04285554), for the Company's intravascular iRF Denervation System to determine safety in patients with type 2 diabetes (T2D). Physicians at HSHS St. John's Hospital in Springfield, IL treated the first patient in the U.S. DeLIVER study, \"we are excited to be participating in this ground-breaking, minimally invasive treatment for patients with type 2 diabetes,\" stated Krishna Rocha-Singh, M.D., Chief Scientific Officer of the Prairie Heart Institute. \"There remains a substantial unmet clinical need for improved treatment options in the management of type 2 diabetes. The prospect of adding an endovascular therapy as an adjunct to the care of this challenging patient population is compelling and exciting.\" People with T2D have abnormal levels of sugar, also known as glucose, in their blood. A key contributor to this unwanted glucose is often the patient's own liver. The liver plays a central role in the proper regulation of glucose levels, but excessive release of glucose into the bloodstream by the liver, triggered by overactive sympathetic nerve signaling, can be a major limitation in the control of T2D. Metavention's patented iRF Denervation System is designed to be a one-time transcatheter procedure utilizing radio frequency energy to inhibit overactive sympathetic nerve signaling to the liver, thereby improving overall glucose control. \"T2D continues to be a global epidemic. Patients are expected to accept lifelong daily use of complex and expensive drug regimens with high probability of disease progression, resulting in insulin dependence and serious health complications,\" said Todd Berg, CEO of Metavention. \"Metavention's iRF Denervation System has the potential to provide patients with a fundamentally new treatment option for the management of their T2D by targeting an underlying cause of their disease.\" About Type 2 Diabetes T2D is a chronic, progressive disease that affects more than 400 million people worldwide. Despite significant treatment efforts with lifestyle changes and medications, about 50% of patients fail to achieve adequate blood sugar control, putting them at a higher risk of complications. Potential complications of T2D include increased risk of heart disease, stroke, high blood pressure and narrowing of blood vessels (atherosclerosis), nerve damage, kidney failure, glaucoma, and blindness. About Metavention Inc. Developer of the iRF Denervation System,Metavention, Inc. is a privately held medical device company headquartered in Minneapolis, Minnesota. This procedure is intended to be a \"one and done\" adjunctive therapy that provides improved control of T2D, high blood pressure, and other metabolic diseases. For more information, please visit www.metavention.com. CAUTION - The iRF Denervation System is an investigational device and is limited by Federal (or United States) Law to investigational use. SOURCE Metavention Related Links https://www.metavention.com", "role": "user" }, { "content": "Metavention Announces Initiation of U.S. Clinical Trial for Novel Treatment of Type 2 Diabetes", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: INDIANAPOLIS, Aug. 18, 2020 /PRNewswire/ --The American Legion issued the following statement today highlighting its commitment to veterans who rely on timely mail delivery to receive prescriptions: \"Millions of our nations' veterans depend on a strong U.S. Postal Service for critical needs such as prescription refills.The Department of Veterans Affairs fills over half a million prescriptions each day through the Consolidated Mail Output Pharmacy system. The vast majority of these prescriptions are mailed to veterans through the USPS. \"Due to the COVID-19 pandemic, reduced availability of in-person services at VA facilities, including access to the pharmacy, places veterans in larger reliance on mail-ordered prescriptions and a strong USPS.If our leaders in Washington, D.C. choose not to fund the post office by the end of September,The American Legion is concernedit could have dire consequences for the millions of veterans who rely on the mail every day to deliver life-saving medication. The postal service often plays a pivotal role in the delivery of paperwork needed to process claims for veterans who have been disabled in the service of their country. \"The American Legion has spoken out in favor of a strong USPS before with the passage ofa resolution at our national convention in 2016.The American Legion implores Congress to address this issue impacting our nation's veterans in an expeditedmanner so they can continue to receive the critical services they need during these difficult times.\" The American Legion, www.legion.org, is the nation's largest veterans service organization and was founded in 1919 on the four pillars of a strong national defense, the care and wellbeing of U.S. military veterans, patriotic youth programs and Americanism. Media contacts: Indianapolis: John Raughter (317) 630-1350, [emailprotected]; Washington: Paul Harris (202) 263-2991, [emailprotected] SOURCE The American Legion Related Links http://www.legion.org", "role": "user" }, { "content": "The American Legion: 'Vets Need Reliable Postal Service'", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ST. PETERSBURG, Fla., May 15, 2020 /PRNewswire/ --Having closely tracked the impact of COVID-19 on buying behavior in grocery and drug stores since mid-February, shopper intelligence leader Catalina has compared sales data with its partner Koupon, the leading promotion solution provider for small format retail, to gain a more holistic understanding of the pandemic's impact on cross-channel consumer purchases.While wine, beer and spirits have each experienced a boost in sales during the pandemic across grocery, drug and c-store channels, the wine category has seen particularly strong sales growth. Wine Category Sees Strong Gains across the Board Catalina's shopping data reveals a significant increase in wine sales for the 10-week period beginning Feb. 23 through May 2, 2020 across grocery and drug channels, when sheltering in place became more common vs. the same period a year ago: Wine total dollar sales increased by 38%, with unit sales up by 32% The number of wine buyers increased by 16% Dollars spent per wine buyer were up 15% -- from $62.74 to $71.94 (for the total 10-week period) Units purchased per wine buyer were up 10% -- from 6.3 to 6.9 (for the total 10-week period) 46% of wine buyers made a repeat purchase (2+ trips during the 10-week period) vs. 36% a year ago In 2020, 45% of trips included purchases of two or more bottles of wine, compared to 36% of trips in 2019 3+ bottles were purchased this year on 19% of trips, compared to 14% of trips last year 6+ bottles were purchased this year on 7.3% of trips, compared to 5.8% of trips last year Many new buyers have entered the category as well, and they are making repeat purchases. New category buyers in grocery & drug (they didn't buy the category in the previous 52 weeks): % new buyers % new buyers repeating Wine - COVID period (10 weeks) +13% +21% Wine - same period year ago +11% +15% Beer - COVID period (10 weeks) +10% +21% Beer - same period year ago +10% +16% Spirits - COVID period (10 weeks) +18% +19% Spirits - same period year ago +16% +13% Across alcoholic beverages, wine has seen the greatest overall increase compared to the pre-COVID period: Total dollar sales vs. a year ago (grocery/drug): 6 weeks pre-COVID 10-Week COVID period Change Wine +4% +38% +34 pts Beer +9% +35% +26 pts Spirits +10% +42% +32 pts According to Koupon, as virtual happy hours have become more popular, there has been a clear shift toward C-store visits later in the day, and a corresponding increase in the sales of adult beverages. In the C-store channel, for the same 10-week period vs. year ago: Wine total dollar sales were up 9%, beer was up 6%, and spirits up 24% 32% of wine buyers were new to the category within c-store, and 17% of these first-time buyers have made a repeat purchase For consumers buying both before and during the crisis, wine basket size was up 4%, beer up 11% and spirits up 6% Wine Industry Perspectives\"During times of crisis, new behaviors and habits emerge for some consumers while others return to the familiar,\" said Stephanie Gallo, Chief Marketing Officer, E. & J. Gallo. \"The rise of virtual observances - happy hours, baby showers, birthdays and even weddings - means consumers are using technology in new ways while enjoying wine and spirits as a part of their connections. Several of our wineries are now engaging consumers through weekly virtual happy hours with winemakers and cooking demonstrations with chefs.\"Added Jeff Dubiel, Chief Marketing Officer of The Wine Group, \"During the initial panic-buy period, the wine category saw the same consumer pantry-loading behaviors as other categories like paper towels and shelf-stable goods. As we have seen with previous crises, the increased purchase and consumption continued to hold following the initial wave of pantry-loading as consumers adapted to sheltering in place. Americans are resilient, and we have seen and heard wine enthusiasts finding inventive news ways, such as virtual happy hours and wine tastings - to enjoy their favorite beverages with friends and family.\"Adapting for a New NormalFor the week ending May 3, convenience store sales have returned to year-over-year growth levels across the majority of in-store categories. As more states begin to reopen and consumers adjust to a new normal, consumer goods producers, including the wine category, will continue to adapt.\"We have seen shifts in consumer behavior where larger indulgences like vacations are being replaced with small moments of joy and reward, such as a nice glass of wine at the end of the day. Consumers are moving toward leading brands that are comfortable and familiar,\" said Jeff Dubiel. \"The way consumers interact, shop and spend their time has morphed into a more digital experience, so our ability to quickly adjust our engagement during the pandemic has been important. As an example, when the Coachella music festival was postponed, Cupcake Vineyards provided a 'Couchella' live stream event and a chance to win Coachella tickets for the rescheduled event in October.\"Stephanie Gallo explained, \"Maintaining a sense of community matters more now than ever, and people are looking for ways to discovernew ways to fill their time at home. Because many arepeople are turning to cooking, we'velaunched a weekly cooking demo 'Supper Series'on Saturdays and Sundays on Instagram Live, hosted by @louismmartiniwineryExecutive Chef Jeffery Russell and @ J Vineyards & WineryExecutive Chef Carl Shelton. These weekly appearances bring loyal and new consumers closer to our brands, while presenting authentic, relatable content, and we expect to continue programs like this moving forward.\"About CatalinaCatalina is the market leader in shopper intelligence and highly targeted in-store and digital media that personalizes the shopper journey. Powered by the world's richest real-time shopper database, Catalina helps CPG brands, retailers and agencies optimize every stage of media planning, execution and measurement to deliver $6.1 billion in consumer value annually. Based in St. Petersburg, FL, Catalina has operations in the United States, Europe and Japan. To learn more, please visit www.catalina.comor follow us on Twitter @Catalina.About Koupon Koupon provides C-store retailers and brands with the easiest way to connect and engage with shoppers to grow sales. Koupon works with brands to easily deploy personalized, channel-wide promotions, and helps retailers to secure additional brand trade spending and grow shopper engagement. Members of the Koupon Network - the leading C-store collaborative with 30 of the top 50 C-store retailers and over 70 brands realize the benefit from Koupon's unmatched channel reach, proprietary technology and data, and campaign management services. Since its founding in 2011, Koupon has delivered over 4 billion offers. To learn more, please visit www.kouponmedia.com. SOURCE Catalina Related Links http://www.catalina.com", "role": "user" }, { "content": "Pandemic Fuels Wine Sales at Grocery & Convenience Stores per Latest Shopping Data Shared by Catalina and Koupon E. & J. Gallo and The Wine Group See Strong Category Uptick", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WALTHAM, Mass.--(BUSINESS WIRE)--Eighty-five percent of online shoppers start their online purchase journeys at a marketplace whether they have a product in mind for purchase or not. Business buyers want the same level of ease and comparison and Yottaa, the leading cloud platform for accelerating ecommerce, and Episerver, the customer-centric digital experience company, have made it possible through Yottaas RAPID inSITE via the Episerver App Marketplace for business users to choose an app to fit their needs. Episerver offers the most complete ecommerce suite for growing brands, said Chris Ash, director of alliances for Yottaa. In order for these brands to maximize online growth they need to add rich third-party features to their sites that enhance shopper experience. With the addition of RAPID inSITE into its App Marketplace, Episerver is providing its customers a powerful tool to improve overall site performance and increase online conversion. RAPID inSITE enables brands to gain full visibility into how their website is currently performing and see how third-party technologies and other site elements are impacting page load time. Studies have shown that third parties account for up to 75% of site latency and that slow loading pages result in lower conversion. To be able to participate in the Episerver App Marketplace, RAPID inSITE had to pass strict design, quality, verification, compliance and support standards to ensure impeccable integrations for purchasers seeking quick extensibility in the form of B2C-like shopping. Episerver App Marketplace is mission critical for companies looking to customize their technology stack without the hassle or headaches associated with customization, said Karen Chastain, senior director of global alliances at Episerver. While Episerver is an end-to-end digital experience platform, our goal is to offer unparalleled accessibility to the best-of-breed software our customers want to use. To do this, Episerver App Marketplace offers a select-and-succeed model so back-end logic and integration helps engineer show-stopping front-end experiences. As an app for Episervers Commerce Cloud, RAPID inSITE meets business demand for faster performing eCommerce sites while also enabling brands to add a multitude of the third-party features that shoppers have come to expect without impacting site speed. Adding Yottaa within Episerver App Marketplace speaks to the need for business users to have complete autonomy over what their software platforms do for them as an organization with hyper-specific needs another company, even in their own industry, may not have, said Chastain. RAPID inSITE is a tremendous value add to the Episerver ecosystem and a powerful solution for brands to significantly improve site performance in order to grow their online businesses. Episerver tests each new application or add on for functionality, security and user-interface; ongoing support is held with Yottaa. For more information about the app, visit https://marketplace.episerver.com/. As part of this new partnership, Yottaa is presenting on an Episerver webinar titled, Extending Your Episerver Solution Through the App Marketplace: A Web Series, to be held today, Wednesday, November 4 at 9 a.m. CT. Click here to register for the webinar. A recorded version of the webinar will also be available through your registration. About Yottaa Leading brands such as Ann, Inc., Carters, Express, Lands End, Mattress Firm, Nutrisystem, Ralph Lauren, and Samsonite rely on Yottaa to accelerate, optimize, and control third-party ecommerce technologies, high resolution images, and other website elements, resulting in superior customer experiences, up to 60% faster web performance, and up to 20% increases in online conversion. To learn more about how Yottaa can optimize every page load on your ecommerce site and increase conversions, please visit www.yottaa.com or follow @yottaa on Twitter. About Episerver Episerver empowers businesses to scale through the most customer-centric approach to digital experiences. Its Customer-Centric Digital Experience Platform features best-in-class content management and robust commerce, both backed by AI powered data and personalization solutions. The platform has consistently earned industry, analyst and media recognition for its vision, capabilities and customer commitment. Episervers 900+ partners and 1100+ employees in offices around the globe are proud to help more than 9,000 brands enrich their customer lifetime value, increase revenue and grow their brands. Learn more at www.episerver.com", "role": "user" }, { "content": "Yottaa Brings eCommerce Acceleration as an Application in the Episerver App Marketplace With Yottaa RAPID inSITE for Episerver Commerce Cloud, Customers Maximize Business Investment, Extend Platform Functionality", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Nov. 9, 2020 /PRNewswire/ -- The Global Surgical Robotic Systems Market size is expected to reach $13.3 billion by 2026, rising at a market growth of 21% CAGR during the forecast period. Surgical robots have seen a worldview change in a recent couple of years because of technological progressions in the regions of 3D-imaging, top-notch microscopic cameras, data recorders, data analytics frameworks, motion sensors, remote navigation frameworks, robotic controlled catheters, and different accessories valuable for medical procedures. This is to grow new applications for existing platforms and create disruptive advancements that will boost the future market.Read the full report: https://www.reportlinker.com/p05983171/?utm_source=PRN The business is seeing a growing pattern of robotic organizations teaming up on technology stages with third-party vendors to create new surgical applications. Robotic surgery can be considered as a minimally invasive surgery that uses robotics for performing surgeries. These robotic frameworks are worked by specialists and comprise of miniaturized surgical tools which are mounted on robotic arms, in this way permitting specialists to perform the medical procedures accurately.The key elements boosting the surgical robots market size are expanding requirement for automation in the healthcare industry and the shifting pattern towards cutting edge robotic surgeries. However, the significant expense related to surgical robotic procedures and robotic frameworks will limit the clinical robot market. Furthermore, the rise in loss of life and wounds because of robotic surgeries will likewise hinder the development of the surgical robot market. Additionally, undeveloped economies, for example, Brazil, India, China, and other developing economies will make possibilities for growth for the surgical robot market.Based on Component, the market is segmented into Accessories, Systems and Services. Based on Application, the market is segmented into Gynecology Surgery, Orthopedic Surgery, Urology Surgery, Neurosurgery, General Surgery and Others. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Intuitive Surgical, Inc., Kuka AG, Johnson and Johnson, Siemens AG, Medtronic PLC, Smith & Nephew PLC, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., and TransEntrix, Inc.Strategies deployed in Surgical Robotic Systems MarketPartnerships, Collaborations, and Agreements:Srp-2020: Siemens Healthineers came into partnership with WakeMed Health & Hospitals in North Carolina. The partnership includes robotics initiatives, advanced imaging capabilities, AI, and staff and provider training across the health system's cardiovascular intervention and imaging programs. WakeMed would serve as a best-in-class cardiovascular laboratory and will have a world-class hybrid operating room, along with the ARTIS Icono and a Corindus CorePath GRX robot. These new innovations aimed to enhance the delivery of care across cardiac, vascular, neurosurgical, orthopedic, cancer, and trauma services. It will also be provided with advanced imaging technology, with top-line equipment and precise robotic assistance for greater diagnostic capabilities and 3D imaging capabilities for added patient comfort.Jul-2020: TransEnterix, Inc. announced an agreement with Maastricht University Medical Center+ (MUMC+). Following the agreement, the Medical Center leased and utilized a Senhance Surgical System. This is the first hospital to acquire a Senhance to be utilized in pediatric minimally invasive surgery.Aug-2016: Intuitive Surgical signed a joint development deal with Dextera Surgical, a company that designs and manufactures stapling devices for minimally invasive surgical procedures. The agreement was aimed to develop a surgical stapler and cartridge for Intuitive's da Vinci robotic surgical system.Acquisition and Mergers:Feb-2020: Medtronic announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training. The acquisition strengthened Medtronic robotic-assisted surgery platform and has applicability for Medtronic's broader portfolio.Dec-2019: Johnson and Johnson signed an agreement to acquire the remaining stake in Verb Surgical, Inc. Verb Surgical's world-class robotics and data science capabilities have been integrated with Johnson & Johnson's health care leadership and global reach. The integration advanced the company's vision to make medical interventions smarter, less invasive, and more personalized.Oct-2019: Stryker acquired Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics). Mobius Imaging and Cardan Robotics provided expertise in advanced imaging and robotics, as well as a robust product pipeline, that increased Stryker's presence in Orthopaedics, Spine, and Neurotechnology.Oct-2019: Siemens completed the acquisition of Corindus Vascular Robotics, a manufacturer of robotic-assisted PCI systems. The combination of Siemens Healthineers' strong medical technology portfolio with its digital platforms and solutions, together with Corindus' precision robotics platform, would transform health care delivery that provides better care at a lower cost.Jul-2019: Intuitive took over Scholly Fiberoptic's robotic endoscope business. This acquisition integrated Scholly's robotic endoscope manufacturing line, and two Scholly sites into Intuitive operations. The acquisition strengthened Intuitive's supply chain and increased its manufacturing capacity for imaging products.Mar-2019: Smith & Nephew announced an agreement to acquire Brainlab orthopedic joint reconstruction business. The acquisition would support Smith & Nephew's strategy to invest in best in class technologies that further its multi-asset digital surgery and robotic ecosystem.Feb-2019: Johnson and Johnson's subsidiary Ethicon, Inc. signed an agreement to acquire Auris Health, Inc. is a developer of robotic technologies. This acquisition would accelerate Johnson & Johnson's entry into robotics with the potential for growth and expansion into other interventional applications.Sep-2018: TransEnterix, Inc. completed the acquisition of the assets of MST Medical Surgery Technologies Ltd., an Israel medical technology company. The acquisition increased the effectiveness of surgeons, making procedures quicker and less error-prone, leading to better outcomes for the patient.Sep-2018: Globus Medical acquired Nemaris and its Surgimap planning software. Following the acquisition, Globus Medical integrated Nemaris tech into its ExcelsiusGPS robot-assisted surgery platform. The acquisition of Surgimap bolstered Globus Medical's efforts to advance the future of computer-assisted surgery to improve patient outcomes.Aug-2017: Globus Medical took over KB Medical, SA, a robotic developer based in Lausanne, Switzerland. The acquisition enabled Globus Medical to accelerate, enhance, and expand its product portfolio in Imaging, Navigation, and Robotics.Jul-2016: Zimmer Biomet took over Medtech SA, a developer, and maker of the ROSA robotic device for neurological and spine procedures. Zimmer purchased almost 59 percent of the outstanding share capital of Medtech. This acquisition provided Zimmer with innovative technologies and expanded its footprint.Jan-2016: Smith & Nephew completed the acquisition of Blue Belt Holdings, Inc., a leader in orthopedic robotics-assisted surgery. Blue Belt Technologies' NAVIO surgical system provides robotics-assistance in unicondylar or partial knee replacement surgery through CT-free navigation software and a unique hand-held, robotic bone-shaping device. NAVIO and Smith & Nephew's partial knee implant portfolio form a strong combined business to accelerate growth in this attractive area of surgery.Product Launches and Product Expansions:Sep-2020: Medtronic launched Hugo RAS System, a new robot-assisted surgery platform. This platform is a more flexible and cost-effective system. The Hugo system includes a tower, surgeon console, surgical end effectors, and robotic arm carts.Jul-2020: Smith & Nephew introduced the Real Intelligence brand of enabling technology solutions, as well as its new-generation handheld robotics platform, the CORI Surgical System. Real Intelligence would address clinical challenges through the continuum of care including patient engagement, digital and robotic surgery, pre-operative planning, post-operative assessment, and outcomes measurement. The new CORI surgical platform is available for both unicompartmental knee arthroplasty and total knee arthroplasty. It is a small and portable system, making it ideal for ambulatory surgery centers (ASCs) and outpatient surgery.Scope of the StudyMarket Segmentation:By Component Accessories Systems ServicesBy Application Gynecology Surgery Orthopedic Surgery Urology Surgery Neurosurgery General Surgery OthersBy Geography North Americao USo Canadao Mexicoo Rest of North America Europeo Germanyo UKo Franceo Russiao Spaino Italyo Rest of Europe Asia Pacifico Chinao Japano Indiao South Koreao Singaporeo Malaysiao Rest of Asia Pacific LAMEAo Brazilo Argentinao UAEo Saudi Arabiao South Africao Nigeriao Rest of LAMEACompanies Profiled Stryker Corporation Intuitive Surgical, Inc. Kuka AG Johnson and Johnson Siemens AG Medtronic PLC Smith & Nephew PLC Zimmer Biomet Holdings, Inc. Globus Medical, Inc. TransEntrix, Inc.Unique Offerings Exhaustive coverage Highest number of market tables and figures Subscription based model available Guaranteed best price Assured post sales research support with 10% customization freeRead the full report: https://www.reportlinker.com/p05983171/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com", "role": "user" }, { "content": "Global Surgical Robotic Systems Market By Component, By Application, By Region, Industry Analysis and Forecast, 2020 - 2026", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CESENA, Italy--(BUSINESS WIRE)--Helbiz, a global leader in micro-mobility that is the business combination target of GreenVision Acquisition Corp. (Nasdaq: GRNV), today announced that it will launch its fleet of electric bikes in Cesena, Italy. Starting with 60 e-bikes, the fleet will gradually increase to 400 in the coming weeks, allowing citizens to move in a convenient, sustainable and safe way. \"We are happy to see the continued interest from citizens towards our micro-mobility service across Cesena,\" said Luca Santambrogio, Country Manager of Helbiz. \"Cesena, like other Italian cities in the last year, has undertaken an important change that will lead it to revolutionize its transportation options thanks to our efficient and sustainable means. The bikes complete our offering, making our service a full intermodal transportation solution.\" These vehicles join the existing fleet of 200 e-scooters that have been on the ground since July 2020. Since the start of the scooter service, 90K rides have already been made, and a total of over 160K kilometers have been traveled, which corresponds to a CO2 savings of more than 282Kkg. The operational area of bikes and scooters is 17 km2 and extends from the historic center to the districts of Sant'Egidio, Villa Chiaviche and Ponte Abbadesse. The rate for renting bikes is 0.25 for the initial unlock + 0.07 per minute for the ride. Users can also subscribe to Helbiz UNLIMITED at a cost of 29.99 per month, which offers an unlimited number of daily trips lasting 30 minutes (at least 20 minutes apart) and access to the service through Telepass Pay with 30 minutes of free trips. Users can easily access e-bikes and e-scooters through the Helbiz mobile app on Android and iOS, by locating the nearest vehicle on a georeferenced map and unlocking it by scanning a QR code located on the handlebars. Starting today, users within the Romagna municipality can easily choose the means of transport they prefer according to their travel needs. \"2021 has taken on a decidedly important path that will gradually change the conception that Cesena residents have of home-work and home-school trips, said Mayor Enzo Lattuca and Councillor for Sustainable Mobility and Roads, Francesca Lucchi. With the launch of the Urban Plan of Sustainable Mobility and the establishment of the Bicipolitana project, Cesena is preparing to travel on two wheels, offering mobility options that benefit quick, short distances. With new technologies, mobility has become smarter and certainly greener.\". For more informationHelbiz: http://www.helbiz.com About Helbiz Helbiz is a global leader in micro-mobility services. Launched in 2016 and headquartered in New York City, the company operates e-scooters, e-bicycles and e-mopeds in over 30 cities around the world including Washington, D.C., Alexandria, Arlington, Atlanta, Jacksonville, Miami, Milan, Richmond and Rome. Helbiz utilizes a customized, proprietary fleet management platform, artificial intelligence and environmental mapping to optimize operations and business sustainability. Helbiz announced on February 8, 2021 it has entered into a merger agreement with GreenVision Acquisition Corp. (Nasdaq: GRNV) (\"GreenVision\") a SPAC, which, upon closing, will result in Helbiz becoming the first micro-mobility company listed on Nasdaq. About GreenVision Acquisition Corp. GreenVision Acquisition Corp. is a special purpose acquisition company formed under the laws of the State of Delaware for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Forward-Looking Statements Certain statements made in this press release are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as anticipate, believe, expect, estimate, plan, outlook, and project and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from Helbiz, Inc.s (the Companys) or GreenVisions expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; (ii) the ability of the Company to meet Nasdaq listing standards following the transaction and in connection with the consummation thereof; (iii) the inability to complete the transactions contemplated by the Merger Agreement due to the failure to obtain approval of the stockholders of the Company or the stockholders of GreenVision or other reasons; (iv) the failure to meet the minimum cash requirements of the Merger Agreement due to GreenVision stockholder redemptions and the failure to obtain replacement financing; (v) the failure to meet projected development and production targets; (vi) costs related to the proposed transaction; (vii) changes in applicable laws or regulations; (viii) the ability of the combined company to meet its financial and strategic goals, due to, among other things, competition, the ability of the combined company to pursue a growth strategy and manage growth profitability; (ix) the possibility that the combined company may be adversely affected by other economic, business, and/or competitive factors; (x) the effect of the COVID-19 pandemic on the Company and GreenVision and their ability to consummate the transaction; and (xi) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the SEC) by the Company. Additional information concerning these and other factors that may impact the Companys expectations and projections can be found in GreenVisions periodic filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and its preliminary proxy statement on Schedule 14A filed on April 8, 2021. GreenVision's SEC filings are available publicly on the SEC's website at www.sec.gov. Any forward-looking statement made by us in this press release is based only on information currently available to GreenVision and Helbiz and speaks only as of the date on which it is made. GreenVision and Helbiz undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law. Additional Information about the Transaction and Where to Find It In connection with the proposed business combination, GreenVision has filed a preliminary proxy statement on Schedule 14A with the SEC. Additionally, GreenVision will file other relevant materials with the SEC in connection with the business combination, including a definitive proxy statement. Copies may be obtained free of charge at the SECs web site at www.sec.gov. Security holders of GreenVision are urged to read the proxy statement and the other relevant materials when they become available before making any voting decision with respect to the proposed business combination because they will contain important information about the business combination and the parties to the business combination. The information contained on, or that may be accessed through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release. GreenVisions stockholders may also obtain a copy of the preliminary proxy statement or, once available, the definitive proxy statement, as well as other documents filed with the SEC by GreenVision, without charge, at the SECs website located at www.sec.gov or by directing a request to: GreenVision Acquisition Corp., One Penn Plaza, 36th Floor, New York, New York 10019. Participants in Solicitation GreenVision and its directors and officers may be deemed participants in the solicitation of proxies of GreenVisions shareholders in connection with the proposed business combination. Security holders may obtain more detailed information regarding the names, affiliations and interests of certain of GreenVisions executive officers and directors in the solicitation by reading GreenVisions Annual Report on Form 10-K for the fiscal year ended December 31, 2020, the preliminary proxy statement filed with the SEC on April 8, 2021, and the definitive proxy statement and other relevant materials when they are filed with the SEC in connection with the business combination. Helbiz and its officers and directors may also be deemed participants in such solicitation in connection with the business combination. A list of the names of such directors and executive officers and information regarding their interests in the business combination are set forth in the preliminary proxy statement, which was filed on April 8, 2021 with the SEC, and the definitive proxy statement, when it is filed with the SEC, in connection with the proposed business combination. These documents can be obtained free of charge from the sources indicated above. Non-Solicitation This press release does not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. This press release also does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.", "role": "user" }, { "content": "Micro-mobility Leader, Helbiz, Announces Launch of E-bikes in Cesena, Italy Residents have already traveled over 160K km with Helbiz e-scooters since its launch last summer", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MENLO PARK, Calif., Nov. 20, 2020 /PRNewswire/ --Altimeter Growth Corp. (the \"Company\") announced today that commencing November 23, 2020, holders of the units sold in the Company's initial public offering of 45,000,000 units may elect to separately trade the shares of Class A ordinary shares and redeemable warrants included in the units. Those units not separated will continue to trade on the Nasdaq Capital Market (the \"Nasdaq\") under the symbol \"AGCUU.\" Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols \"AGC\" and \"AGCWW,\" respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and redeemable warrants. The units were initially offered by the Company in an underwritten offering. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC acted as book-running managers of the offering. The registration statement relating to the units and the underlying securities became effective on September 30, 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering was made only by means of a prospectus. Copies of the prospectus may be obtained for free from the U.S. Securities and Exchange Commission (\"SEC\") website http://www.sec.gov; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Telephone: 1-800-831-9146; Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282; Telephone: (866) 471-2526; Morgan Stanley & Co. LLC, c/o Attention: Prospectus Department, 180 Varick Street, 2ndFloor, New York, NY 10014. Cautionary Note Concerning Forward-Looking Statements This press release may include \"forward-looking statements,\" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including with respect to the anticipated separate trading of the Company's Class A ordinary shares and redeemable warrants. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as \"anticipate,\" \"believe,\" \"estimate,\" \"expect,\" \"intend\" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus relating to the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. About the Company The Company is a newly organized blank-check company formed by an affiliate of Altimeter Capital Management, LP (\"Altimeter\"). Altimeter is a technology-focused investment firm based in Menlo Park, CA and Boston, MA, with approximately $13 billion of assets under management as of September 30, 2020. Media ContactsAltimeter Growth Corp.Megan Sabel617-310-6182[emailprotected] SOURCE Altimeter Growth Corp. Related Links http://www.altimeter.com", "role": "user" }, { "content": "Altimeter Growth Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing November 23, 2020", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEWYORK, Feb. 17, 2021 /PRNewswire/ --LION Eye Group (\"LION\") announces it has entered into a collaborative agreement with OCLI-Spectrum Vision Partners (\"OCLI\") for integrated eye care. The collaboration was the result of LION's effort to engage in high quality medical optometry in conjunction with building out a better retail centric business model. The partnership gives patients more options, while allowing the ophthalmologists of OCLI to concentrate on laser and cataract surgeries. James Vena, Executive Operating Partner and interim CEO of LION, envisions integrated eye care as an enhanced bridge between medical optometry and the retail side of the industry, offering a better in-office experience as well as ecommerce for LION signature locations. \"While LION originated as an exit strategy, the outlook heading into 2021-2025 may be that we self-finance and partner with venture capital to create a foundation for franchise-like optometric stores.\" About LION Eye Group Launched on January 1, 2020, LION Eye Group is a network of successful optometry practices based in New York. Originally founded as the Long Island Optical Network, the group has expanded to Manhattan and surrounding Burroughs evolving from a turnkey exit strategy group to a sophisticated optometric Network. Utilizing technology, LION is capitalizing opportunities in medical optometry while creating a franchise-like setting for a better in-store\" experience for its patients. Our commitment is vision, our visionis prosperity. Visitlioneyegroup.comfor more information. About OCLI OCLI is a world-renowned, multi-location ophthalmology practice offering eye care services. Our practitioners are some of the most respected physicians in the region, earning their reputations as esteemed innovators and complication-solvers. Visit www.ocli.netfor more information. Mediacontact: Angela Fischels (844) AUTUS 00 x704 [emailprotected] SOURCE LION Eye Group", "role": "user" }, { "content": "LION Eye Group Collaborates with OCLI-Spectrum Vision Partners", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NASHVILLE, Tenn., May 15, 2020 /PRNewswire/ --Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2020 financial results and a Company update after the market closes on Wednesday, May 20, 2020. A conference call and live Internet webcast will be held on Wednesday, May20, 2020at 4:30 p.m. Eastern Time to discuss the results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The conference ID for the rebroadcast is 1692495. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm. Cumberland Pharmaceuticals Inc.is a specialty pharmaceutical company focused on the delivery of high quality prescription brands to improve patient care. The Company develops, acquires and commercializes brands for the hospital acute care, gastroenterology and oncology market segments. These medical specialties are categorized by moderately concentrated prescriber bases that Cumberland believes can be penetrated effectively by targeted sales forces. The Company's portfolio of FDA approved brands includes: Acetadote (acetylcysteine) Injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection, for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ (telavancin) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. RediTrex (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis. For more information on Cumberland's approved products, including full prescribing information, please visit the individual product websites, links to which can be found on the Company's website www.cumberlandpharma.com. The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (\"DMD\"), Systemic Sclerosis (\"SSc\"), and Aspirin-Exacerbated Respiratory Disease (\"AERD\"), Hepatorenal Syndrome (\"HRS\") and Portal Hypertension (\"PH\"). SOURCE Cumberland Pharmaceuticals Inc. Related Links http://www.cumberlandpharma.com", "role": "user" }, { "content": "Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOWELL, Mass., March 2, 2021 /PRNewswire/ -- Jabra today announced the launch of the Jabra Evolve2 30, the latest product to join the Evolve2 range. It is the next generation of the Evolve range, Jabra's best-selling and market-leading UC headset, designed to enhance productivity whether working from the office or at home. The headset is built with the modern-day desk worker in mind, engineered for collaboration, concentration and comfortable productivity all day long at an affordable price of $99. (PRNewsfoto/Jabra) Productivity woes under the new normal The new normal has created the need for a hybrid approach to work, where flexibility between remote working and being office-based is a key priority. Virtual collaboration has grown from 14% in 2019, to 77% in 20203. Meanwhile, productivity is still a big challenge for businesses, as complexity of work increases exponentially, but average productivity rates diminish by the day1. Headsets are playing a crucial role in the flexible revolution of the workplace and Jabra's Evolve2 30 fulfills this with an affordable yet premium quality headset. Seamless collaboration and instant concentration The Jabra Evolve2 30 is perfectly suited for the modern flexible worker users who spend a majority of their day at their desk, in a noisy office setting or at home. Collaboration and concentration continue to be the two key pillars of effective work no matter where that may be. The 2-microphone call technology of the Evolve2 30 can clearly capture your voice so you can participate in calls and online meetings from anywhere, while also meeting Open Office requirements. With 28mm speakers and an advanced digital chipset, you can enjoy great audio quality too, for both calls and media playback. The Evolve2 30 is also available in a Microsoft Teams certified variant, which comes with a dedicated Microsoft Teams button so you can jump in and out of virtual meetings with just one touch, while the boom arm allows you to easily mute and unmute yourself in an instant. Taking collaboration one step further, the Jabra Evolve2 30 meets the Microsoft Open Office requirements which is a strict test of how effective a headset microphone is at suppressing surrounding noise and office talk making sure that the device is suited for any environment. The easy plug-and-play feature means users are able to seamlessly connect to all devices through the USB A or C plug, for maximum collaboration. The Evolve2 30 is also specifically engineered to deliver portable concentration anywhere with the angled earcup design developed to block out background noise. The single-sided busylight within turns on automatically when you're on a call but can also be turned on manually to signal \"do-not-disturb\" to those around you.Reliable all-day comfort The discomfort from prolonged headset wearing can be a huge hindrance to productivity. The Jabra Evolve2 30 is ergonomically designed to support prolonged wear, and to exert evenly distributed pressure. It's built with premium soft memory foam ear cushions that mold to your ear's natural contours and ease the weight of the headset on users' heads, offering ideal comfort all day long. The super lightweight Evolve2 30 is as durable as it is comfortable. Both the headband and slider of the Evolve2 30 are assembled with stainless steel, with a much higher degree of durability and flexibility compared to its predecessor, the Evolve 30. Hundreds of drop tests and boom-arm strength tests have been conducted to ensure the headset is able to stand the test of time even when used for long periods. \"Raising productivity levels is an ongoing uphill battle for every organization,\"said Holger Reisinger, SVP for Business Solutions at Jabra. \"We are excited to be rolling out our latest product aimed at battling productivity distractions for those in the office, but also the flexible workers. We've designed the Jabra Evolve2 30 to be at an affordable price-point so every user can enjoy the benefits of experiencing premium collaboration, concentration and comfort while working. The Jabra Evolve2 30 truly embodies the motto that work is no longer somewhere you go, but something you do.\" Key features and specifications: Enhanced lightweight comfort: 4.4 ounces 2-microphone call technology and 28mm speakers, meeting Open Office requirements UC and Microsoft Teams certified Advanced chipset enables future firmware upgrades Integrated busylight Improved noise-isolating design Reinforced steel headband & slider for increased durability A dedicated Microsoft Teams button on Microsoft variant Jabra Direct, Xpress Sustainable packaging made of recyclable materials Availability The Jabra Evolve2 30 will be available from March 2021 in selected retailers. The Evolve2 30 will be available in Black.Evolve2 30 STEREO MSRP $99 Evolve2 30 MONO MSRP $89 Find out more about Jabra at www.jabra.com/evolveAbout Jabra Jabra is a world leading brand in audio, video, and collaboration solutions engineered to empower consumers and businesses. Proudly part of the GN Group, we are committed to letting people hear more, do more, and be more than they ever thought possible. Jabra engineering excellence leads the way, building on 150 years of pioneering work within the GN Group. This allows us to create integrated tools for contact centers, offices, and collaboration that help professionals work more productively from anywhere; and true wireless headphones and earbuds that let consumers better enjoy calls, music, and media. The GN Group, founded in 1869, operates in 100 countries and delivers innovation, reliability, and ease of use. GN employs 6,500 people and in 2020 reported annual revenue of DKK 13.4bn. The Jabra brand accounts for approx. DKK 8.7bn and employs 1,900 people. GN makes life sound better and is Nasdaq Copenhagen listed. www.jabra.com 2021 GN Audio A/S. All rights reserved. Jabra is a registered trademark of GN Audio A/S. All other trademarks included herein are the property of their respective owners (design and specifications are subject to change without notice). 1Source: Boston Consulting Group 3Gensler US Workplace StudySOURCE Jabra Related Links http://www.jabra.com", "role": "user" }, { "content": "Jabra Launches Evolve2 30 Headset for Remote Work Productivity", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Genius Brands International, Inc. (\"Genius\" or the \"Company\") (NASDAQ: GNUS) securities between March 17, 2020 and July 5, 2020, inclusive (the Class Period). Genius investors have until October 19, 2020 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On June 5, 2020, Hindenburg Research published a report questioning the valuation of the Company and highlighting certain inaccurate statements by Genius. For example, the report stated that Rainbow Rangers, one of the Companys cartoon properties, was actually airing nine times per week, not the 26-airings noted in Genius press release, and was not airing in favorable time slots. On this news, the Companys share price fell $0.92, or over 13%, to close at $5.94 on June 5, 2020, thereby damaging investors. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Nickelodeons purported broadcast expansion of Geniuss Rainbow Rangers cartoon; (2) that subscription fees for the Kartoon Channel!; and (3) the Companys growth potential and overall prospects as a company. Follow us for updates on Twitter: twitter.com/FRC_LAW. If you purchased Genius securities during the Class Period, you may move the Court no later than October 19, 2020 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Genius securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [email protected], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.", "role": "user" }, { "content": "The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Genius Brands International, Inc. (GNUS) Investors Shareholders with $100,000 in losses or more are encouraged to contact the firm.", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Greek Yogurt Market by Type, Flavor, Distribution Channel, and Source: Global Opportunity Analysis and Industry Forecast 2020-2027\" report has been added to ResearchAndMarkets.com's offering. The Greek yogurt market size was valued at $7.2 billion in 2019, and is projected to reach $11.2 billion by 2027, growing at a CAGR of 10.9% from 2019 to 2027. Fermented dairy products are major source of probiotic bacteria. Fermented milk is prepared through inoculation of culture and enzyme, which converts lactose to lactic acid. This inoculation and fermentation process of milk offers various range of products such as butter, cheese, yogurt, Kefir, and others. Flavored yogurt is a fermented dairy product with added flavors and multiple health benefits. It is a preferred breakfast, snack, dessert, or beverage among health-conscious consumers. The fermented milk products mainly yogurt, butter, and cheese have gained popularity, as they have higher demand in various fast foods. Flavored yogurt is available in the market in various product types such as set, frozen, drinkable, and Greek. Greek yogurt is yogurt that is been strained to remove its whey content, which results in a thicker consistency of yogurt than the regular unstrained yogurt, while preserving the original yogurt's distinctive sour taste. Greek yogurt is often made with fermentation process. Additives such as sweeteners, flavors, and fruits are used to enhance the aroma, taste, and consistency of yogurt products. Food & beverage manufacturers have invested a lot in R&D to enhance characteristics, taste, and nutritional value of flavored Greek yogurt. Greek yogurt has almost every nutrient needed for the human body and is considered as an effective food for weight loss and nutritional diet. It is rich in a range of nutrients including calcium, vitamins, and trace minerals such as phosphorus, magnesium, and potassium. Significant protein content in the Greek yogurt influences appetite control and suppresses hunger. Moreover, certain variety of yogurts available in the market are enriched with probiotics, which helps in boosting the digestive health, by reducing common gastrointestinal disorder symptoms such as diarrhea, bloating, and constipation. The above mentioned nutrients such as probiotics, vitamins, and minerals, are beneficial in prevention of illness and enhancement of immunity as well as play a major role in bone health, reducing osteoporosis. In addition, yogurt improves heart health by maintaining blood pressure and increasing good HDL cholesterol. These health benefits of yogurt are anticipated to drive the growth of the global flavored yogurt market during the forecast period. Apart from health benefits, fermentation process helps to prolong the shelf life of the dairy products and also enhances the taste and aroma of the products. Hence, versatile properties exhibited by Greek yogurt are attributed to the significant growth of the Greek yogurt market. Growth in demand for flavored yogurt in emerging nations is attributed to the rise in disposable income, innovative flavors of Greek yogurt products offered by key players, and an increase in health awareness among consumers. This is expected to provide numerous opportunities for the expansion of the global Greek yogurt market. However, presence of additives and stringent regulations related to strain of culture used in fermentation of milk limits the market growth. Some of the key macroeconomic factors such as rise in health awareness and A surge in per-capita income also play an important role in contributing to the overall growth of the Greek yogurt market. However, Asia-Pacific is expected to exhibit significant growth in the future, owing to a rise in demand for different types flavored Greek yogurt such as butter and cheese consumed in fast food products. In addition, the region has witnessed considerable A surge in the number of millennials, who are the forefront consumers of fermented Greek yogurt. Key Benefits Market Dynamics Drivers Restraint Opportunity Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/8r6hui", "role": "user" }, { "content": "Global Greek Yogurt Market to 2027 - by Type, Flavor, Distribution Channel and Source - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, April 29, 2020 /PRNewswire/ --Today, award-winning marketing shop, Cashmere, announced a new division, NiceSweater- a cross-functional practice which focuses on creating brand-driven, digital experiences rooted in culture via social platforms and remote conferencing technology. Nice Sweater connects audiences with impactful content & talent, virtual gatherings, and- most importantly- each other globally. As a social-first agency, Cashmere has always been the go-to solution for brands and entertainment entities to reach consumers through impactful digital campaigns that range from social good, product launches and political initiatives. As the digital world and consumer habits rapidly change, Nice Sweater will utilize their domain expertise in emerging technology platforms, including Zoom, TikTok, Twitch, YouTube Live, Instagram Live and Facebook Live and more to connect artists, brands, entertainment, social good and nonprofit entities through livestreams, gaming, virtual conferences and more. With a renewed focus in social experiences, Nice Sweater will consist of a curated team of specialized experts offering a full spectrum of services, including: in-house remote production, strategy, creative, social, influencer and PR to execute culturally relevant 360 solutions to clients. More than ever, Millennials, Gen Z and beyond, are intentionally seeking content, brands and products that are aligned with their personal ideologies and spending more time discovering new digital landscapes. Digging deeper into the makeup of consumers, especially during this unprecedented time, multicultural consumers are consuming content more than any other demographic and specifically with an increased interest in multicultural content, according to a recent Nielsen report. There has also been an increased uptick in digital consumption across all platforms in Q1 of 2020, specifically rooted in cultural content. Currently 40% of Gen Z spends 5+ hours of their work week consuming video content from YouTube, TikTok , and other social networks with more than 20% saying they spend 10+ hours a week consuming content, while 70% of Millennials watched YouTube to learn how to do something new or learn about something they are interested in. \"We have always been a culture and social first Agency, it's in our DNA,\" said Ted Chung, Chairman, Cashmere Agency. \"More than ever, we are seeing communities being built from a search for meaning and the desire to find grounding in more intentional content consumption. The Nice Sweater executive team brings specific expertise and a passion for concepts with global reach, production technology, and data analysis to fulfill a new demand for virtual experiences that are expected by a rapidly evolving audience.\" The Nice Sweater division officially launches with supporting DoorDash in a virtual dinner series that has led to millions of meals to those in need, an upcoming virtual event hosted by Jack in the Box, partnering Snoop Dogg with live DJ experience for Levi's, and also recently produced a digital experience for Brown & Black Forums of America, in conjunction with VICE Media. For over a decade, Cashmere has created award-winning campaigns for brands, including Google, Jack in the Box, BMW, Levi's, FX, Universal, Disney+, Hulu, Freeform, Netflix, AppleTV and more. ABOUT NICE SWEATERLaunched officially in 2020, Nice Sweater is a cross-functional practice which focuses on creating brand-driven, digital experiences rooted in culture via social platforms and remote conferencing technology. Nice Sweater connects audiences with impactful content & talent, virtual gatherings, and- most importantly- each other globally. As the digital world and consumer habits rapidly change, through this new division, Nice Sweater will utilize their domain expertise in emerging technology platforms, including Zoom, TikTok, Twitch, YouTube Live, Instagram Live and Facebook Live and more to connect artists, brands, entertainment, social good and non-profit entities through livestreams, gaming, virtual conferences and more. With a renewed focus in social experiences, Nice Sweater will consist of a curated team of specialized experts offering a full spectrum of services, including: in-house remote production, strategy, creative, social, influencer and PR to execute culturally relevant 360 solutions to clients. Nice Sweater is a division of award-winning marketing agency, Cashmere. ABOUT CASHMERECashmere is an award-winning shop and is a lifestyle-marketing company comprised of a diverse collective of minds from the worlds of entertainment, advertising, and new media. Cashmere specializes in identifying trends to create and execute campaigns that resonate in and drive culture. Cashmere utilizes social media, creative strategy, digital trends, experiential, influencer and public relations strategies to provide full-service support for campaigns and brands. Cashmere's diverse client roster includes top brands and entertainment companies, including: BMW of North America, Jack in the Box, DoorDash, Facebook, Amazon, Quibi, AppleTV+, adidas, Netflix, Universal Pictures and more. Cashmere has been recognized as a leading force within the Creative Industry and has been the recipient of multiple awards; including 2019 Cannes Lions Creative Award, The Clio Awards, AdColor, A100 and named AdAge's Multicultural 2019 Agency of the Year and recognized in AdAge's 2020 A-List Agencies To Watch list. For more information about Cashmere, please visit www.cashmereagency.com or follow us on Instagram, Twitter, Facebook or LinkedIn @cashmereagency Contact: Brianne Pins Cashmere AgencyVP, Public Relations 323-252-3633 [emailprotected] Camila Crews Cashmere Agency 646-500-9028 [emailprotected] SOURCE Cashmere Agency Related Links http://www.cashmereagency.com", "role": "user" }, { "content": "Cashmere Launches New Digital Experiential Division, Nice Sweater Award-Winning Multicultural Agency Launches New Practice To More Deeply Connect Brands and Entertainment Entities With Data-Driven Experiences", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Aug. 26, 2020 /PRNewswire/ -- Recognizing the unprecedented amount of uncertainty high school students and their families are facing, myKlovr has announced a strategic partnership with NSHSS, the National Society of High School Scholars. MyKlovr's college and career counseling platform is personalized for each student and available completely online. From 9th grade on, myKlovr helps parents and students throughout the entire process of applying to, financing, and being admitted to their best-fit college. \"Students don't have to put their college dreams on hold, from virtual volunteering, college tours, and tutoring, myKlovr has everything a student needs to build a successful future,\" said Jamie Finch, myKlovr's Director of Business Development and Strategic Partnerships. \"I am thrilled that the myKlovr platform will assist NSHSS members and their families who are struggling to navigate the college admissions process.\" \"We heard from NSHSS members that they needed to start prepping for college and career early, but we didn't have a platform to facilitate the kind of detailed planning that they were looking for. We know discounted access to myKlovr will provide that extra bit of breathing space to NSHSS members as they navigate uncertainties and prepare for their next big step in life.Working with myKlovr affords NSHSS higher potential in multiple areas of service to our students. myKlovr not only compliments the core offerings of NSHSS membership, but further underscores our mission of lifetime membership with lasting resources.\" Carly Bryeans, Partnerships Development Manager, NSHSS About myKlovrSimply and affordably, myKlovr puts a dedicated counselor into every student's pocket. Through the power of predictive analytics, it helps each student navigate their journey to success learning about student strengths and preferences, offering timely reminders and suggestions, tapping into a wealth of data and resources to help transform a blur of options into a \"best-fit\" scenario to materially increase their chances of realizing college and career aspirations.www.myklovr.com AboutNSHSS Since 2002, the National Society of High School Scholars (NSHSS) has been supporting young academics on their journey to college and beyond as they prepare to become the leaders of tomorrow. Co-founded by the great-nephew of Alfred Nobel, NSHSS is inspired by the mission of the Nobel Prize to support academic achievement and world betterment. NSHSS pursues this mission by connecting members with scholarships, college fairs, internships, career and leadership opportunities, partner discounts, and more.https://www.nshss.org/ SOURCE myKlovr Related Links http://www.myklovr.com", "role": "user" }, { "content": "Virtual College Counseling Platform, myKlovr, Announces Partnership with International Academic Honor Society", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the Company) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 23 September 2020 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Company (the Board of Directors) of the applicable net asset value (the NAV) in respect of each Sub-Fund for the below stated Dealing Day: Sub-Fund ISIN Outstanding Shares Currency Dealing Day NAV LEI Xtrackers (IE) plc ESG USD Corporate Bond UCITS ETF 1C IE00BL58LJ19 632,390 USD 23-Sep-2020 45.7534 254900YQ6CUXP95AXP64 Xtrackers (IE) plc FTSE All-World ex UK UCITS ETF 1C IE00BM67HJ62 543,392 GBP 23-Sep-2020 64.0656 549300Z2SIL2X411X235 Xtrackers (IE) plc iBoxx USD Corporate Bond Yield Plus UCITS ETF 1D IE00BF8J5974 7,686,744 USD 23-Sep-2020 20.0779 549300QIFH7Y0VUSB550 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 1D IE00BPVLQD13 13,265,459 JPY 23-Sep-2020 1534.8146 549300DIT7F25Z1MYN06 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 2D - GBP Hedged IE00BPVLQF37 792,829 GBP 23-Sep-2020 14.81 549300DIT7F25Z1MYN06 Xtrackers (IE) plc JPX-Nikkei 400 UCITS ETF 4C - USD Hedged IE00BTGD1B38 624,281 USD 23-Sep-2020 17.2624 549300DIT7F25Z1MYN06 Xtrackers (IE) plc MSCI AC World UCITS ETF 1C IE00BGHQ0G80 18,350,000 EUR 23-Sep-2020 22.0465 549300T1PSHCUYSNHE68 Xtrackers (IE) plc MSCI Emerging Markets ESG UCITS ETF 1C IE00BG370F43 10,700,000 USD 23-Sep-2020 51.1496 54930068DSSGNFYYVR85 Xtrackers (IE) plc MSCI Emerging Markets UCITS ETF 1C IE00BTJRMP35 58,948,000 USD 23-Sep-2020 51.4984 5493002C2LG0TVRY4T35 Xtrackers (IE) plc MSCI Europe ESG UCITS ETF 1C IE00BFMNHK08 3,630,000 EUR 23-Sep-2020 20.0062 549300I5MYV9MCPQD952 Xtrackers (IE) plc MSCI GCC Select Swap UCITS ETF 1C IE00BQXKVQ19 1,252,621 USD 23-Sep-2020 16.9837 5493003PO25H4G3SSF64 Xtrackers (IE) plc MSCI Japan ESG UCITS ETF 1C IE00BG36TC12 37,380,000 USD 23-Sep-2020 19.5828 549300VT3CD217Z7Q476 Xtrackers (IE) plc MSCI Nordic UCITS ETF 1D IE00B9MRHC27 9,209,224 EUR 23-Sep-2020 37.0873 5493007KGDIVBDEQHM64 Xtrackers (IE) plc MSCI USA Banks UCITS ETF 1D IE00BDVPTJ63 23,925,000 USD 23-Sep-2020 13.8657 254900P9QIPJGCJR6N80 Xtrackers (IE) plc MSCI USA Consumer Discretionary UCITS ETF 1D IE00BGQYRR35 856,157 USD 23-Sep-2020 55.9895 549300E63DJSRCJZ6614 Xtrackers (IE) plc MSCI USA Consumer Staples UCITS ETF 1D IE00BGQYRQ28 5,800,000 USD 23-Sep-2020 34.265 54930096GV0MTBBDYV48 Xtrackers (IE) plc MSCI USA Energy UCITS ETF 1D IE00BCHWNS19 225,000 USD 23-Sep-2020 16.0009 5493008L9YO5GRO3ZN19 Xtrackers (IE) plc MSCI USA ESG UCITS ETF 1C IE00BFMNPS42 14,500,000 USD 23-Sep-2020 32.4381 549300GV7ND6DPBVN624 Xtrackers (IE) plc MSCI USA Financials UCITS ETF 1D IE00BCHWNT26 23,800,000 USD 23-Sep-2020 16.8658 549300M68RNPQMXLBB25 Xtrackers (IE) plc MSCI USA Health Care UCITS ETF 1D IE00BCHWNW54 18,011,246 USD 23-Sep-2020 41.4734 549300IH60G2OJH57P83 Xtrackers (IE) plc MSCI USA Information Technology UCITS ETF 1D IE00BGQYRS42 16,713,272 USD 23-Sep-2020 50.941 549300M6JAZI5LWML141 Xtrackers (IE) plc MSCI USA Minimum Volatility UCITS ETF 1D IE00BDB7J586 115,000 USD 23-Sep-2020 39.3866 5493000I1N60EFHBLR44 Xtrackers (IE) plc MSCI USA UCITS ETF 1C IE00BJ0KDR00 60,207,536 USD 23-Sep-2020 90.7042 549300J9YPZW8OQXLF38 Xtrackers (IE) plc MSCI World Communication Services UCITS ETF 1C IE00BM67HR47 14,435,797 USD 23-Sep-2020 14.9831 549300RZO14LB1V7K773 Xtrackers (IE) plc MSCI World Consumer Discretionary UCITS ETF 1C IE00BM67HP23 4,417,672 USD 23-Sep-2020 41.7813 549300OF256895TPBN07 Xtrackers (IE) plc MSCI World Consumer Staples UCITS ETF 1C IE00BM67HN09 7,501,417 USD 23-Sep-2020 37.9413 549300SWTOHJYCRTIU71 Xtrackers (IE) plc MSCI World Energy UCITS ETF 1C IE00BM67HM91 7,314,918 USD 23-Sep-2020 17.7243 549300PD0M2UW0Y2XV93 Xtrackers (IE) plc MSCI World ESG UCITS ETF 1C IE00BZ02LR44 26,550,000 USD 23-Sep-2020 24.5994 549300KBPMH7CRUHUW62 Xtrackers (IE) plc MSCI World Financials UCITS ETF 1C IE00BM67HL84 5,615,753 USD 23-Sep-2020 15.7907 54930037UOCTZSIPKX79 Xtrackers (IE) plc MSCI World Health Care UCITS ETF 1C IE00BM67HK77 20,475,527 USD 23-Sep-2020 39.3687 549300J9P50W4IOBWS91 Xtrackers (IE) plc MSCI World High Dividend Yield UCITS ETF 1D IE00BCHWNQ94 2,239,000 USD 23-Sep-2020 17.3293 5493000MMCBYY20QMC86 Xtrackers (IE) plc MSCI World Industrials UCITS ETF 1C IE00BM67HV82 10,522,073 USD 23-Sep-2020 37.1677 549300749B86R75HG635 Xtrackers (IE) plc MSCI World Information Technology UCITS ETF 1C IE00BM67HT60 31,483,748 USD 23-Sep-2020 44.0599 549300CM6KL5NIENK841 Xtrackers (IE) plc MSCI World Materials UCITS ETF 1C IE00BM67HS53 2,202,173 USD 23-Sep-2020 41.8358 5493001RFO47M71FEX43 Xtrackers (IE) plc MSCI World Minimum Volatility UCITS ETF 1C IE00BL25JN58 15,400,000 USD 23-Sep-2020 33.3495 54930014T94RHSFQFQ97 Xtrackers (IE) plc MSCI World Momentum UCITS ETF 1C IE00BL25JP72 6,525,000 USD 23-Sep-2020 42.9931 549300JTUIN0HTFEH791 Xtrackers (IE) plc MSCI World Quality UCITS ETF 1C IE00BL25JL35 7,800,000 USD 23-Sep-2020 41.7817 549300IILXM4ST526335 Xtrackers (IE) plc MSCI World UCITS ETF 1C IE00BJ0KDQ92 72,656,407 USD 23-Sep-2020 68.4502 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World UCITS ETF 1D IE00BK1PV551 15,675,440 USD 23-Sep-2020 62.1123 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World UCITS ETF 2D - GBP Hedged IE00BZ1BS790 3,803,992 GBP 23-Sep-2020 14.8647 549300ZPCMJ0UKSMRS71 Xtrackers (IE) plc MSCI World Utilities UCITS ETF 1C IE00BM67HQ30 2,258,433 USD 23-Sep-2020 26.6277 5493005SK6V4E5KRXN82 Xtrackers (IE) plc MSCI World Value UCITS ETF 1C IE00BL25JM42 8,425,000 USD 23-Sep-2020 27.2473 5493003ZC4YBJJRSAX18 Xtrackers (IE) plc Russell 2000 UCITS ETF 1C IE00BJZ2DD79 4,476,157 USD 23-Sep-2020 204.6236 549300RDZXTM5DJWDC22 Xtrackers (IE) plc Russell Midcap UCITS ETF 1C IE00BJZ2DC62 3,765,808 USD 23-Sep-2020 25.1269 5493001R2VWIV9D4XH46 Xtrackers (IE) plc S&P 500 Equal Weight UCITS ETF 1C IE00BLNMYC90 11,393,226 USD 23-Sep-2020 54.0412 549300K5EREWUG10PC82 Xtrackers (IE) plc S&P 500 UCITS ETF 2C - GBP Hedged IE00BM67HX07 5,177,619 GBP 23-Sep-2020 53.5179 549300NZCAJCKZWK5644 Xtrackers (IE) plc S&P Europe ex UK UCITS ETF 1D IE00BGV5VM45 10,640,000 EUR 23-Sep-2020 50.7839 254900AV94BB0XCLC120 Xtrackers (IE) plc US Treasuries Ultrashort Bond UCITS ETF 1C IE00BM97MR69 93,371 USD 23-Sep-2020 53.5546 254900OSQHTSXUWQKZ28 Xtrackers (IE) plc USD Corporate Bond UCITS ETF 1D IE00BZ036H21 62,447,593 USD 23-Sep-2020 16.6175 549300TN3252QWI8QN78 Xtrackers (IE) plc USD Emerging Markets Bond Quality Weighted UCITS ETF 1D IE00BD4DX952 5,465,406 USD 23-Sep-2020 13.4431 549300BQBF21JCBVKV46 Xtrackers (IE) plc USD High Yield Corporate Bond UCITS ETF 1D IE00BDR5HM97 24,121,303 USD 23-Sep-2020 14.4487 549300XH6DDPBRY7P527 This announcement is for information purposes only. Shareholders are not required to take any action. Capitalised terms used in this notice shall have the same meaning ascribed to them in the latest version of the prospectus of the Company (the Prospectus) unless the context otherwise requires. Any further information in relation to the Sub-Funds may be obtained by contacting the x-trackers ETF hotline on +44 (20) 7547 1747 or +49 (69) 910 30549 or by sending an email to [email protected]. Xtrackers (IE) plc Board of directors Contact information Xtrackers (IE) plc 78 Sir John Rogerson's Quay Dublin 2 Registered in Dublin as an open-ended variable capital umbrella investment company with limited liability and as an umbrella fund with segregated liability between sub-funds. Regulated by the Central Bank of Ireland. Registration Number 393802. Registered Office as above. Directors: Tom Murray (Irish), Michael Whelan (Irish), Alex McKenna (UK), Gerry Grimes (Irish), Manooj Mistry (UK)", "role": "user" }, { "content": "Net Asset Value(s)", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WASHINGTON, March 20, 2020 /PRNewswire/ -- Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry's commitmentto finding solutions to prevent, diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus. The decades-long investments biopharmaceutical companies have made in new technologies, research and treatments have prepared the industry to act swiftly to respond to the public health crisis. America's biopharmaceutical companies are working around the clock to: Work with government agencies and diagnostic partners to increase COVID-19 testing capability and capacity. Screen vast global libraries of medicines to identify potential treatments and have numerous clinical trials underway to test existing therapies. Research and develop new therapies and treatments for those infected with the virus. Use investments in new technologies to speed the development of safe and effective vaccines. \"I'm confident our industry will achieve its shared goal to beat coronavirus, and our commitment underscores how we are uniquely positioned to do so,\" said Stephen J. Ubl, president and chief executive officer of PhRMA. \"We have deep scientific knowledge gained from decades of experience with similar viruses; the industry has invested billions in technologies that have dramatically shortened the time it takes to decode viruses and develop a potential vaccine; and our companies alone have the ability to manufacture and broadly disseminate vaccines or treatments.\" \"Researchers at America's biopharmaceutical companies are working around the clock to contain the spread of the novel coronavirus and deliver treatments to those impacted by this deadly disease,\" said Jim Greenwood, president and CEO of BIO. \"Today, we renew our commitment as an industry to help those in need, protect our workforce and ensure any treatments we develop in response to this pandemic are accessible and affordable for everyone. These are the principles that always guide our industry, and they serve as the foundation for our response to this global health crisis.\" America's biopharmaceutical companies are working in close collaboration with government agencies and other stakeholders in the quest to beat coronavirus. Everyone has a unique role to play and we are confident that together we can succeed. View the industry's print ad about our commitment to beat coronavirus here. View the industry's commitment to beat coronavirus here. Learn more at PhRMA.org/coronavirusand bio.org/coronavirus. About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $900 billion in the search for new treatments and cures, including an estimated $79.6 billion in 2018 alone. About BIO BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces theBIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. SOURCE Pharmaceutical Research and Manufacturers of America (PhRMA) Related Links https://phrma.org", "role": "user" }, { "content": "America's Biopharmaceutical Companies Working Around the Clock to Beat Coronavirus Companies are Coming Together to Achieve Shared Goal of Eradicating the Virus", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PARIS--(BUSINESS WIRE)--Regulatory News: Mediawan Alliance (BidCo Breteuil)1 welcomes the outcome of the public tender offer (the Offer) for Mediawans (Paris:MDW) shares and warrants published today by the Autorit des marchs financiers (AMF). 18,948,814 shares and 17,561,514 warrants of Mediawan were tendered to the Offer initiated by a consortium formed by Mediawan Founders, MACSF, Bpifrance and KKR through Mediawan Alliance (BidCo Breteuil)1 on all Mediawan securities not held by Mediawan Founders and MACSF. Upon completion of the initial Offer period, which lasted from July 30, 2020 to October 5, 2020, Mediawan Alliance (BidCo Breteuil)1 will own2 86.24% of shares and 82.29% of warrants of Mediawan, amounting to 85.23% of Mediawans share capital on a fully diluted basis. The notice of the result of the Offer released today is available on the website of the AMF (www.amf-france.org). Pierre-Antoine Capton, Chairman of the Board of Mediawan and Chairman of Mediawan Alliance declared: Xavier Niel, Matthieu Pigasse and I are pleased of the success of the tender offer which enables us to keep control over Mediawan Group and anchor its footprint in France, with the support of our partners. Simultaneously to the ongoing acquisition of Lagardre Studios, this transaction enables us to generate synergies with Groupe Troisime Oeil and cooperation projects with Leonine, a leading German independent content company, and to support Mediawans development ambition across Europe and globally. Reopening of the Offer Pursuant to article 232-4 of the AMFs General Regulations, the Offer will be reopened from October 9 to October 22, 2020 (inclusive), at the same prices, i.e. 12 per share and 0.65 per warrant, to enable shareholders who have not yet done so to tender their securities to the Offer. Terms of the Offer are identical to the ones set forth in the Offer document as approved by the AMF on July 28, 2020 under visa no. 20-372. The initiator will reserve the right to undertake a squeeze out on shares and warrants not tendered if the applicable conditions are satisfied following the completion of the Offer. Availability of documents relating to the Offer BidCo Breteuil's Offer document and Mediawan's response document, as approved by the AMF on July 28, 2020, under visa no. 20-372 and visa no. 20-373 respectively, as well as documents relating notably to legal, financial and accounting information of each company, filed with the AMF on July 28, 2020, and published on July 29, 2020 , are available on the websites of the AMF (www.amf-france.org) and Mediawan (www.mediawan.com). Mediawans shareholders and warrant holders who wish to obtain more information on the terms and conditions of the Offer may visit the section dedicated to the Offer on Mediawan's website (https://www.mediawan.com/en/our-investors#public-offer). Disclaimer: This press release is not an offer to purchase securities. This press release was prepared for informational purpose only. It is not an offer to the public. The diffusion of this press release, the Offer and its acceptance may be subject to specific regulations or restrictions in certain countries. The Offer is not made for persons subject to such restrictions, neither directly nor indirectly, and may not be accepted in any way from a country where the Offer would be subject to such restrictions. This press release is not for diffusion in these countries. Consequently, persons in possession of this press release shall inquire about potential applicable local restrictions and comply with them. Mediawan and Mediawan Alliance (BidCo Breteuil) exclude all liability in the event of any breach of the applicable legal restrictions by any person 1 Temporary name 2 Taking into account the securities that will be contributed by the founders and MACSF", "role": "user" }, { "content": "Success of the Tender Offer Initiated by Mediawan Alliance (BidCo Breteuil)1 On Mediawan", "role": "assistant" } ]